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Human rhinoviruses (HRV) are extremely common human respiratory pathogens, most 
commonly associated with mild upper respiratory tract infections.  The three known 
species of HRV (HRV-A, -B and –C) are members of the family Picornaviridae and 
genus Enterovirus.  In contrast to the enterovirus (EV-A-D) species that commonly infect 
the gut, HRV are generally thought to be acid labile with replication restricted to the 
respiratory tract.     
Investigations of the clinical correlations of HRV infections detected on diagnostic 
screening of respiratory specimens demonstrated no specific association between HRV 
variant and clinical presentation.  For example, similar species distributions were observed 
in patients admitted to the ITU and those discharged with minor illness.   Unexpectedly, 
screening of stool specimens for HRV showed a prevalence of 10% with viral loads 
similar to EV infections.   These findings suggested that a reappraisal of HRV tropism and 
disease associations may be warranted.  
HRV-A and -B isolates were originally classified into 100 serotypes by serological 
neutralisation properties. As HRV-C is difficult to isolate, no attempt had been previously 
made to classify the wealth of available HRV-C sequences.  To facilitate definition of 
novel HRV types and classification of HRV-C, a system was devised to divide HRV 
sequences into genotypically defined types.  Pairwise VP1 nucleotide p-distance analysis 
revealed distinct thresholds between inter- and intra- type divergence and available 
sequences were classified into 77 HRV-A, 29 -B and 51 -C types.  This provides a 
standardised basis for type definition and identification, allowing consistency in studies of 
genetic diversity, epidemiology and evolution.  It has been adopted by the ICTV 




Although the occurrence of recombination has been documented within the coding region 
of EV, analysis of dated HRV sequences revealed an overall lack of intra-species 
recombination between three coding regions of HRV-B and -C.  In contrast, full HRV-A 
type groups appeared to have been subject to a large number of recombination events, 
suggesting extensive recombination during the period of its diversification into types.  
Putative recombination breakpoints localised to the non-structural region.  Within HRV-A 
and HRV-B, recombination within the 5ˈUTR was infrequent.  However, over 60% of 
analysed HRV-C strains grouped within the HRV-A clade and two recombination 
hotspots were identified.  An additional interspecies recombination event was detected 
between HRV-A/C in the 2A coding region, with putative breakpoints mapping to the 
boundaries of the C-terminal domain of the proteinase.   
The studies within this thesis provide evidence for a broadened understanding of the 
clinical significance of HRV.  In addition, the assignment of HRV sequences into 
genotypically defined types allowed description of the observed genetic diversity and 
completion of analysis which reaffirmed the sporadic nature of recombination within the 





Declaration of Originality 
I declare that the work recorded within this thesis was completed entirely by myself 
at the Centre for Infectious Diseases and Roslin Institute of the University of 
Edinburgh between September 2009 and March 2013.  In cases where others have 
made a contribution to the results obtained, this is clearly stated within the text.  This 
work has not been submitted for any other degree or professional qualification.  In 
cases where portions of the work contained within this thesis have been published in 
academic journals, this is indicated within the text and copies of papers are given as 
appendices.  Where required by license agreement, permission to include published 













A hundred people have contributed in a thousand unique ways to the completion of this PhD 
and there is not enough paper in the world to thank them all as much as they deserve. 
For my supervisor, Professor Peter Simmonds.  Thank you for giving this opportunity to a 
young surgical trainee with little experience.  Your unending patience, enthusiasm and 
dedication over the last 4 years has taken me from a clueless newcomer to a fledgling 
scientist able and willing to think for herself.  I cannot thank you enough.      
For the others who have been involved in my academic and scientific growth, a special 
thanks.  For Professor Paul Sharp who has always been available for advice and support.  For 
Dr Heli Harvala, whose infectious enthusiasm and incredible passion for virology has 
widened the horizons of my interest and experience far beyond what I initially imagined.  
For Dr Carol McWilliam-Leitch who took me from having never held a pipette to 
confidently designing my own PCR protocols far faster than I ever thought possible.  For all 
the PhD students and post-docs in our lab past and present; Elly, Ingrid, Sinead, Nora, Nigel, 
Jereon, Donald, Jill, Colin, Inga, Nicky, Richard and Carol.  Not only have you all been at 
various times an indispensible source of wisdom, but you have brightened my days and 
almost never been too busy to meet for a beer and a giggle after hours.  To the students 
whose projects I have been fortunate enough to be involved in, thank you for allowing me to 
learn how to teach and keeping me smiling with your enthusiasm and humour.   
For my wonderful parents who have been unfailingly loving and supportive and never 
questioned my decision to follow my passion.  Without you, none of this would have ever 
been possible.  You have always made me feel like a star!  I cannot thank you enough.   
For my best friend, life-partner, handyman, life-coach, chef, therapist, IT-support, removal 
man, musical hero, brew-master and most of all, amazing husband; Kevin.  Thank you for 
being so endlessly, uncomplainingly, beautifully patient with me; with my long working 
hours, tiredness, frustration and endless, obsessive fixation on minute details.  Your love and 
support has been the cornerstone of everything I’ve done.  And most of all, to our little bun 
in the oven.  I hope that someday you will read this and smile.   




List of Original Publications 
Original publications directly associated with this thesis 
McIntyre CL, McWilliam Leitch EC, Savolainen-Kopra C, Hovi T, Simmonds 
P. 2010. Analysis of genetic diversity and sites of recombination in human 
rhinovirus species C. J Virol 84:10297–310. 
McIntyre CL, Savolainen-Kopra C, Hovi T, Simmonds P. 2013. Recombination 
in the evolution of human rhinovirus genomes. Arch Virol.  [Epub ahead of print] 
Simmonds P, McIntyre CL, Savolainen-Kopra C, Tapparel C, Mackay IM, 
Hovi T. 2010. Proposals for the classification of human rhinovirus species C into 
genotypically assigned types. J Gen Virol 91:2409–19. 
Harvala H, McIntyre CL, McLeish NJ, Kondracka J, Palmer J, Molyneaux P, 
Gunson R, Bennett S, Templeton K, Simmonds P. 2012. High detection frequency 
and viral loads of human rhinovirus species A to C in fecal samples; diagnostic and 
clinical implications. J Med Virol 84:536–42. 
McIntyre CL, Knowles NJ, Simmonds P. 2013. Proposals for the classification of 
human rhinovirus species A, B and C (HRV-A, -B and –C) into genotypically 
assigned types.  Submitted.   
 
Original publications to which the author has otherwise contributed 
Gaunt ER, Harvala H, McIntyre CL, Templeton KE, Simmonds P. 2011. 
Disease burden of the most commonly detected respiratory viruses in hospitalized 
patients calculated using the disability adjusted life year (DALY) model. J Clin 
Virol. 52(3):215-21 
McLeish NJ, Witteveldt J, Clasper L, McIntyre CL, McWilliam Leitch EC, 
Hardie A, Bennett S, Gunson R, Carman WF, Feeney SA, Coyle PV, Vipond B, 
Muir P, Benschop K, Wolthers K, Waris M, Osterback R, Johannessen I, 
Templeton K, Harvala H, Simmonds P. 2012. Development and assay of RNA 
transcripts of enterovirus species A to D, rhinovirus species A to C, and human 
parechovirus: assessment of assay sensitivity and specificity of real-time screening 
and typing methods. J Clin Micro 50:2910–7. 
List of Original Publications 
vi 
 
Harvala H, Gaunt E, McIntyre CL, Roddie H, Labonte S, Curran E, Othieno R, 
Simmonds P, Bremner J. 2012. Epidemiology and clinical characteristics of 
parainfluenza virus 3 outbreak in a Haemato-oncology unit. J Infect. 65(3):246-54 
Harvala H, McIntyre CL, Imai N, Clasper L, Djoko CF, LeBreton M, 
Vermeulen M, Saville A, Mutapi F, Tamoufé U, Kiyang J, Biblia TG, Midzi N, 
Mduluza T, Pépin J, Njouom R, Smura T, Fair JN, Wolfe ND, Roivainen M, 
Simmonds P. 2012. High seroprevalence of enterovirus infections in apes and old 
world monkeys. Emerg Infect Dis 18(2):283–6.  
Harvala H, Mcleish N, Kondracka J, Mcintyre CL, Leitch ECM, Templeton K, 
Simmonds P. 2011. Comparison of Human Parechovirus and Enterovirus Detection 
Frequencies in Cerebrospinal Fluid Samples Collected Over a 5-Year Period in 
Edinburgh : HPeV Type 3 Identified as the Most Common Picornavirus Type. J Clin 





AdV   adenovirus 
A&E   Accident and Emergency department 
AICc   small sample Akaike information criterion 
AOM   acute otitis media 
Arg   arginine 
ATCC   American Tissue Culture Collection 
BEAST  Bayesian Evolutionary Analysis of Sampling Trees 
BEAUti  Bayesian Evolutionary Analysis Utility 
BLAST  Basic Local Alignment Search Tool 
BRAV   Bovine rhinitis A virus 
BRBV   Bovine rhinitis B virus 
CAV   Coxsackie A virus 
CBV   Coxsackie B virus 
cDNA   complementary deoxyribonucleic acid 
CFLI    cold and flu-like illness 
CHI   community health index 
CNS    central nervous system 
cre   cis-acting replication element  
CSF   cerebrospinal fluid 
Cys   cysteine 
CT   cycle threshold for real-time PCR 
DAF   decay accelerating factor 
DDBJ   DNA Databank of Japan 
DNA   deoxyribonucleic acid 
dNTP   deoxynucleotide triphosphates 
dsRNA  double stranded ribonucleic acid 
EDTA   ethylenediaminetetraacetic acid 
EMBL   European Molecular Biology Laboratory 
EMCV   encephalomyocarditis virus 
ERAV   equine rhinitis A virus 
ERBV   equine rhinitis B virus 




FluA   influenza A virus 
FluB   influenza B virus 
FMDV   foot and mouth disease virus 
GARD   genetic algorithm for recombination detection 
GP    general practitioner  
HAV   hepatitis A virus 
HCoV   human coronavirus 
HCV   hepatitis C virus 
HDU    High Dependency Unit 
HIV   human immunodeficiency virus 
HKY   Hasegawa-Kishino-Yano model of nucleotide substitution 
HPA    Health Protection Agency 
HMPV   human metapneumovirus 
HRV    human rhinovirus 
HSV   herpes simplex virus 
ICAM-1  intercellular adhesion molecule 1 
ICTV   International Committee on the Taxonomy of Viruses 
IFA   immunofluorescence 
indels   insertions and deletions in nucleotide sequences 
IRES   internal ribosomal entry site 
ITU    Intensive Care/Therapy Unit 
kB   kilobase 
L   leader protein 
LDL   low density lipoprotein 
LRTI   lower respiratory tract infection 
MAU   Medical Assessment Unit 
MCL   maximum composite likelihood 
MCMC  Markov Chain Monte Carlo 
MEGA  Molecular Evolutionary Genetics Analysis 
NCBI   National Center for Biotechnology Information 
NJ   neighbour joining 
NPEV    non polio enterovirus 
nt   nucleotide   
OTU   operational taxonomic unit 




PBS   phosphate buffered saline  
PCR    polymerase chain reaction 
PIM2   Paediatric Index of Mortality score  
PIV   parainfluenza virus 
PPT   polypyrimidine tract 
PV    poliovirus 
RDP    Recombination detection program 
RF   recombinant form 
RHSC    Royal Hospital for Sick Children (Edinburgh) 
RIE   Royal Infirmary of Edinburgh 
RNA    ribonucleic acid 
RT   reverse transcription 
RT-PCR   reverse transcription polymerase chain reaction 
SBP   Single breakpoint recombination detection 
SGPB   Streptomyces griseus proteinase B 
SVC    Scottish Virology Centre 
TAE   tris-acetate EDTA 
Tm   melting temperature 
UTR    untranslated region 
URTI   upper respiratory tract infection 
UV   ultraviolet 
VPg   viral protein genome linked 
VZV   varicella zoster virus 





List of Figures 
FIGURE 1.1 Neighbour joining phylogenetic tree depicting relationships 
between species within the Enterovirus genus…………….. ..7 
FIGURE 1.2 Neighbour joining phylogenetic tree showing the prototype 
strains of HRV-A and corresponding biological properties...12 
FIGURE 1.3 The structure of human rhinovirus virions…………………..13 
FIGURE 1.4 Sequence of cleavages during proteolytic processing of the 
translated genome of enteroviruses………………………….16 
FIGURE 1.5 RNA secondary structure of picornavirus IRES elements…..18 
FIGURE 1.6 Summary of the picornavirus life cycle……………………..20   
FIGURE 2.1 “One way” laboratory system for the prevention of carryover 
contamination in PCR reactions……………………………..37 
FIGURE 3.1 Total number of respiratory samples referred to the SVC for 
virological testing per month from Oct 05 to May 11………68 
FIGURE 3.2 Epidemiological analysis of HRV infections in patients from 
September 2008 – May 2009………………………………..72 
FIGURE 3.3 HRV species isolated from distinct patient groups………… 74 
FIGURE 3.4 Neighbour joining phylogenetic trees of the VP4/VP2 region 
of HRV-A, HRV-B and HRV-C…………………………....78 
FIGURE 3.5 Neighbour joining phylogenetic tree showing the VP4/VP2 
region of HRV positive samples from respiratory specimens 
and stool specimens…………………………………………82   
FIGURE 4.1 Distributions of pairwise nucleotide p-distances for the VP1 
region of all three species of HRV…………………………100  
FIGURE 4.2   Distribution of pairwise nucleotide p-distances for the VP1 
region of all HRV sequences………………………………101     
FIGURE 4.3 Phylogenetic trees showing the VP1 region of HRV-A, -B and 
–C…………………………………………………………..102 
FIGURE 4.4 Neighbour joining phylogenetic trees showing classical HRV 
serotype pairs which do not conform to the proposed VP1 
divergence thresholds…………………………………….  108 
List of Figures 
xi 
 
FIGURE 4.5 Frequency histogram showing the distribution of HRV-A VP1 
pairwise p-distances immediately surrounding the threshold of 
13% ………………………………………………………..110 
FIGURE 4.6 Neighbour joining phylogenetic trees showing the VP4/VP2 
region of all three species of HRV…………………………124 
FIGURE 4.7 Distributions of pairwise nucleotide p-distances for the 
VP4/VP2 region of all three species of HRV……………   126 
FIGURE 4.8 Total number of identified HRV strains divided by 
geographical location of isolation………………………….132 
FIGURE 5.1 Neighbour joining phylogenetic trees of study sequences and 
corresponding regions from published complete genome 
sequences from the VP4/VP2, VP1 and 3Dpol regions of 
HRV-C……………………………………………………  147 
FIGURE 5.2 Comparison of phylogenies obtains from analysis of the 5ˈ and 
3ˈ ends of 3Dpol of HRV-C sequences…………………….149 
FIGURE 5.3 Neighbour joining phylogenetic trees showing the partial 
5ˈUTR and VP4/VP2 regions……………………………   151 
FIGURE 5.4 Neighbour joining phylogenetic tree showing the 5ˈUTR 
region of all HRV-C full genomes…………………………152 
FIGURE 5.5 Recombination breakpoints for three representative HRV-Ca 
sequences…………………………………………………..154 
FIGURE 5.6 Sequence variability scan of the 5ˈUTR showing mean HRV-
A, -B and –Cc intertype distances and interspecies distance of 
HRV-A/Cc…………………………………………………156 
FIGURE 5.7 GroupScan analysis of the extreme 5ˈ end of the HRV-C 
genome……………………………………………………..157 
FIGURE 5.8 Mean pairwise (uncorrected) p-distances of nucleotide (A) and 
amino acid (B) sequences in the VP4/VP2, VP1 and 3Dpol 
regions of all three HRV species…………………………  158 
FIGURE 5.9 Sequence divergence scans showing mean nucleotide and 
amino acid divergences within complete genome sequences of 
HRV-C and between HRV-C and HRV-A/-B…………….159 
 
List of Figures 
xii 
 
FIGURE 5.10 Neighbour joining phylogenetic trees showing the putative 
recombinant portion (3267 – 3525) of the 2A coding region as 
compared with 5ˈ (3006 – 3266) and 3ˈ (3526 – 3786) flanking 
regions……………………………………………………...161 
FIGURE 5.11 Neighbour joining phylogenetic trees showing the 5ˈUTR and 
recombinant 2A regions of HRV-C sequences…………….163 
FIGURE 5.12 Sequence alignment of the 2A region of selected HRV-A, -B 
and –C sequences…………………………………………. 164 
FIGURE 5.13 Pairwise nucleotide and amino acid p-distances for the 2A 
coding region of HRV-A, HRV-C and HRV-A/-C………. 171 
FIGURE 6.1 Neighbour joining phylogenetic trees showing the VP4/VP2 
and VP1 region of HRV-A, -B and –C…………………….182 
FIGURE 6.2 Likelihood mapping analysis of the VP4/VP2, VP1 and 3Dpol 
regions of HRV-A, -B and –C……………………………..184 
FIGURE 6.3 Mean substitution rates and 95% highest posterior density 
intervals for two coding regions of HRV-A and HRV-C….185 
FIGURE 6.4 Comparison of pairwise nucleotide p-distances between the 
VP1 and 3Dpol regions of HRV-A, -B and –C……………187 
FIGURE 6.5 Neighbour joining phylogenetic trees showing the VP1 and 
partial 3Dpol regions of all available HRV-A strains……...189 
FIGURE 6.6 Neighbour joining phylogenetic trees showing distinct patterns 
of recombination observed in HRV-A sequences………….194 
FIGURE 6.7 Neighbour joining phylogenetic trees showing the P1, P2 and 
P3 regions of HRV-A sequences…………………………  196 
FIGURE 6.8 Comparison of pairwise nucleotide p-distances between the 
P1/P2 and P2/P3 regions of HRV-A……………………….200 
FIGURE 6.9 Neighbour joining phylogenetic trees of HRV-B (A) and 
HRV-C (B) VP1 and partial 3Dpol sequences…………….202 
FIGURE 6.10 Neighbour joining phylogenetic trees showing the P1, P2 and 
P3 regions of HRV-B sequences…………………………...203 
FIGURE 6.11 A:  GroupScan of two representative recombinant HRV-A 
types.  B:  Calculated coding region recombination 
breakpoints for all HRV-A recombinant types mapped onto a 
diagram of the HRV-A full genome……………………….205 
List of Figures 
xiii 
 
FIGURE 6.12 Neighbour joining phylogenetic trees constructed for the 
5ˈUTR and VP4 regions of HRV-A and HRV-B 





List of Tables 
TABLE 1.1 Members of the family Picornaviridae and their natural 
hosts…………………………………………………………..4 
TABLE 1.2 Cell surface receptors used by selected picornavirus 
genera......................................................................................21 
  
TABLE 2.1  Reagents included in reverse transcription reactions………..39 
TABLE 2.2 Codes for individual nucleotides and ambiguous bases used 
for design of PCR primers…………………………………..41 
TABLE 2.3 Reagents used in PCR reactions…………………………….42 
TABLE 2.4 Cycling conditions used in PCR reactions………………….42 
TABLE 2.5 Modifications to standard PCR protocols used for individual 
PCR reactions……………………………………………….43 
TABLE 2.6 Reagents used in Superscript III RT-PCR 
reactions……………………………………………………..45 
TABLE 2.7 Cycling conditions used in Superscript III RT-PCR 
reactions……………………………………………………..45 
TABLE 2.8 Reagents used in sequencing reactions……………………   48 
TABLE 2.9 Cycling conditions used in sequencing reactions…………   48 
TABLE 3.1 Clinical characteristics of patients with HRV isolated from 
stool samples………………………………………………...79 
TABLE 3.2 Comparison of detection rates between HRV positives isolated 
from stool and respiratory samples……………………….... 83 
TABLE 4.1 Co-ordinates of capsid coding genome regions used in analysis 
and corresponding HRV reference strain………………….. 97 
TABLE 4.2  Limits of intra- and inter- clade VP1 p-distance for HRV-A, 
 -B and –C…………………………………………………. 103 
TABLE 4.3 Confirmed HRV-A, -B and -C types with full genome 
sequences available………………………………………...112 
TABLE 4.4  Confirmed HRV-C types defined by VP1 sequence...........120 
List of Tables 
xv 
 
TABLE 4.5 Provisionally assigned types of HRV based on VP4/VP2 
sequence divergence……………………………………….127 
TABLE 4.6 Limits of inter- and intra-clade divergence in HRV types 
which do not conform to VP4/VP2 thresholds……………128 
TABLE 5.1 Accession numbers of sequences generated during the study of 
recombination in HRV-C in 2006/2007………………….  145 
TABLE 5.2 Calculated 5ˈUTR recombination breakpoints for HRV-C 
types analysed……………………………………………...155 
TABLE 6.1 Phylogenetic incongruities observed between VP1 and 3Dpol 
in HRV-A sequences……………………………………....191 
TABLE 6.2 Phylogenetic incongruities observed between the P1, P2 and 
P3 regions in HRV-A sequences which lack bootstrap support 
in the VP1 or 3Dpol regions……………………………….197 
FIGURE 6.3 HRV-A types which displayed evidence of phylogenetic 





Abstract ................................................................................................................................. i 
Declaration of Originality ................................................................................................... iii 
Acknowledgements ............................................................................................................. iv 
List of Original Publications ................................................................................................ v 
Abbreviations ..................................................................................................................... vii 
List of Figures ...................................................................................................................... x 
List of Tables .................................................................................................................... xiv 
Contents ............................................................................................................................ xvi 
Chapter 1 Introduction .......................................................................................................... 1 
1.1 Introduction ................................................................................................................. 1 
1.2 Taxonomy and classification of viruses ...................................................................... 1 
1.2.1 General virus classification ............................................................................... 1 
1.2.2 Classification of the Picornaviridae .................................................................. 3 
1.2.3 Classification of the genus Enterovirus ............................................................. 5 
1.2.4 Classification of human rhinoviruses (HRV) .................................................... 7 
1.3 General aspects of picornavirus biology.................................................................... 13 
1.3.1 Structure of picornavirus virions ..................................................................... 13 
1.3.2 Genome organisation and proteolytic processing ............................................ 14 
1.3.3 RNA secondary structure in picornavirus genomes ........................................ 17 
1.3.4 Life cycles of picornaviruses ........................................................................... 19 
1.3.5 Pathogenesis of enterovirus infections ............................................................ 23 
1.4 Evolution of RNA viruses ......................................................................................... 25 
1.4.1 General points in the evolution of RNA viruses ............................................. 25 
1.4.2 Point mutations ................................................................................................ 26 
1.4.3 Recombination ................................................................................................ 27 
1.5 Aims of this thesis ..................................................................................................... 29 
Chapter 2 Materials and Methods ...................................................................................... 33 
2.1 Storage and archiving of clinical samples ................................................................. 33 
2.2 Laboratory techniques ............................................................................................... 35 
2.2.1 Prevention of contamination of polymerase chain reaction products .............. 35 
2.2.2 Extraction of RNA from clinical samples ....................................................... 37 
2.2.3 Reverse transcription ....................................................................................... 38 
2.2.4 PCR and sequencing of HRV positive samples .............................................. 40 
2.3 Computational Methods ............................................................................................ 48 
2.3.1 Statistical methods ........................................................................................... 48 




2.3.3 Database searching .......................................................................................... 49 
2.3.4 Likelihood mapping analysis ........................................................................... 51 
2.3.5 Construction of phylogenetic trees .................................................................. 52 
2.3.6 Bootstrapping .................................................................................................. 54 
2.3.7 Recombination detection methods .................................................................. 55 
2.3.8 Bayesian Evolution Analysis of Sampling Trees (BEAST) ............................ 60 
Chapter 3 Epidemiology and Clinical Correlations of HRV ........................................... 62 
3.1 Introduction ............................................................................................................... 62 
3.2 Materials and Methods .............................................................................................. 67 
3.2.1 Sample selection .............................................................................................. 67 
3.2.2 Amplification of 5ˈUTR and VP4/VP2 region of HRV positive samples ...... 70 
3.3 Results ....................................................................................................................... 70 
3.3.1 Epidemiological characteristics of HRV circulating in Edinburgh between 
September 2009 and May 2010 ....................................................................... 70 
3.3.2 Comparison of characteristics of HRV positive paediatric patients between 
acute and high dependency care settings ......................................................... 73 
3.3.3 Screening of CSF samples for HRV ................................................................ 75 
3.3.4 Isolation of HRV from faecal samples ............................................................ 76 
3.3.5 Discrepancy of screening results between real time PCR in diagnostic setting 
and VP4/VP2 screening PCR .......................................................................... 80 
3.3.6 Analysis of concurrent HRV circulation in respiratory samples during 
September and December 2010 ....................................................................... 83 
3.4 Discussion .................................................................................................................. 84 
3.4.1 Epidemiology and clinical correlations of HRV respiratory infections in 
Edinburgh ........................................................................................................ 84 
3.4.2 Screening for HRV in cerebrospinal fluid samples ......................................... 87 
3.4.3 Isolation of HRV from faecal specimens ........................................................ 87 
Chapter 4 Proposals for the Classification of All Three Species of Human Rhinovirus 
into Genotypically Assigned Types ..................................................................................... 91 
4.1 Introduction ............................................................................................................... 91 
4.1.1 The standard approach to typing in HRV ........................................................ 91 
4.1.2 Definition of new EV types based on sequence divergence in the VP1 region
 93 
4.1.3 The requirement for genotypic classification of HRV .................................... 94 
4.2 Materials and Methods .............................................................................................. 95 
4.2.1 Selection of samples ........................................................................................ 95 
4.2.2 Amplification of the VP1 region ..................................................................... 96 
4.2.3 Sequence alignment, calculation of pairwise nucleotide p-distances and 
phylogenetic analysis ...................................................................................... 97 
4.2.4 Analysis of recombination within the capsid region of HRV-A, -B and –C ... 98 




4.3.1 Assigning nucleotide divergence thresholds in the VP1 region of HRV-A, -B 
and –C ............................................................................................................. 98 
4.3.2 Phylogenetic analysis of the VP1 region ....................................................... 101 
4.3.3 Identification of putative new HRV types on the basis of sequence divergence 
in VP1 ............................................................................................................ 104 
4.3.4 Analysis of HRV type groups which do not conform to the proposed VP1 
divergence thresholds .................................................................................... 106 
4.3.5 Assignment of type designations based on VP1 divergence for all three species 
of HRV .......................................................................................................... 111 
4.3.6 Analysis of recombination within the capsid coding region of HRV and 
phylogenetic analysis of the VP4/VP2 region ............................................... 122 
4.3.7 Assigning nucleotide divergence thresholds for the VP4/VP2 region .......... 125 
4.3.8 Analysis of confirmed HRV types which do not conform to VP4/VP2 
thresholds ...................................................................................................... 128 
4.3.9 Geographical distribution of HRV types ....................................................... 130 
4.4 Discussion ................................................................................................................ 133 
4.4.1 Development of a sensitive and specific RT-PCR for the amplification of the 
VP1 region of HRV ....................................................................................... 133 
4.4.2 The importance of genotyping in HRV ......................................................... 134 
4.4.3 Proposed criteria for the division of HRV into genotypically defined types 134 
4.4.4 Future directions ............................................................................................ 136 
Chapter 5 Analysis of genetic diversity and sites of recombination in HRV-C ............ 138 
5.1 Introduction ............................................................................................................. 138 
5.1.1 Recombination in the evolution of human enteroviruses .............................. 138 
5.1.2 Recombination in the 5ˈUTR of HRV-C ...................................................... 140 
5.1.3 Genetic features of HRV-C ........................................................................... 141 
5.2 Materials and Methods ............................................................................................ 143 
5.2.1 Sample selection ............................................................................................ 143 
5.2.2 Amplification of the VP4/VP2, VP1 and 3Dpol regions of HRV-C ............. 143 
5.2.3 Amplification of the 5ˈUTR region of HRV-C ............................................. 143 
5.2.4 Amplification of the 2A region of HRV-C.................................................... 144 
5.2.5 Dataset construction ...................................................................................... 144 
5.3 Results ..................................................................................................................... 146 
5.3.1 Phylogenetic analysis of the VP4/VP2, VP1 and 3Dpol regions of HRV-C 146 
5.3.2 Phylogenetic analysis of the 5ˈUTR of HRV-C ............................................ 150 
5.3.3 Determination of recombination breakpoints within the 5ˈUTR of HRV-C . 153 
5.3.4 Sequence divergence across the full genome of HRV-C .............................. 157 
5.3.5 Analysis of recombination within the 2A region of HRV-C ......................... 159 
5.4 Discussion ................................................................................................................ 165 
5.4.1 Absence of recombination within the coding region of HRV-C ................... 165 




5.4.3 Putative recombination events within the 2A coding region of HRV-C ....... 169 
Chapter 6 Recombination in the evolution of HRV genomes ........................................ 175 
6.1 Introduction ............................................................................................................. 175 
6.2 Materials and Methods ............................................................................................ 176 
6.2.1 Sample selection ............................................................................................ 176 
6.2.2 Amplification of three coding regions of HRV ............................................. 177 
6.2.3 Construction of datasets for recombination analysis ..................................... 177 
6.2.4 Likelihood mapping analysis ......................................................................... 178 
6.2.5 Analysis of mean substitution rates ............................................................... 179 
6.2.6 Recombination analysis ................................................................................. 179 
6.3 Results ..................................................................................................................... 181 
6.3.1 Phylogenetic analysis within HRV type groups ............................................ 181 
6.3.2 Likelihood mapping analysis ......................................................................... 183 
6.3.3 Analysis of mean substitution rates ............................................................... 184 
6.3.4 Comparisons of pairwise nucleotide p-distances .......................................... 186 
6.3.5 Analysis of recombination within the coding region of HRV-A ................... 188 
6.3.6 Recombination between the P1, P2 and P3 regions of HRV-A .................... 195 
6.3.7 Analysis of recombination within the coding region of HRV-B and HRV-C 
sequences ....................................................................................................... 201 
6.3.8 Determining putative recombination breakpoints ......................................... 204 
6.3.9 Recombination within the 5ˈUTR of HRV-A and HRV-B ........................... 206 
6.4 Discussion ................................................................................................................ 208 
6.4.1 Estimation of mean substitution rates and analysis of pairwise nucleotide p-
distances ........................................................................................................ 208 
6.4.2 Analysis of recombination within the coding region of HRV-A, HRV-B and 
HRV-C .......................................................................................................... 210 
6.4.3 Putative recombination breakpoints within the coding region ...................... 214 
6.4.4 Recombination within the 5ˈUTR of HRV-A and HRV-B ........................... 214 
6.4.5 Conclusion ..................................................................................................... 215 
Chapter 7 Concluding remarks ........................................................................................ 217 
7.1 A broad view of the global importance of HRV ...................................................... 217 
7.2 Novel findings in the clinical epidemiology of HRV .............................................. 218 
7.3 Classification of HRV into genotypically defined types ......................................... 221 
7.4 Recombination in the evolution of HRV ................................................................. 223 
7.5 Conclusion ............................................................................................................... 227 
Appendix 1 – List of Primers ............................................................................................ 229 
Appendix 2 – Permissions for reproduction of publications and figures ...................... 232 








Human rhinoviruses (family Picornaviridae, genus Enterovirus) are best known as 
one of the major causes of the common cold.  Although mainly associated with a 
mild and self-limiting upper respiratory tract infection (URTI), human rhinoviruses 
(HRV) are an established cause of other more serious clinical illness (Broberg et al., 
2011; Hicks et al., 2006; Gutman et al., 2007; Fuji et al., 2011; Tapparel et al., 
2009c).  Childhood wheezing secondary to HRV infections has also been extensively 
implicated in the subsequent development of asthma (Jartti and Korppi, 2011; 
Jackson et al., 2008; Gern and Busse, 1999).   In addition, the common cold places a 
considerable economic and social burden upon suffering populations, in terms of lost 
productivity, purchase of over-the-counter remedies and even unnecessary 
prescription of antibiotics (Fendrick et al., 2003).  The last ten years have seen HRV 
research blossom with the discovery of an entire new species, many new types and 
ever increasing association with more severe disease.  As the scope of clinical impact 
of HRV becomes clear, the necessity of developing an understanding of the 
evolutionary processes shaping the enormous diversity of these viruses and 
developing formal criteria for their classification has become evident.  The studies 
presented within this thesis have aimed to address aspects of these issues.    
1.2 Taxonomy and classification of viruses 
1.2.1 General virus classification 
The taxonomic classification and naming of viruses in a manner which allows 




Since 1971, a broad method of virus classification related to the nature of the viral 
genome and the method of translation has been used for high-level grouping of 
viruses.  This is known as the Baltimore Classification System (Baltimore, 1971) and 
divides viruses into seven groups based on nucleic acid type, sense of genome and 
method of replication.  Although this system remains extremely useful for 
developing a broad understanding of the properties of certain virus groups, the vast 
number of diverse subgroups within each class highlights the need for a system of 
defining and cataloguing smaller groups.   
The International Committee for the Taxonomy of Viruses (ICTV) has overseen 
issues relating to the naming and taxonomic grouping of viruses since the 1970s.   
The committee exists to provide a universal system of classification and 
nomenclature and releases in the form of reports and amendments are the state of the 
art in the field.  The currently used system of virus classification is similar to, but 
distinct from other biological classification systems.  Classification is based on 
sequence data and certain biological properties where known.  Groups of virus 
variants, strains or types are classified as species.  The ICTV defines a virus species 
as “a monophyletic group of viruses whose properties can be distinguished from 
those of other species by multiple criteria” (www.ictvonline.org).  Distinguishing 
features of different species include phylogenetic relationships, sequence identity, 
host range, cell tropism, pathogenesis and antigenicity.  The assignment and naming 
of variants, strains or types is overseen by various subcommittees or study groups 
with a particular expertise in a certain virus family.  In ascending order of magnitude, 
virus species are grouped together according to common aspects and phylogenetic 
relationships to form a genus, a group of genera forms a family and a group of 
families forms an order.  In instances of complex hierarchical problems, subfamilies 
of several genera can be created.  However, subfamily membership is not a necessary 




orders, 96 families, 22 subfamilies, 420 genera and 2618 species of virus
1
.  Although 
all proposals for naming and taxonomy of viruses above the species level must be 
ratified by ICTV members, each virus family is overseen by a subcommittee or study 
group who are responsible for the development and submission of such proposals.   
1.2.2 Classification of the Picornaviridae 
Picornaviruses are one of five virus families which fall within the order 
Picornavirales (also including Dicistroviridae, Marnaviridae, Iflavirus and 
Secoviridae) (Sanfaçon et al., 2011).    The order consists of a diverse range of 
viruses with a single stranded positive sense ribonucleic acid (RNA) genome, 
grouped together on the basis of similar capsid structure and viral life cycles.  
Picornavirales have a very wide host range including humans, animals, plants, algae, 
insects and birds.  In terms of viral capsid structure, these diverse viruses share a 
non-enveloped capsid consisting of 60 protomers, each with three distinct “jelly-roll” 
domains (Le Gall et al., 2008).  The formal designation of the order Picornavirales 
replaces the putative “picorna-like supergroup”.  In addition to the five known 
families within the order, there are two unassigned genera (Bacillarnavirus and 
Labyrnavirus) which belong to no known family (www.picornavirales.com).   
The largest family within the order Picornavirales are the Picornaviridae.  Not only 
is this an extremely large and genetically diverse virus family, but it contains many 
human and veterinary pathogens of great clinical importance, including poliovirus 
(PV) and foot and mouth disease virus (FMDV).  The family Picornaviridae 
currently contains 17 recognised genera (Knowles et al., 2012)
2
 which cause clinical 
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 These figures have been updated since the publication of the Ninth Report of the ICTV and the 
figures reported here reflect these updates (www.ictvonline.org).   
2
 Five of the seventeen picornavirus genera mentioned (Aquamavirus, Cosavirus, Dicipivirus, 
Megrivirus and Salivirus) were approved in Feburary 2013 and hence did not appear in the 9
th
 ICTV 
report released in 2012.  These newly approved genera appear in the revised ICTV Master Species 
List (www.ictvonline.org).   In addition, over 20 currently unassigned putative picornaviruses have 
been found in such diverse host species as bats, eels, cats, chickens, mice and tortoises 




disease in a wide range of human and animal hosts (Table 1.1).  The family is named 
for the fact that all members are extremely small (pico) RNA viruses.  
TABLE 1.1: Members of the family Picornaviridae and their natural hosts 









cattle and pigs) 
Bovine rhinitis A 
virus (BRAV) 
2 Cows 
Bovine rhinitis B 
virus (BRBV) 
1 Cows 






Theilovirus 12 Rodents 
Humans 
Aquamavirus Aquamavirus A 2 Seals 
Avihepatovirus Duck hepatitis A 
virus 
3 Ducks 
Cosavirus Cosavirus A 24 Humans 
Dicipivirus Cadicivirus A 1 Dogs 
Enterovirus Enterovirus A (EV-A) 23 Humans 
Primates 
Enterovirus B (EV-B) 60 Humans  
Primates 
Pigs 
Enterovirus C (EV-C) 23 Humans 
Enterovirus D (EV-D) 5 Humans 
Primates 
Enterovirus E (EV-E) 4 Cows 
Enterovirus F (EV-F) 6 Cows 
Possums 
Enterovirus G (EV-G) 6 Pigs 
Sheep 
Enterovirus H (EV-H) 1 Primates 
Enterovirus J (EV-J) 6 Primates 















Erbovirus Equine rhinitis B 
virus (ERBV) 
3 Horses 




Kobuvirus Aichivirus A 3 Humans 
Dogs 
Mice 
Aichivirus B 2 Cows 
Aichivirus C 1 Pigs 
Megrivirus Melegrivirus A 1 Turkeys 
Parechovirus Human parechovirus 16 Humans 
Ljungan virus 4 Rodents 
Salivirus Salivirus A 2 Humans 
Primates 
Sapelovirus Porcine sapelovirus 1 Pigs 
Simian sapelovirus 1 Primates 
Avian sapelovirus 1 Birds 
Senecavirus Seneca valley virus 1 Pigs 






  Information included on number of types and known host species is adapted from information 
available on the Picornavirus study group website (www.picornaviridae.com) and additional 
references (Pallansch and Roos, 2007; Knowles et al., 2012). 
b 
The number of HRV types given relates to the number of types officially recognised in early 2013.  
Studies presented within this thesis have identified and proposed a number of additional HRV types 
from all three species.   
 
The criteria for the definition of members of the same genus within the 
Picornaviridae are homology between certain important polypeptides (specifically, 
the leader protein, 2A, 2B and 3A coding regions), RNA structural homology of the 
internal ribosomal entry site (IRES) and amino acid identity of more than 40% in the 
P1 and P2 coding regions and more than 50% in the P3 coding region (Knowles et 
al., 2012).   
1.2.3 Classification of the genus Enterovirus 
The enteroviruses (EV) originally consisted of only viruses isolated from humans 
and were divided into four main groups based on their pathogenesis in man and 
suckling mice.  The Coxsackie A viruses (CAV) were first isolated in 1948 from 
stool samples of children with an illness clinically similar to poliomyelitis (Dalldorf 
and Sickles, 1948).  In contrast to PV which infected primates, CAV caused a flaccid 




cases of aseptic meningitis (Melnick et al., 1949) and were found to cause a spastic 
paralysis and severe systemic infection in suckling mice.  The final classical group of 
human EV were the echoviruses.  These were first isolated in 1951 (Robbins et al., 
1951) from tissue culture samples.  They are named enteric cytopathogenic human 
orphan viruses due to their initial lack of association with clinical disease in either 
humans or laboratory animals.     
While the classification based on pathogenicity was useful, as sequence data 
accumulated  it became apparent that these subgroups did not correlate with observed 
phylogenetic relationships (Hyypiä et al., 1997).  In addition, each observed type 
appeared to cause a wide spectrum of disease and so classification in clinical terms 
was impossible.  Therefore, human EV were classified into four species (EV-A – D) 
on the basis of sequence identity and phylogenetic relationships.  Within each 
species, individual types were defined either by investigation of serological 
properties or sequence identity (discussed in Chapter 4).     
The classification of picornaviruses on the basis of phylogenetic relationships and 
sequence identity has led to the recognition that a great many animal viruses 
additionally fall within the Enterovirus genus (Table 1.1). Indeed, many EV that 
infect primates are members of the same species as those infecting humans.  For 
instance, EV-A, -B and –D all predominantly infect humans and contain several 
simian EV (Harvala et al., 2011; Oberste et al., 2002; Harvala et al., 2012a).  The 
recognition of this host species diversity within a single EV species has resulted in 
the recent proposal to remove the host species from the enterovirus name (resulting 
in nine EV species named EV-A – J
3
).  HRV (for which no other host species is 
currently known) were also reclassified as members of the Enterovirus genus on the 
basis of observed similarities in life cycle, genome organisation and phylogenetic 
relationships (Laine et al., 2005) 
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FIGURE 1.1:  Neighbour joining phylogenetic tree depicting relationships between species within 
the Enterovirus genus.  Tree was constructed as described in Chapter 2 and using simian sapelovirus 
sequence AY064708 as an outgroup.  Branch to tree root has been collapsed.  Enterovirus species 
have been collapsed for ease of reference.  Host species for each EV species are given in Table 1.1.  
Branches are scaled by genetic distance.   
 
1.2.4 Classification of human rhinoviruses (HRV) 
1.2.4.1 Classification of human rhinoviruses based on biological and 
serological properties 
Since the isolation of HRV-A1 in 1956 by two independent laboratories (Pelon et al., 
1957; Price, 1956), the classification of HRV has undergone many revisions.   Early 
studies of the biology of HRV sought to classify them as “H” or “M” strains 




strains of HRV were classified in this way, with the vast majority being found to 
replicate only in human embryonic kidney cells (designated H strains).  Only 2 HRV 
strains (which are known under the current classification system as HRV-A1 and 
HRV-A2) were found to be able to replicate in both human and monkey kidney cells 
(designated M strains) (Taylor-Robinson and Tyrrell, 1962; Arden and Mackay, 
2010).  This particular classification of HRV based on properties of in vitro cell 
culture was abandoned and is now of historical interest only.   
Between 1967 and 1987, all of the known HRV isolates were collected and tested by 
serological neutralisation assays to determine their antigenic relationships (Kapikian 
et al., 1967; Hamparian et al., 1987; Kapikian et al., 1971)  This collaborative 
program was completed in three stages and resulted in the definition of 100 
sequentially numbered HRV serotypes.  As the existence of distinct species of HRV 
was not recognised at this time, sequential numbering remains interspersed 
throughout the two HRV species now known as HRV-A and HRV-B
4
.  Serotypes 
were initially defined on the basis of antigenic distinctness and a lack of significant 
cross-reactivity with known HRV serotypes (Kapikian et al., 1967).  However, 
subsequent studies identified a number of HRV serotype pairs which exhibited 
reciprocal cross-reactivity (HRV-1A/1B, 2/49, 3/14, 9/32, 12/78, 13/41, 15/74, 
29/44, 36/58, 8/95) and an even greater number of serotype pairs which exhibited 
non-reciprocal cross-neutralisation (Cooney et al., 1982; Ledford et al., 2004; 
Halfpap and Cooney, 1983).  However, the antibody titres to heterotypic HRV were 
generally low. 
An additional classification criteria applied to HRV-A and –B was cell surface 
receptor usage.  Before the major receptors for HRV infection were known, 
competitive binding assays were used to demonstrate the existence of two distinct 
receptor groups.  If a cell culture assay was saturated with one HRV type, most other 
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 For clarity, HRV types are now conventionally listed with their species designation included (for 




known types could not bind and establish infection.  In fact, only 4 of 24 HRV types 
showed no inhibition.  It was therefore inferred that the majority of HRV used the 
same receptor (Abraham and Colonno, 1984).  This “major group” HRV receptor 
was eventually identified as the cell surface glycoprotein intercellular adhesion 
molecule 1 (ICAM-1) (Greve et al., 1989); a protein which is expressed in abundance 
on endothelial cells.  All known HRV-A and –B were then classified into two groups 
on the basis of receptor usage (Uncapher et al., 1991); with 91 serotypes falling 
within the major group and 9 within the minor.  The minor group receptor was 
shown to be a member of the low density lipoprotein family (LDL) (Hofer et al., 
1994).  One type, HRV-87, was determined to use a third receptor (Uncapher et al., 
1991).  However, this was later reclassified as a member of the EV-D species (EV-
68) (Blomqvist et al., 2002b; Ishiko et al., 2002) with tropism for the respiratory 
tract.   
Finally, HRV have also been classified in terms of sensitivity to certain classes of 
antiviral drugs.  In 1990, all 100 HRV serotypes were tested against a specific panel 
of 15 antiviral compounds and this revealed the existence of two antiviral 
susceptibility groups (Andries et al., 1990).  Group A consisted of 33 serotypes 
which were susceptible to elongated compounds, such as WIN517111 and Group B 
consisted of 67 serotypes susceptible to short compounds, such as chalcone, 
dichloroflavan and R61837.  Further analysis of the amino acid sequence of this 
region revealed that specific mutations were predictive of the susceptibility of a 
particular HRV serotype to a further antiviral drug, known as pleconaril (Ledford et 
al., 2005).       
Although methods of HRV classification based on observable biological properties 
have proved extremely useful in HRV research, all require extensive and time-




available sequence data for the classification of HRV has allowed much more timely 
and easy identification.      
1.2.4.2 Classification of human rhinoviruses based on phylogenetic 
relationships 
The recognition that the 100 recognised serotypes of HRV could be divided into two 
species (HRV-A and –B) was achieved by phylogenetic analysis.  These two distinct 
species groupings were shown to be present throughout the capsid coding region 
(Horsnell et al., 1995; Savolainen et al., 2004; Laine et al., 2005), the 5ˈ untranslated 
region (UTR) (Kiang et al., 2008) and the 3Dpol region at the 3ˈ end of the coding 
genome (Savolainen et al., 2004).  The completion of full genome sequences for all 
100 HRV-A and –B strains in 2009 additionally confirmed these two species 
groupings (Palmenberg et al., 2009). 
The common usage of molecular methods in studies of HRV epidemiology has led to 
the rapid accumulation of sequence data and a revised understanding of many aspects 
of HRV classification and taxonomy.  As previously mentioned, HRV were initially 
classified within the genus Rhinovirus (distinct from Enterovirus) on the basis of cell 
tropism and disease manifestations.  HRV generally replicate in the respiratory tract 
and cause respiratory disease, whereas EV predominantly replicate in the 
gastrointestinal tract.  However, studies of phylogenetic relatedness and sequence 
identity between these two groups has led to the re-classification of HRV within the 
genus Enterovirus (Laine et al., 2005; Savolainen et al., 2004).  It has been shown 
that the division of HRV into subgroups based on biological properties, as described 
above, does not correlate exactly with the phylogenetic relationships observed within 
the two species (Lewis-Rogers et al., 2009).  All HRV-B and most HRV-A are 
members of the major receptor group.  All HRV-B, except HRV-B27 are members of 
antiviral group A and all HRV-A, except HRV-A8 and –A95 are members of 




several distinct clusters.  However, these do not form a distinct genetic subgroup 
(Figure 1.2).   
In 2006, a divergent phylogenetic clade of HRV variants were discovered from 
sequencing of HRV from respiratory samples (Lamson et al., 2006; Renwick et al., 
2007; Arden et al., 2006; McErlean et al., 2007; Lau et al., 2007; Kistler et al., 
2007a; Lee et al., 2007).  These viruses were originally referred to as HRV-A2 or 
HRV-C and they received approved status by the ICTV as a distinct HRV species in 
2009 (called HRV-C).  HRV-C are genetically divergent from HRV-A and –B, 
except in the 5ˈUTR where there was evidence for inter-species recombination with 
HRV-A (Huang et al., 2009; Wisdom et al., 2009a).  HRV-C have proven to be 
refractory to in vitro cell culture by classical methods used for isolation of HRV 
(McErlean et al., 2008).  Recently, a cell culture system based on propagation of 
HRV-C in sinus mucosal organ culture has been developed  and although this 
appears to be sensitive for HRV-C detection, the organ culture method is not 
practical for widespread use (Bochkov et al., 2011).  Due to the lack of a suitable 
system for extensive analysis of the biological and replicative properties of HRV-C, 
these viruses have not been added to the classification systems described for HRV-A 
and HRV-B (including receptor usage, antigenicity and drug sensitivity profiles).  
Instead, classification of HRV-C must necessarily rely on nucleotide and amino acid 





FIGURE 1.2:  Neighbour joining phylogenetic tree showing the prototype strains of HRV-A and 
corresponding biological properties.  Tree was constructed as described in Chapter 2.  The majority 
of HRV-A strains are members of the major receptor group.  Members of the minor receptor group 
are marked with a black dot.  Members of antiviral group A are marked by a black box.  Branches are 








1.3 General aspects of picornavirus biology 
1.3.1 Structure of picornavirus virions 
Picornaviruses are very small RNA viruses of around 30nm in diameter.  They are 
non-enveloped and therefore their infectivity is not affected by inorganic solvents.  
Despite the genetic heterogeneity observed with the capsid coding sequences of 
picornaviruses, the basic structure of the capsid is conserved throughout the family 
(Racaniello, 2007).  The three dimensional structure of the virus capsid has been 
determined for such diverse picornaviruses as HRV (Figure 1.3), Seneca Valley 
Virus and FMDV (Oliveira et al., 1993; Garriga et al., 2012; Hadfield et al., 1997; 
Medappa et al., 1971; Venkataraman et al., 2008). 
 
 
FIGURE 1.3:  The structure of human rhinovirus virions.  Adapted with permission from 
(Dreschers et al., 2007).  A:  Electron micrograph of purified rhinoviruses.  B:  Structural model of 
rhinovirus capsid obtained from analysis of cryoelectron microscopic data.  C:  Relative positions of 
capsid proteins VP1, VP2 and VP3 on the rhinovirus capsid. 
 
The capsid is composed of 60 protomers, each containing one copy of the four capsid 
proteins VP1 to VP4.  As one of the few exceptions, parechoviruses contain only 
three capsid proteins, as VP2 and VP4 are retained in their uncleaved precursor form 
VP0 (Stanway et al., 1994).  The external capsid proteins, VP1 to VP3 form an 8 




feature to other members of the order Picornavirales (Le Gall et al., 2008).  The VP4 
protein is located towards the internal aspect of the capsid.  Groups of five protomers 
are arranged into 12 pentamers and these pentamers form a rigid pseudo-spherical 
structure with icosahedral symmetry.  This configuration balances the stability and 
durability required for transmission with the flexibility required for cell surface 
binding and virion disassembly.  Several studies have suggested that the picornavirus 
capsid may be a dynamic structure, which transiently exposes internal proteins (such 
as VP4 and the N-terminus of VP1) in a “breathing” process (Li et al., 1994; Lewis 
et al., 1998).  This is important for release of the RNA genome.  Capsid breathing 
also has implications for the development of antiviral therapies, as not only can 
antibodies raised against these internal regions neutralize infectivity in PV-1 but 
these can also confer cross-serotypic neutralization in HRV due to the highly 
conserved nature of this protein (Katpally et al., 2009; Li et al., 1994).        
The virion has three axes of symmetry; a five fold, three fold and two fold axis.  In 
most picornaviruses, a depression is formed near the five fold axis of symmetry by 
the beta barrels of the VP1 protein and this is known as the canyon.  The canyon is 
the receptor binding site for major (but not minor) group HRV (Hewat et al., 2000; 
Colonno et al., 1988).  Apthoviruses have been found to lack the canyon site and 
instead the receptor binds to a flexible loop which projects from the surface of the 
virion (Acharya et al., 1989).   In EV, immediately below the canyon floor lies a 
hydrophobic pocket region which contains a “pocket factor” (Oliveira et al., 1993; 
Verdaguer et al., 2000).  This region is a drug target for various antiviral drugs and 
successful binding has been shown to inhibit the uncoating of the RNA genome and 
subsequent delivery into the host cell (Smith et al., 1986).   
1.3.2 Genome organisation and proteolytic processing 
The genome of all picornaviruses consists of single-stranded, positive sense, non-




coding region which is flanked by 5ˈ and 3ˈ UTRs of varying lengths.  In addition, 
the 3ˈ polyA tail also varies significantly in length between genera and has been 
shown to be required for infectivity (Spector, 1974; Racaniello, 2007).  The VPg 
(viral protein genome-linked) is a small protein that is covalently linked to the 5ˈ end 
of the genome and acts as a primer for genome replication.  The VPg is encoded by 
the short and well conserved 3B genome region (Figure 1.4).  In contrast to other 
picornaviruses, FMDV and aquamavirus A encode more than one VPg molecule 
(Forss and Schaller, 1982; Knowles and Wadsworth, 2010). 
The picornavirus genome consists of a single open reading frame translated as a 
single polyprotein.  However, the complete polyprotein is cleaved co-translationally 
and so is never evident in the cell (Racaniello, 2007).  Unlike mammalian RNA, 
picornavirus RNA lacks a methylated 5ˈ cap structure and initiation of translation at 
the ribosome is carried out by the IRES within the 5ˈUTR.  The translated 
polyprotein is divided into capsid and non-structural regions, known as P1, P2 and 
P3 (Rueckert and Wimmer, 1984).  These regions encode four structural and seven 
non-structural proteins, which are cleaved by virus-encoded proteinases in a cascade 
of proteolytic processing events (Figure 1.4).  The cascade shown is specific to the 
sequence of events in EV in keeping with the focus of this thesis.  However, several 
notable differences between proteolytic processing events in other picornavirus 





FIGURE 1.4:  Sequence of cleavages during proteolytic processing of the translated genome of 
enteroviruses.  Organisation of picornavirus genome is shown on the top line.  Relative sizes of 
protein products are taken from annotation from Genbank entry for HRV-B14 : X01087.  The Leader 
protein (L) is not present in EV and position in the genome is shown for reference only.  Intermediate 
and final protein products are shown.   
The junction between the P1 and P2 coding regions is cleaved in EV by the 2A 
proteinase.  However, in certain other genera, including Cardiovirus, Parechovirus, 
Hepatovirus and Apthovirus, this junction is cleaved by the 3C proteinase 
(Racaniello, 2007), as the 2A protein does not have proteolytic activity.  Several 
picornavirus genera (Apthovirus, Cardiovirus, Erbovirus, Kobuvirus and 
Sapelovirus) encode an additional leader protein (L), at a 5ˈ position to the VP4 
capsid protein (position shown by dotted box in Figure 1.4).  This functions as a 
proteinase in apthoviruses and has a role in the inhibition of host-cell protein 
synthesis (Devaney et al., 1988).  However, in cardioviruses, the leader protein lacks 
proteolytic activity and is instead cleaved from the polyprotein by 3C.  Other 









proteinase.   The encoded proteins 2B, 2BC and 3AB are all membrane associated 
proteins with roles in viral replication (VR Racaniello, 2007).   VP1 to VP4 assemble 
into the final capsid structure and the last event in the assembly of the picornavirus 
virion is the cleavage of VP0 to form VP4 and VP2.  
1.3.3 RNA secondary structure in picornavirus genomes 
In addition to the encoded proteins, picornavirus genomes contain several well 
defined areas of functional RNA secondary structure.  RNA secondary structure is 
formed by base pairing of single stranded RNA with itself and leads to the formation 
of structures such as stem-loops and pseudoknots.  RNA secondary structure can 
form randomly or can have a high degree of functional importance and in practice it 
is often challenging to separate these two.   
Certain structural elements are present in picornavirus genomes, including elements 
within the UTRs and the cis-acting replication element (cre) within the coding 
region.  The cre is an RNA secondary structure which has been observed within the 
genome of several picornavirus genera.  It has been implicated in negative strand 
RNA synthesis (Goodfellow et al., 2000) and in VPg uridylation, allowing VPg to 
function as a primer for genome replication (Paul et al., 2000).  The location of the 
cre has been pinpointed in several different picornavirus genera and there is a high 
degree of structural conservation.  Despite this, cre elements from different species 
exhibit high nucleotide sequence divergence and are located in different parts of the 
coding or non-coding regions of the genome (Cordey et al., 2008; Goodfellow et al., 
2000; Witwer et al., 2001; McKnight and Lemon, 1998; Gerber et al., 2001).  In fact, 
it has been suggested that this variability in position may be used as an additional 
classification tool for identifying species of HRV and EV (Cordey et al., 2008).   
The IRES is a long and highly structured stretch of nucleotides within the 5ˈUTR.  
Picornavirus genomes lack the 5ˈ cap structure observed in mammalian RNA, which 




initiation of translation for picornavirus genomes in 1988 (Pelletier and Sonenberg, 
1988; Jang et al., 1988).  There are five classes of viral IRES and two main types are 
present in picornaviruses. The type I and type II IRES of EV and 
apthoviruses/cardioviruses respectively have little homology in either structure or 
sequence and yet provide the same basic function (Racaniello, 2007) (Figure 1.5).  
Hepatitis A virus (HAV) contains a further distinct IRES, designated type III 
(Belsham, 2009).  In addition, several other picornavirus genera (including 
Avihepatovirus, Teschovirus, Senecavirus, Sapelovirus and Tremovirus) have been 
shown to contain IRES elements which are similar to those observed in hepatitis C 
virus and pestiviruses in the virus family Flaviviridae (Willcocks et al., 2011; Hellen 
and de Breyne, 2007).  Although it is possible that this IRES type (type IV; Figure 
1.X) may have evolved independently, it has also been suggested that this may have 
arisen by recombination and modular exchange of replication elements between 
members of different virus families (Hellen and de Breyne, 2007).   
 
FIGURE 1.5:  RNA secondary structure of picornavirus IRES elements.  Presented with permission 
from (Fitzgerald and Semler, 2009).  A:  Type I IRES, as observed in Enterovirus.  B:  Type II IRES, 
as observed in Apthovirus.   
In addition to these two regions of RNA secondary structure present in all 




required in viral replication (Brown et al., 2005) and a 5ˈ cloverleaf structure has 
been observed in the 5ˈUTR of enteroviruses (Palmenberg et al., 2009).  This 5ˈ 
structure has been implicated in the initiation of RNA synthesis (Barton et al., 2001).  
The entire 5ˈUTR of EVs can be divided into six functional domains, consisting of 
the cloverleaf structure (domain I) and the IRES (domains II – VI)  (Rohll et al., 
1994).  Within the cloverleaf, four individual stem-loops exist (A-D).  Stem loop B 
specifically binds with poly(rC)-binding proteins and stem loop D interacts with the 
viral 3C and 3CD proteases (Du et al., 2004).  These have been implicated in the 
switch between translation and replication  (Rohll et al., 1994).   
1.3.4 Life cycles of picornaviruses 
The replication of picornaviruses takes place in the cytoplasm of the host cell.  
Attachment of the virus to a specific cell surface receptor leads to structural changes 
in the capsid which allow the uncoating of the RNA genome and its subsequent entry 
into the cell.  The genome is first translated to provide copies of the viral proteins 
required for genome replication.  Replication is preceded by negative strand 
synthesis and this strand is then used as a template for positive strand RNA synthesis.  
Capsid proteins and newly synthesized viral genomes assemble into mature virions 
and are then released from the cell.  The entire cycle is complete in around 5 to 10 
hours (Racaniello, 2007) (Figure 1.6).    
Attachment of picornaviruses to host cells occurs via a wide variety of cell surface 
receptors.  Cell surface receptor specificity is an essential determining factor in 
cell/tissue tropism and therefore both disease manifestations and host species.  
However, many cellular receptors exploited by picornaviruses are expressed in a 
wide variety of tissues and therefore tropism may not be primarily determined by 
receptor expression alone.  For example, both I-CAM1 and CD155, members of the 




body and yet, the primary sites of replication of HRV and PV are the respiratory and 
gastrointestinal tracts respectively.   
 
FIGURE 1.6:  Summary of the picornavirus life cycle.  Presented with permission from (Whitton et 
al., 2005).  The figure summarises key events in the replication of picornaviruses and the main events 
are described in the text below.  © represents the cap present on most cellular mRNA.  
 
The receptor usage profile of picornaviruses is complex and receptor specificities of 
some major picornavirus species are summarised in Table 1.2.  Some EV and HRV  
utilise receptors which are members of the immunoglobulin superfamily and binding 
occurs in the canyon region (Colonno et al., 1988).  This leads directly to the 




TABLE 1.2:  Cell surface receptors used by selected picornaviruses 




I-CAM1 HRV Human Respiratory 
tract 
























LDL HRV Human Respiratory 
tract 






















EV71 Humans Gastrointestinal 
tract 
Hepatitis A virus 
receptor 
HAV-cr1 HAV Humans Gastrointestinal 
tract 
-  Information adapted from (Tuthill et al., 2010; Racaniello, 2007; Pallansch and Roos, 2007) 
Binding of the cell surface receptor leads to uncoating of the viral genome.  Unlike 
enveloped viruses which can directly fuse their lipid coat with the host cell plasma 
membrane, the non-enveloped picornaviruses must exploit a variety of different 
mechanisms in order to effectively deliver their genome into the cytoplasm.  
Picornaviruses do not enter the cell directly through the plasma membrane, instead 
relying on endocytosis and subsequent release from vesicles (Brandenburg et al., 
2007; Tuthill et al., 2010).  The mechanism by which endocytosis takes place and the 




plasticity of the conformation of the capsid and the phenomenon of “capsid 
breathing”  is of crucial importance to this process (Roy and Post, 2012). 
Endocytosis can be clathrin-mediated, as is observed for apthoviruses, some HRV 
and HAV (Tuthill et al., 2010).  Some EV undergo endocytotic uptake via a caveolin 
mediated pathway, whereas PV depends on a non-caveolin non-clathrin mediated 
process (Brandenburg et al., 2007; DeTulleo and Kirchhausen, 1998).  The actual 
uncoating of the RNA genome depends on either a direct mechanical cue secondary 
to receptor binding (as in major group HRV) or a chemical cue such as low pH 
(Suomalainen and Greber, 2013).  This occurs at around pH 5.4 in the minor group 
HRV (Brabec et al., 2003).  The N-myristoylated VP4 capsid protein and the N-
terminus of the VP1 protein, usually present on the internal surface of the virus, are 
externalised.  The exposed segment of the VP1 protein tethers the virus to the 
membrane, while the VP4 protein can form a pore which is suggested to allow the 
release of the genome into the cytoplasm (Davis et al., 2008; Fricks and Hogle, 1990; 
Danthi et al., 2003).  Post release of the genome, the 80S empty particle of EV is still 
present within the endosome.  However, the capsids of apthoviruses and 
cardioviruses dissociate into respective pentameric subunits (Tuthill et al., 2010).  
Uncoating of picornaviruses with a canyon region within the capsid can be blocked 
by certain antiviral compounds, such as pleconaril or WIN compounds.  These bind 
to the canyon and stabilize the capsid conformation, thereby blocking the release of 
VP4 (Roy and Post, 2012).   
Once in the cytoplasm, the viral RNA must be first translated in order to provide 
copies of the viral proteins necessary for genome replication, which are not naturally 
present in the host cell.  Once sufficient viral proteins have been synthesized, the 
switch from translation to replication occurs, as both cannot occur on the same RNA 
template simultaneously (Racaniello, 2007).  The viral RNA dependent RNA 




Both the cellular protein poly(rC) binding protein and the viral 3CD protease bind to 
the 5ˈ cloverleaf structure to form the ribonucleoprotein complex (Rohll et al., 1994; 
Andino et al., 1990).  A protein-protein bridge is then formed between this complex 
and the cellular polyA binding protein that is bound to the 3ˈ end of the viral genome 
(Herold and Andino, 2001).  This has the effect of circularizing the RNA, which in 
turn initiates negative strand RNA synthesis from the 3ˈpolyA region.  Negative 
strand RNA synthesis results in the formation of a positive/negative RNA duplex 
known as the replication form.  Positive strand synthesis then occurs using the 
negative strand as a template and secondary to the anchoring of the negative strand 
by virally encoded protein 2C.  Uridylated VPg is required as a primer for RNA 
replication.  RNA replication takes place within replication complexes bound to 
smooth membrane vesicles (Bienz et al., 1994).  The compartmentalization of RNA 
replication may increase efficiency of replication by localising all required 
components and additionally may facilitate the avoidance of eliciting a dsRNA 
activated immune response during the replication cycle (Racaniello, 2007).   
Some of the newly produced positive stranded RNA viral genomes are translated to 
produce viral capsid proteins.  Each positive stranded RNA genome is linked to a 
VPg protein and encapsidated.  The final event before cell lysis is the maturation 
cleavage of capsid protein VP0 to form VP4 and VP2 (Lee et al., 1993).          
1.3.5 Pathogenesis of enterovirus infections 
Members of the genus Enterovirus comprise a large number of pathogens of both 
humans and animals (Table 1.1).  Although the human EV have been documented to 
cause such varied clinical presentations as respiratory infections, hepatitis, acute 
haemorrhagic conjunctivitis and myocarditis (Gaaloul et al., 2012; Pallansch and 
Roos, 2007), the main public health concern for this group of viruses is their 
propensity to cause infections of the central nervous system (CNS).  These include 




syndromes, aseptic meningitis and encephalitis (Siafakas et al., 2001; Kupila et al., 
2006).  Members of all four species of human EV have been documented to cause 
infections of the human CNS. 
The CNS is protected from pathogens and toxins in circulating blood by the blood-
brain-barrier.  This consists largely of endothelial cells which regulate the transport 
of molecules in and out of the cerebrospinal fluid (CSF).  There are two postulated 
mechanisms of EV entry into the CNS; either through haematogenous spread and 
subsequent violation of the blood brain barrier or invasion of peripheral nerves 
leading to retrograde axonal flow to the brain (Ren and Racaniello, 1992; Ohka et al., 
1998).  The phenomenon of retrograde axonal flow, whereby virus gains access to 
the CNS via invasion of peripheral nerves has been specifically observed for PV 
infections.  In general, invasion of the CNS by EV is thought to occur due to 
haematogenous spread.  Upon entry via the faecal-oral route, EV initially replicates 
within the associated lympatic tissues of the small bowel and subsequent invasion of 
the blood vessels leads to viraemia.  Viraemia can occur even in cases of 
asymptomatic EV infection (Welch et al., 2001).  Excretion of the virus occurs in 
faeces for weeks after the initial infection and occurs in both symptomatic and 
asymptomatic infections.     
Human EV notably possess acid stable virions and are therefore able to pass through 
the highly acidic environment of the stomach prior to establishing infection in the 
small bowel.  In contrast, HRV are thought to be acid labile (Giranda et al., 1992) 
and therefore have a respiratory tropism.  The same association is observed in 
apthoviruses, which are acid labile viruses that replicate predominantly in the 
respiratory tract.  HRV also appear to propagate in vitro preferentially at 33°C, which 
has been interpreted as an adaptation to the cooler environment of the upper 
respiratory tract.  However, recent studies have indicated that HRV are capable of 




and within the lower respiratory tract itself  (Gern et al., 1997; Mosser et al., 2002; 
Papadopoulos et al., 2000).   
1.4 Evolution of RNA viruses 
1.4.1 General points in the evolution of RNA viruses 
The genetic diversification and evolution of viruses occurs by three main 
mechanisms; point mutations, recombination and reassortment.  Point mutations 
cause small changes in the genome sequence during replication, secondary to the 
error prone nature and lack of proof-reading activity of the viral polymerase 
(Steinhauer et al., 1992).  Recombination and reassortment cause the creation of 
chimaeric genomes, by transferring large genome regions between different viruses.  
Reassortment involves the transfer of entire genome segments and therefore occurs 
only in viruses with segmented genomes (such as influenza).  Reassortment is not 
discussed in the brief review below.   
RNA viruses generally have short replication cycles which allow the production of 
many virions, including a great number of mutants in each cycle.  The fixation of 
mutations in these viruses leads to divergent RNA sequences and therefore 
frequently altered protein sequences.  Although a large number of mutants are 
generated with each replication cycle, all are required to conserve essential functions 
to maintain viability.  All mutant genomes are subjected to the same selective 
pressures and the observed genetic diversity of a viral population depends not only 
on the mechanism of generation of mutants, but on their fitness and ability to 
produce infectious progeny.  Some RNA viruses are thought to exist as a swarm of 
closely related mutants clustering around a general consensus sequence, known as a 
quasispecies (Domingo et al., 1996, 2008).  The rapid generation of diversity means 
that viral populations can quickly adapt to changing environments, which has 




Constraints on observed genetic diversity are imposed in several ways.  Not only 
does every mutation or recombination event have implications for viral fitness, but 
the total genome size of picornaviruses is constrained by the fixed internal space 
within the viral capsid.  However, PV with up to an additional 1500 nucleotides have 
been shown to be successfully packaged (Alexander et al., 1994).  In addition, viral 
evolution can have important consequences for virulence and a balance must be 
struck between successful viral propagation and causing the premature death of the 
host cell.   
1.4.2 Point mutations 
Nucleotide misincorporation is estimated to occur at a frequency as high as one 
mutation per genome per round of replication in RNA viruses (Drake and Holland, 
1999).  The existence of picornaviruses as a related swarm of micro-variants or 
quasispecies means that there is a large pool of slightly mutated genomes present at 
any one time, which may become fitter variants as the selection pressures exerted by 
the host change.   Picornaviruses are a highly genetically diverse group of viruses, 
both within and between species.  Despite the fact that most random mutations are 
likely to be deleterious, it has been found that increasing the fidelity of the RNA 
polymerase actually causes attenuation of PV (Pfeiffer and Kirkegaard, 2005).  
However, decreasing the fidelity of the polymerase will necessarily lead to the 
creation of a large number of non-viable progeny and eventual complete inability to 
replicate (error catastrophe).  For example, the small molecule ribavirin has been 
demonstrated to cause error catastrophe in PV by reducing the fidelity of the 
polymerase (Crotty et al., 2001).  Therefore, random mutations in RNA viruses are a 
delicate balance between generating sufficient viral diversity to adapt to a rapidly 
changing host environment and avoidance of crossing the error threshold.       
Point mutations occur by the random introduction of either single or multiple 




profound effects on viral phenotype and therefore these small, incremental changes 
are subject to the evolutionary forces of positive and negative selection.  A progeny 
genome with a lowered fitness will be outcompeted by other variants in the 
population and therefore is likely to disappear quickly.  Random non-synonymous 
mutations (which cause a change in amino acid sequence) can decrease viral fitness 
by altering the essential secondary structure or interactions of the encoded proteins.  
Insertions and deletions in the nucleotide sequence (indels) are significantly less 
commonly observed in sequenced viral genomes than single base point mutations.  
This is due to the fact that the addition or removal of a single base will cause a 
frameshift mutation resulting in a protein that is non-functional or truncated (if the 
indel introduces a stop codon).  In order to maintain viability of the virus, the indel 
must occur in a region of genome that is not functionally conserved and must result 
in the insertion or deletion in multiples of three to preserve downstream coding.   
Different segments of the genome have distinct roles in the viral life cycle and 
therefore are subjected to differing evolutionary pressures.  For example, a 
staggeringly high genetic diversity is observed within the majority of the capsid 
coding region of both HRV and EV (McIntyre et al., 2010; Lindberg et al., 2003; 
Laine et al., 2006).  This is likely secondary to the fact that these proteins are 
exposed to the host immune system and the generation of diversity, especially in the 
binding sites of neutralizing antigens likely allows immune escape.                
1.4.3 Recombination 
Genetic diversity is also routinely created in RNA viruses by recombination.  
Recombination is the joining of two genome regions from related or unrelated 
viruses to create a chimaeric genome.  This results in both new viral phenotypes 
which may obtain an evolutionary advantage and also is thought to decrease the load 




Recombination can be inferred indirectly from analysis of sequence data, as different 
recombinant genome regions will display different evolutionary histories.  Although 
computational and phylogenetic methods in use today for the detection of 
recombination are both powerful and accurate, recombination between very closely 
related parents cannot be detected.  Non-viable recombinants that are likely 
generated randomly within a single replication cycle also cannot usually be detected.  
Recombination within RNA viruses can be classified as homologous, aberrant 
homologous or nonhomologous (Lai, 1992).  Homologous recombination occurs 
within a homologous region of two related viruses.  Due to the likelihood of these 
generated recombinants being viable and able to propagate, it is these that are most 
often observed.  Aberrant homologous recombination occurs between homologous 
viruses that are not in strict alignment and the relatively infrequent nonhomologous 
recombination occurs between two completely unrelated viruses.   
The most widely accepted model of recombination in RNA viruses is known as the 
copy-choice model, whereby the RNA dependent RNA polymerase switches 
template strand during synthesis of the negative strand (Kirkegaard and Baltimore, 
1986).  This mechanism is necessarily replication dependent and relies both on co-
infection of the same host cell by two different viruses and replication of the two 
viruses within the same cellular compartment.  The dissociation and resulting 
switching may be related to “pausing” of the polymerase secondary to regions of 
RNA secondary structure or nucleotide misincorporations (Agol, 1997).  A second 
mechanism is proposed whereby recombination occurs by the breaking and re-
joining of RNA strands (Gmyl et al., 2003) and this is not replication dependent.   
Recombination has been extensively documented in a variety of picornavirus genera, 
including Apthovirus (Heath et al., 2006), Parechovirus (Benschop et al., 2008; 
Calvert et al., 2010),  Teschovirus (Simmonds, 2006) and Enterovirus (Oprisan et al., 




genera, documented recombination events have tended to occur in the 5ˈUTR and the 
non-structural coding regions.  Natural recombination of vaccine PV strains with 
circulating EV is also widely responsible for the generation of vaccine escape 
mutants and subsequent outbreaks of vaccine associated poliomyelitis, which has 
grave implications for the PV eradication campaign (Jegouic et al., 2009; Cuervo et 
al., 2001; Guillot et al., 2000).  The oral live-attenuated poliovirus vaccine (Sabin) 
contains three serotypes of poliovirus (PV-1, -2 and -3).  After administration of the 
oral vaccine, replication occurs in the gut tissues and thereby elicits a strong, local 
immune response preventing subsequent infection with wild poliovirus via the 
faecal-oral route.  Unfortunately, the nature of the live-attenuated vaccine presents 
significant opportunities for inter-typic recombination of PV strains during 
replication.  Recombinant PV strains have been widely linked to cases of vaccine 
associated paralytic poliomyelitis and documented recombination partners have 
included other Sabin vaccine strains (Cuervo et al., 2001), circulating wild poliovirus 
(Dahourou et al., 2002) and other related EV-C types (Jegouic et al., 2009).     
Understanding the frequency and nature of recombination events occurring in the 
natural circulation of a virus is vital for potential development and implementation of 
therapeutic strategies and potential vaccines.     
1.5 Aims of this thesis 
With the discovery of the novel HRV-C species in 2006 and the gradual realisation 
that HRV are responsible for a much wider variety of more severe clinical illness 
than was previously thought has come a renewed interest in research of the clinical 
and biological features of HRV.  This thesis comprises of several distinct studies of 
the epidemiology, classification and evolution of HRV. 
One of the primary goals of this research was to conduct preliminary explorations of 




traditionally thought to be acid labile and are therefore to only infect the respiratory 
tract, acid-stable mutants have been previously isolated (Skern et al., 1991).   The 
closely related human EV are an established and important cause of aseptic (viral) 
meningitis and are frequently isolated from stool specimens.  In light of this fact, 
CSF and stool samples were screened for HRV, in order to determine whether the 
virus was present and if so, whether any epidemiological patterns could be elicited.  
In addition, concurrent studies were undertaken of circulating HRV epidemiology in 
respiratory samples isolated from Edinburgh.  These studies are outlined in Chapter 3 
and aspects pertaining to HRV isolation from stool and CSF were published as part 
of a larger study in 2012 (Harvala et al., 2012b).     
The numerous studies of HRV epidemiology undertaken across the globe has led to 
the rapid accumulation of a vast amount of HRV sequence data.  Indeed, in the 
analysis of sequence data acquired from our own epidemiological studies and 
published sequences, a large number of sequence groups were identified that 
appeared to be divergent from known HRV types.  At the time that this work was 
initially undertaken, the main method of classification of HRV and assignment of 
putative new types was by studies of neutralisation properties.  These methods were 
not suitable for the study of HRV-C, as the virus cannot be isolated in standard cell 
lines and at that time, no alternative means of in vitro propagation existed.  However, 
a system had been in use for several years, whereby EV could be classified and novel 
types assigned by nucleotide sequence divergence in the VP1 region (Oberste et al., 
1999a, 1999b).  Chapter 4 focusses on the determination of nucleotide sequence 
divergence thresholds in two capsid coding regions of HRV and their subsequent 
application in both defining new types and redefining previous erroneous 
classifications.  Our proposals for the classification of HRV-C into genotypically 
defined types was published in 2010 and has now been adopted by the Picornavirus 




addition, we have formulated proposals for the extension of this classification system 
to include HRV-A and HRV-B (McIntyre et al., 2013a). 
The classification of all available HRV sequence data into types defined by  
phylogenetic relationships and sequence identity allowed the completion of studies 
of the evolution of HRV species and types.  Although the phenomenon of 
recombination is frequently observed in EV, several studies had suggested that it was 
relatively rare in the evolution of HRV coding genomes (Kistler et al., 2007b; Lewis-
Rogers et al., 2009).  Studies of the occurrence of recombination within the coding 
region of HRV species which included many isolates of the same type had not, to our 
knowledge, been undertaken.  However, prior evidence did exist for widespread 
recombination between the 5ˈUTR regions of HRV-A and HRV-C (Huang et al., 
2009; Wisdom et al., 2009a).  Chapter 5 describes an analysis of recombination 
within the coding region and genetic diversity of HRV-C strains and includes an in-
depth analysis of recombination in the 5ˈUTR.  This analysis was published in 2010 
(McIntyre et al., 2010).   
However, the vast majority of HRV-C sequences generated for this study originated 
from the same 12 month period within the same geographical location.  It has been 
previously noted that even the frequently recombinant EV-B sequences are not 
always evident as such during a short time-scale (McWilliam Leitch et al., 2009a).  
Therefore, the analysis of recombination in HRV was extended to include samples 
from all three HRV species and covering a time-span of at least 14 years.  The study 
of the occurrence of recombination in the evolution of all three species of HRV is 












Materials and Methods  
Materials and methods that were used in the completion of the studies within this 
thesis comprise two main strands.  Firstly, laboratory techniques that were applied to 
both screening large number of samples for the presence of HRV and producing 
sequence fragments from known positive isolates for evolutionary studies are 
described in Section 2.2.  The second strand comprised computational analyses 
directed towards the construction of comprehensive datasets, phylogenetic and 
recombination analyses and determination of mean substitution rates in specific 
genome regions.  These are described in Section 2.3.  Also central to both areas of 
study were a series of archives of clinical specimens at the Scottish Virology Centre 
(SVC), described in Section 2.1.    
2.1 Storage and archiving of clinical samples 
Since 2005, large archives of clinical samples referred for virological testing have 
been maintained in collaboration between the SVC based at the Royal Infirmary of 
Edinburgh (RIE) and the University of Edinburgh.   Referral of patient samples for 
diagnostic virology is generally undertaken for system-specific suspected diagnoses 
(for example, pneumonia for respiratory samples and aseptic meningitis for CSF 
samples).  Although certain situations exist where the referral of samples is strongly 
indicated, such as pyrexia of unknown origin or severe unexplained headache, the 
process is largely dependent on the clinical judgement of the attending medical staff.  
Although effective interventions do not yet exist for a large number of viruses that 
are routinely screened for, viral diagnostics are also essential for prediction of 
prognosis (including possible complications) in individual patients, creating infection 
control protocols and for disease surveillance (Templeton, 2007). 
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The collection and storage of these referred samples additionally facilitates the 
completion of many studies of viral epidemiology, clinical characteristics and 
evolution that would not otherwise be easily possible.  Samples stored in each 
archive are allocated an anonymised number and any information which would 
render the individual patient identifiable are removed.  This includes name, date of 
birth and Community Health Index (CHI)/patient number.  Approval for the retention 
of specific, anonymised patient data for the purposes of epidemiological research 
was initially requested by Professor P. Simmonds in 2005 and granted by the Lothian 
Regional Ethics Committee (Development of molecular methods to enhance 
diagnostic testing for viruses and other infectious agents; REC reference number 
08/S1102/2).  Non-identifiable patient information is retained in the form of a secure 
(password protected) database.  This includes age band of the patient, year and 
month of collection, patient location (whether based in an Intensive Therapy Unit 
(ITU), general ward or community health centre), sample type, basic clinical 
information and the results of routine diagnostic screening.  As the basic clinical 
information recorded largely consists of details given on referral forms, data is 
frequently missing or incomplete.  Prospective data collection for specific studies has 
allowed certain records to retain more detailed non-identifiable clinical information 
for specific cases.  In addition, the results of other microbiology screening are 
recorded (Templeton et al., 2004; Scheltinga et al., 2005; Gaunt et al., 2010). 
In parallel with the maintenance of the archive of original clinical samples, nucleic 
acid extracts produced during routine viral diagnostic procedures are stored in a 
related and cross-referenced archive. Original clinical samples are stored at -80°C, 
while extracted RNA/DNA is stored at either -45°C or -20°C.  A supplementary 
archive of any complementary DNA (cDNA) produced is kept at -20°C.  However, 
these cDNA samples are kept for further use only when they are made by 
amplification with random primers and therefore are useful for screening for other 
RNA viruses.    With the exception of samples obtained from Finland (Chapter 6), all 
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clinical samples and HRV positive isolates used within the course of these studies 
were obtained from these clinical archives. 
2.2 Laboratory techniques 
2.2.1 Prevention of contamination of polymerase chain reaction 
products 
The studies contained within this thesis relied on the generation of large amounts 
sequence data by polymerase chain reaction (PCR) amplification of genome 
fragments from HRV positive samples and subsequent Sanger sequencing.  The 
exquisitely high sensitivity of PCR based techniques is potentially subject to 
contamination by extraneous DNA sequences and avoidance of this has been 
especially important for the work described herein.  The accuracy of studies which 
include both screening large numbers of samples for a specific virus and amplifying 
non-consecutive genome fragments for evolutionary analysis can be severely 
compromised by PCR contamination.   
Considerable precautions were taken in the completion of laboratory based work.  In 
addition to employing standard good laboratory practice and practicing aseptic 
technique at all times, reagents and primers for the preparation of PCR mixes were 
kept in small aliquots and reserved for sole use of specific individuals where 
possible.  In an attempt to prevent false positives resulting from contamination of 
adjacent PCR tubes in the preparation of reaction mixtures, DNA was added to the 
reaction mixture after all other reagents (Kwok and Higuchi, 1989).  In order to 
detect potential reagent contamination, a negative control prepared from the same 
reagent mix as all actual samples was included with all PCR based experiments.  
As even one round of PCR generates extremely high copy numbers of DNA 
fragments, one potential method of significantly reducing contamination is to limit 
carryover.  Carryover occurs when PCR reaction mixtures are contaminated with 
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products of previous reactions.  In order to limit this, we used separate areas and 
dedicated equipment for the various stages in the amplification of DNA from clinical 
samples (Figure 2.1).  This comprised of a “one-way” laboratory system, where only 
unidirectional transfer of reagents, equipment or samples between certain areas was 
permitted (marked by filled arrows on Figure 2.1).    
Sample preparation, including defrosting, processing, cataloguing and nucleic acid 
extraction was carried out in a dedicated area reserved specifically for this purpose.  
PCR buffers and reagents were prepared in a clean room, with separate laboratory 
and personal protective equipment.  In the latter part of this work, positive controls 
comprised of known copy number RNA transcripts (McLeish et al., 2012).  Due to 
the potential for contamination of PCR reactions with high copy number transcripts, 
serial dilutions of RNA transcripts were additionally carried out in a dedicated 
laboratory area, separated from the area reserved for preparation of PCR reagents.    
cDNA synthesis and first round PCR reactions were carried out in the same area 
(marked with white arrows on Figure 2.1).  In the majority of this work, second 
round PCR was carried out in a dedicated laboratory area, separate from gel 
electrophoresis and preparation of sequencing reactions.  However, in later work, due 
to laboratory layout and space restrictions, backwards travel was necessary between 
the dedicated areas for these three procedures (marked by grey box on Figure 2.1).  
The adherence of all group members to these protocols has ensured that the 
occurrence of PCR contamination observed within the completion of the studies 
contained within this thesis has been minimal.   
 




FIGURE 2.1:  “One way” laboratory system for the prevention of carryover contamination in PCR 
reactions.  Filled arrows denote steps between areas which originally were designed to flow in one 
direction.  Backwards travel of reagents, samples or equipment was not permitted between these 
areas.  White arrows denote procedures which can be carried out in the same work-space.  In later 
laboratory work, due to space restrictions, second round PCR preparation and preparation of 
sequencing reactions were required to be carried out within the same laboratory area (marked with 
grey box).  An effort was still made to separate physical bench space, reagents and pipettes for these 
procedures.     
2.2.2 Extraction of RNA from clinical samples 
In cases where nucleic acids extracted during routine diagnostics at the SVC were 
not available for use in research studies, RNA was directly extracted from clinical 
specimens using the Qiagen Viral RNA Mini Kit (Qiagen, UK), according to the 
manufacturers’ instructions.  Samples were stored at -40°C and aliquots were 
defrosted in a microbiological safety cabinet.  Stool samples were thoroughly mixed 
with phosphate buffered saline (PBS) and clarified by low-speed centrifugation.  The 
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resulting supernatant was used in extraction procedures.  Respiratory and CSF 
samples were used directly in the extraction protocol.  
An identical protocol for RNA extraction was used in the processing of all sample 
types.  Briefly, 140µL of sample was incubated at room temperature with 560µL 
viral lysis buffer (Buffer AVL) prepared with 1µg/µL carrier RNA.  The addition of 
carrier RNA to the reaction mixture reduces degradation of viral nucleic acid by 
residual RNases and also assists the binding of RNA to the QIAamp Mini column 
membrane.  560µL of 96-100% ethanol was added and mixed by pulse vortexing.  
Each sample was passed through a QIAamp Mini column at 6,000 xg for 1 minute.  
Each sample was then subjected to two wash steps.  The first was with 500µL of 
wash buffer 1 (Buffer AW1) followed by centrifugation at 6,000 x g for 1 minute and 
the second with wash buffer 2 (Buffer AW2) followed by centrifugation at full speed 
for 3 minutes.  Residual buffer was removed by repeated centrifugation at full speed 
for 1 minute.  RNA was then eluted in nuclease free water in two 40µL volumes.  
The use of a double elution step is suggested to increase RNA yield to up to 90%.  
Extracted RNA was either used in downstream applications immediately or stored at 
-20°C or -45°C.      
2.2.3 Reverse transcription 
In the majority of studies, a two-step RT-PCR protocol was used.  Therefore, single 
stranded cDNA was generated by reverse transcription (RT) to allow amplification of 
extracted viral RNA by PCR.  RT was carried out using the A3500 Reverse 
Transcription System (Promega, UK) according to the manufacturers’ instructions 
but with certain modifications.   
Briefly, 5µL of eluate obtained from RNA extraction was incubated at 70°C for 10 
minutes.  15µL of master-mix containing RT reagents (Table 2.1) was added to each 
sample.  The reaction mixture was then incubated for 10 minutes at room 
temperature followed by an elongation step which was increased to 50 minutes at 
Materials and Methods 
39 
 
42°C.  Samples were then incubated for 5 minutes at 95°C and kept on ice for a 
further five minutes, in order to inactivate the reverse transcriptase enzyme and 
prevent it binding to the single stranded cDNA.  cDNA was then either used 
immediately for PCR reactions or stored at -20°C.   
TABLE 2.1:  Reagents included in reverse transcription reactions 
4µL 25mM MgCl 
2µL 10X reverse transcription buffer
5
 
2µL 10mM deoxynucleotide triphosphates 
(dNTPs) 
0.5µL Recombinant RNasin ribonuclease 
inhibitor (25U/µL) 
1µL 100µM random hexamers 
0.6µL Avian myeloblastoma virus reverse 
transcriptase (10U/µL) 
4.9µL Nuclease free H2O 
All positive and negative controls for use in subsequent PCR reactions were included 
in the RT step to ensure consistency of results.  The use of random primers in the RT 
reaction enabled cDNA generated to be used both for the analysis of multiple 
genome regions and for studies of other RNA viruses.  As an alternative to random 
primers, an RT reaction utilising the outer PCR primers designed for the desired 
genome fragment can give increased sensitivity.  This technique was used in the 
analysis of certain samples which proved challenging to amplify with standard 
procedures.  However, as this technique precludes the use of generated cDNA for 
other purposes and is therefore not cost-effective, it was only used sparingly.   
In the screening of CSF samples for HRV, samples were combined into pools of 10 
prior to RT.  10 sequential samples from the CSF archive were selected and 2µL of 
RNA from each was combined to create a 20µL pool.  This was then thoroughly 
vortex mixed and 5µL used in the RT reaction.  The study of HRV incidence in CSF 
samples and the repeated screening of certain reported HRV negative respiratory 
                                                     
5
 10X reverse transcription buffer was supplied with the Reverse Trasncription System kit (Promega, 
UK) and was composed of 100mM Tris-HCl (pH 9.0 at 25°C), 500mM KCl and 1% Triton® X-100.   
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samples (described in Chapter 3) were the only studies undertaken for which samples 
were pooled.  Although the value of pooling samples for screening large numbers of 
patients has been previously demonstrated for human metapneumovirus (HMPV) 
(Gaunt et al., 2009) and coronavirus (HCoV) (Gaunt et al., 2010), the overall 
incidence of HRV in respiratory samples is too high to give any value to the 
procedure in investigations of respiratory epidemiology.   
2.2.4 PCR and sequencing of HRV positive samples 
Within the studies presented in this thesis, PCR had a dual role.  Firstly, samples 
were screened by PCR based methods (Chapter 3) for the presence of HRV and 
secondly, specific sequence fragments were amplified for studies of genetic 
diversity, recombination and evolution within the HRV genome.   
2.2.4.1 PCR Primer Design 
The design of PCR primers for use in the amplification of various genome regions of 
all three species of HRV required a delicate balance between primer degeneracy (to 
counteract high genetic diversity within regions) and primer specificity (to avoid 
amplification of non-target sequences).   All PCR primers were designed in-house, 
either as part of a previous study (Wisdom et al., 2009b, 2009a) or specifically for 
the studies described.   Upon initial design, each primer set was tested for sensitivity 
using serial 10-fold dilutions of known positive clinical samples
6
.   
The first step in the design of PCR primers was to obtain all relevant sequences from 
Genbank.  These aligned sequences were then inspected for areas of high sequence 
conservation around the target regions.  Regions of high sequence conservation were 
                                                     
6
 In 2011, known copy number RNA transcripts were developed of several of these positive clinical 
samples which had been previously used for both positive controls and sensitivity testing (McLeish et 
al., 2012).  After the advent of these RNA transcripts, sensitivity tests were carried out using known 
copy number samples at 10-fold dilutions. 
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then analysed and a fragment for the PCR primer was selected according to the 
following criteria: 
o High sequence conservation – as few degenerate bases as possible 
o Length of close to 23-25 nucleotides (not less than 16 and not more 
than 26) 
o Melting temperature (Tm) predicted to be close to 60°C 
o G+C content of 40-60% with 3ˈ GC clamp where possible 
o No self-annealing or hairpin formation 
Calculations of Tm and analysis for self-annealing/hairpin formation were carried 
out in with the aid of the OligoCalc progam (available at 
http://www.basic.northwestern.edu/biotools/oligocalc.html).  Primer pairs for use in 
the same PCR reaction were selected to have a Tm of within 5 degrees of each other, 
where possible.  The specificity of each primer set was confirmed by analysis with 
primer BLAST (www.ncbi.nlm.nih.gov/tools/primer-blast) to ensure that primers did not 
match human or other non-target sequences in the sample.   
TABLE 2.2:  Codes for individual nucleotides and ambiguous bases used for design of PCR 
primers 




T  Thymine 
K G or T 
M A or C 
S G or C 
W A or T 
Y T or C 
R G or A 
B G, C or T 
V G, C or A 
D G, A or T 
H A, C or T 
N A, C, G or T 
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2.2.4.2 PCR protocols 
PCR was used to amplify DNA fragments either for detection (in screening) or 
sequencing.  The PCR protocol consists of a number of temperature dependent steps 
carried out in a cyclical fashion.  The reaction mixture (Table 2.3) is subjected to 
incubation at 94°C which allows denaturation of the target DNA (either cDNA or 
first round PCR product).  The mixture is then incubated at 50°C to allow primer 
annealing and then at 72°C for nucleotide extension.  This is carried out for 30 cycles 
as standard, followed by a final extension step at 72°C.  Specific primers for each 
PCR reaction are detailed in Appendix 1.   
        TABLE 2.3:  Reagents used in PCR reactions   TABLE 2.4:  Cycling conditions used  
                in PCR reactions 







 30 94°C 18s 
Sense primer (100µM) 1µL  50°C 30s 
Antisense primer (100µM) 1µL  72°C 90s 
Taq polymerase
b 
(5U/µL) 0.08µL  1 72°C 300s 
Either cDNA or first round 
PCR product
c 
1 – 2µL     
Nuclease free H2O Up to 20µL     
 
a 
dNTPs were acquired as separate dATP, dGTP, dCTP and DTTP 25mM aliquots (Promega, UK).  
These were then diluted to make 3mM stocks for use in PCR.   
b 
 Taq polymerase was GoTaq® DNA Polymerase (Promega, UK).  
c 
 For the first round of PCR, 2µL cDNA was incorporated into the reaction mixture.  For the second 
round of PCR, 1µL of first round product was used.    
 
The reagent concentrations and cycling conditions detailed above (Table 2.3 and 
Table 2.4) represent the standard conditions used.  All protocols with new primers 
were attempted initially under these conditions.  However, individual PCR protocols 
were optimised prior to use with study samples.  This involved using 10-fold dilution 
series of positive control samples and sequentially varying certain parameters to 
determine the optimal set of conditions for each PCR reaction.  Detection of HRV 
RNA transcript dilutions with 1000 copies present was targeted.  The most 
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commonly modified parameters included the annealing temperature and dNTP 
concentration.  In several cases, the sensitivity of a PCR protocol was greatly 
improved by using one of the same primers in both rounds (a hemi-nested reaction).  
All modifications to the standard protocol used for individual PCRs are given below 
(Table 2.5), along with a reference to the thesis chapter to which these reactions 
relate.   
TABLE 2.5:  Modifications to standard PCR protocols used for individual PCR reactions   










5ˈUTR Screening UTR Screen None Annealing 
temperature of 
53°C in the 
second round 
Chapter 3 
VP4/VP2 Typing VP4/VP2 None None Chapter 3 
HRV-A VP1 
Amplifcation 






Same first round 
product used for 
both second round 
fragments 




B VP1 Hemi-nested 
reaction – same 

















C VP1 PCR 2 All reaction 
components 
scaled up to give a 











UTR 2 Hemi-nested 
reaction – same 




53°C in the 
second round 
Chapter 5 





UTR 3 Hemi-nested 
reaction – same 




53°C in the 
second round 
Chapter 5 
HRV-C 5ˈUTR 5ˈ 
end 










reaction – same 









A 3Dpol None Annealing 
temperature of 





B 3Dpol None Annealing 
temperature of 





C 3Dpol None Annealing 
temperature of 






C 2A Same first round 
product used for 
both second round 
fragments 
 
4µL 3mM dNTPs 
used in first 
round
b




PCR 2) obtained 









For reactions using more than two primers, the volume of nuclease free H2O was adjusted 
accordingly.  
b  
Where volume of dNTPs used is increased, the volume of nuclease free H2O was adjusted 
accordingly. 
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2.2.4.3 SuperScript One-Step reverse transcription polymerase chain reaction 
(RT-PCR) 
For samples which were difficult to amplify using the optimised GoTaq protocols 
listed above, a more sensitive one-step combined RT and PCR protocol was used.  
This utilised the Superscript III One-Step RT-PCR system with Platinum Taq DNA 
polymerase (Invitrogen, UK) with parameters and cycling conditions as previously 
optimised for the amplification of EV (McWilliam Leitch et al., 2009a). 
  TABLE 2.6:  Reagents used in Superscript III          TABLE 2.7:  Cycling conditions used  
  RT-PCR reactions                                        in Superscript III RT-PCR reactions 
2X Reaction Mix
7
 10µL  Number 
of cycles 
Temperature Time 




 1 43°C 1 hour 
Outer Antisense PCR primer 
(100µM) 
1µL  20 53°C 60s 




0.4µL  55°C 60s 
Extracted RNA 6µL  1 70°C 15 
min 
Nuclease free H2O 1.6µL  1 94°C 2 min 
   40 94°C 30s 
   50°C 30s 
   68°C 90s 
   1 68°C 5 min 
 
All reactions were prepared on ice and contained reagents as detailed (Table 2.6).  
RNA directly extracted from clinical specimens was used.  As the outer PCR primers 
for the particular reaction were used for the RT step, the resulting product could only 
be used for amplification of that specific segment.  The Platinum Taq used in the 
amplification is complexed with an activity blocking antibody that renders it 
unreactive at room temperature.  This prevents non-specific annealing and therefore 
                                                     
7
 2X Reaction Mix is supplied with the Superscript III One-step RT-PCR kit and contains 4mM of 
each dNTP and 3.2mM of MgSO4. 
8
 In contrast to standard reverse transcription reactions, RT undertaken with the Superscript III system 
used Moloney murine leukaemia virus reverse transcriptase (M-MLV-RT), as opposed to AMV-RT.    
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increases sensitivity.  The complexed antibody is denatured at the high temperatures 
used in the thermal cycling (Table 2.7) and polymerase activity resumes.  The first 
round product obtained from the Superscript III reaction was used directly in second 
round of PCR, as previously described.        
2.2.4.4 Gel Electrophoresis 
The presence of PCR positive samples and the approximate length of DNA fragment 
amplified was visualised by agarose gel electrophoresis.  2% agarose gels were 
prepared with 1X tris-acetate-EDTA (TAE) buffer (Severn biotechnologies, UK) and 
1/10000 ethidium bromide (10mg/µL)
9
.  10µL of second round PCR product was 
thoroughly mixed with 1.5µL of 6X loading dye and loaded directly into a well of 
prepared gel in an electrophoresis tank containing 1X TAE buffer.  As the loading 
dye is significantly denser than the TAE buffer, it allows the sample to sink into the 
well.  The dye is also negatively charged and so co-migrates with the DNA within 
the sample, allowing monitoring of the progress of the sample along the gel.  An 
exACTGene Low Range Plus DNA ladder (Fisher Scientific, UK) was loaded 
alongside the PCR products.    
All second round PCR products were electrophoresed at 150 volts for 30 to 45 
minutes, depending on the size of the expected product.  Resulting bands were 
visualised using a UV transilluminator.        
2.2.4.5 Gel extraction and purification of amplified products 
In cases where multiple products were visualized on an agarose gel and the PCR 
reaction could not be further optimised, bands were excised and purified using the 
Illustra GFX PCR DNA and Gel Band Purification Kit (GE Life Sciences, UK), 
according to the manufacturers’ instructions.  Briefly, DNA bands were manually 
                                                     
9
 Ethidium bromide was used for the majority of initial screening studies undertaken during this thesis.  
However, as it is an intercalating agent and is a known carcinogen with prolonged exposure, certain 
University areas discourage its use.  For later studies, SybrSAFE was used as an alternative. 
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excised under UV transillumination with minimal exposure time to prevent DNA 
damage.  Excised bands were incubated at 60°C with 10µL of Capture Buffer 3 per 
10mg agarose, until the agarose was completely dissolved.  The DNA within the 
sample was bound to a silica membrane with a Illustra GFX Spin Column by 
spinning at 16,000 xg for 30 seconds.  The sample was then washed with an ethanol 
containing buffer to remove salts and impurities.  Finally, each sample was incubated 
at room temperature for one minute with 50µL nuclease free water and eluted by 
spinning at 16,000 xg for 30 seconds.  If not required for immediate use, both 
excised bands and eluted DNA could be stored for up to one week at -20°C.      
2.2.4.6 PCR clean-up procedures 
All PCR products which were not extracted directly from agarose gels underwent an 
additional PCR clean-up step to remove unincorporated primers and dNTPs and to 
improve the fidelity of sequencing reactions.  This step was carried out using 
EXOsap-IT (Fisher Scientific, UK), which is a combination of Exonuclease I to 
degrade single stranded DNA and Shrimp Alkaline Phosphatase to dephosphorylate 
excess dNTPS.  2µL of EXOsap-IT was incubated with 5µL second round PCR 
product at 37°C for 15 minutes.   The active enzymes were then denatured at 80°C 
for 15 minutes.  The resulting mixture in theory contained only PCR product, 
nucleosides and inorganic phosphate and was then used directly for sequencing 
reactions.   
2.2.4.7 Sanger sequencing 
All sequencing undertaken during the course of this work employed the Sanger 
method, whereby the reaction mixture contains all four chain terminating 
dideoxynucleotides labelled with distinct fluorescent dyes allowing the DNA 
sequence to be determined sequentially.  This was performed using the ABI BigDye 
Terminator kit (Applied Biosystems, Warrington, UK), with reagents and cycling 
conditions described below (Table 2.8 and Table 2.9).  PCR products were 
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sequenced in both sense and antisense orientation using second round PCR primers.  
The amount of BigDye used in each reaction was adjusted according to fragment 
size, with up to 2µL being used for the largest sequence fragments. 
        TABLE 2.8:  Reagents used in    TABLE 2.9:  Cycling conditions used  
        sequencing reactions     in  sequencing reactions 
PCR product 2µL  Number 
of cycles 
Temperature Time 
BigDye v3.1 1µL - 2µL
 
 25 95°C 30s 
Primer (100µM) 1µL  50°C 20s 
Nuclease free H2O to 20µL  60°C 4 min 
   1 68°C 5 min 
   
Reactions products were sent to the in-house sequencing facility at The Genepool 
(Ashworth Laboratories, Kings Buildings, Edinburgh) and results were returned in 
the form of FASTA and corresponding ABI files.   
2.3 Computational Methods 
2.3.1 Statistical methods 
Unless otherwise stated, all statistical tests carried out on epidemiological data were 
two-tailed Fishers exact tests, appropriate for small datasets with limited categories 
for each variable.  
2.3.2 Sequence alignment 
All phylogenetic and evolutionary analyses were entirely dependent on the 
construction of a sequence alignment in which homologous sequences were correctly 
identified and aligned.  The alignment process is central to all downstream analysis 
and prevents false conclusions regarding phylogeny, genetic diversity and 
recombination.      
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Sequences were imported into SSE v1.0 (Simmonds, 2012) and initially aligned with 
a combination of the CLUSTAL-W or MUSCLE version 3.8 algorithms (Thompson 
et al., 1994; Edgar, 2004) implemented within SSE v1.0.  Alignments were refined 
where absolutely necessary by manual editing at the amino acid level (for coding 
sequences) and nucleotide level (for non-coding sequences).  PCR products were 
sequenced in both sense and antisense directions to allow for dual coverage.  Any 
gaps and mismatches between the sense and antisense sequences were resolved by 
inspection of accompanying chromatograms in the Chromas software 
(www.technelysium.com.au).  Amino acid sequences were obtained by translation of 
nucleotide sequences carried out in the SSE v1.0 software package (Simmonds, 
2012) and using a standard genetic code.       
2.3.3 Database searching 
A critically important step in many of the analyses within this thesis was the 
construction of comprehensive datasets containing all published sequences of a 
particular gene region or species.   The inclusion of all available published sequences 
with sequences generated from our studies allowed the most comprehensive 
investigations possible to be carried out.  All database searches were carried out of 
nucleotide sequences available in the three major online databases (Genbank NCBI, 
European Molecular Biology Laboratory (EMBL) and DNA Databank of Japan 
(DDBJ)).  The existence of a reciprocal agreement between the three major databases 
to cross-submit all sequences allowed all information required to be accessed via the 
NCBI Basic Local Alignment Search Tool (BLAST). 
The BLAST method of searching sequence databases was first described in 1990 
(Altschul et al., 1990) and is based on locating regions of local similarity between a 
query sequence and all database entries.  This procedure was then extended in 1997 
to an algorithm more based in biological reality due to its ability to deal with gaps in 
sequence alignments (Altschul et al., 1997).  BLAST is an heuristic, which while fast 
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and reasonably accurate does sacrifice some of its accuracy for speed and cannot 
guarantee that all homologous sequences will be returned.  The optimization of 
certain parameters is therefore vital to the accuracy of the endeavour.     
All studies presented within this thesis utilised a nucleotide BLAST procedure to 
obtain the maximum number of matching and potentially homologous sequences for 
analysis.  In brief, an input query sequence in FASTA format is broken down into 
“words” of a certain length.  The entire database is then searched for occurrences of 
every possible word generated from the query sequence.  These have a default length 
of 11 nucleotides.  However, as an exact match of the entire word length is required 
for progression of the algorithm, the word length can be specified in order to alter the 
sensitivity and specificity of the protocol.  When a match is located in a database 
sequence, the hit is extended by adding bases from the query sequence at both the 5ˈ 
and 3ˈ ends and checking for matches in the database sequence.  The growing 
alignment is sequentially scored based on a specified match/mismatch penalty.  The 
default value for match/mismatch score is 1/-2.  However, this was decreased to 1/-1 
for searches for sequences which were more distantly related.  The alignment 
extension is continually scored until the score drops below a specified threshold (20 
for nucleotide sequences).  The extension step allows the differentiation of 
meaningful matches from random ones.  Sequences returned were assigned an E-
value, which is an estimate of the probability of a hit being a false positive. 
In searches which were conducted in order to obtain the total number of VP4/VP2 
sequences, specificity was sacrificed for sensitivity in terms of both match/mismatch 
scoring and word length.  Alignment results were then edited manually to contain 
only sequences that covered >90% of the query region (therefore excluding small, 
random matches) and those which were annotated as other Picornavirus species.  All 
published sequences obtained by database searching are catalogued in our alignments 
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and presented in phylogenetic trees and other analyses by accession number; which 
is consistent across all three major databases.         
A large number of HRV polyprotein sequences (which are not yet associated with 
publications) contain large gaps within the coding sequence, presumably due to 
incomplete coverage during Illumina sequencing.  As they are all nearly complete 
genomes, these sequences were considered as complete genomes and were only 
excluded if the gaps affected the regions under investigation and comprised of more 
than 10% of the region.   
2.3.4 Likelihood mapping analysis 
In the analysis of the occurrence of recombination between three coding regions of 
HRV-A, -B and –C, likelihood mapping analysis was used to visualise the 
phylogenetic signal content of the alignment a priori (Strimmer and von Haeseler, 
1997).  In addition, this method confirms that sequences have undergone the correct 
mode of evolution to result in a resolved bifurcating phylogenetic tree and therefore 
that conclusions based upon such an inferred tree would be valid.   
Likelihood mapping analysis is based on quartet puzzling and was implemented in 
the TREE-PUZZLE v5.2 software (Schmidt et al., 2002).  Briefly, maximum 
likelihoods were calculated for each of the 3 possible unrooted trees derived from 4 
randomly chosen sequences from the alignment (a quartet) (Strimmer, 1994).  Using 
the Hasegawa-Kishino-Yano  (HKY) model of substitution, a total of 10,000 quartets 
were analysed and each was assigned into a particular category based on the 
maximum likelihood.  The results are plotted onto a triangular surface, whereby the 
proportion of quartets in each of the three vertices represent fully resolved 
bifurcating phylogenetic trees and those located in the sides of the triangle represent 
equal observed likelihoods between two of the calculated trees.  The proportion of 
quartets in the centre of the triangle represent those with an unresolved star-like 
phylogeny, whereby the likelihoods of all three possible trees are equal.  Any 
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analysis with more than 20-30% of analysed quartets showing unresolved phylogeny 
are not considered reliable for phylogenetic reconstruction.  Possible explanations 
include “noisy” data, lack of sequence homology, alignment errors and 
recombination within the region subjected to the analysis.    
Likelihood mapping analysis has been previously used to confirm the suitability of a 
subset of HRV VP4/VP2 sequences (Savolainen et al., 2002) and EV sequences 
(Andersson et al., 2002; Lindberg et al., 2003) for phylogenetic analysis.  In addition, 
the method has also been used to demonstrate the star-like bursting radiation 
resulting from the rapid transmission of human immunodeficiency virus 1C (HIV-
1C) after introduction to South America (Véras et al., 2011) and to assess suitability 
of different regions of HAV for genotyping (Joshi et al., 2008).   
2.3.5 Construction of phylogenetic trees 
Phylogenetic analysis uses sequence information to provide an estimate of the 
evolutionary relationships between sequences, provided that adequate homology 
exists.  Studies within this thesis were largely reliant on the use of the Molecular 
Evolutionary Genetics Analysis (MEGA) software version 4.0 (Tamura et al., 2007) 
and latterly, version 5.0 (Tamura et al., 2011).  Unless otherwise stated, all 
phylogenetic trees used for HRV typing and analyses of recombination were 
constructed by neighbour-joining method (Saitou and Nei, 1987) from 100 bootstrap 
re-sampled sequence alignments of maximum composite likelihood (MCL) (Guindon 
and Gascuel, 2003) distances with pairwise deletion for missing data 
10
.  
Phylogenetic trees were improved by the inclusion of an outlier, which rooted the 
tree and therefore provided an estimate of which nodes under study were the most 
ancient.  For full HRV species analyses that were conducted, sequence NC_001430: 
EV70 was used to root the tree.  However, for analyses of less genetically diverse 
                                                     
10
 Phylogenetic trees included in Chapter 6 were latterly constructed with 1000 bootstrap repetitions.  
These were compared directly with trees constructed with 100 bootstraps and no detectable difference 
was found.     
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sequences (within HRV species), a sequence of different species or type was used 
(specified throughout).    
The neighbour-joining (NJ) method was first described by Saitou and Nei in 1987 
(Saitou and Nei, 1987).  It is a distance based method that produces an additive tree 
and is one of the most widely used methods for phylogenetic tree reconstruction 
(Gascuel and Steel, 2006).  While the authors have stated that the method is not 
guaranteed to always produce the minimum evolution tree, it has good reliability in 
producing the correct tree topology (Saitou and Nei, 1987).  The fact that it is 
significantly more computationally efficient than more traditional methods based on 
maximum parsimony allows the relatively fast calculation of trees reconstructed 
from a large number of operational taxonomic units (OTUs).  As the name suggests, 
NJ is based on the principle of sequentially joining the most closely related OTUs via 
a single interior node in an unrooted bifurcating tree.  Initially, all OTUs/sequences 
are represented in a star-like tree with no internal clustering.  Evolutionary distances 
are calculated in a pairwise fashion between all sequences and the OTU pair with the 
shortest inferred branch lengths are joined by an internal tree node.  The algorithm 
then considers this pair as a single OTU and repeats the process of analysing 
evolutionary distances between all sequences, culminating in the joining of the pair 
to their nearest neighbour.  This process is repeated sequentially until all sequences 
are included in the final tree.    
One of the limitations of the NJ method is that it assumes that no backwards or 
parallel substitutions have taken place.  Therefore, NJ trees are subject to long branch 
attraction (Felsenstein, 1978), whereby it can predict that two OTUs are more closely 
related than they actually are, as the algorithm cannot correct for multiple 
substitutions at specific sites.  Other phylogenetic reconstruction methods such as 
those relying on maximum likelihood optimality criterion are generally more 
biologically accurate due to their greater ability to correct for multiple hits (Holder 
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and Lewis, 2003).  However, as maximum likelihood methods of tree-building seek 
to explore a significant proportion of the tree space and score each tree, they are very 
computationally intensive methods and not practical for use on large datasets.   
The dual problems of inaccurate phylogeny estimation and long branch attraction 
exhibited in pure NJ algorithms can be prevented by the usage of an MCL method to 
calculate evolutionary distances within a dataset (Tamura et al., 2004).  The 
calculation of MCL distances is ideal for rapidly evolving sequences, as it 
automatically corrects for multiple mutational events at the same site and 
additionally incorporates a model of nucleotide substitution which is optimized 
automatically to fit the data (Tamura et al., 2011).  This includes such aspects as 
transition/transversion ratios, whereby it is recognised that purine-purine and 
pyrimidine-pyrimidine substitutions occur more readily than purine-pyrimidine in 
natural mutations. 
For datasets that were analysed with Bayesian Evolutionary Analysis of Sampling 
Trees (BEAST) software (Drummond and Rambaut, 2007), phylogenetic trees were 
additionally constructed by Bayesian methods implemented in the program.  These 
were found, in each case, to present identical tree topology to trees produced by the 
neighbour-joining maximum composite likelihood method.  
2.3.6 Bootstrapping 
In order to determine the robustness of observed phylogenetic groupings within the 
tree, all trees were constructed with either 100 or 1000 bootstrap resamplings.  The 
bootstrap is a statistical technique that was first applied to assessing confidence 
levels in phylogenetic groupings by Professor J. Felsenstein of the University of 
Washington in 1985  (Felsenstein, 1985).  The generation of bootstrap values for 
internal nodes of a phylogenetic tree gives an estimate of the reproducibility of a 
monophyletic clade.  Sequence data used to construct the original tree is randomly 
resampled and trees constructed from each of the pseudo-replicates produced.  The 
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proportion of observed trees in which each monophyletic clade is observed is then 
computed and reported as the bootstrap value (Holder and Lewis, 2003).  A high 
bootstrap value (close to 100) indicates that analysis of randomly selected subsets of 
the alignment data consistently predict the same clade (Berry and Gascuel, 1996).  
One of the major limitations of bootstrap analysis is that it fails to provide an 
estimate of the probability of an observed tree and merely indicates a degree of 
robustness for the tree phylogeny.  For instance, due to the inherent bias in methods 
of calculation of evolutionary distances, long branches subject to long branch 
attraction can have good bootstrap support, even if they do not represent a “true” 
phylogenetic relationship  (Swofford et al., 2001).      
For all phylogenetic studies included in this thesis, a bootstrap value of 70 was used 
as the threshold for determining adequate support.  MEGA v4.0 and v5.0 software 
packages present phylogenetic trees as both a majority rule bootstrap consensus tree 
and as the originally determined tree with bootstrap values superimposed.  The 
bootstrap consensus tree was used for phylogenetic analyses.   
2.3.7  Recombination detection methods 
The general strategy for the detection of recombination in sequence alignments was 
multi-faceted.  Central to all analysis undertaken was the topology of bootstrap 
supported phylogenetic trees.  Phylogenetic trees were constructed containing 
sequence fragments of varying sizes (depending on the specific analysis undertaken).  
Trees from sequential genome regions were manually inspected to identify 
phylogeny violations between clades with bootstrap support above the threshold of 
70.  All recombination events detected from the inspection of phylogenetic trees 
were further characterised by analysis with GroupScan and where possible, putative 
breakpoints were determined. 
In addition to the initial screening of sequence datasets by phylogenetic 
reconstruction, several computational analyses were undertaken to effectively screen 
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each dataset for the occurrence of recombination.  This was done to supplement and 
support results obtained from phylogenetic analysis.  Although a great number of 
methods for the detection of recombination in sequence data currently exist, methods 
often give differing or even, contradictory results (Posada and Crandall, 2001; 
Posada, 2002) and therefore a variety of different approaches were combined within 
this work. Screening analyses were undertaken with programs implemented in the 
Recombination Detection Program (RDP) v4.0 (Martin et al., 2010) and SSE v1.0 
(Simmonds, 2012) software packages and those available through the HyPhy 
datamonkey webserver (www.datamonkey.org).  All algorithms used for the 
detection and description of putative recombination events are discussed below.     
2.3.7.1 Recombination Detection Program v4.0  
The initial screening of each sequence dataset for the occurrence of recombination 
with bioinformatics based methods was undertaken using algorithms implemented in 
RDP v4.0 (Martin et al., 2010).  RDP v4.0 incorporates numerous different methods 
for the analysis of recombination in sequence data.  Of these, we subjected our 
datasets to analysis with RDP (Martin and Rybicki, 2000), GeneConv (Padidam et 
al., 1999), MaxChi (Smith, 1992), Chimaera (Posada and Crandall, 2001), SiScan 
(Gibbs et al., 2000) and BootScan (Martin et al., 2005).  A putative recombination 
event was accepted for further analysis if it was detected by more than two of these 
methods and returned a p-value of less than 0.05.  Although these algorithms employ 
varying methods of detecting and characterising potential recombination events, only 
BootScan within the RDP package takes account of phylogenetic incongruence 
observed between different sequence fragments.  As GroupScan offers a preferable 
method to BootScan for the identification of putative recombination breakpoints 
(Section 2.3.7.4), the algorithms available within the RDP v4.0 software package 
were used only for screening purposes.      
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2.3.7.2 Genetic Algorithm for Recombination Detection (GARD) and Single 
Breakpoint Recombination (SBP) 
All coding region datasets analysed for the occurrence of recombination were 
analysed with the Genetic Algorithm for Recombination Detection (GARD) and 
Single Breakpoint Recombination (SBP) programs (Kosakovsky Pond et al., 2006b, 
2006a), available on the HyPhy Datamonkey webserver (www.datamonkey.org). 
The two programs operate in a highly similar manner.  However, SBP seeks to 
confirm the presence of recombination within a sequence alignment and GARD 
seeks to locate all potential recombination breakpoints.  The method is based on a 
search for sequence specific phylogenies between different regions of an alignment, 
concentrating on a single inferred breakpoint for SBP and with a more heuristic 
approach in GARD.  Briefly, a NJ tree is constructed for the full sequence alignment 
and an AICc (small sample Akaike Information Criterion) score is calculated.  The 
score takes into account the nucleotide model specified and rate parameters and 
branch lengths are estimated by maximum likelihood.  The sequence alignment is 
then split into sequential blocks with a breakpoint (i) in the middle.  An NJ tree and 
corresponding AICc score are calculated for each block.  In SBP, this process is 
repeated for every possible location of the breakpoint.  If the AICc score is higher for 
any individual segment than for the alignment as a whole, recombination is deemed 
to have acted on the alignment.  In GARD analysis, a more heuristic approach to 
searching the space for putative breakpoints is employed, as scanning every possible 
combination of breakpoint locations is not practical.  In order to infer a putative 
recombination breakpoint, the algorithm does not always require a topological 
change to be observed.  Instances of changes in branch length between segments are 
additionally reported (Kosakovsky Pond et al., 2006b, 2006a).   
Datasets were analysed both as full HRV species and as individual HRV types.  In 
addition, sets of sequences involved in recombination events observed by other 
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methods (ie/ RDP or phylogenetic incongruity) were specifically subjected to 
analysis with GARD and SBP, in order to verify events observed.   Due to the 
restriction placed upon individual server usage, a full analysis of all three HRV 
species concurrently was not able to be carried out in this manner.   The model 
selection tool offered within the datamonkey webserver was employed and the 
appropriate model of nucleotide substitution was used for each GARD/SBP analysis. 
2.3.7.3 TreeOrderScan 
The program TreeOrderScan in SSE v1.0 is a sequence analysis tool used to directly 
visualize the frequency of recombination events in a particular sequence alignment 
and provide a preliminary analysis of potential breakpoints.  TreeOrderScan analyses 
a sequence alignment over sequential fragments of defined length and increment.  
Optimal trees are produced for each sequence fragment and branches collapsed to a 
pre-specified bootstrap support threshold.  The program then directly compares the 
branching order of trees from each fragment and catalogues any phylogeny 
violations.  This is then presented as a half-diagonal matrix, giving an overview of 
the degree of phylogenetic incongruence observed in each region and additionally as 
a specific list of putative violations.  Sequence datasets can be sub-divided into 
groups, which then allows the computation of frequencies of phylogeny violations 
both within and between groups (for instance, different HRV species).     
TreeOrderScan was used as an initial tool to screen alignments for recombination, 
using a sequence fragment of 300 nucleotides and an increment of 30.  This was 
implemented in analysis of recombination within the 5ˈUTR of HRV-C (Chapter 5) 
and analyses of recombination within the coding regions of all three HRV species 
(Chapter 6).  All analyses were undertaken using EV70 : NC_001430 as an outgroup.   
This technique has also been used for the analysis of recombination in apthoviruses 
(Heath et al., 2006), HRV (Linsuwanon et al., 2011) and EV (Simmonds and Welch, 
2006).      




In instances where recombination was detected by inspection of phylogenetic trees 
and the usage of the computational methods described above, GroupScan was used in 
order to verify putative events and determine recombination breakpoints where 
possible.  GroupScan is also implemented within the SSE v1.0 software package.   
GroupScan was first described in 2005 (Simmonds and Midgley, 2005) and is used 
to score the extent of grouping of a query sequence with two or more control groups.  
The grouping score is a measure of how deeply embedded within a particular group a 
query sequence is.  For instance, a score of 0 indicates that there is no grouping and a 
score of 1 indicates that the query sequence groups deep within a clade of control 
sequences.   Sequences are analysed in a sequential fashion, with both fragment size 
and increment being specified by the user.  The output shows a graph with the 
midpoint of the analysed fragment represented on the x axis and the grouping score 
on the y.  This can be used to determine approximate recombination breakpoints, 
when a query sequence is scanned against its nearest neighbours in both regions.  
The putative breakpoint is determined by point of intersection of the grouping score 
trace of both parental sequences.   
The GroupScan method was used for all determinations of recombination 
breakpoints.  In preference to the method commonly employed in BootScan and 
Simplot analyses, GroupScan can consider entire groups of sequences as control 
groups and therefore doesn’t lose valuable phylogenetic information by condensing 
these sequences to a single consensus.  This also allows the calculation of 
recombination breakpoints in circumstances where parental sequences are not present 
within the dataset analysed.  The RDP algorithm also returns estimations of 
recombination breakpoints.  However, the RDP method relies purely on the analysis 
of evolutionary distance data, whereas GroupScan bases the score on observations 
conducted of bootstrap supported phylogenetic trees.   
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Within this thesis, GroupScan was used to pinpoint recombination breakpoints both 
in coding (Chapter 6) and non-coding (Chapter 5) genome regions.  The program 
was also used as an adjunct to other analyses in the further characterisation of 
putative recombination events highlighted by computational analyses, but not 
observed on bootstrapped phylogenetic trees.  All analyses carried out used a 
fragment size of 300 nucleotides and an increment of 30, unless otherwise stated.  
Coding region recombination breakpoints (Chapter 6) were additionally analysed 
with a 600 base fragment and 30 base increment.  These additional program runs 
generated highly similar results.         
2.3.8 Bayesian Evolution Analysis of Sampling Trees (BEAST) 
In order to model the evolutionary history of selected HRV sequence fragments and 
determine mean substitution rates, the BEAST software package was used 
(Drummond and Rambaut, 2007) to out Bayesian Markov Chain Monte Carlo 
(MCMC) analysis of input sequence datasets.  Sequence data is prepared for analysis 
using the adjunct software Bayesian Evolutionary Analysis Utility (BEAUti).  This 
allows input of tip dates for sequences (where known) and specification of priors, 
including a nucleotide substitution model and molecular clock.  The SRD06 model 
was used for all studies within this thesis, as has been recommended for the analysis 
of protein coding sequence data (Shapiro et al., 2006).  This model specifies an HKY 
model of nucleotide substitution, assumes equal base frequencies and specifies 
gamma distributed rate heterogeneity.  Additionally, the SRD06 model links the first 
two bases of a codon but allows the third base to have a different substitution rate 
and transition/transversion ratio.  A constant population size prior and a relaxed 
molecular clock were used for all analyses.  A relaxed molecular clock does not 
assume a constant mutation rate between lineages and so can assign different 
mutation rates to different tree branches.  All other priors are optimized during the 
execution of the program.     
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The XML file generated in BEAUti was input into BEAST and the MCMC 
algorithm was run for 20 million steps.  Initially, the program produces a 
phylogenetic reconstruction from the input sequence data and calculates the posterior 
probability density of this tree.  The algorithm then randomly varies a few of the 
input parameters to create a small, sequential step in the parameter space.  The 
posterior probability density of this step is calculated and a decision is made 
regarding the position of the chain in the parameter space.  If the posterior 
probability of the new step is higher, the chain moves on.  If a large drop is observed, 
then the chain maintains its position and an identical step is created.  However, if the 
posterior probability density decreases only slightly, the move is accepted in a 
proportion of cases.  This process is then repeated millions of times.  As the steps 
taken are small and incremental, chains tend to stay in regions of high posterior 
probability and therefore converge upon a specific reconstruction with a high 
posterior probability.   
BEAST output was analysed in the Tracer program, as part of the BEAST package.  
On completion, inspection of the output files can help to give an indication of 
whether the number of steps in the chain was sufficient.  Each output parameter is 
reported with an estimated sample size value (ESS).  Values of less than 200 indicate 
a requirement to optimize input priors or increase the number of MCMC steps.  In 
order to reconstruct phylogenetic trees produced by Bayesian methods, tree must be 
annotated in TreeAnnotator program (also part of the BEAST package) and 
visualized in the FigTree software.   
In order to verify that the specified priors were not inadvertently influencing the 
results obtained, each sequence dataset was subjected to an “empty” run of the 
BEAST algorithm with sequence data excluded.  In addition, each sequence dataset 






Epidemiology and Clinical Correlations of HRV 
3.1 Introduction 
3.1.1 Characteristics of circulating HRV in populations of patients with 
respiratory illnesses 
 
HRV are very common respiratory infections and the classic triad of rhinorrhoea, 
cough and headache has been experienced on numerous occasions by most of the 
population.  Seropositivity for HRV exceeds 90% by two years of age (Blomqvist et 
al., 2002a).  However, even this staggeringly high seroprevalence is likely to be an 
underestimate, as the methods employed in this study would have overlooked not 
only 12 now recognised HRV-A/-B types
11
 (www.picornaviridae.com) but the entire 
species C.    The gradual shift to the use of molecular based methods for HRV 
screening has enabled much more accurate estimates of HRV incidence and 
worldwide circulation to be produced.   
HRVs are routinely detected in respiratory samples in every month of the year and 
all three species have been found to have a global distribution (Briese et al., 2008).  
The documented detection frequency of HRV in respiratory samples ranges from 
7.9% - 64.3% (Alper et al., 2008; du Prel et al., 2009; Brittain-Long et al., 2010; 
Chan et al., 2012; Chidlow et al., 2012; Renwick et al., 2007; Lamson et al., 2006; 
Arden et al., 2006; Kistler et al., 2007a)
12
.  Two seasonal peaks in HRV detection are 
generally observed; one in the early autumn and one in the spring (Jin et al., 2009; 
                                                     
11
 Throughout this chapter, the term “HRV type” is used to refer to a phylogenetic group of HRV 
sequences with pairwise nucleotide p-distance in VP4/VP2 of below the proposed threshold for each 
species (Simmonds et al., 2010; McIntyre et al., 2013a).  The process of defining these thresholds and 
assigning HRV sequences into genotypically assigned types in described in Chapter 4.   
12
 Only detection rates from published studies which used RT-PCR based screening methods are 
given.   
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El-Sahly et al., 2000).  In contrast to other common respiratory viruses and other EV 
species, HRV types do not appear to circulate in an epidemic fashion (with a small 
number of circulating types being periodically replaced).  Instead, a large number of 
genetically distinct HRV types circulate concurrently (Savolainen et al., 2002; 
Wisdom et al., 2009b), with no discernible predominance of a particular strain or 
species (Fry et al., 2011).  The existence of over 150 distinct types and the lack of 
cross-immunity make this constant circulation possible.  Despite the abundance of 
HRV types circulating during one peak season, there appears to be relatively limited 
persistence of types from one season to the next.  One study which considered HRV 
circulating between September 2006 and Feburary 2007 found that only 5 of the 43 
types observed were present in both study months and one HRV-C positive patient 
was found to be re-infected with HRV-A only 5 days later (Wisdom et al., 2009b).  
The characteristic, almost random, fashion in which HRV appears to circulate in 
respiratory samples makes discerning patterns and possible networks of transmission 
nearly impossible. 
HRV-A strains are generally the most frequently detected, while HRV-B is 
comparatively rare (Chidlow et al., 2012; Wisdom et al., 2009b).  A few sporadic 
studies, mostly originating from the Asian-Pacific region have reported a higher 
prevalence for HRV-C (Chan et al., 2012; Jin et al., 2009).  No consistent bias 
towards infection of male or female patients has been evident in published studies.  
Although one study found an a slight excess of HRV-C infections in female patients 
(Wisdom et al., 2009b), another found a slight excess overall of HRV in male 
patients (Chan et al., 2012).  Overall, precise epidemiological characteristics of HRV 
infections are difficult to discern, due to the very high incidence in the general 
population and the large number of distinct strains circulating concurrently.   
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3.1.2 Involvement of HRV in infections out with the upper respiratory 
tract  
The classical perception of HRV as merely an agent of the “common cold” caused 
this group of viruses to be largely overlooked for many years.  In addition to their 
known association with mild URTIs, the realisation that HRV can effectively 
replicate in the lower airways has led to a now extensive association with lower 
respiratory tract infection (LRTI), especially in immunocompromised patients 
(Gutman et al., 2007; Parody et al., 2007; Papadopoulos et al., 2000; Kusel et al., 
2006; Papadopoulos et al., 1999; Han et al., 2009; Linsuwanon et al., 2009; Garbino 
et al., 2009).  The reported detection frequency of HRV in lower respiratory tract 
specimens ranges from 12.6% to 37.8% (Fry et al., 2011; de Almeida et al., 2010; 
Costa et al., 2011; Arden et al., 2006).  HRV are also clinically important causes of 
exacerbation of chronic lung diseases, such as asthma (Khetsuriani et al., 2008; 
Bizzintino et al., 2011; Miller et al., 2009a; Friedlander and Busse, 2005) and cystic 
fibrosis (de Almeida et al., 2010; Smyth et al., 1995).   
In addition to severe illness within the respiratory tract, HRV has been implicated in 
the development of acute otitis media (AOM) (Nokso-Koivisto et al., 2006; 
Pitkäranta et al., 1998; Savolainen-Kopra et al., 2009a).  Indeed, one study isolated 
HRV from middle ear fluid in 41% of episodes of AOM (Blomqvist et al., 2002a).  
However, this rate was obtained from screening samples by cell culture based 
methods and is therefore likely to represent a significant underestimate of the true 
incidence.  HRV have also been linked to the development of acute and chronic 
sinusitis (Pitkäranta et al., 2001, 1997), which are significant causes of morbidity in 
the general adult population.     
HRV have also been isolated, albeit infrequently, from blood samples of infected 
patients.  This is suggestive of a potential role of HRV viraemia in development of 
severe disease (Xatzipsalti et al., 2005).  Several isolated case reports have discussed 
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the occurrence of HRV in critically and systemically unwell patients, with HRV 
RNA being obtained from such distant sites as plasma, pericardial fluid, urine and 
stool (Broberg et al., 2011; Tapparel et al., 2009c).  However, these reports of 
isolation of HRV from sites other than the upper and lower respiratory tract do 
remain rare.  The current perception of HRV as predominantly causative agents of 
mild and unimportant illness has probably stifled the desire of the research 
community to investigate other potential clinical associations.    
3.1.3 The role of enteroviruses in aseptic meningitis 
The four known species of EV (EVA-D) are often isolated from faecal samples and 
have been associated with a wide variety of acute and chronic clinical illness 
(Pallansch and Roos, 2007).  However, despite a broad spectrum of clinical 
associations, all four species have been linked with CNS infection, especially aseptic 
(viral) meningitis.   
Although viral meningitis is generally self-limiting, it can potentially lead to 
devastating sequelae for affected patients, including seizure disorders and rapid 
deterioration of mental state in cases of progression to meningoencephalitis (Valcour 
et al., 2008).  A viral aetiology can only be defined in around 66% of cases of aseptic 
meningitis and of these EV are the most common, with an overall detection 
frequency of around 26% (Kupila et al., 2006).  Other clinically important causes of 
viral meningitis include herpes simplex viruses (HSV) types 1 and 2 and varicella 
zoster virus (VZV).   
Despite the close genetic relationship of HRV with EV and known phenotypic 
overlap in the causation of respiratory infections, to our knowledge, a potential 
relationship of HRV with previously undiagnosed cases of aseptic meningitis had not 
been examined.  Interestingly, HRVs have been isolated during the molecular 
surveillance of sewage samples in Finland, Latvia and Slovakia (Blomqvist et al., 
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2009) and in investigation of acute flaccid paralysis in South Asian children 
(Victoria et al., 2009).  The gastrointestinal tract is the major site of EV replication 
and many cases of meningitis are diagnosed on the basis of EV in stool samples.  
HRV have been traditionally thought to be unable to infect the gastrointestinal tract 
secondary to acid lability.  The isolation of HRV strains from environmental sewage 
samples was initially attributed to swallowed respiratory secretions or discarded 
tissues (Blomqvist et al., 2009).  One previous case report detailed the isolation of an 
HRV-C strain from the stool of a systemically unwell patient with pneumonia and 
pericarditis (Tapparel et al., 2009c).  In this case, HRV was also isolated from blood 
plasma and pericardial fluid.  However, the significance of the HRV positive stool 
sample was uncertain as it had a low observed viral load.  The detection frequency of 
HRV in stool samples had, at the time of the completion of our study, not been 
discussed. 
The studies presented within this chapter further investigate several intriguing 
aspects of the epidemiology of HRV.  Two studies of the epidemiology of HRV 
respiratory infections in Edinburgh aimed to further expand upon previous work 
carried out in this geographical region (Wisdom et al., 2009b) by analysing clinical 
features of HRV positive patients and directly comparing distribution of HRV 
species between patients with severe respiratory disease necessitating care in the ITU 
and those cared for on a general ward-based setting.  Preliminary investigations of 
the occurrence and detection frequency of HRV infections in both CSF and stool 
specimens were conducted, involving 1500 and 288 referred samples respectively.  
The results of these studies have highlighted a potential overlap in the disease 
manifestations of HRV/EV and highlight the requirement for further study of these 
areas. 
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3.2 Materials and Methods 
3.2.1 Sample selection 
3.2.1.1 Sample selection for screening of respiratory samples 
In order to investigate the clinical correlations of HRV species and types circulating 
in respiratory samples in Edinburgh, 556 samples were selected from the SVC 
archive for screening.  These were selected randomly from all samples referred for 
testing between September 2008 and May 2009.   
The SVC archive has been maintained since October 2005.  The total number of 
samples referred to the SVC has increased slightly every year and regular peaks in 
the number of referrals are additionally observed during the so-called “cold and flu 
months”.  These peaks coincide with the Health Protection Agency (HPA) influenza 
monitoring programme, which runs from October to May (www.hpa.org.uk).   
A sharp increase in the number of samples referred to the SVC was noted after the 
announcement of the H1N1 global swine flu pandemic in June 2009 (Figure 3.1).  In 
particular, the proportion of samples referred from community based patients 
increased dramatically, from between 1-3% in 2006 – 2008 to 9% in 2009 (marked in 
black on Figure 3.1).  The peak of referrals from community health care centres was 
21% of all referred samples in June 2009, coinciding with the official announcement 
by the World Health Organisation (WHO) of the H1N1 swine flu pandemic.  This 
increase could be attributed to greater public awareness and anxiety regarding cold 
and flu like illness (CFLI), a lower referral threshold and the practice of routine 
sampling of asymptomatic contacts in suspected cases.   
As a consequence of the artificially increased numbers of referred samples, it was 
deemed both inappropriate and impractical to use archived samples from this period 
for this study.  Therefore, samples were randomly selected from the 9 month period 
immediately prior to June 2009.  The universally high observed detection frequency 
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of HRV in respiratory samples diminishes the value of pooling samples for screening 
and therefore they were selected randomly to provide a cross-section of the time 
period, while still maintaining manageable numbers for a small study.  
 
FIGURE 3.1:  Total number of respiratory samples referred to the SVC for virological testing per 
month from October 2005 to May 2011.  Sections coloured in black represent the proportion of 
samples that were referred from community settings, whereas sections coloured in grey represent 
those referred from hospitalised patients.  The date of declaration of the swine flu pandemic by the 
WHO is marked by a dotted line. 
3.2.1.2 Sample selection for comparison of patients with acute and critical 
illness 
In order to investigate clinical associations between HRV species and severity of 
illness, a preliminary study was conducted comparing characteristics of HRV 
positive patients in both the Intensive Treatment Unit (ITU) and the Accident & 
Emergency department (A&E) or general wards.  A small subset of HRV positive 
samples from July 2007 until June 2008 with comprehensive patient information 
available were selected for inclusion.  These had previously undergone routine 
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diagnostic screening for respiratory viruses by staff at the SVC using standard 
protocols (Bennett et al., 2011; Dierssen et al., 2008; Scheltinga et al., 2005).  
Samples which were from the same patient were excluded.  All other data, including 
age and clinical details were obscured during the selection process.        
3.2.1.3 Sample selection for screening of CSF samples  
In parallel with the respiratory archive, an archive is maintained of all referred CSF 
samples and corresponding extracted RNA.  In order to investigate HRV as a 
potential causative agent of aseptic meningitis, one full year (2009) of referred CSF 
samples were selected and extracted RNA was combined into pools of 10 for 
screening.   
3.2.1.4 Sample selection for screening of stool samples 
The study presented within this thesis involved screening a total of 288 referred stool 
samples for HRV.  This work formed a part of a larger published study that included 
screening undertaken at the SVC by Dr H. Harvala of a further 333 diagnostic stool 
samples by real-time PCR (Harvala et al., 2012b).  The 288 samples included in this 
study comprised of stool samples isolated in May (n=90), September (n=108) and 
December (n=90) of 2010.  These represented referred specimens for routine 
diagnostic analysis and included a number of patients referred in the investigation of 
suspected norovirus outbreaks.      
3.2.1.5 Sample selection for screening of respiratory samples from September 
and December 2010 
In order to determine whether detection of HRV in stool specimens coincided with 
an increase in the same strains isolated from respiratory specimens, screening of a 
subset of respiratory samples was undertaken.  These were taken from the two 
calendar months with the highest detection frequency of HRV in stool samples.  Due 
to the concentration of HRV infections in stool in children under the age of five and 
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older adults, the sample selection was restricted to these age bands.  This led to the 
inclusion of a total of 731 respiratory samples (September: n= 221, December: 
n=510).   
3.2.2 Amplification of 5ˈUTR and VP4/VP2 region of HRV positive 
samples 
All samples were initially screened for HRV using a nested RT-PCR strategy for the 
5ˈUTR of HRV  and positive samples were then amplified in the VP4/VP2 region 
(described in Chapter 2).  VP4/VP2 sequences of samples grouped into phylogenetic 
clusters (types), in accordance with grouping with an HRV prototype strain.  
3.3 Results 
3.3.1 Epidemiological characteristics of HRV circulating in Edinburgh 
between September 2009 and May 2010 
556 samples were screened in the 5ˈUTR for HRV and VP4/VP2 typing was 
attempted for the 141 detected positive samples.  Of these, 8 samples (6%) were 
found to be EV strains, 6 samples could not be typed and 127 (23 %) were confirmed 
to be positive for HRV.  HRV-A was the most frequently observed (54%), followed 
by HRV-C (36%) and HRV-B was present in only 10% of samples  The observed 
prevalence of HRV infection was slightly higher in males (26%) than in females 
(20%) and a broadly similar relative frequency of HRV species was observed in both 
groups (Figure 3.2 A).  HRV was significantly more frequently detected in 
hospitalised patients than in patients in community based or outpatient settings 
(p=0.0001).  There was additionally no evidence of predominant circulation of any 
particular HRV species or type within any time period.   
Samples included were divided into those obtained from the upper respiratory tract 
(including nasopharyngeal aspirates) and those isolated from the lower respiratory 
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tract (including bronchoalveolar lavage).  The majority were taken from the upper 
respiratory tract (n=476; 86%).  There was no difference in detection frequency of 
HRV recorded in upper and lower respiratory samples (23% and 24% respectively).  
However, there was a statistically significant association between HRV-A detection 
and isolation of sample from the lower respiratory tract (p=0.034) (Figure 3.2 B).    
HRV infection was more frequently detected in patients under the age of 5 (31.2%) 
than in those aged 6 and over (12.1%) (p=0.001).  The relative frequency of different 
HRV species was largely similar across different age bands (Figure 3.2 C), with the 
only statistically significant difference being a higher rate of detection of HRV-C in 
the 7-12 month age group (p=<0.0001).   
The samples included in this study had previously undergone diagnostic screening at 
the SVC for adenovirus (AdV), parainfluenza virus (PIV) types 1-4, influenza A 
(FluA) and influenza B (FluB).  In addition, these samples had been previously 
screened for three types of human coronavirus (HCoV); HKU1, OC43 and 229E 
(Gaunt et al., 2010).  The most common co-infection observed was by AdV 
representing 10.2% of HRV infections (n=13).   There were four triple infections and 
one quadruple infection, all involving both HRV and AdV.  All triple infections 
originated from paediatric patients for in the general ward.  However, the quadruple 
infection was observed in a 7-12 month old ITU patient.  Detailed clinical data for 
this particular sample is missing, although the sample type is recorded as a 
bronchoalveloar lavage specimen.  Bronchoalveolar lavage is a traumatic and 
invasive sampling technique which is only carried out when indicated by high 
clinical suspicion of lower respiratory tract pathology.  This supports the assumption 
that there is likely to have been a relatively severe lower respiratory tract 
involvement in this child’s illness.   




FIGURE 3.2:  Epidemiological analysis of HRV infections in patients from September 2008 – May 
2009.  Comparison of the detection frequency of HRV-A, -B and –C infections in male and female 
subjects (A) and upper and lower respiratory tract samples (B).  Subject/sample totals are given 
above each graph.  Six samples had no sample type information available.  (C) Detection frequency of 
HRV-A, -B and –C in each age band studied (m = months, y = years).   
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One paediatric patient, aged 7-12 months, appeared to harbour a persistent infection 
with both the same HRV-C (C8) and HCoV (OC43) types over a 2 month period.  
This patient was suffering Pneumocystis carinnii pneumonia, secondary to severe 
combined immunodeficiency and requiring mechanical ventilation.  Besides HRV 
infection, no other co-infections were noted.  These observations suggest that 
persistence of HRV may occur in immunocompromised patients who are critically 
unwell.   
3.3.2 Comparison of characteristics of HRV positive paediatric patients 
between acute and high dependency care settings 
In order to investigate clinical characteristics of HRV positive paediatric patients in 
acute and high dependency care settings, a subset of 64 samples were typed in the 
VP4/VP2 region.  These were all from patients being treated in the Royal Hospital 
for Sick Children, Edinburgh (RHSC) and spanned a single calendar year from July 
2007 to June 2008.  35 samples (55%) originated from patients being cared for in a 
high dependency ward setting, including both the ITU and high dependency unit 
(HDU).  29 samples (45%) were taken from patients during acute and short-term 
admissions.  Acute admissions were defined as those patients discharged from A&E 
or those under short-term observation within the Medical Assessment Unit (MAU).  
This group had an average length of stay in hospital of 2.42 days (range 0 to 13 
days), whereas high dependency patients had an average length of stay in hospital of 
35 days (range 3 to 170 days).    
Within the total population studied, we observed a detection frequency of 69% HRV-
A (n=44), 6% HRV-B (n=4) and 25% HRV-C (n=16).  There was no difference in 
HRV species detection between the two patient groups (p = 0.69) (Figure 3.3).  The 
large number of different types identified (43 HRV types in 64 patients) rendered any 
attempt to determine associations between specific HRV strains and disease 
presentations impossible.   




FIGURE 3.3:  HRV species isolated from distinct patient groups.  Values are shown separately for 
ITU/HDU, A&E/MAU and total cohort separately.   
The vast majority of HRV positive samples were from those under the age of 5 
(86%).  The species prevalence within each age band followed the expected and 
previously observed pattern with HRV-A most prevalent and HRV-B the least.  
When grouped by age bands, patients did not segregate by admission to ITU or 
A&E. 
30% of children sampled had evidence of a co-infection (n=19).  Similar frequencies 
of co-infections were observed in patients admitted to ITU (74%) and patients seen 
in the acute care setting (67%).  The most common co-infection observed in both 
settings was by AdV.  This was not found to be correlated with an increased length 
of stay in hospital or more severe respiratory symptoms in this sample set.  Notably, 
only two bacterial co-infections were identified; one with Moraxella catarrhalis and 
one with Haemophilus influenzae.  Both of these occurred in children aged one to 
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two years admitted to ITU with severe respiratory distress requiring ventilatory 
support and both had an additional viral co-infection with AdV.   
The Paediatric Index of Mortality (PIM2) scoring system is a tool for rating the 
severity of illness and mortality risk in children at the time of their admission to ITU 
(Slater et al., 2003).  Consideration of a variety of clinical factors allows the 
calculation of a score correlating with a percentage likelihood of mortality.  The 
likelihood of mortality as predicted by PIM2 score showed no significant difference 
between HRV species.  Additionally, no relationship was evident between viral loads 
in respiratory samples and PIM2 score.  However, these results are difficult to 
interpret due to a lack of detailed clinical information regarding the primary cause of 
illness in each child.  For example, one child with an extremely high PIM2 score of 
0.48317 was admitted to ITU with cardiac failure post cardiac arrest and a long-
standing history of immunosuppression and mitochondrial cytopathy.  Mitochondrial 
cytopathy predisposes to the development of LRTIs secondary to poor muscle tone 
and swallowing difficulties.  However, the post-arrest status of this child and 
resulting cardiac failure are likely to have been the primary reasons for ITU 
admission and it is likely that the documented respiratory infection was a secondary 
concern which was already resolving (CT value of 38.64).   Further studies would 
benefit from prospective collection of significantly more detailed clinical data.         
3.3.3 Screening of CSF samples for HRV 
As EV are an extremely common cause of aseptic meningitis, screening of CSF 
samples for HRV was undertaken in order to determine whether these closely related 
pathogens may also play a role in the development of this disease.  A total of 1500 
CSF samples from 2009 were screened for HRV in pools of 10.  Of these, only one 
was positive, which originated from a female neonate (under the age of 3 months).  
The limited clinical data available identified a sepsis-like illness.  It is not known 
whether the patient was immunocompromised.  HRV was additionally present in a 
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throat swab from the same patient.  However, stool samples and blood cultures were 
not obtained.  These results indicate that HRV is an extremely rare and currently 
unrecognised potential cause of aseptic meningitis.     
3.3.4 Isolation of HRV from faecal samples 
Stool samples are referred to the SVC principally for diagnosis of suspected viral 
gastroenteritis or viral meningitis and also commonly in investigation of suspected 
infective outbreaks of diarrhoea and vomiting within the hospital setting.   
A total of 26 from 288 stool samples screened were PCR-positive for HRV (9%). 
Positives were amplified and sequenced in the VP4/VP2 region for HRV species and 
type identification.  All positive samples were isolated from hospitalised patients, of 
which over a third (35%) were obtained from patients under investigation for 
potential norovirus infections.  The highest frequency of detection of HRV in an 
individual month was observed in September (10%).  However, both May and 
December also displayed relatively high detection rates (7% and 8% respectively).   
In the 26 positive samples, a total of 15 HRV VP4/VP2 types were identified (5 
HRV-A, 2 -B and 8 -C).  This suggests that rather akin to the pattern of circulation 
observed in respiratory specimens, a large number of types circulate concurrently 
each epidemic season (Savolainen et al., 2002).  HRV species identified in the 
positive samples comprised 50% species C (n=13), 42% species A (n=11) and 8% 
(n=2) species B.  Additionally, phylogenetic analysis reveals that HRV sequences 
obtained from stool samples were genetically diverse in the VP4/VP2 region (Figure 
3.4).   
Five HRV positive patients infected with highly similar strains of HRV-A1 were 
identified (marked with black dots on Figure 3.4).  All of these patients presented in 
September 2010 with diarrhoea (Table 3.1) and had stool samples referred as part of 
the investigation of a norovirus outbreak.  However, as the patients were treated in 
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three different locations, it is unlikely that these five samples represent an isolated 
outbreak of HRV infection.  
In the absence of a control group with no gastrointestinal symptoms, it is not possible 
to conclusively link the presence of HRV in stool with gastrointestinal disease. 
However, 77% (n=20) had no documented evidence of concurrent respiratory tract 
infection, such as bronchiolitis or URTI.  27% (n=7) of HRV positive patients 
required treatment in an ITU setting.  The majority of putative HRV gastrointestinal 
infections were observed in children under the age of 5 years (n=18, 69%), with a 
further peak observed in the over 65 age group (n=6, 23%).  Nine of the HRV 
positive patients were patients who were initially referred as part of the investigation 
of suspected norovirus outbreaks and tested negative for norovirus.     
Only three co-infections were noted in stool samples; two with AdV and one with 
Salmonella enteritidis.  One child who was co-infected by AdV had symptoms of 
both an URTI and diarrhoea.  Further screening performed by real-time PCR used for 
EV detection by Dr H. Harvala at the SVC detected 11 HRV positive stool samples 
from 333 tested (Harvala et al., 2012b).  The false positivity for HRV in EV 
screening in the diagnostic setting arising from the high level of sequence 
conservation in the 5ˈUTR may have led to misrepresentation of the frequency of EV 
infections in clinical samples. 
 




FIGURE 3.4:  Neighbour joining phylogenetic trees of the VP4/VP2 region of HRV-A, HRV-B and 
HRV-C.  Sequences from isolates recovered from stool samples are marked with black dots.  Trees 
were constructed using NC_001430 : EV70 as an outgroup.  Branches are scaled by genetic distance.     
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May 2010 6-10 years RHSC Diarrhoea 
10_512 May 2010 7-12 months RHSC URTI, diarrhoea and vomiting 
10_518 May 2010 3-5 years RHSC Diarrhoea and fever 
10_520 May 2010 7-12 months ESCITU Diarrhoea and seizure 
10_521 May 2010 <3 months ESCITU Diarrhoea, vomiting and fever 
10_522 May 2010 <3 months RHSC Bronchiolitis and vomiting 
10_547
 a
 May 2010 7-12 months RHSC Diarrhoea and vomiting 
10_568
 a
 May 2010 3-5 years RHSC Diarrhoea and vomiting 
10_91
 a
 Sept 2010 >65 years RIE Diarrhoea 
10_92
 a
 Sept 2010 37-65 years ITU Diarrhoea and fever 
10_93
 a
 Sept 2010 >65 years ITU Diarrhoea and fever 
10_94 Sept 2010 1-2 years RHSC Diarrhoea and fever 
10_95 Sept 2010 <3 months RHSC Diarrhoea and vomiting 
10_100 Sept 2010 7-12 months RHSC Loose stools and irritability 
10_128 Sept 2010 <3 months RHSC Bronchiolitis and loose stools 
10_129
b 
Sept 2010 1-2 years RHSC Fever (post-transplant) 
10_141
c 
Sept 2010 3-6 months RHSC Diarrhoea 
10_149
b 
Sept 2010 1-2 years RHSC URTI and loose stool 
10_153
 a
 Sept 2010 >65 years ITU Diarrhoea and fever 
10_121 Dec 2010 3-6 months ESCITU Bronchiolitis and vomiting 
10_123 Dec 2010 7-12 months ESCITU Bronchiolitis and vomiting 
10_124 Dec 2010 7-12 months RHSC Gastroenteritis 
10_125 Dec 2010 7-12 months RHSC Diarrhoea and seizure 
10_128
 a
 Dec 2010 >65 years RIE Diarrhoea and vomiting 
10_1213
 a
 Dec 2010 >65 years RIE Diarrhoea and vomiting 
10_1218
 a
 Dec 2010 >65 years RIE Diarrhoea and vomiting 
RIE – Royal Infirmary of Edinburgh, RHSC – Royal Hospital for Sick Children (Edinburgh), ITU – 
Intensive Therapy Unit (RIE), ESCITU – Edinburgh Sick Children ITU (RHSC) 
a  
Nine patients were investigated as part of suspected norovirus outbreaks 
b  
Two co-infections with Adenovirus were identified 
c  
One co-infection with Salmonella enteritidis indentified 
 
In order to ascertain whether HRV obtained from stool samples was present at 
concentrations consistent with the possibility of gastrointestinal infection, viral loads 
were recorded and compared for both HRV and EV positive samples.  There was no 
significant difference in viral load (as measured by real-time PCR CT value) between 
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HRV (28.5; standard deviation ±3.5) and EV (28.9; standard deviation ±1.9) positive 
samples (p=0.77).  However, one-step real-time PCR specific for the HRV 5ˈUTR 
performed as per SVC protocols detected only 42% (n=11) of the 26 HRV positive 
samples identified by nested RT-PCR.  Despite the high frequency of HRV detection 
observed in all three months, more extensive sampling would be required to 
determine whether HRV RNA is found in stool samples throughout the year.   
3.3.5 Discrepancy of screening results between real time PCR in 
diagnostic setting and VP4/VP2 screening PCR 
In order to investigate the characteristics of concurrent HRV circulation in 
respiratory illnesses during September and December 2010, 731 respiratory samples 
were screened for HRV.  A total of 572 of these had previously undergone screening 
procedures at the SVC using the standard HRV 5ˈUTR real-time RT-PCR.  Of these, 
115 (20%) were recorded as HRV positive and therefore typed by sequencing of the 
amplified VP4/VP2 region.  Eight of these positive samples could not be amplified in 
VP4/VP2 and repeat screening with the 5ˈUTR nested RT-PCR previously described 
was negative (Wisdom et al., 2009b).  
The 457 samples recorded as negative on routine diagnostic screening were 
combined into pools of 6 and screened by nested 5ˈUTR RT-PCR.  15 of these 
samples (3%) were actually HRV positive and typed in the VP4/VP2 region (shown 
in red on Figure 3.5).  These 15 samples comprised 4 of species A, 10 species C and 
one species B.     
The samples which were negative on initial 5ˈUTR PCR screening were genetically 
diverse, from all three HRV species and did not segregate in VP4/VP2.  Within 
HRV-A, three out of the four previously negative samples grouped with samples that 
were identified by 5ˈUTR real-time PCR screening.  Within HRV-C, five initially 
false-negative samples grouped with three types that had been identified by the 
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5ˈUTR real-time PCR screening.  This suggests that the detection failure may be 
secondary to low viral load in these cases. 
However, 6 false-negative HRV-C samples belonging to four types did not group 
with any previously identified HRV-C positive samples.  All four of these belonged 
to groups that have been previously documented to be recombinant HRV-Ca types 
(Wisdom et al., 2009a; McIntyre et al., 2010, 2013b).  Analysis of a small fragment 
of the 5ˈUTR that is additionally amplified during the VP4/VP2 typing PCR 
confirmed these 5ˈUTR groupings (data not shown).  This may indicate that the 
addition of a single extra primer specific for HRV-Cc strains may not be sufficient 
and a redesign of primers used in this particular screening protocol may be warranted 











FIGURE 3.5:  Neighbour joining phylogenetic tree showing the VP4/VP2 region of HRV positive 
samples from respiratory specimens and stool specimens.  NC_001430: EV70 was used as an 
outgroup for analysis for all trees and branch to tree root has been collapsed for ease of reference.  
Positive samples from the SVC respiratory archive are shown in bold black, positives from stool 
screening are shown in bold blue.  HRV positive samples which were negative on initial real-time 
HRV 5ˈUTR RT-PCR screening are shown in red.  Two HRV-B and two HRV-C VP4/VP2 sequences 
belonging to putative new types are outlined by a blue box (later designated HRV-Bpat4 and HRV-
Cpat17 – see Chapter 4).  Branches are scaled by genetic distance.   
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3.3.6 Analysis of concurrent HRV circulation in respiratory samples 
during September and December 2010     
A total of 142 HRV positive samples were identified in retrospective screening of 
731 respiratory samples from September and December 2010.  The overall detection 
frequency seen was relatively higher than that observed in stool samples (Table 3.2).  
However, the distribution of the three species of HRV was highly similar.  HRV-C 
was the most frequently detected in both, closely followed by HRV-A, while HRV-B 
was relatively rare (Table 3.2).  Additionally, in both sample types, HRV was 
relatively more common in September than December.   



































HRV positive samples observed represented 51 HRV types (21 HRV-A, 9 HRV-B 
and 21 HRV-C).  Of the 13 HRV types detected in stool specimens from September 
and December 2010, only 6 were seen co-circulating in respiratory samples from the 
same month (marked on Figure 3.5).  In addition, only two potential matches 
between a stool and respiratory sample could be identified.  This was surprising, as 
although there was a low incidence of respiratory symptoms within the group of 
patients with HRV positive stool specimens, 7 of these were treated in ITU.  The 
majority of ITU admissions with fever or other infective symptoms are routinely 
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subjected to a full septic screen comprising of respiratory, stool and urine samples 
with blood cultures.  One HRV-A1 positive patient had the virus identified in both 
stool and upper respiratory secretions (sample numbers 10_94 and Resp_28852).  In 
addition, HRV-C39 was isolated from both stool and upper respiratory secretions of 
a child aged 3-6 months admitted to the RHSC (sample numbers 10_141 and 
Resp_28726).  Although matched respiratory samples could not be identified for 
HRV-C24 positive stool samples, three HRV-C24 positive respiratory samples were 
isolated from patients also admitted to the RHSC in the same month.  HRV positive 
samples of the same type from the same month were also observed for HRV-A89, -
B52 and –C39.   
3.4 Discussion  
3.4.1 Epidemiology and clinical correlations of HRV respiratory 
infections in Edinburgh 
Throughout the course of this work, we have completed three studies of the 
epidemiology and clinical correlations of HRV respiratory infections in Edinburgh, 
including a study of the distribution of HRV species between ITU and A&E patients 
and investigations of concurrently circulating HRV in the same time period as HRV 
positive stool samples.  A number of samples included in the study of HRV 
respiratory samples matched with stool samples had been previously screened for the 
presence of HRV by real-time RT-PCR specific for the 5ˈUTR of HRV.  Of 
particular concern is the observation that this commonly used diagnostic PCR failed 
to detect a number of HRV positives.  Indeed, around 3% of the samples that had 
been reported as negative by real-time PCR were actually HRV positive.  Published 
literature on this subject indicates that this is not an isolated occurrence and not 
restricted to this particular PCR.  Of 10 commonly used HRV 5ˈUTR primer pairs, 
no single pair could reliably detect all HRV present in a testing panel (Faux et al., 





.  In accordance with our observations (Figure 3.5), the erroneous negative 
results did not correspond to a particular HRV species or type.  Although the primer 
sets published previously (Wisdom et al., 2009b, 2009a) and used with modifications 
described within have not been independently tested for sensitivity and specificity, 
other work undertaken within our group found that the 5ˈUTR and VP4/VP2 nested 
PCRs were consistently able to detect RNA transcripts of all species of HRV in 
samples with close to 10
3
copies/µL (McLeish et al., 2012).   
Within the set of randomly selected respiratory samples from Edinburgh, HRV was 
found in 23% of cases, which falls within the range of 7.9% - 64.3% previously 
described (Alper et al., 2008; du Prel et al., 2009; Brittain-Long et al., 2010; Chan et 
al., 2012; Chidlow et al., 2012; Renwick et al., 2007; Lamson et al., 2006; Arden et 
al., 2006; Kistler et al., 2007a).  We found that HRV was significantly more common 
in hospitalised patient populations than in the community based patients.  However, 
the number of community based patients with referred respiratory samples was small 
and only four positive samples were identified in this group.  Although the incidence 
of HRV is likely to be significantly higher in cases of mild URTI, patients with mild 
illness do not usually present and are not routinely sampled.  Previous reports 
indicate that the incidence of HRV infection in asymptomatic individuals may vary 
from 2% to over 50% (Fry et al., 2011; Alper et al., 2008; Peltola et al., 2008; 
Brittain-Long et al., 2010; Chidlow et al., 2012).  A valuable addition to future work 
would be the prospective collection of both samples and data from a community 
based control group, including both symptomatic and asymptomatic patients.         
In accordance with previous studies, HRV-A was generally the most prevalent HRV 
species in respiratory samples.  However, in both stool samples and respiratory 
samples from September 2010, HRV-C was the most commonly isolated species 
                                                     
13
 Primers in use in both the research and diagnostic setting in Edinburgh were not included in this 
published analysis.   
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(Figure 3.5).  There was no difference in the distribution of infecting HRV species by 
age.  Despite several published studies suggesting a correlation between HRV-C 
infection and more severe clinical illness, we found no significant difference between 
HRV species distribution or co-infection rate in patients admitted to ITU or A&E.   
Although ITU admission was presumed to correlate with illness severity, it may 
represent a somewhat crude estimate in some respects.  For instance, some patients 
are likely to have required ITU care for another, unrelated condition, with the 
documented respiratory infection being a secondary concern.  The limited amount of 
clinical data that was able to be collected for each patient retrospectively limited the 
analysis.  Future studies would benefit from prospective data collection.  
The results of these studies have several notable differences from a similar study of 
456 Edinburgh respiratory samples carried out in 2006/2007 (Wisdom et al., 2009b).  
Although this study was carried out less than 5 years prior to the studies within this 
thesis, they found that HRV-A were considerably more frequent  among patients 
admitted to ITU and HRV-C strains were entirely absent.  In addition, they found a 
significantly elevated incidence of HRV infection in the over 65 age group, whereas 
we observed HRV in only 4% of this group.  However, certain other features, such as 
a lack of male or female bias and the generally more frequent isolation of HRV-A are 
consistent not only between these two studies, but are widely repeated observations.  
In accordance with our study, Wisdom and co-workers also identified a large number 
of genetically distinct co-circulating HRV strains (Wisdom et al., 2009b).  
Determining the finer details of HRV circulation patterns, epidemiological features 
and clinical correlates are unlikely to be achieved with small, isolated clinical 
studies.  An unprecedented volume of data would be required in order to effectively 
investigate the correlation of specific HRV strains with specific disease 
presentations.  A large, multicentre, prospective epidemiological study carried out 
over a period of several years and over many geographical locations, using 
standardised PCR reagents and primers would potentially allow characterisation of 
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such features.  However, such an endeavour, whilst undoubtedly worthwhile would 
likely prove to be both logistically challenging and labour intensive.   
3.4.2 Screening for HRV in cerebrospinal fluid samples 
Despite the detection of HRV RNA in stool samples from patients with acute flaccid 
paralysis and in vitro propagation of live virus from sewage under conditions 
optimised for the growth of EV (Victoria et al., 2009; Blomqvist et al., 2009), there 
was only very little evidence of HRV in CNS infection.  Indeed, the one positive 
sample that was recovered led to an overall detection frequency of HRV in aseptic 
meningitis of less than 0.5%, which although low is still remarkable.  The 
identification of only one positive sample led to the consideration of the possibility 
of contamination or laboratory error.  However, the individual sample underwent the 
process of RNA extraction, nested PCR and sequencing on two independent 
occasions and produced an identical result.  In addition, no other laboratory work 
with HRV positive samples was being carried out during this period.  Overall, these 
results suggest that although it is significantly more rarely observed than EV, HRV is 
a potential cause of neonatal sepsis-like illness and potentially other CNS disease.   
3.4.3 Isolation of HRV from faecal specimens 
Since the publication of our work on this subject (Harvala et al., 2012b), two further 
studies detailing the presence of HRV in diagnostic stool specimens have been 
published  (Lau et al., 2012; Honkanen et al., 2013).  In addition, one analysis of 
HRV positive children in Malaysia contained an incidental finding that 34.8% had a 
primary symptomatology of diarrhoea and vomiting, rather than respiratory 
symptoms (Chan et al., 2012).  Although the high incidence of nearly 10% we 
observed was surprising, the possibility that HRV may be routinely present in stool 
samples has been evident for a long time.  Not only has HRV been isolated from 
sewage samples (Blomqvist et al., 2009), from cases of acute flaccid paralysis 
(Victoria et al., 2009) and from stool samples from critically ill children (Tapparel et 
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al., 2009c; Broberg et al., 2011), but information available from the ATCC archive 
indicates that the original HRV-33 prototype strain was isolated from a pool of 
human stools collected in Maryland in 1939 (strain VR-330).  This suggests that 
HRV has been potentially circulating in faecal samples largely undetected for many 
years.   
HRV-C was the most frequently isolated HRV species from stool samples and 
accounted for 50% of HRV positive samples.  Lau et al also found that HRV-C was 
detected most frequently in stool samples (Lau et al., 2012).  However, in a large 
study of 4184 stool samples isolated from Finnish children, HRV-A was the most 
frequently detected HRV species (Honkanen et al., 2013).  We found no specific 
species or strain to be associated with gastrointestinal infection.  Although Honkanen 
and co-workers reported that HRV-A61 was the most commonly amplified HRV 
type (Honkanen et al., 2013), we did not observe any occurrences of this type within 
our sample set.  The genetic diversity of HRV strains in stool suggests that there may 
not be specifically enteropathic HRV strains and indeed, all HRV may be capable of 
infecting the gastrointestinal tract under favourable circumstances.  Although there 
was very little overlap between circulating infections with identical HRV strains in 
stool and respiratory samples between September and December, the same broad 
trends were observed (Table 3.2).  Not only was HRV-C over-represented in both 
sample sets but the detection frequency of HRV was uniformly higher in September.  
This correlates with a previously observed high frequency of HRV infection in 
Edinburgh in September (Wisdom et al., 2009b), which is possibly linked to the 
declining temperatures and the start of the school year leading to increased person to 
person contact in a warm, humid environment.  The relatively high incidence of 
HRV-C in both sample sets may be an incidental finding related to small sample 
sizes or it may be indicative of a genuinely higher circulation of HRV-C near the 
close of 2010.   
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HRV are traditionally considered to be acid labile and indeed, retention of infectivity 
at pH of less than 5 was often used to differentiate EV from HRV in clinical 
diagnostics.  Previous findings that may have raised the possibility of HRV as a 
gastrointestinal pathogen have been attributed merely to swallowed respiratory 
secretions or discarded tissues (Blomqvist et al., 2009).  However, our observation of 
infrequent reporting of respiratory symptoms in cases of HRV positive stool suggests 
that swallowed respiratory secretions may not play a significant role.  This assertion 
is further strengthened by the observation of high viral loads, which are incompatible 
with swallowed HRV being diluted by liquid gut contents.  In addition, if simply 
suffering an upper respiratory HRV infection could lead to the routine isolation of 
HRV from stool or sewage samples, the detection frequency of HRV in stool 
samples would surely be substantially higher.  Neither our study, nor any published 
since can claim to prove causality by observation of this association with HRV 
positive stool samples and gastrointestinal pathology.  However, there was no 
statistically significant difference between viral loads in HRV and EV positive 
samples (Harvala et al., 2012b).  As EV is known to replicate in the gastrointestinal 
tract, this observation lends weight to the assertion that HRV may be a causative 
factor in these infections and should potentially be further investigated.  
The isolation of HRV from stool samples of symptomatic patients at a similar rate to 
the isolation of EV indicates the potential value of addition of HRV to the diagnostic 
screening procedures currently employed.  Some diagnostic laboratories use the 
presence of EV in stool samples as an adjunct to screening CSF samples in the 
diagnosis of aseptic meningitis.  As HRV appears to potentially have a significant 
role in gastrointestinal infection, this approach may lead to overdiagnosis of EV 
meningitis in cases where the sample is not further typed.  Indeed, 15% of reported 
EVs identified by diagnostic screening PCR carried out at the SVC were 
subsequently found to be HRV (Harvala et al., 2012b).   
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In conclusion, in common with previously published data, studies of HRV 
epidemiology in respiratory infections did not reveal any association of a particular 
strain or species with illness severity or clinical presentation.  Significantly larger 
studies which span a wide geographical area over the course of many years may be 
the only possible method of determining whether these patterns actually exist and if 
so, what their nature may be.  In contrast to the high incidence of EV observed in 
cases of CNS infection, HRV was observed at an extremely low frequency in CSF, 
suggesting that it may be a rare cause of CNS disease.  Intriguingly, we found 
evidence of HRV in around 9% of stool samples from patients with symptomatic 
gastrointestinal infections and viral loads were similar to that observed for EV 
infections.  Although this was the first published report of the incidence of HRV 
RNA in the GI tract, two other studies published subsequently have reported similar 
findings (Lau et al., 2012; Honkanen et al., 2013).  Further studies of HRV infection 
in stool may focus on larger sample sets to determine seasonality and potential 
circulation patterns, as well as clinical correlates. Investigations in the biological 
differences in acid stability between these strains and those commonly isolated from 
respiratory infections may allow determination of the genetic factors that make such 






Proposals for the Classification of All Three Species 
of Human Rhinovirus into Genotypically Assigned 
Types 
4.1 Introduction 
4.1.1 The standard approach to typing in HRV 
By the 1960’s, a large number of antigenically distinct HRV isolates had been 
identified and development of a system for their classification became essential.  On 
the basis of neutralisation properties, HRV were divided into 100 serotypes by 1987 
(Kapikian et al., 1967; Hamparian et al., 1987) and prototype strains of each were 
lodged at the American Tissue Culture Collection (ATCC). 
For many years, serological methods were the standard technique used for typing 
HRV and EV isolates.  Serological typing comprises isolation of the virus in cell 
culture, followed by neutralisation with intersecting pools of type-specific antisera 
and confirmation with a single type-specific antiserum.  This approach was 
extremely time-consuming, laborious and fraught with difficulty.  HRV are 
challenging to propagate in cell-culture, requiring specific HRV susceptible cell-lines 
and certain growth requirements (for example, an incubator at 33°C and roller-bottle 
culture vessels).  With over 100 strains recognised, accurately typing even one 
isolate was a formidable task and standardised sera are in limited supply.  The result 
was that typing was not generally undertaken in HRV and only rarely in EV.   
When undertaken, serotyping in EV took 1-2 weeks.  In most cases, an umbrella 
diagnosis of EV infection was deemed sufficient as the results of serotyping had a 
negligible impact on patient management.  The most clinically useful application was 
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to distinguish between PV and non-polio enterovirus (NPEV) infections in 
enterovirus surveillance.   
Serotyping also routinely encountered numerous problems leading to reports of 
“untypeable” isolates.  Failure due to virus aggregation within the sample was 
commonly encountered (Wallis and Melnick, 1967).  This could be overcome by 
filtration or treatment with sodium deoxycholate (JG Kapsenberg, A Ras, 1980).  
Similarly, failure arising from the presence of a mixture of viruses within the sample 
could be circumvented by plaque purification or limiting dilutions (Blomqvist et al., 
2008).  However, both these solutions created additional time-consuming steps in an 
already lengthy and complex procedure.   
As a further difficulty, antisera that were originally developed against strains of HRV 
and EV isolated in the 1950s and 1960s, increasingly showed reduced or non-
reciprocal cross-neutralisation with contemporary isolates through antigenic drift.  
Several of these antigenic variants (later identified as belonging to a specific type by 
VP1 sequence analysis (Oberste et al., 2000)) were known as prime strains. These 
contemporary isolates cannot be neutralised by antisera to the prototype strain while 
antisera to the contemporary isolate can neutralise the prototype.  This has been 
reported on several occasions for EV (Abraham and Holmes, 1974; Schmidt et al., 
1966; Norder et al., 2002), and for HRV (Halfpap and Cooney, 1983).  These “inter-
type” strains showing intermediate serological properties likely represent variants in 
the process of diverging into antigenically different types.  
Cell culture based screening routinely undertaken for EV and HRV relied on visual 
inspection of cultures for cytopathic effect and was therefore subjective, especially 
when used on a large scale.  Serological based techniques also suffer from the same 
subjectivity, even in experienced hands.  In one published survey of twelve labs, 
none reported the correct or expected serotyping results for all ten EV samples 
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included and an overall rate of accurate reporting of around 60% was recorded (van 
Loon et al., 1999).   In addition, the requirement for multiple cell lines to screen for 
HRV and HEV simultaneously (as would be preferable in screening of stool 
samples), renders cell culture screening nearly impossible.  PCR based screening 
methods offer an easier and more objective alternative.     
Other alternatives proposed to serotyping include viral protein fingerprinting 
(Holland et al., 1998) and immunofluorescence (IFA) based methods (Kiang et al., 
2009), both of which can be highly accurate.  However, viral protein fingerprinting 
requires specialised instruments, generates radioactive waste and relies on 
comparison with available protein sequences, which are significantly less abundant 
than nucleotide sequence data.  IFA based methods suffer from some of the same 
problems as serological typing, in that reagents are limited and not all known 
serotypes are able to be tested.    
As PCR is a ubiquitous technique in most labs and online databases contain a wealth 
of nucleotide sequence data, a classification system based on sequence data was 
ideal.  Such a system was developed in 1999 for EV (Oberste et al., 1999b). 
4.1.2 Definition of new EV types based on sequence divergence in the 
VP1 region 
In order to classify EV by sequence data, it was essential to consider the likely 
molecular determinants of serotype.  Sequence of the VP1 region correlates with 
serotype designation in PV isolates (Kilpatrick et al., 1998) and other NPEV 
(Oberste et al., 1999b, 1999a; Kiang et al., 2009).  Studies of sequence divergence in 
VP1 led to the proposal of a threshold of 25% nucleotide and 12% amino acid 
divergence for the identification of EV types (Oberste et al., 1999b).  These 
thresholds are now routinely used and a great number of new EV types have been 
classified on this basis (Oberste et al., 2002, 2007; Brown et al., 2009; Oberste et al., 
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2004c; Smura et al., 2007b).  As some EV isolates have documented evidence of 
recombination within the capsid region (Bouslama et al., 2007; Blomqvist, 2003; 
Zhang et al., 2010), only VP1 is recommended to be used for typing in EV.  Previous 
attempts to classify EV by VP2 sequences (Arola et al., 1996; Oberste et al., 1998) 
have been unsuccessful. 
The classification of EV isolates by molecular methods has now replaced 
neutralization assays in standard practice.  These methods have been found to 
consistently outperform serotyping, in terms of accuracy, speed and ability to classify 
new types (Oberste et al., 2000; Kiang et al., 2009). The method also has benefits in 
the arena of polio eradication, allowing investigators to distinguish between vaccine 
derived and wild PV and to track emerging recombinant forms.     .   
4.1.3 The requirement for genotypic classification of HRV 
With such a broad scope of genetic diversity and wide range of distinct clinical 
manifestations, it is no longer practical or desirable to consider all HRV types as one 
biological and clinical entity.  There are presently no known specific associations of 
any HRV types with a particular disease.  However, as the range of serious clinical 
illness that can be attributed to HRV infection is becoming more fully appreciated, 
there will likely be a requirement to routinely screen for HRV in the diagnostic 
setting and to commence large-scale epidemiological studies to uncover circulation 
patterns and strain associations.  An easy and practical system of classifying HRV 
into types, analogous to the system now in use for EV (Oberste et al., 1999a) will 
allow investigations of potential outbreaks and nosocomial transmission and 
investigation of type-specific biological properties such as identification of specific 
types with potentially increased virulence.    
Methods which rely on cell culture isolation are not practical for detection and 
characterisation of HRV, especially HRV-C.  Indeed, HRV-C cannot be isolated by 
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most standard cell culture techniques and propagation currently relies on sinus 
mucosal organ culture (Bochkov et al., 2011).  In vitro propagation of HRV-C has 
previously been attempted in WI-38, WisL, BEAS-2B, A549, HeLa, MRC-5, 
primary human lung fibroblasts and bronchial, sinus and adenoidal epithelial cells 
with no success (Bochkov et al., 2011; Kistler et al., 2007a; McErlean et al., 2007).  
In other viruses, such as hepatitis C virus (HCV), which are challenging or 
impossible to grow in standard cell culture, genotyping has provided a useful 
alternative means of classification.   
The studies presented within this chapter aimed to develop a system of classification 
informed by nucleotide divergence for all three species of HRV.  In 2010, we 
published proposals for the classification of HRV-C into genotypically defined types 
(Simmonds et al., 2010).  These have now been adopted by the Picornavirus Study 
Group as the primary mechanism for defining HRV-C types.  In addition, we have 
extended this classification system to include HRV-A and HRV-B, leading to a full 
re-evaluation of type designations within the two species (McIntyre et al., 2013a).  
Since the original division of HRV into 100 serotypes, an additional 62 types have 
now been designated.  These include 52 HRV types determined from the results of 
studies contained within this thesis. The term “serotype” implies identification and 
classification by direct investigation of antigenic properties.  Therefore, we have 
simply used the term “type” throughout to represent HRV types which have been 
identified and classified by sequence data alone, as is common practice for newly 
identified EV types.      
4.2 Materials and Methods 
4.2.1 Selection of samples 
A selection of both published and unpublished studies of HRV epidemiology and 
evolution in Edinburgh yielded a wealth of HRV VP4/VP2 sequences (Gaunt et al., 
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2011; Wisdom et al., 2009b, 2009a; Harvala et al., 2012b; McIntyre et al., 2010).  
VP4/VP2 sequences from our studies (431 HRV-A and 113 HRV-B) were divided 
into groups based on phylogenetic clustering.   Any isolate which did not show a 
close grouping with a prototype full genome was selected for amplification of the 
VP1 region.       
In addition, the 508 available HRV-C VP4/VP2 sequences obtained from isolates 
within the SVC archive were divided into groups on the basis of phylogenetic 
clustering.  Representatives from each cluster, presumed to be analogous to HRV-C 
types, were selected for VP1 amplification.  
4.2.2 Amplification of the VP1 region 
The full VP1 region of HRV-A and -B isolates was amplified and sequenced in two 
overlapping sequence fragments (as described in Chapter 2).  For HRV-A28 samples, 
amplification of the 5ˈ fragment was not possible with the standard protocol and a 
specific inner anti-sense primer was designed.  In all cases, where amplification with 
GoTaq polymerase (Promega, UK) was unsuccessful, it was attempted using a 
SuperScript III (Invitrogen, UK) protocol.   
Two differing protocols were used for the amplification of the VP1 region of HRV-C 
during the course of this work.  The first HRV-C VP1 PCR used the standard 
protocols described above and primers labelled as C VP1 PCR 1 (Appendix 1:  
Primer sequences).  This resulted in two sequence fragments with a 105 base overlap 
(McIntyre et al., 2010).  As this assay was only successful in amplifying 72 of 89 
samples, a second outer anti-sense primer was developed (labelled as C VP1 PCR 2 
in Appendix 1: Primer sequences).  This improved assay allowed the amplification of 
the full HRV-C VP1 region and only failed to amplify one HRV-C isolate tested.  
The second round of this nested PCR reaction was carried out with an annealing 
temperature of 45°C and in a 50 μl reaction volume.  PCR products were then 
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separated at 150V for 45 minutes on a 2% agarose gel and DNA bands of 1000 bases 
were excised manually under UV transillumination.  Excised DNA bands were 
purified using the Illustra GFX PCR DNA and Gel Band Purification Kit (GE 
Healthcare, UK) and sequenced as previously described.     
4.2.3 Sequence alignment, calculation of pairwise nucleotide p-distances 
and phylogenetic analysis   
All available HRV VP4/VP2 and VP1 sequences were downloaded from Genbank in 
November 2012.  The genome regions analysed in this study included the full VP1 
region and a fragment of VP4/VP2 that is commonly used in studies of HRV 
epidemiology (Savolainen-Kopra et al., 2009a; Kaida et al., 2011; Piralla et al., 2011; 
Xiang et al., 2010a; Han et al., 2009; Mizuta et al., 2010; Henquell et al., 2012; 
Miller et al., 2009a; Blomqvist et al., 2009).  Any sequences which were less than 
90% complete across these regions (Table 4.1) or classified as non-functional were 
excluded.   
TABLE 4.1 : Co-ordinates of capsid coding genome regions used in analysis and corresponding 
HRV reference strain 
HRV Species Numbered by: VP4/VP2 Region VP1 Region 
HRV-A FJ445111 (HRV-A1) 627 – 1015 2337 – 3197 
HRV-B X01087 (HRV-B14) 625 – 1013 2296 – 3192 
HRV-C EF582385 (HRV-C4) 616 – 1004 2305 – 3125 
 
All sequences were aligned in SSE v1.0 and pairwise nucleotide p-distances were 
calculated using the program SequenceDist within SSE v1.0 software package.  
Phylogenetic trees were constructed as previously described and all phylogenetic 
analysis was undertaken using NC_001430 (EV-D70) as an outgroup.   
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4.2.4 Analysis of recombination within the capsid region of HRV-A, -B 
and –C 
Phylogenetic trees were visually inspected for evidence of incongruence between 
VP4/VP2 and VP1.  Datasets containing these two non-consecutive regions were 
concatenated to give one continuous sequence, which was then additionally analysed 
with RDP and GARD software packages.   
4.3 Results 
4.3.1 Assigning nucleotide divergence thresholds in the VP1 region of 
HRV-A, -B and –C 
In order to determine whether a distinct threshold that divided pairwise p-distance 
comparisons into intra- and inter-type values existed within each HRV species, 
distributions of pairwise nucleotide p-distances were constructed from a total of 435 
HRV-A, 133 HRV-B and 206 HRV-C sequences (Figure 4.1). These showed a 
maximum within-species nucleotide p-distance of 39.4%, 33.9% and 42.9% 
respectively and minimum values between 10% and 14% divergence.  Detailed 
inspection allowed identification of minimum values in the distribution and 
assignment of a nucleotide divergence threshold (marked in grey on Figure 4.1 A2, 
B2, C2).  A threshold of 13% was identified for both HRV-A and HRV-C sequences, 
while the less divergent HRV-B isolates showed a minimum value that supported a 
12% threshold.  Although analysis of nucleotide divergence thresholds for HRV-C 
sequences was carried out in 2010 (Simmonds et al., 2010), the results presented 
herein  represent a repeated analysis incorporating an additional 120 HRV-C VP1 
sequences.  However, despite larger scale of the renewed investigation, the observed 
nucleotide divergence threshold of 13% remains unchanged from our original 
proposals (Simmonds et al., 2010).   
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As the majority of the sequences included originated from a large variety of clinical 
and evolutionary studies and types show different prevalences, there was an unequal 
representation of different putative HRV types.  The number of strains available for a 
specific type ranged from 1 to a maximum of 13 for HRV-A (A49), 10 for HRV-B 
(B69) and 22 for HRV-C (C3).  Therefore, an additional analysis was carried out 
including only the prototype strains of all three species (coloured grey on Figure 4.2 
A1, B1 , C1).  Prototype strains of HRV-A and -B were the earliest isolated full 
genome sequence of a known type and in HRV-C, prototype strains were those 
defined in our original classification scheme (Simmonds et al., 2010).  The 
distributions of pairwise nucleotide p-distances of prototype strains closely 
reproduced the larger analyses (Figure 4.1).   
Distributions of pairwise nucleotide p-distances within the VP1 region of HRV-A 
and HRV-C sequences showed a single large peak representing inter-type 
comparisons.  In contrast, HRV-B sequences had two large peaks within the inter-
type distance range.  Further analysis revealed that the smaller peak, between p-
distance values of 0.190 and 0.260 corresponds to comparisons between HRV-B 
types within each of the four  basally branching phylogenetic clusters (marked by 
grey boxes on Figure 4.3).  The larger peak corresponds to comparisons between 
variants in different clusters.           
When sequences from all three species of HRV were compared, the pairwise 
nucleotide p-distances fell into three distinct distributions (Figure 4.2).  As expected, 
the lowest values represented comparisons from within the same type and the highest 
(between 43% and 56% divergence) were between isolates of different species.  The 
large number of comparisons between 15% and 43% divergence represent isolates of 
the same species but differing type.  The existence of a discrete inter-species p-
distance threshold reinforces the notion that HRV species may be defined on the 
basis of nucleotide divergence in the capsid region.      
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FIGURE 4.1:  Distributions of pairwise nucleotide p-distances for the VP1 region of all three 
species of HRV.  HRV-A is shown in section A1, HRV-B in B1 and HRV-C in C1.  Analysis including 
all available VP1 sequences is shown in black with y-axis scale on the left.  Analysis including 
prototype strains only is shown in grey with y-axis scale on the right.  A detailed analysis of the 
distribution values adjacent to the proposed thresholds for HRV-A (A2), HRV-B (B2) and HRV-C (C2) 
is also shown and the proposed nucleotide divergence threshold is shown by a red dotted line.      
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FIGURE 4.2:  Distribution of pairwise nucleotide p-distances for the VP1 region of all HRV 
sequences.     
4.3.2 Phylogenetic analysis of the VP1 region 
Phylogenetic trees were constructed of the VP1 region of HRV-A, -B and –C (Figure 
4.3).  All HRV sequences were divided into groups which were defined by bootstrap 
supported phylogenetic clades that closely matched types assigned by sequence 
distances.  These groups were numbered either by clustering with a known prototype 
strain (HRV-A/B 1-100) or by order of submission of full genome (HRV-A101-106, 
HRV-B100-104 and HRV-C1-11) or VP1 sequence (HRV-C12-51).  The majority of 
sequences which grouped together within the same putative type group showed intra-
clade VP1 divergence of less than the proposed thresholds of 13% in HRV-A and 
HRV-C and 12% in HRV-B  (Table 4.2).  Most of these also showed a minimum 
inter-clade VP1 divergence (with the nearest neighbour type group) of greater than 
the proposed threshold.  However, a number of HRV type groups (13, 2 and 1 in 
HRV-A, -B and –C respectively) violated the proposed VP1 thresholds (marked in 
red on Table 4.2 and further discussed in section 4.4.4). 
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FIGURE 4.3:  Phylogenetic trees showing the VP1 region of HRV-A, -B and –C.  Putative type 
groups and branch to tree root has been collapsed for ease of reference.  Within HRV-B, phylogenetic 
clusters with pairwise p-distances ranging from 0.190 to 0.260 are bounded by grey boxes.  Instances 
where two types have been combined to form a single type are marked in yellow (see Section 4.3.3).  
New HRV types defined on the basis of sequence divergence in VP1 are marked in red and HRV types 
with intermediate VP1 divergence are marked in purple.  Branches are scaled by genetic distance.   
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A1 0.091 0.119  A67 0.095 0.178  B102 0 0.163 
A1B 0.109 0.119  A68 0.104 0.150  B103 0.035 0.113 
A2 0.106 0.141  A71 0.005 0.172  B104 0.085 0.121 
A7 0.005 0.182  A73 0.003 0.182  C1 0.052 0.229 
A8 0.004 0.015  A74 0.006 0.164  C2 0.057 0.165 
A9 0.109 0.148  A75 0.079 0.161  C3 0.039 0.146 
A10 0.099 0.170  A76 0.092 0.161  C4 0.016 0.139 
A11 0 0.172  A77 0.001 0.185  C5 0.042 0.170 
A12 0.099 0.263  A78 0.116 0.263  C6 0.066 0.146 
A13 0.082 0.171  A80 0.087 0.203  C7 0.075 0.152 
A15 0.103 0.163  A81 0.129 0.172  C8 0.132 0.219 
A16 0.089 0.172  A82 0.105 0.195  C9 0.110 0.282 
A18 0.086 0.175  A85 0.006 0.159  C10 0.037 0.205 
A19 0.098 0.227  A88 0.001 0.182  C11 0 0.170 
A20 0.099 0.150  A89 0.088 0.120  C12 0.101 0.197 
A21 0.095 0.205  A90 0 0.174  C13 0.005 0.264 
A22 0.113 0.190  A94 0 0.158  C14 0 0.215 
A23 0.107 0.143  A95 0 0.015  C15 0.092 0.271 
A24 0.076 0.131  A96 0 0.180  C16 0.044 0.147 
A25 0.006 0.093  A98 0 0.107  C17 0.018 0.147 
A28 0.112 0.228  A100 0 0.147  C18 0.053 0.193 
A29
d 
0.007 0.072  A101 0.061 0.261  C19 0.072 0.302 
A30 0.111 0.143  A102 0 0.151  C20 0.007 0.151 
A31 0.117 0.140  A103 0.069 0.216  C21 0.009 0.152 
A32 0.001 0.148  A104 0 0.131  C22 0.037 0.250 
A33 0.103 0.161  A105 0.067 0.129  C23 0.081 0.269 
A34 0.096 0.158  A106 0 0.172  C24 0 0.227 
A36 0.115 0.120  B3 0.005 0.218  C25 0.109 0.227 
A38 0.094 0.192  B4 0.094 0.196  C26 0.039 0.261 
A39 0.009 0.234  B5 0.014 0.166  C27 0.031 0.224 
A40 0.121 0.159  B6 0.088 0.113  C28 0.034 0.193 
A41 0.006 0.171  B14 0.018 0.186  C29 0 0.239 
A43 0.110 0.161  B17 0.008 0.124  C30 0 0.184 
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A44
d 
0.007 0.072  B26 0.002 0.186  C31 0 0.219 
A45 0.081 0.252  B27 0.003 0.176  C32 0.028 0.136 
A46 0.006 0.203  B35 0.013 0.191  C33 0.021 0.189 
A47 0.122 0.140  B37 0.078 0.147  C34 0.027 0.151 
A49 0.100 0.141  B42 0.098 0.167  C35 0 0.326 
A50 0.002 0.158  B48 0.110 0.188  C36 0.111 0.256 
A51 0.099 0.190  B52 0.006 0.121  C37 0 0.207 
A53 0.103 0.222  B69 0.102 0.181  C38 0.034 0.174 
A54 0.087 0.107  B70 0.116 0.124  C39 0.026 0.136 
A55 0.056 0.207  B72 0.099 0.186  C40 0.070 0.165 
A56 0 0.201  B79 0.005 0.192  C41 0.075 0.184 
A57 0 0.129  B83 0.088 0.169  C42 0.086 0.241 
A58 0.086 0.157  B84 0.101 0.223  C43 0.116 0.247 
A59 0.089 0.136  B86 0.105 0.218  C44 0 0.197 
A60 0.098 0.197  B91 0.085 0.143  C45 0.043 0.239 
A61 0.102 0.180  B92 0.005 0.169  C46 0 0.256 
A62 0.007 0.093  B93 0.002 0.176  C47 0 0.222 
A63 0 0.174  B97 0.004 0.194  C48 0 0.189 
A64 0.006 0.158  B99 0.001 0.182  C49 0.031 0.139 
A65 0.065 0.150  B100 0 0.166  C50 0 0.286 
A66 0.085 0.130  B101 0.016 0.163  C51 0.005 0.207 
a
  For ease of reference, the prefix HRV- has been omitted from list of HRV type designations.  
Comparisons of prototype strains which show pairwise p-distance values that violate the proposed 
thresholds are shown in red. 
b
  Maximum VP1 p-distance observed within a bootstrap supported phylogenetic clade or putative 
type group. 
c
  Minimum VP1 p-distance observed between one particular bootstrap supported phylogenetic clade 
and it’s nearest neighbour 
d
 In cases where contemporary strains group separately from prototype strains of two types, which 
should potentially be combined (A29/A44), the p-distance listed involves the prototype strains only.  
 
4.3.3 Identification of putative new HRV types on the basis of sequence 
divergence in VP1 
Three new types HRV-A and one of HRV-B have been previously defined on the 
basis of sequence divergence in VP1; HRV-A101 (Rathe et al., 2010), HRV-A102 
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(de Vries et al., 2008), HRV-A103 and HRV-B100 (Linsuwanon et al., 2011).  In 
addition, the current analysis has yielded three putative new HRV-A types 
(tentatively labelled HRV-A104 – A106) and four novel HRV-B types (HRV-B101 – 
B104).  These are marked in red on phylogenetic trees presented (Figure 4.3).    
HRV-C sequences are now divided into 51 distinct types on the basis of sequence 
divergence in the VP1 region (Table 4.3).  HRV-C1-33 were first defined in 2010 
(Simmonds et al., 2010), while HRV-C36-46 were subsequently recognised in 2012 
(McIntyre et al., 2013b).  In addition, HRV-C34, C35 and C47-51 have been 
submitted from other sources and confirmed as distinct types by the Picornavirus 
Study Group (www.picornaviridae.com). 
Several of the putative new HRV-A and –B types included showed a lower limit of 
inter-clade VP1 nucleotide divergence that was close to or below the 13% and 12% 
thresholds respectively (Table 4.2).  For example, the 6 available sequences from the 
novel group putatively designated as HRV-B103 showed VP1 distances from their 
nearest neighbour type (HRV-B6) ranging from 0.113 to 0.148, with maximum intra-
type pairwise p-distances for HRV-B6 and HRV-B103 of 0.088 and 0.035 
respectively.  For these two types, only two pairwise comparisons fell below the 12% 
threshold and both involved sequence F110_9318.  When this single sequence is 
excluded from the analysis, the minimum value was 0.126.  This discrepancy might 
have originated from sequencing or assembly errors, an evolutionarily intermediate 
sequence between HRV-B6 and HRV-B103 arising during their subsequent 
differentiation into distinct types or a chimaera generated by inter-type 
recombination of closely related types.   
In contrast to the borderline VP1 divergence observed between HRV-B6 and HRV-
B103, new HRV-B types -B100-102 showed pairwise p-distances in VP1 of 0.214, 
0.190 and 0.227 from their nearest neighbour (HRV-B35).  The novel type 
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designation HRV-B104 represents a division of a previously single type group 
(HRV-B52).  This division is based on the existence of two discrete phylogenetic 
clades with VP1 p-distance of 0.121 to 0.142 between them.  In this case, the clade 
containing the original ATCC isolates, including strains FJ445188 and EF173424 has 
retained the HRV-B52 type designation, whereas the clade containing field isolate 
FJ445137 and JF781506 has been designated HRV-B104.    
The three putative new types detected within available HRV-A sequences consisted 
of two groups with borderline VP1 divergence (HRV-A104/A105) and one which 
had a p-distance of 0.172 from its nearest neighbour, HRV-A71 (HRV-A106).  
While HRV-A104 can technically be considered to be a borderline new HRV-A type, 
the lowest inter-clade VP1 p-distance observed between it and HRV-A24 was just 
above the proposed threshold (0.131).   The six available HRV-A105 VP1 sequences 
group in a bootstrap supported clade which is closely related to, but distinct from the 
HRV-A57 prototype sequence, FJ445141.  Pairwise VP1 p-distances range from 
0.129 to 0.140 between the two groups.  Only two sequences within HRV-A105 had 
a pairwise VP1 p-distance of below 13% with HRV-A57; AY355238 and 
AY450495.  HRV-A105 has therefore been classified as a putative new HRV-A type 
with intermediate VP1 divergence.     
4.3.4 Analysis of HRV type groups which do not conform to the 
proposed VP1 divergence thresholds 
With the definition of VP1 nucleotide divergence thresholds for EV, several pairs of 
types showing divergence below this value were combined into single types. In many 
cases, this reassignment into single types was consistent with demonstrated 
serological cross-reactivity.   As examples from human EV classification, 
CAV13/CAV18 and CAV11/CAV15 have been reclassified as CAV13 and CAV11 
respectively (Brown et al., 2003).  Analysis of pairwise VP1 divergence between 
Proposals for the Classification of All Three Species of Human Rhinovirus into 
Genotypically Assigned Types 
107 
 
previously recognised HRV types revealed several similar examples.  For example, 
HRV-A8  and HRV-A95 have been combined and renamed as HRV-A8, due to an 
inter-type VP1 p-distance range of 0.015 to 0.019 and previously documented 
serological cross-reactivity (Ledford et al., 2004) (Figure 4.4 A1).   
Among other candidates, HRV-A29 and HRV-A44 have previously demonstrated 
cross-reactivity (Cooney et al., 1982) and the two clades containing the prototype 
strains had an inter-type VP1 p-distance of 0.0724 (Figure 4.4 A2).  However, 
contemporary strains isolated between 2003 and 2009 grouped separately from both 
serotype groups and cannot be classified as either by VP1 p-distance.  When both 
contemporary and prototype strains are considered, the A29/A44 group had a 
maximum divergence of 0.159 (involving the most divergent strain FJ042596).  All 
instances of intra-clade VP1 divergence of more than 13% involved one of the two 
most divergent strains, FJ042596 or FJ042606 compared with another contemporary 
strain.   However, all contemporary strains had a VP1 p-distance with the A29 and 
A44 prototype strains (FJ445125 and DQ473499) that is below the threshold of 13%.  
The most divergent strains mentioned are represented in each case by one sequence 
only and therefore it is not possible to determine at this stage whether these represent 
variants that happen to be at the extreme end of the distribution of intra-type 
divergence values or genuine intermediates in the process of diverging into a new 
HRV type.  As data accumulates from further epidemiological and evolutionary 
studies, this may become clear.  However, due to the well supported phylogenetic 
grouping with other strains within this group and the p-distance comparisons with 
prototype strains that universally fell below the threshold of 13%, this entire group of 
sequences has been combined and renamed as HRV-A29.   
HRV-A54 and HRV-A98 are a third type pair that are more closely related than 
expected, with a pairwise nucleotide VP1 p-distance of 0.107 to 0.124.  
Unfortunately, the cross-neutralisation properties of these two serotypes have not 
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been analysed in previous studies (Cooney et al., 1982; Ledford et al., 2004).  
However, on the basis of close phylogenetic relatedness (Figure 4.4 A3) and analysis 
of VP1 divergence, we would suggest that these may be combined. 
These three combined pairs of classical types may have been erroneous 
classifications in original studies (marked in yellow on Figure 4.3).  In the new 
proposed HRV classification system, they have been assigned to a type number of 
the earliest submitted full genome.  This therefore removes designations HRV-A44, 
A54 and A95.  In order to avoid confusion arising from published literature referring 
to the now abolished type designations, we would propose retaining these gaps in the 
numbering scheme.   
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FIGURE 4.4: Neighbour joining phylogenetic trees showing classical HRV type pairs which do not 
conform to the proposed VP1 divergence thresholds.  For ease of reference, the branch to tree root 
has been collapsed and the previously recognised prototype strain of each HRV type is highlighted in 
blue.  Three HRV-A type pairs which have been combined are shown in A1, A2 and A3.  Four HRV 
type pairs which display intermediate divergence values are shown in B1, B2, B3 and B4.  Branches 
are scaled by genetic distance.   
In addition to those type pairs which have been combined into single type 
assignments, a number of other HRV types display intermediate divergence values 
that violate the proposed thresholds.  HRV-A1/A1B are serologically cross-reactive 
(Cooney et al., 1982) but fall into two discrete phylogenetic groups and have 
pairwise p-distances that fall above the VP1 threshold (Figure 4.4 B1).  While the 
overall inter-clade distance ranges from 0.119 to 0.149, analysis of the prototype 
strains alone (A1: FJ445111 and A1B: D00239) showed a distance of 0.122.  While 
we suggest that these two clades be considered as HRV-A1, this type designation 
should be reviewed as more sequence data becomes available. 
As a contrasting problem, HRV-A25/A62 showed inter-clade VP1 pairwise distances 
ranging from 0.093 to 0.103 (Figure 4.4 B3), despite no evidence of cross-
neutralisation between these two serotypes (Cooney et al., 1982).  Therefore, this 
pair have retained their current type designation and been highlighted as an 
intermediate type pair.  Future studies should include re-assessment of the 
serological relationship between these two types and their designation revised 
accordingly. 
HRV-A36 and HRV-A89 strains fell into two distinct bootstrap supported 
phylogenetic clades and the prototype strains (DQ473508 and M162488) showed a 
VP1 p-distance of 0.129, on the borderline of being classified as the same type.  
However, although serum specific to HRV-A36 strains can neutralize HRV-A89, -
A50 and –A58, there was no reciprocal neutralisation (Cooney et al., 1982).  
Analysis of all nine known strains of HRV-A36 and five known strains of HRV-A89 
yielded an inter-clade VP1 divergence ranging from 0.117 to 0.172.  We would 
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suggest considering these two type designations as distinct entities with an 
intermediate nucleotide divergence in VP1. 
Only one HRV-C type showed p-distance values that violated proposed thresholds.  
HRV-C8 strains were divided into two clades, one previously classified as HRV-
Cpat28 and both containing contemporary sequences (Figure 4.4 B4).  The VP1 p-
distance between the two clades ranged from 0.129 to 0.132.  In consultation with the 
chairman of the Picornavirus Study Group (personal communication, N. Knowles, 
Picornavirus Study Group), it was decided that these two clades should remain 
classified as HRV-C8 on the basis of borderline VP1 divergence. 
 
FIGURE 4.5:  Distribution of HRV-A VP1 pairwise p-distances immediately surrounding the 
threshold of 13%.  VP1 p-distances between or within types which violate the proposed thresholds 
are marked in different colours.  Types which should be combined are shown in green, while those 
which remain discrete HRV types have inter-type distances falling below the threshold are pink.  
Intra-type comparisons falling above the divergence threshold are shown in purple.   
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Despite the large number of sequences available for all three species, HRV-A alone 
showed considerable evidence for VP1 pairwise p-distance comparisons that violate 
the proposed divergence thresholds.  Of these, the majority represent comparisons 
between types which should be combined (labelled in green on Figure 4.5).  Only 6 
discrete HRV-A types showed inter-clade distances which are below the threshold 
(labelled in pink on Figure 4.5) and intra-clade distances which are above the 
threshold (labelled in purple on Figure 4.5).  We would suggest the combined use of 
phylogenetic analysis and pairwise VP1 p-distance analysis in the classification of all 
HRV sequences, especially those suspected to be members of intermediate type 
groups.   
4.3.5 Assignment of type designations based on VP1 divergence for all 
three species of HRV 
The conclusion of the analysis of all available HRV VP1 data divided sequences into 
77 HRV-A types, 29 HRV-B and 13 HRV-C on the basis of full genome sequences 
(Table 4.3).  In addition, a further 38 HRV-C types were defined with only VP1 
sequence data available (Table 4.4).  The prototype sequence designated was the 
earliest submitted full genome or VP1 sequence (labelled in red in Table 4.3 and 
Table 4.4).  In cases where an HRV-C type originally defined on the basis of VP1 
sequence now has a full genome sequence available, the type has retained the first 
submitted VP1 sequence as the prototype strain (Simmonds et al., 2010).  In addition, 
certain inconsistencies in naming exist where novel strains have been submitted by 
individual researchers at separate times. These have been classified based on date of 
submission to the Picornavirus Study Group, rather than the earliest isolated strain.  
These inconsistencies are unfortunately unavoidable and should remain in place for 
clarity.       
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TABLE 4.3: Confirmed HRV-A, -B and –C types with full genome sequences available 


























HRV 1B 1/2/00 4 14 (Hughes et al., 
1988) 
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TC-71602 27/6/07 6 7 (Kistler et al., 
2007b) 











10/4/09 2 4 (Palmenberg 
et al., 2009) 
HRV-A15 DQ473493 
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10/4/09 3 7 (Palmenberg 
et al., 2009) 
HRV-A22 FJ445122 ATCC 
VR-1132 
10/4/09 1 4 (Palmenberg 










HRV 24 15/6/07 3 8 (Tapparel et 
al., 2007) 
HRV-A25 FJ445123 ATCC 
VR-1135 
10/4/09 1 3 (Palmenberg 















TC-67821 27/6/07 2 10 (Kistler et al., 
2007b) 
HRV-A31 FJ445126 ATCC 
VR-506 
10/4/09 1 7 (Palmenberg 
et al., 2009) 
HRV-A32 FJ445127 ATCC 
VR-1142 
10/4/09 1 3 (Palmenberg 
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TC-72617 27/6/07 3 5 (Kistler et al., 
2007b) 









10/4/09 4 6 (Palmenberg 
et al., 2009) 






10/4/09 2 5 (Palmenberg 
et al., 2009) 
HRV-A45 FJ445132 ATCC 
VR-1155 
10/4/09 1 5 (Palmenberg 
et al., 2009) 







10/4/09 3 10 (Palmenberg 






TC-66958 27/6/07 5 13 (Kistler et al., 
2007b) 
HRV-A50 FJ445135 ATCC 
VR-517 
10/4/09 1 3 (Palmenberg 





10/4/09 2 4 (Palmenberg 
et al., 2009) 
HRV-A53 DQ473507 
JN798587 







10/4/09 3 7 (Palmenberg 
et al., 2009) 
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10/4/09 2 3 (Palmenberg 
et al., 2009) 
HRV-A57 FJ445141 Fs ship#1 10/4/09 1 1 (Palmenberg 





10/4/09 2 5 (Palmenberg 
et al., 2009) 
HRV-A59 DQ473500 
JN541266 






10/4/09 2 4 (Palmenberg 





10/4/09 2 6 (Palmenberg 
et al., 2009) 
HRV-A62 FJ445145 ATCC 
VR-1172 
10/4/09 1 4 (Palmenberg 
et al., 2009) 
HRV-A63 FJ445146 ATCC 
VR-1173 
10/4/09 1 3 (Palmenberg 
et al., 2009) 
HRV-A64 EF173417 
FJ445181 







10/4/09 3 5 (Palmenberg 







10/4/09 4 6 (Palmenberg 





10/4/09 1 6 (Palmenberg 





10/4/09 2 4 (Palmenberg 
et al., 2009) 
HRV-A71 FJ445152 ATCC 
VR-1181 
10/4/09 1 3 (Palmenberg 
et al., 2009) 
HRV-A73 DQ473492 TC-73172 27/6/07 1 3 (Kistler et al., 
2007b) 












TC-70326 27/6/07 5 8 (Kistler et al., 
2007b) 
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HRV-A77 FJ445154 ATCC 
VR-1187 
10/4/09 1 3 (Palmenberg 
et al., 2009) 
HRV-A78 EF173418 
FJ445183 








10/4/09 4 6 (Palmenberg 







10/4/09 4 6 (Palmenberg 









27/6/07 5 7 (Kistler et al., 
2007b) 








HRV 89 7/2/03 6 7 (Duechler et 
al., 1987) 
HRV-A90 FJ445167 ATCC 
VR-1291 
10/4/09 1 3 (Palmenberg 
et al., 2009) 
HRV-A94 EF173419 
FJ445185 
HRV 94 15/7/07 2 4 (Tapparel et 
al., 2007) 
HRV-A96 FJ445171 ATCC 
VR-1296 
10/4/09 1 3 (Palmenberg 
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1/8/12 3 3 Unpub. 
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16/5/12 2 2 Unpub. 
HRV-B3 DQ473485 
EF173422 










10/4/09 1 3 (Palmenberg 











HRV 14 11/6/93 3 4 (Lee et al., 
1993) 
HRV-B17 EF173420 HRV 17 15/7/07 1 3 (Tapparel et 
al., 2007) 
HRV-B26 FJ445124 ATCC 
VR-1136 
10/4/09 1 3 (Palmenberg 
et al., 2009) 
HRV-B27 EF173421 
FJ445186 




TC-73280 27/6/07 2 4 (Kistler et al., 
2007b) 








10/4/09 4 6 (Palmenberg 
et al., 2009) 
HRV-B48 DQ473488 
JN990698 












10/4/09 4 10 (Palmenberg 
et al., 2009) 
HRV-B70 DQ473489 
JQ245974 
TC-72589 27/6/07 2 6 (Kistler et al., 
2007b) 
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10/4/09 6 8 (Palmenberg 
et al., 2009) 
HRV-B79 FJ445155 ATCC 
VR-1189 
10/4/09 1 3 (Palmenberg 





10/4/09 2 4 (Palmenberg 










10/4/09 7 9 (Palmenberg 
et al., 2009) 
HRV-B86 FJ445164 ATCC 
VR-1196 
10/4/09 1 3 (Palmenberg 
et al., 2009) 
HRV-B91 FJ445168 ATCC 
VR-1292 
10/4/09 1 4 (Palmenberg 
et al., 2009) 
HRV-B92 FJ445169 ATCC 
VR-1293 
10/4/09 1 3 (Palmenberg 
et al., 2009) 
HRV-B93 EF173425 HRV 93 15/7/07 1 3 (Tapparel et 
al., 2007) 
HRV-B97 FJ445172 ATCC 
VR-1297 
10/4/09 1 3 (Palmenberg 
et al., 2009) 
HRV-B99 FJ445174 ATCC 
VR-1299 
10/4/09 1 3 (Palmenberg 
et al., 2009) 
HRV-
B100 
HQ123444 CU211 23/1/11 1 1 (Linsuwanon 































F10 10/4/09 2 4 (Palmenberg 
et al., 2009) 
HRV-C1 EF077279 
HQ123443 
NAT001 20/10/06 2 5 (Kistler et al., 
2007a) 
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024 27/4/07 2 2 (Lau et al., 
2007) 

















N4 29/5/09 3 4 (Huang et al., 
2009) 
HRV-C9 GQ223228 N10 29/5/09 1 8 (Huang et al., 
2009) 




21/5/10 1 1 (Tapparel et 
al., 2009a) 




LZ508  2 2 Unpub. 
a
  Designated prototype strain is shown in red. 
b  
Strain identifier and date of submission both refer to prototype strain. 
c  
Number of VP1sequences available including full genomes. 
d 
Where some classical HRV type groups have been combined, the new prototype strain given is the 
earliest isolated full genome of either classical type.  
   
e 
In cases where more than one full genome has been sequenced and submitted concurrently, the full 
genome derived from amplification of an original ATCC strain has been designated as the prototype 
strain.   
f
 JX025555 has been designated as the prototype strain of HRV-A104, as the other available polyprotein 
sequence JQ245971 has a large gap within the VP1 region. 
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HRV-C12 JF317017 HM236958 Resp_3922/07 14/5/10 7 (McIntyre et 
al., 2010) 
HRV-C13 - HM236908 Resp_2951/06 14/5/10 2 (McIntyre et 
al., 2010) 





HM236963 Resp_4644/07 14/5/10 4 (McIntyre et 
al., 2010) 




HM236936 Resp_5145/07 14/5/10 3 (McIntyre et 
al., 2010) 
HRV-C18 - HM236918 Resp_3631/07 14/5/10 6 (McIntyre et 
al., 2010) 
HRV-C19 - EU840728 CL-Fnp5 20/6/08 3 (Tapparel et 
al., 2009a) 
HRV-C20 - HM236923 Resp_3995/07 14/5/10 2 (McIntyre et 
al., 2010) 
HRV-C21 - HM236903 Resp_5071/07 14/5/10 2 (McIntyre et 
al., 2010) 
HRV-C22 JN621242 HM236905 Resp_2748/06 14/5/10 3 (McIntyre et 
al., 2010) 
HRV-C23 - HM236901 Resp_3053/06 14/5/10 2 (McIntyre et 
al., 2010) 





HM236952 Resp_2832/06 14/5/10 4 (McIntyre et 
al., 2010) 
HRV-C26 JX193796 HM236904 Resp_2514/06 14/5/10 3 (McIntyre et 
al., 2010) 
HRV-C27 - HM236906 Resp_2784/06 14/5/10 4 (McIntyre et 
al., 2010) 
HRV-C28 JN798569 HM236954 Resp_3105/06 14/5/10 2 (McIntyre et 
al., 2010) 
HRV-C29 - HM236949 Resp_5345/07 14/5/10 1 (McIntyre et 
al., 2010) 
HRV-C30 - HM236968 Resp_3898/07 14/5/10 1 (McIntyre et 
al., 2010) 
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HM236897 Resp_6131/07 14/5/10 12 (McIntyre et 
al., 2010) 
HRV-C33 - HM236934 Resp_4917/07 14/5/10 2 (McIntyre et 
al., 2010) 
HRV-C34 JF436926 JF519798 PNG7111-
3625 
22/6/12 2 (Chidlow et 
al., 2012) 
HRV-C36 JN541267 JF416311 Resp_2480/07 22/8/11 5 (McIntyre et 
al., 2013b) 
HRV-C37 - JF416321 Resp_6135/08 22/8/11 1 (McIntyre et 
al., 2013b) 
HRV-C38 JN837691 JF416322 Resp_6142/08 22/8/11 2 (McIntyre et 
al., 2013b) 




JF416312 Resp_2800/06 22/8/11 6 (McIntyre et 
al., 2013b) 
HRV-C41 JN798565 JF416323 Resp_9449/08 22/8/11 3 (McIntyre et 
al., 2013b) 




JF416307 Resp_13229/08 22/8/11 4 (McIntyre et 
al., 2013b) 
HRV-C44 - JF416310 Resp_15588/09 22/8/11 1 (McIntyre et 
al., 2013b) 
HRV-C45 JN837686 JF416308 Resp_13958/08 22/8/11 3 (McIntyre et 
al., 2013b) 
HRV-C46 - JF416318 Resp_5153/07 22/8/11 2 (McIntyre et 
al., 2013b) 
HRV-C47 - JF519760 PNG7254-
3947 
22/6/12 1 (Chidlow et 
al., 2012) 
HRV-C48 - JF519762 PNG7293-
3193 
22/6/12 1 (Chidlow et 
al., 2012) 
HRV-C49 JF907574 JF946738 WA11040M 22/10/11 3 (Wiertsema 
et al., 2011) 
HRV-C50 - JQ739202 SG1 24/4/12 1 Unpub. 
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4.3.6 Analysis of recombination within the capsid coding region of HRV 
and phylogenetic analysis of the VP4/VP2 region 
Within EV isolates, recombination has been documented within the capsid coding 
region (Bouslama et al., 2007) and therefore the VP1 region alone is deemed suitable 
for typing.  However, recombination within the capsid coding region of HRV is 
thought to be relatively infrequent (Palmenberg et al., 2009; Kistler et al., 2007b; 
Lewis-Rogers et al., 2009).   
The well conserved and readily amplified VP4/VP2 region of HRV is commonly 
used in studies of its epidemiology and clinical associations.  Recent and rapid 
accumulation of sequence data has created over 3900 HRV sequences in the region 
available on GenBank compared to 384 sequences of the VP1 region, a region that is 
problematic to amplify without species or type-specific primers.  Therefore, in view 
of this imbalance, it is important to verify that known HRV types can be correctly 
identified through analysis of the VP4/VP2 region if sequence data from this region 
is to be employed in epidemiological and clinical studies.   
The majority of HRV strains grouped congruently between VP1 and VP4/VP2 (data 
not shown), indicating that phylogenetic grouping in VP4/VP2 was predictive of the 
type group assigned using VP1 sequences.  Only one sequence showed evidence of 
phylogenetic incongruence within the capsid region.  JX291115 is a member of 
HRV-C51 type group in the VP1 region, with a pairwise nucleotide p-distance of 
0.005.  However, in VP4/VP2, this sequence had a VP1 p-distance of 0.1459 from 
HRV-C51 and groups as a poorly supported outgroup to HRV-C15.  Analysis with 
the RDP software package confirms this sequence as a putative recombinant and 
similar to the pattern observed from phylogenetic analysis, there was no known 
minor recombination parent.  Analysis of HRV-A and -B carried out with RDP and 
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GARD highlighted no evidence of recombination between regions.  This suggests 
that the VP4/VP2 region may additionally be used for classification of HRV types.   
We previously proposed a divergence threshold of 10% for the purpose of classifying 
HRV-C sequences by VP4/VP2 sequence (Simmonds et al., 2010).  This was 
calculated using all HRV sequences that were over 90% complete across a fragment 
of VP4/VP2 from position 615 – 1043 (numbered by EF582385).  In the revised 
analysis, the use of a shorter fragment was considered (615 – 1004 numbered by 
EF582385), as this would allow inclusion of a large number of additional VP4/VP2 
sequences.  Inspection of phylogenetic trees constructed for both fragments showed 
no change in the uniformly high bootstrap support for individual type groups and no 
change in the clade membership of individual sequences.  Therefore, the smaller 
fragment was used in all subsequent phylogenetic and p-distance analysis (Figure 
4.6). 
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FIGURE 4.6: Neighbour joining phylogenetic trees showing the VP4/VP2 region of all three 
species of HRV.  For ease of reference, individual type groups and the branch to tree root have been 
collapsed.  Divergent groups which have been temporarily designated as provisionally assigned types 
are shown in red.  HRV type groups which do not conform to the proposed VP4/VP2 thresholds are 
shown in purple.  The single recombinant sequence detected, JX291115 is marked by a purple box.  
Branches are scaled by genetic distance.       
 
4.3.7 Assigning nucleotide divergence thresholds for the VP4/VP2 
region 
Pairwise p-distance comparisons are divided into two distributions in the VP4/VP2 
region (Figure 4.7).  Detailed inspection of distributions of pairwise distances 
allowed a threshold of 10.5%, 9.5% and 10.5% to be assigned for HRV-A, -B and –C 
respectively.  Due to the fact that VP4/VP2 is a considerably shorter and less 
divergent sequence fragment than VP1, the thresholds are less clearly defined, with a 
greater number of pairwise comparisons close to the assignment threshold. 
The original HRV-C classification included 28 provisionally assigned types, which 
were assigned on the basis of VP4/VP2 sequence divergence alone.  When a 
corresponding VP1 sequence was obtained and confirmed to display at least 13% 
divergence, a new confirmed type was created and the provisionally assigned type 
designation discarded.  Of these original 28 provisionally assigned types, only 11 
remain (listed in Table 4.5).  In 2012, VP1 sequencing of HRV-C isolates from 10 
provisionally assigned type groups led to confirmation of further species C types 
HRV-C36 to HRV-C46 (McIntyre et al., 2013b).  To date, only one provisionally 
assigned type has been combined into an existing type (HRV-C8/Cpat28).  This 
reaffirms the usefulness of the provisionally assigned type system for identifying 
candidate new types and guiding the use of VP1 region sequencing for confirming 
these.     
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FIGURE 4.7:  Distributions of pairwise nucleotide p-distances for the VP4/VP2 region of all three 
species of HRV.  HRV-A is shown in section A1, HRV-B in B1 and HRV-C in C1. A detailed analysis 
of the distribution values adjacent to the proposed thresholds for HRV-A (A2), HRV-B (B2) and HRV-
C (C2) is also shown and the proposed nucleotide divergence threshold is shown by a red dotted line.      
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Based on this principle, 4 previously unrecognised divergent VP4/VP2 groups were 
observed in HRV-A and 4 in HRV-B (labelled in red on Figure 4.6).  A further three 
provisionally assigned HRV-C types were also detected (designated HRV-Cpat29-
pat31).  All showed divergence above the VP4/VP2 threshold proposed for their 
species (Table 4.5).  Only one of these provisionally assigned types, HRV-Apat2 had 
a corresponding sample which existed within our archive.  However, the sample was 
missing and so VP1 sequencing could not be attempted.          

















Type strain ref 
A Apat1 GU568105 13/10/10 2 A73 0.106 (Xiang et al., 2010b) 
A Apat2 GQ476621 4/12/09 4 A47 0.119 (Wisdom et al., 
2009b) 
A Apat3 AB549407 10/3/10 6 A43 0.144 (Kaida et al., 2011) 
A Apat4 EU590059 24/6/09 12 A46 0.112 (Savolainen-Kopra et 
al., 2009a) 
B Bpat1 EF077241 23/8/07 1 B83 0.119 (Kistler et al., 2007a) 
B Bpat2 HM366914 3/1/11 2 B48 0.122 (Piralla et al., 2011) 
B Bpat3 HM366910 3/1/11 11 B97 0.097 (Piralla et al., 2011) 
B Bpat4 AB548901 10/3/10 15 B91 0.107 Unpub. 
C Cpat10 EU590054 25/3/08 17 C2 0.200 (Savolainen-Kopra et 
al., 2009a) 
C Cpat14 EU697852 5/5/08 6 Cpat16 0.106 (Briese et al., 2008) 
C Cpat16 EU752358 26/5/08 5 Cpat14 0.106 (Miller et al., 2009a) 
C Cpat17 EU752398 26/5/08 14 C29 0.133 (Miller et al., 2009a) 
C Cpat18 EU752412 26/5/08 28 Cpat19 0.146 (Miller et al., 2009a) 
C Cpat19 FJ598096 31/12/09 17 Cpat18 0.146 Unpub. 
C Cpat20 FJ615722 9/1/09 1 C41 0.105 (Miller et al., 2009b) 
C Cpat21 FJ615737 9/1/09 7 C36 0.144 (Miller et al., 2009b) 
C Cpat22 FJ615745 9/1/09 7 C33 0.121 (Miller et al., 2009b) 
C Cpat24 FJ869923 27/3/09 2 C28 0.106 (Han et al., 2009) 
C Cpat27 GU214340 18/11/09 10 C18 0.105 (Piralla et al., 2009) 
C Cpat29 FR820909 3/4/12 3 C50 0.113 (Henquell et al., 
2012) 
C Cpat30 AB550405 23/12/11 1 C5 0.110 (Fujitsuka et al., 
2011) 
C Cpat31 AB628117 24/2/12 1 C27 0.115 Unpub. 
a  
This represents the closest HRV type by p-distance and phylogenetic analysis.   
b  
Lowest inter-clade VP4/VP2 pairwise nucleotide p-distance between provisionally assigned type 
and nearest neighbour  
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4.3.8 Analysis of confirmed HRV types which do not conform to 
VP4/VP2 thresholds 
Analysis of inter- and intra-type pairwise nucleotide p-distances in VP4/VP2 
revealed many groups which violated the proposed divergence thresholds (22, 10 and 
6 types of HRV-A, -B and –C respectively).   HRV-A1 and HRV-A25/62 displayed 
the same patterns as in the VP1 region, in which they were designated as 
intermediate types.     
TABLE 4.6:  Limits of inter- and intra- clade divergence in HRV types which do not conform to 
VP4/VP2 thresholds 
















D00239 44 0.124 0.124 
HRV-A2 X02316 15 0.123 0.133 
HRV-A15 DQ473493 17 0.107 0.147 
HRV-A20 FJ445120 23 0.119 0.119 
HRV-A22 FJ445122 13 0.136 0.148 
HRV-A25 FJ445123 7 0.075 0.064 
HRV-A28 DQ473508 30 0.114 0.151 
HRV-A29
b 
DQ473499 42 0.159 0.151 
HRV-A31 FJ445126 10 0.097 0.083 
HRV-A46 DQ473506 14 0.137 0.119 
HRV-A47 FJ445133 39 0.098 0.083 
HRV-A53 DQ473507 28 0.109 0.128 
HRV-A54 FJ445138 12 0.129 0.125 
HRV-A61 FJ445144 17 0.112 0.135 
HRV-A62 FJ445145 7 0.064 0.064 
HRV-A63 FJ445146 24 0.118 0.136 
HRV-A66 FJ445148 16 0.112 0.130 
HRV-A78 EF173418 83 0.153 0.163 
HRV-A80 FJ445156 15 0.129 0.129 
HRV-A81 FJ445157 17 0.107 0.152 
HRV-A82 DQ473509 20 0.135 0.147 
HRV-A100 FJ445175 5 0.143 0.147 
HRV-B3 U60874 13 0.128 0.142 
HRV-B35 DQ473487 13 0.102 0.135 
HRV-B37 EF173423 6 0.102 0.118 
HRV-B48 DQ473488 22 0.129 0.122 
HRV-B52 EF173424 32 0.005 0.093 
HRV-B69 FJ445151 61 0.131 0.099 
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HRV-B70 DQ473489 16 0.100 0.097 
HRV-B72 FJ445153 17 0.102 0.151 
HRV-B86 FJ445164 7 0.107 0.138 
HRV-B104 FJ445137 5 0.092 0.093 
HRV-C4 EF582385 6 0.031 0.100 
HRV-C8 GQ223227 25 0.147 0.169 
HRV-C12 HM236958 67 0.113 0.134 
HRV-C32 HM236897 19 0.071 0.090 
HRV-C39 JF416306 46 0.074 0.090 
HRV-C49 JF946738 8 0.049 0.100 
a  
Confirmed types which are distinct in the VP1 region but violate the divergence thresholds in 
VP4/VP2 are marked in bold italics.     
b  
Please note that new HRV type designations as presented in Table 4.3 are used in this analysis. 
 
Four type pairs had VP4/VP2 divergence that was below the proposed threshold.  
HRV-A31/A47, HRV-B52/B104, HRV-C4/C49 and HRV-C32/C39 had inter-type p-
distances in VP4/VP2 of 0.083, 0.093, 0.100 and 0.090 respectively.  In each case, 
VP1 divergence between the two members of the pair confirmed them to be distinct 
types and each type group forms a distinct phylogenetic cluster which is readily 
distinguishable from its nearest neighbour.  These represent confirmed type groups 
which are distinct in the VP1 region, but less divergent than would be expected in 
VP4/VP2 (marked in bold italics on Table 4.6).     
Most type groups contained two sub-clusters; one containing older strains closely 
related to the prototype and the other containing contemporary isolates.  The majority 
of type groups with intra-type VP4/VP2 distances which violated the thresholds had 
a representative VP1 sequence from the divergent contemporary cluster.  Invariably, 
these fell within the proposed thresholds for divergence in the VP1 region.  These 
types represent confirmed type groups which are more divergent in VP4/VP2 than 
would be expected (marked in bold italics on Table 4.6).  Each of these types formed 
a distinct phylogenetic cluster in VP4/VP2.   
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The remaining 12 HRV types showed divergence above the threshold in VP4/VP2 
and had no available VP1 sequence to confirm the type designation.  These could be 
categorised into two groups.  For the majority of these types (including HRV-A15, -
A53, -A63, -A100, -B35, -B69, -B72 and –C12), all p-distance comparisons above 
the threshold occurred between contemporary isolates.  When considered 
individually, every contemporary strain had a p-distance from the prototype strain of 
less than 10.5% or 9.5%.  Therefore, these types contained examples of divergent 
contemporary strains that were still type group members.  The remaining types could 
not be definitively classified.  HRV-A46, -A61, -A86 and –B3 all contained at least 
one contemporary strain that had a pairwise nucleotide p-distance of greater than 
10.5% or 9.5% with their corresponding prototype strain.  However, in each case, 
phylogenetic analysis revealed that the divergent strain was embedded within a clade 
containing type group members. 
The existence of such a large number of HRV types which violate the proposed 
thresholds highlights the fact that it is not sufficient to rely on pairwise nucleotide p-
distance analysis for identification of HRV types.  However, when considered in 
parallel with phylogenetic analysis, all strains could be readily classified into types 
with a degree of certainty.      
4.3.9 Geographical distribution of HRV types 
An analysis of the broad geographical distribution of HRV types was undertaken by 
obtaining information on geographical location of isolation of all VP4/VP2 
sequences, where available.  VP4/VP2 sequences were selected in preference over 
VP1 sequences, as this region is the most commonly used in prevalence studies of 
HRV.  Although most sequences had associated geographical data available, 492 
HRV isolates could not be associated with a particular location.   
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Although there is clearly a finite limit to the number of currently circulating HRV 
types, the continuing discovery of novel HRV types suggests that the limit has not 
yet been reached.  HRV screening has been undertaken over a wide geographical 
base including Europe, USA, Australia and Asia.  For the purposes of this analysis, 
sequences were divided into those isolated in 4 large regions; USA, Asia, Europe and 
other (including Australia, Jordan and Africa).  As a substantial number of the 
sequences included were derived from our own screening, sequences from the UK 
and those from other European studies were separated into two distinct categories.  
The distribution of all identified strains between the geographical regions was highly 
similar across all three species, which indicates a lack of bias in the transmission and 
circulation of any HRV species within a particular geographical region (Figure 4.8).   
Several HRV types were excluded from the analysis, on the basis of limited 
availability of geographical information (HRV-A50, -A57, -A64, -B5, -B17- B91 
and –C50).  All of these types consisted of one or two VP4/VP2 sequences.  In 
addition, 5 HRV-C and 2 HRV-B types were represented by one available strain 
only.  Without further large-scale epidemiological studies of HRV circulation and 
type distribution over a wide geographical area, it is difficult to speculate on the 
significance of these seemingly rare types.  It is possible that these represent types 
which have a tendency to cause more mild and self-limiting infections, which would 
not be seen on screening carried out among hospitalised patients.  No single HRV 
type with a large number of VP4/VP2 sequences available was found to display 
geographical restriction, which suggests that most HRV types circulate freely 
worldwide.  A generalised increase in the practice of routine HRV typing will allow 
further investigation of the geographical distribution of HRV types.   
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FIGURE 4.8: Total number of identified HRV strains divided by geographical location of isolation.  
HRV-A, -B and –C are shown separately.  The total representation of sequences from each 
geographical area is shown in inset pie-chart.   
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4.4.1 Development of a sensitive and specific RT-PCR for the 
amplification of the VP1 region of HRV   
The ability to perform genotyping directly from clinical specimens removes the need 
for cell culture passage and therefore greatly reduces time required for an accurate 
diagnosis and exposure of staff to live cultures.  This has been achieved in studies of 
EV (Mirand et al., 2009; Nix et al., 2006; McWilliam Leitch et al., 2009b).  The 
HRV specific assays developed in the course of this work allow the amplification of 
the full VP1 region from respiratory specimens, which often have low viral titres.  
Unfortunately, due to the high degree of genetic diversity, it was not possible to 
develop an assay capable of amplifying all three species of HRV concurrently.  
Indeed, even within a single HRV species, maintaining the required balance between 
allowing sufficient primer degeneracy to amplify all types and avoiding non-specific 
amplification was challenging.   
Several studies have advocated the use of a one-step PCR for EV typing, comprising 
only of a first round of amplification (She et al., 2010; Kiang et al., 2009), with the 
suggestion that a “closed system” is less likely to suffer from contamination.  
However, one of the above studies reported that almost one third of tested isolates 
could not be effectively amplified in the VP1 region and those that were successful 
showed significant non-specific product (She et al., 2010).  We have found that a 
nested PCR method dramatically reduces non-specific amplification and is much 
more effective for the amplification of very low titre samples.  Also, with effective 
and universal adherence to the “one-way” system in PCR laboratories, with spatial 
separation of dedicated areas for nucleic acid extraction, first round and second 
round PCR, the occurrence of contamination is greatly reduced (Chapter 2).     
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4.4.2 The importance of genotyping in HRV 
The identification and definition of HRV types by analysis of available sequence 
data within the capsid region has the potential to revolutionise HRV typing.  The 
ease with which this can be carried out, requiring very little additional equipment or 
training, should make the endeavour of classifying all detected HRV sequences much 
more feasible and attractive.  A global system of type identification should allow 
large-scale investigations of epidemiology, transmission and evolution. Classification 
and centralised reporting of new HRV types improves the ability of researchers to 
commence study of the distribution of new types quickly.  Whereas previously a 
considerable latent period would have been necessary while waiting for type-specific 
antiserum to be developed and dispatched, now sequence data for comparison is 
available worldwide almost instantly. 
4.4.3 Proposed criteria for the division of HRV into genotypically 
defined types 
The usage of nucleotide divergence thresholds for the definition of new EV types for 
several years with great success strengthens the assertion that this is a valid method 
of classification for the closely related HRV.  The criteria that we have developed 
and have been proposed formally (Simmonds et al., 2010; McIntyre et al., 2013a) are 
summarised below.  The overall conclusions and recommendations are informed by 
and consistent with those already used for EV.  However, by incorporating lower 
thresholds and acknowledging the lack of capsid recombination by proposing a 
VP4/VP2 divergence threshold, we have taken into account the differences between 
HRV and EV in terms of biological properties and genetic diversity.  
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Proposed criteria for the assignment of genotypically defined types of 
HRV 
1.  An HRV type should be phylogenetically distinct from other HRV types.   
2. Analysis of divergence in the VP1 region should include at least 90% of the full VP1 coding 
region for each species. 
3. In the VP1 region, an HRV type should have at least 13% (HRV-A), 12% (HRV-B) or 13% 
(HRV-C) nucleotide divergence from all other HRV types.  
4. In cases where nucleotide divergence in VP1 is not sufficient to definitively assign types, 
phylogenetic relationships may be taken into account.   
5. VP4/VP2 sequences can be used for type identification in epidemiological studies.   
6. If a putative new HRV type is initially identified from VP4/VP2 sequences and no VP1 
sequence data is available, it should be designated as a provisionally assigned type.   
7. For putative new types that are confirmed by VP1 nucleotide divergence, a permanent HRV 
type designation should be assigned. 
8. New HRV type names should be numbered sequentially and include the species designation 
(eg/ HRV-A104). 
9. The “prototype strain” of each new HRV type should be the first reported full genome 
sequence or, if this is unavailable, the first reported full VP1 sequence. 
10. The Picornavirus Study Group should continue to oversee assignment of new HRV types, as 
the group includes members with specific expertise in enterovirus type assignment and a 
number of scientists currently active in HRV research.   
 
The use of only capsid coding regions in type assignment criteria should not detract 
from the importance of continued investigation of other genomic regions, in 
particular where these may contribute to the phenotype and disease associations of 
HRV.  In addition, the use of the VP1 region for definition of new HRV types should 
not discourage the widespread continued use of 5ˈUTR and VP4/VP2 screening 
protocols.  Screening with these relatively conserved regions allows a much greater 
opportunity for discovery of previously unknown HRV types.    
Although this represents, to our knowledge, the most comprehensive survey of HRV 
sequence data currently possible, the guidelines should be subject to further review 
as additional data becomes available.   
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4.4.4 Future directions 
In all three species, the phylogeny of the full VP1 region reliably separated isolates 
of known differing type into distinct bootstrap supported clades.  As VP1 also 
contains a large number of the neutralizing immunogenic sites observed in HRV-A 
and -B (Kistler et al., 2007b), we can assume that this region is an accurate molecular 
determinant of the serotype.  An interesting potential future addition to this work 
would be confirmation of serological properties of HRV-C type groups.  This would 
require an easily implementable system for the cultivation of HRV-C in vitro.  The 
sinus mucosal organ culture system currently available represents an excellent 
opportunity to study biological properties of HRV-C (Bochkov et al., 2011).  
However, it is not suitable for the extensive use that would be required to confirm 
type designations as not only is it more labour-intensive than other cell culture 
methods, but requires regular access to a local Department of Head and Neck 
Surgery to obtain viable sinus tissue.  Limited serotyping studies would also be 
useful in re-confirming some potentially aberrant HRV-A and HRV-B type 
assignments where cross-reactivity is uncertain (such as HRV-A54/A98).      
There is a possibility that a smaller fragment of VP1 could be suitable for genotyping 
in HRV.  Oberste et al highlighted that a 450 base segment at the 3ˈ end of VP1 
could be used for EV typing and the results had a 100% correlation with 
neutralization results (Oberste et al., 1999a).   A second study showed full correlation 
of a 303 nucleotide stretch of VP1 with neutralization data, but this was only applied 
to 59 Genbank strains  (Kiang et al., 2009).  In addition, a simple, fast and effective 
method of typing EV by pyrosequencing has recently been developed (Silva et al., 
2008).  This may become extremely useful as pyrosequencing becomes more widely 
available worldwide.    
Finally, there is potential for the development of an interactive web tool which would 
allow users to input a FASTA sequence and receive an HRV type designation.  The 
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service could include an additional step comprising of request for input of a VP1 
sequence and subsequent analysis in cases where type designation is dubious.  A 
similar system is already in use for EV and Noroviruses (Kroneman et al., 2011).  
However, this would have to be modified significantly to allow assignment of HRV 
types, as the described algorithm is based solely on phylogeny.  In order to 
accurately assign HRV types, it would be desirable to consider both inferred 
phylogeny and calculated pairwise nucleotide p-distances from all prototype strains.  
Such a tool, widely and free available on the internet, would make HRV genotyping 









Analysis of genetic diversity and sites of 
recombination in HRV-C 
5.1  Introduction 
5.1.1 Recombination in the evolution of human enteroviruses 
Human EV are divided into four species by phylogenetic analysis (EV-A-D) and the 
three serotypes of PV are now classified as EV-C.  EV-B is the largest and most 
clinically common human EV species.  Developing a detailed understanding of the 
frequency and occurrence of recombination in circulating EV has been vital in 
surveillance of outbreaks of vaccine derived poliomyelitis, whereby vaccine PV 
strains may recombine either with each other or with circulating EV-C strains to 
produce neurovirulent PV (Cuervo et al., 2001; Blomqvist, 2003; Jegouic et al., 
2009).     
 Circulating EV strains undergo frequent recombination, which manifests as 
observed incongruities between inferred phylogenies in distant genome fragments.  
Intra-species recombination within the coding region has been described in EV-A 
(Simmonds and Welch, 2006; Huang et al., 2008; McWilliam Leitch et al., 2012; 
Santti et al., 1999), EV-B (Simmonds and Welch, 2006; Lukashev et al., 2005; 
Lindberg et al., 2003; McWilliam Leitch et al., 2009a, 2010; Chevaliez et al., 2004; 
Andersson et al., 2002) and EV-C (Jegouic et al., 2009; Dahourou et al., 2002).  EV 
has a similar genome structure to HRV with four structural and seven non-structural 
proteins translated as a single polyprotein that is cleaved post-translationally.  
Recombination breakpoints are often observed to occur within the non-structural 
protein coding region and frequently near the boundary with the structural protein 
coding region.  Specifically, recombination breakpoints have been isolated in the 2A 
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protease coding region (van der Sanden et al., 2011), 2B (Lindberg et al., 2003; 
Chevaliez et al., 2004), 2C (Lukashev et al., 2005; Andersson et al., 2002), at the 5ˈ 
end of 3D (van der Sanden et al., 2011) and (in PV recombinants generated in vitro) 
within the 3C region (Runckel et al., 2013).   
The frequent recombination between the capsid and non-structural protein coding 
regions has led to a theory that these genome regions of EV strains evolve in a 
modular and independent fashion (Santti et al., 1999; Lukashev et al., 2005).  This 
implies that EV diversity is derived from constant recombination between capsid 
sequences and pools of non-structural genome sequences.  The combination of a 
capsid sequence and non-structural region generates a specific recombinant form 
(RF).  These RFs have been shown to rise to dominance and then disappear entirely 
over the span of only a few years  (McWilliam Leitch et al., 2009a).   
In contrast, only rarely is recombination observed within the capsid coding region of 
EV (Santti et al., 1999; Lindberg et al., 2003; McWilliam Leitch et al., 2009a; 
Simmonds and Welch, 2006) and this has been previously attributed to the 
significantly greater sequence divergence seen within the capsid coding region 
(Lindberg et al., 2003).  It has been suggested that the increased divergence may 
present a biological compatibility barrier, which renders variants with chimaeric 
capsid regions unviable or simply less fit than parental strains (Simmonds and 
Welch, 2006).  The theory of the biological compatibility barrier is additionally 
supported by the observation that inter-species recombination in any part of the 
coding region is only very rarely observed in EV.  One recent study of PV 
recombination in vitro used a deep sequencing technique to isolate not only viable 
PV recombinants, but all genomes generated during viral replication (Runckel et al., 
2013).  Analysis of recombination breakpoints in over 50,000 generated genomes 
found that there was actually no difference between the frequency of occurrence of 
recombination within the capsid and the non-structural protein coding region.  This 
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supports the assertion that capsid recombinants are likely routinely randomly 
generated, but are less able to compete with wild type viruses.  Viable circulating EV 
strains with chimaeric capsids have been infrequently isolated (Blomqvist, 2003; 
Bouslama et al., 2007; Zhang et al., 2010).  In addition, one study found a 
recombination breakpoint near the 5ˈ end of the VP4 region, presumably related to 
recombination within the 5ˈUTR (Lukashev et al., 2005). 
Within all four species of human EV, 5ˈUTR sequences cluster phylogenetically into 
two large groups (Pöyry et al., 1994).  Sequences from EV-A and –B are interspersed 
within one group (Group I) and sequences from EV-C and –D within the other 
(Group II) (Pöyry et al., 1996).  Extensive phylogenetic incongruence has been 
observed between the 5ˈUTR and capsid coding regions (Simmonds and Welch, 
2006) and no evidence has been found of a correlation between phylogenetic 
grouping in the 5ˈUTR region and other putative recombinant regions downstream 
(Lukashev et al., 2005).  In addition, four recently described new EV types (EV-A90, 
EV-A91, EV-C104 and EV-C109) have 5ˈUTR sequences which group outwith the 
5ˈUTR cluster expected by their EV species designation (Yozwiak et al., 2010; 
Tapparel et al., 2009b; Smura et al., 2007a).  Two of these are EV-C types (EV-C104 
and EV-C109) which group closely with EV-A/-B sequences in the 5ˈUTR and two 
(EV-A90 and EV-A91) are EV-A types which cluster with EV-C/-D in the 5ˈUTR.  
This indicates a degree of reciprocal exchange between the two 5ˈUTR clusters in the 
contemporary evolution of EV strains.   
5.1.2 Recombination in the 5ˈUTR of HRV-C 
HRV-C was only discovered relatively recently (McErlean et al., 2008; Arden et al., 
2006; Kistler et al., 2007b; Lamson et al., 2006; Renwick et al., 2007; Lau et al., 
2007) and at the time that this work was undertaken, only limited information 
regarding the frequency and occurrence of recombination within the HRV-C genome 
had been published (Huang et al., 2009; Wisdom et al., 2009a).  However, 
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recombination was thought to be rare within the coding region of HRV-A and -B 
(Kistler et al., 2007b; Lewis-Rogers et al., 2009).  In contrast, preliminary studies 
undertaken of circulating genetic diversity of HRV-C strains indicated that they fell 
into two distinct phylogenetic groups (Han et al., 2009; Huang et al., 2009; Wisdom 
et al., 2009a).  In fact, over 60% of sequenced strains which are members of HRV-C 
species by sequence analysis in the capsid region group within the HRV-A clade in 
the 5ˈUTR (Wisdom et al., 2009a).  It appears that similar to EV strains, inter-species 
recombination in the 5ˈUTR has taken place extensively in the evolutionary history 
of this species.  Studies of the clinical correlates and molecular epidemiology of 
HRV-C strains have found no difference in the clinical outcomes or circulation 
patterns of recombinant (HRV-Ca) or non-recombinant (HRV-Cc) strains (Huang et 
al., 2009; Wisdom et al., 2009a).     
The grouping of the majority of HRV-C strains within the HRV-A clade has 
probably contributed to the relatively recent discovery of HRV-C, despite the fact 
that it appears to have been circulating in human populations for many years (Briese 
et al., 2008).  Prior to the recognition of recombinant HRV strains, it was common 
practice to use 5ˈUTR sequence comparisons for HRV species and type identification 
(Kiang et al., 2008); a practice which would have led to the misidentification of over 
two thirds of HRV-C strains as HRV-A.  However, it is now generally accepted that 
this typing method is fundamentally flawed (Savolainen-Kopra et al., 2009b) and the 
majority of published studies utilise the VP4/VP2 region instead.   
5.1.3 Genetic features of HRV-C 
HRV-C strains share the same basic genome organisation with HRV-A and -B and 
other EVs, including an approximately 7kB genome encoding a single open reading 
frame.  HRV-C have been found to have a generally shorter coding region than other 
Picornaviridae, secondary to deletions within the VP1 capsid protein coding region 
(Lau et al., 2007; Arden et al., 2010).  Also in common with other HRV are the 
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observed amino acid sequence motifs at the start of the coding region (MGAQVS) 
and within the 3D polymerase coding region (YGDD, YGL, FLKR, SIRWT) (Lau et 
al., 2007; Arden et al., 2010; McErlean et al., 2008).  These are all fully conserved in 
other HRV species (Savolainen et al., 2004) and the 3Dpol motifs are additionally 
conserved in EV strains (Brown et al., 2003).     
Distinguishing features of HRV-C genomes include the unique position of the cis-
acting replication element (cre) within VP2 (Cordey et al., 2008; Arden et al., 2010).  
In contrast, this has been located within 2A in HRV-A (Gerber et al., 2001) and VP1 
in HRV-B (McKnight and Lemon, 1998).  In addition, HRV-C are found to have a 
generally elevated G+C content of between 42-43% compared to HRV-A and –B 
(39-40%), although this is generally lower than the G+C content seen in EV (46%) 
(Arden et al., 2010; Lau et al., 2007).      
Similar to all members of the genus Enterovirus, HRV-C strains possess a 5ˈUTR of 
approximately 600 bases.  The 5ˈUTR is a highly structured and well conserved 
region which contains certain elements essential to effective replication of the virus.  
As all EV, HRV possess a type I IRES, which is essential for the internal initiation of 
translation of the uncapped mRNA (Palmenberg et al., 2009).  In addition, a 5ˈ 
cloverleaf structure, implicated in the initiation of RNA synthesis was present and 
structurally conserved in all three species of HRV (Palmenberg et al., 2009).  The 
high degree of conservation of both RNA sequence and secondary structure observed 
within this region may contribute to the observed propensity for recombination 
within the 5ˈUTR of HRV-A/-C.        
The majority of the analysis presented within this chapter focussed on the occurrence 
of recombination within samples collected from Edinburgh patients between 2006 
and 2007. This has been previously published (McIntyre et al., 2010).  However, 
section 5.3.2 also refers to an additional analysis of the 5ˈUTR region of all 
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published HRV-C full genomes, undertaken in 2012 and published as part of a 
further paper (McIntyre et al., 2013b).    
5.2 Materials and Methods 
5.2.1 Sample selection 
A previously conducted study had produced sequences from VP4/VP2 and a small 
fragment of the 5ˈUTR of 144 HRV-C sequences derived from Edinburgh patients. 
These fell into 46 phylogenetic clusters, now known to be analogous to type groups.  
Samples for inclusion in the study of recombination within the coding region of 
HRV-C were selected in order to include at least one representative from as many of 
these phylogenetic groups as possible.  In addition, a further 15 samples from 
epidemiological studies (Chapter 3) were selected.  This resulted in the inclusion of 
35 HRV-C types in the 5ˈUTR, VP4/VP2 and 3Dpol regions and 28 in the VP1 
region.   
5.2.2 Amplification of the VP4/VP2, VP1 and 3Dpol regions of HRV-C 
The VP4/VP2 and VP1 regions were amplified as previously described (Chapter 3, 
Chapter 4).  A 3Dpol fragment (from positions 6384 – 6854 numbered by EF582385) 
was amplified using a nested PCR protocol (described in Chapter 2 and primers 
listed in Appendix 1).  Samples negative on initial nested PCR were amplified using 
a SuperScript III protocol (Chapter 2).      
5.2.3 Amplification of the 5ˈUTR region of HRV-C 
Two sequence fragments with a 61 base overlap were produced, allowing a 
composite 5ˈUTR sequence of 680 bases to be constructed.  The amplification of the 
5ˈUTR region utilised the two primer sets (UTR2 and UTR3).  In addition, a further 
12 HRV-C variants were further amplified using hemi-nested combined HRV-
A/HRV-C primers to give sequence complete from nucleotide position 27 to 355 
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(primer set UTR1 in Appendix 1).  Cycling conditions for all reactions are described 
in Chapter 2.   
5.2.4 Amplification of the 2A region of HRV-C 
The 2A coding region of HRV-C strains was amplified in two fragments with a 303 
base overlap, to produce a single sequence of 884 bases.  Both second round PCRs 
used the same first round PCR product.  Due to the fact that the first round fragment 
to be amplified was almost 1000 bases in length, we found that the addition of 2µL 
3mM dNTPs in the first round gave a higher sensitivity (concentration of nuclease-
free H2O was adjusted accordingly to give a final reaction volume of 20µL).  
Resulting amplified DNA bands of the appropriate size were then cut out from 
agarose gels visualized under UV transillumination.  The target DNA was then 
extracted from the agarose gel and sequenced as previously described (Chapter 2).   
5.2.5 Dataset construction 
A total of 89 HRV-C positive samples corresponding to 40 phylogenetic groups were 
amplified in the VP4/VP2 and 3Dpol regions
14
.  Two samples (Resp_3856 and 
Resp_6131) could not be amplified in the 5ˈUTR, possibly due to low viral loads in 
the original sample.  However, both of these samples came from phylogenetic groups 
in which other members were represented within the 5ˈUTR dataset.   
Of the 89 HRV-C positive samples with sequences available for the 5ˈUTR, 
VP4/VP2 and 3Dpol regions, only 71 could be successfully amplified in the VP1 
region.  This corresponded to 33 of the 40 phylogenetic groups.  This was due to 
limitations in the sensitivity of the originally described HRV-C VP1 nested PCR and 
                                                     
14
 74 of the included VP4/VP2 sequences had been previously amplified as part of a previously 
published study (Wisdom et al., 2009a). 
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subsequent redevelopment of this protocol led to a much improved sensitivity
15
 
(McIntyre et al., 2013b).  Sequences which could not be amplified in the VP1 region 
did not cluster together on phylogenetic trees in other regions.  We can therefore 
conclude that these did not represent an identifiable genetic subset whose omission 
would have significantly affected the analysis.   
Sequences generated in the course of this study have been submitted to Genbank and 
assigned accession numbers as described (Table 5.1).  In addition, VP4/VP2 
sequences generated as part of the previous study by Wisdom et al are published with 
accession numbers in the series GU294336 to GU294480 (Wisdom et al., 2009a).   
TABLE 5.1: Accession numbers of sequences generated during the study of recombination in 






VP4/VP2 15 HM352737 – HM352752 
VP1 71 HM236897 – HM236968 
3Dpol 89 HM485468 – HM485556 
5ˈUTR 86 HM581802 – HM581888 
 
All available HRV-C full genomes (n=10) were initially obtained from Genbank in 
April 2010.  For the inter-species recombination and full genome sequence 
divergence analysis, these were combined into a single dataset with available HRV-
A (n=82) and HRV-B (n=25) full genome sequences.  An additional analysis of the 
5ˈUTR region of all available full genome sequences of HRV-A and HRV-C was 
undertaken in July 2012.  This included all full genome sequences which had a 
5ˈUTR fragment that was more than 90% complete across the region 167-626 
(numbered by FJ445111 : HRV-A1).  167 HRV-A and 59 HRV-C sequences were 
included in the analysis.    
                                                     
15
 Recombination studies which utilised this improved HRV-C VP1 nested PCR protocol are detailed 
in Chapter 6.  In addition, HRV-C36-C46 VP1 sequences were generated using the improved HRV-C 
VP1 PCR.     
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Phylogenetic trees were constructed as previously described (Chapter 2) and 
recombination analysis was undertaken primarily by inspection of phylogenetic trees 
for bootstrap supported changes in tree topology or branch length.  This analysis was 
supplemented by screening datasets with the TreeOrderScan software within the SSE 
v1.0 package (Simmonds, 2012).  Breakpoints were determined by analysis with the 
program GroupScan within the SSE v1.0 software package. 
5.3 Results 
5.3.1 Phylogenetic analysis of the VP4/VP2, VP1 and 3Dpol regions of 
HRV-C 
For analysis of recombination within the coding region of HRV-C, three genome 
regions (VP4/VP2, VP1 and 3Dpol) were included.  VP1 sequences are the basis for 
type designations of HRV-C (Simmonds et al., 2010) whereas VP4/VP2 and 3Dpol 
represent the extreme 5ˈ and 3ˈ ends of the coding genome.  In all three regions, 
sequences fell into clearly defined, bootstrap supported groups (Figure 5.1).  A total 
of 15 HRV types were represented by a single sequence only and the remainder were 
represented by several unique variants.  In both VP4/VP2 and 3Dpol, the majority of 
sequences clustered according to their type assignment, as defined by VP1. The 
phylogeny of all three coding regions was remarkably congruent, in terms of both 
clade membership and branch length.   
Only one HRV-C sequence showed evidence of incongruent phylogenetic position 
(shaded box in Figure 5.1).  GQ223227, a previously published full genome 
sequence (Huang et al., 2009), is the HRV-C8 prototype strain as defined by VP1 
(Simmonds et al., 2010).  Our sample selection contained one other HRV-C8 variant 
(Resp_10300) confirmed by phylogenetic grouping and pairwise nucleotide p-
distances. However, while Resp_10300 maintained its phylogenetic position relative 
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to other sequences in 3Dpol region, GQ223227 changes tree position to group with 
the HRV-C9 prototype strain, GQ223228 in 3Dpol. 
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FIGURE 5.1:  Neighbour joining phylogenetic trees of study sequences and corresponding regions 
from published complete genome sequences from the VP4/VP2, VP1 and 3Dpol regions of HRV-C.  
Branches showing at least 70% bootstrap support are indicated.  Branch to tree root has been 
collapsed for ease of reference.  Complete genome sequences were labelled in black.  The putative 
recombinant sequence group containing GQ223227 and Resp_10300 (HRV-C8) are marked with blue 
boxes.  Branches are scaled by genetic distance.     
 
On inspection of these two full genome sequences, the change in tree topology 
appeared to occur within 3Dpol.  At the 5ˈ end of 3Dpol (position 6384 – 6645), 
GQ223227 had a pairwise nucleotide p-distance of 0.08 from Resp_10300.  
However, at the 3ˈ end of 3Dpol (position 6646 – 6854), this sequence was nearly 
identical (p-distance 0.01) to GQ223228 and was much more distantly related (p-
distance 0.35) to Resp_10300.  Inspection of phylogenetic trees for the 5ˈ and 3ˈ 
ends of 3Dpol clearly showed the change in grouping of GQ223227 within the region 
(Figure 5.2).   
This observation is complicated by the fact that both GQ223227 and GQ223228 
originated from the same published study within the same laboratory (Huang et al., 
2009).  Although we cannot definitively exclude that this sequence represents a 
genuine natural recombination event, in light of the extremely rare nature of 
recombination within the rest of the sample set and the origination of both segments 
of this chimaeric genome from the same laboratory, it seems prudent to question its 
authenticity.  As the other HRV-C8 sequence available within our dataset shows no 
evidence of this putative recombination event, it was felt that the hybrid genome may 
instead represent a sequencing or assembly error.  As a result, GQ223227 was not 
considered as a genuine recombinant genome in the remainder of the analysis carried 
out.     
 
 




FIGURE 5.2:  Comparison of phylogenies obtained from analysis of the 5ˈ and 3ˈ ends of 3Dpol of 
HRV-C sequences.  Published full genomes are marked with black circles.  Sequences involved in 
putative recombination event are labelled with coloured arrows.     
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5.3.2 Phylogenetic analysis of the 5ˈUTR of HRV-C 
Phylogenetic trees constructed for the 5ˈUTR region of HRV-C sequences from 
2006-2007 (and including 10 HRV-C full genomes) showed that sequences 
continued to group within their types (as defined by VP1) in the 5ˈUTR.  Even the 
putative recombinant HRV-C8 type (consisting of GQ223227 and Resp_10300) was 
congruent in the 5ˈUTR (marked by shaded grey boxes on Figure 5.3).  However, 
there was extensive breakdown in the deeper relationships between HRV-C type 
groups observed between the 5ˈUTR and VP4/VP2 regions. 
In accordance with previous reports (Wisdom et al., 2009a; Huang et al., 2009), we 
found that HRV-C sequences grouped into two distinct clades in the 5ˈUTR.  The 
largest of these clades (marked as HRV-Ca on Figure 5.3) contains HRV-C 
sequences which group within the HRV-A clade
16
.  In total, over 70% of analysed 
HRV-C sequences (n=68) representing 30 of the 40 included HRV-C types grouped 
with HRV-A sequences.  The remaining 10 HRV-C types grouped in a distinct clade, 
labelled as non-recombinant HRV-Cc strains (marked in red on Figure 5.3).  Putative 
recombinant (HRV-Ca) strains were scattered within the VP4/VP2 region, indicating 
the possibility that recombination between the 5ˈUTR of HRV-A/-C has occurred on 
multiple occasions throughout HRV-C diversification (shown by blue lines and grey 
arrows on Figure 5.3).  
Analysis of 5ˈUTR and VP4/VP2 sequences with TreeOrderScan showed a 
minimum of 12 phylogeny violations between the two regions (data not shown).  On 
inspection of phylogenetic trees, inter-type relationships showed a great deal of 
inconsistency between the two regions, with some large clades being entirely 
maintained and others showing breakdown in phylogenetic relationships.  Two large 
HRV-Ca clades containing 6 and 8 HRV-C types respectively were bootstrap 
                                                     
16
 For ease of reference, relationships between HRV-C sequences only are presented in Figure 5.3.   
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supported in both regions with completely congruent tree topology (marked by grey 
boxes on Figure 5.3).   
 
FIGURE 5.3:  Neighbour joining phylogenetic trees showing the partial 5ˈUTR and VP4/VP2 
regions.  Putative recombinant (HRV-Ca) sequences are coloured in blue.  Non-recombinant (HRV-
Cc) sequences are coloured in red.  Two samples which could not be amplified in the 5ˈUTR region 
are shown in yellow.  The phylogenetic position of recombinant HRV-Ca sequences are shown by blue 
lines.  Two contiguous and congruent clades of HRV-Ca sequences are shown by grey boxes and grey 
arrows.  Branches are scaled by genetic distance.   




FIGURE 5.4:  Neighbour joining phylogenetic tree showing the 5ˈUTR region of all HRV-A and 
HRV-C full genomes.  HRV-A sequences are marked in blue, with HRV-C marked in red.  Branch to 
tree root has been collapsed for ease of reference.  The largest portion of the HRV-A clade, which had 
no HRV-C sequences embedded within it has been additionally collapsed.  Branches are scaled by 
genetic distance.     
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An additional analysis of all available HRV-A and HRV-C 5ˈUTR regions from 
published polyprotein sequences revealed a similar pattern, whereby the majority of 
HRV-C sequences and type groups were embedded within the HRV-A clade (Figure 
5.4).  This analysis included 59 HRV-C 5ˈUTR sequences representing 30 HRV-C 
type groups.  All sequences analysed grouped in the 5ˈUTR region according to their 
assigned type.  Recombinant sequences were not distributed throughout the entire 
HRV-A 5ˈUTR clade, but fell into three distinct groups.  One group of HRV-C 
sequences appeared to share a common ancestor with HRV-A12, -A45, A78 and –
A101, while another was closest to HRV-A51, -A65, -A71 and –A103.  The third 
small clade consisted only of HRV-C4 and –C49.  Although this group fell within the 
HRV-A clade, they did not group closely with any known HRV-A sequence.   
5.3.3 Determination of recombination breakpoints within the 5ˈUTR of 
HRV-C 
In order to determine the location of putative recombination breakpoints in the HRV-
C 5ˈUTR, amplified 5ˈUTR and VP4/VP2 sequences were joined to give a single, 
long sequence which was scanned between positions 185 – 903 (numbered by 
EF582385) using the program GroupScan.  The sequences generated in the current 
study were combined with the 10 available published HRV-C complete genomes, 34 
5ˈUTR sequences previously published (Huang et al., 2009) and all available HRV-
A/-B complete genome sequences to construct the dataset for analysis.  Each putative 
recombinant (HRV-Ca) sequence was scanned against HRV-A, HRV-B and control 
HRV-Cc (n=29) sequences and the recombination breakpoint was calculated from 
the intersection of the two lines (Figure 5.5). 
Of the 51 confirmed HRV-C types, 42 had UTR sequences that were more than 90% 
complete across the region analysed.  Of these, 31 HRV-C types were members of 
the HRV-Ca group and breakpoints were calculated.  Calculated recombination 
breakpoints were similar within HRV-C type groups and all calculated breakpoints 
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occurred within the UTR (Table 5.2).  The majority of HRV-Ca sequences showed 
putative recombination breakpoints that fell within two “hotspot” regions.  These 
mapped within the IRES to the polypyrimidine tract (PPT) between stem loops 5 and 
6 (positions 561-576; mean, 565) and near the terminal loop of stem-loop 5 (position 
508-544; mean,523).  Only two HRV-C types had recombination breakpoints out 
with these two regions and both were at a more 5ˈ site (position 479-489; mean, 
481).       
 
FIGURE 5.5:  Recombination breakpoints for three representative HRV-Ca sequences.  Analysis 
was carried out in the program GroupScan using HRV-A, -B and –Cc sequences as control groups.  
Above the graphs is a diagrammatic summary of 5ˈUTR RNA structure elements (stem-loops 1-6 
(Anderson et al., 2007) and polypyrimidine tract [PPT]).  Breakpoint is calculated from intersection 
of two lines.  Association values/grouping scores of less than 0.5 refer to distantly related outgroups 
(marked in blue).   
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TABLE 5.2:  Calculated 5ˈUTR recombination breakpoints for HRV-C types analysed 
 
a 
HRV-C26/-C27 are labelled as HRV-Ca/Cc groups, as previously published sequences of these types 












C1 Ca 5 520 519-523 
C2 Ca 1 564 - 
C3 Ca 2 526 526-527 
C4 Ca 1 561 - 
C5 Ca 3 563 563-564 
C6 Ca 10 524 524-526 
C7 Ca 2 574 574 
C8 Ca 4 565 561-570 
C9 Cc - - - 
C10 Ca 1 525 - 
C11 Ca 2 554 552-557 
C12 Ca 4 508 508 
C13 Ca 1 523 - 
C14 Cc - - - 
C15 Ca 3 483 479-489 
C16 Ca 3 520 518-526 
C17 Ca 1 567 - 
C18 Ca 8 528 518-544 
C19 Cc - - - 
C20 Cc - - - 
C21 Ca 6 572 570-575 
C22 Ca 2 576 576 
C23 Ca 3 562 552-570 
C24 Ca 1 560 - 
C25 Ca 1 558 - 
C26 Ca/Cc
a 
- - - 
C27 Ca/Cc
a 
3 535 522-559 
C28 Ca 2 543 536-550 
C29 Cc - - - 
C30 Ca 1 561 - 
C31 Ca 1 528 - 
C32 Ca 9 524 523-527 
C33 Cc - - - 
C35 Cc - - - 
C36 Cc - - - 
C37 Cc - - - 
C38 Ca 2 555 555 
C40 Ca 1 560 - 
C41 Ca 1 548 - 
C42 Ca 1 479 - 
C46 Cc - - - 
C49 Ca 1 570 - 
C51 Cc - - - 
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An analysis of mean pairwise p-distance within and between HRV species groups 
(with HRV-Ca and HRV-Cc considered separately) confirmed high sequence 
conservation within the 5ˈUTR.  In particular, sequences of the stem-loop regions 
either side of the recombination hotspot centring on position 523 were highly 
conserved (Figure 5.6).  A further analysis of this data performed by Professor P. 
Simmonds showed that HRV-Ca variants with a 5ˈ sequence that was HRV-A like 
and a 3ˈ sequence that was closely related to HRV-C showed similar predictive 
pairing to both non-recombinant HRV-A and HRV-Cc sequences.  It was therefore 
hypothesized that this region could comfortably accommodate a recombination event 
without destabilising the stem-loop and therefore disrupting the function of the 










FIGURE 5.6:  Sequence variability scan of the 5ˈUTR showing mean HRV-A, -B and –Cc inter-
type distances and interspecies distance of HRV-A/Cc.  The pairwise p-distances are averaged over 
a 30 base window.  The position of known 5ˈUTR structures and putative location of recombination 
breakpoints are shown.   
Within the fragment of 5ˈUTR analysed (from position 185), all sequences showed 
evidence of only one recombination breakpoint.  At the 5ˈ end of the sequence 
fragment, all sequences grouped strongly within the HRV-A clade.  In order to 
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investigate whether a 5ˈ breakpoint existed in HRV-C 5ˈUTR sequences, a subset of 
11 HRV-Ca variants were sequenced to position 27.  All 11 sequences analysed 
grouped with HRV-A at the extreme 5ˈ end of the genome.  In each case, association 
values with HRV-A at the 5ˈend were significantly higher than the 0.5 score which 
signifies an outgroup position (an example is shown in Figure 5.7).  Analysis of 
phylogenetic trees constructed from 50 and 100 base fragments of this region showed 
no evidence for grouping of any HRV-Ca variants outside the HRV-A clade (data not 







FIGURE 5.7:  GroupScan analysis of the extreme 5ˈ end of the HRV-C genome.  This analysis used 
a subset of control sequences which were complete from position 27 to scan against the 11 HRV-Ca 
query sequences. 
5.3.4 Sequence divergence across the full genome of HRV-C 
Mean pairwise nucleotide and amino acid p-distances were calculated for the 
VP4/VP2, VP1 and 3Dpol regions of HRV-A, -B and –C (Figure 5.8)
17
.  Across all 
three species, VP1 was uniformly found to be the most divergent region (pairwise 
nucleotide p-distance of 0.290, 0.265 and 0.347 respectively), while VP4/VP2 was 
consistently the most conserved region.  A significantly greater within-species 
divergence in all three regions was seen in HRV-C, compared with HRV-A and –B.  
In fact, the amino acid divergence of HRV-C in both VP4/VP2 and 3Dpol is almost 
twice that observed in other species.     
                                                     
17
 For HRV-C, only the 10 published full genomes available at the time of this analysis and the 
sequences generated in this study were included in this calculation.   




FIGURE 5.8:  Mean pairwise (uncorrected) p-distances of nucleotide (A) and amino acid (B) 
sequences in the VP4/VP2, VP1 and 3Dpol regions of all three HRV species.  Actual values are 
shown above each bar. 
In order to investigate sequence divergence across the full HRV-C genome and 
highlight any other potential areas of recombination, a divergence scan using a 
fragment length of 300 nucleotides, an increment of 30 nucleotides and including all 
HRV-A/-B and 10 HRV-C full genomes was performed (Figure 5.9).  Sequence 
divergence of HRV-C compared with HRV-A or HRV-B was uniformly higher 
throughout the genome than within species divergence of HRV-C.  This was true for 
both nucleotide and amino acid p-distances.  Interestingly, a small (approximately 
260 base) region showed inter-species HRV-A/HRV-C divergence that approached 
intra-species HRV-C divergence.  This area of reduced inter-species divergence fell 
approximately between positions 3268 and 3525 within the 2A proteinase coding 
region.  HRV-B sequences remained divergent from both HRV-A and HRV-C within 
this region.  This highlighted the possibility of inter-species recombination involving 
the 2A coding region of HRV-C sequences.   




FIGURE 5.9:  Sequence divergence scans showing mean nucleotide and amino acid divergences 
within complete genome sequences of HRV-C and between HRV-C and HRV-A/-B.  Mean inter-
species pairwise distances between HRV-A and HRV-C are shown in red, between HRV-B and HRV-C 
are shown in green and mean intra-species distance for HRV-C is shown in blue.  Fragment length of 
300 nucleotides and an increment of 30 nucleotides was used.  A genome diagram showing different 
HRV-C genes is shown underneath (with annotation taken from sequence EF582385).  The P1 region 
is marked in red, P2 in pale blue and P3 in blue.   
5.3.5 Analysis of recombination within the 2A region of HRV-C 
Initially, in order to further investigate the approximately 260 base region of 
decreased divergence between HRV-A and HRV-C, phylogenetic trees were 
constructed of the putative recombinant region and 5ˈ/3ˈ flanking regions of equal 
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length (Figure 5.10).  The phylogeny of HRV-A and HRV-C sequences in the 
putative recombinant region (3268-3525) was remarkably incongruent with that 
observed in flanking regions of the same length.  All 10 HRV-C sequences grouped 
within the HRV-A clade in a similar manner similar to the 5ˈUTR region.  However, 
in the putative recombinant 2A region, all HRV-C sequences (including HRV-Cc 
strain GQ223228) were actually embedded within the HRV-A clade.  HRV-B 
sequences retained a phylogenetic position distinct from both HRV-A and HRV-C 
throughout 2A. 
Subsequently, 38 additional 2A sequences from HRV-C strains in Edinburgh were 
combined with 58 HRV-C complete polyprotein sequences (>90% complete across 
the region 3127 – 3552 numbered by EF582385) downloaded in 2012 to give a 
complete dataset consisting of 96 HRV-C 2A sequences, representative of 39 HRV-
C types.  Analysis additionally included 194 HRV-A complete polyprotein sequences 
for comparison.  This showed similar features to the original analysis with only 10 
HRV-C complete genomes.  All HRV-C sequences from all HRV-C types grouped in 
several distinct clades within the HRV-A clade within the putative recombinant 
region (3127 – 3552), implying the occurrence of several separate recombination 
events, similar to that observed in the 5ˈUTR.  However, bootstrap values for inter-
type relationships were generally poor for trees constructed from both datasets and so 
recombination parents could not be determined.  Despite poor bootstrap support for 
inter-type relationships within the region, the grouping of HRV-C within HRV-A is 









FIGURE 5.10:  Neighbour joining phylogenetic trees showing the putative recombinant portion 
(3267 – 3525) of the 2A coding region as compared with 5ˈ (3006 – 3266) and 3ˈ (3526 – 3786) 
flanking regions.  Numbering is from sequence EF582385 (HRV-C4).  HRV-C sequences are labelled 
in black and HRV-A are labelled in white.  The accession numbers of HRV-A/-B variants have been 
prefixed with their corresponding serotype designation.  Branches are scaled by genetic distance.      
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Of the 96 HRV-C strains with available sequences for the 2A region, 73 also had a 
5ˈUTR sequence that was complete to position 179 (including all 38 strains isolated 
sequenced in this study).  We had previously reported a monophyletic group of 
HRV-C sequences that was maintained in both the 5ˈUTR and 2A region (including 
types HRV-C1, -C3, -C6, -C7 and –C11) (McIntyre et al., 2010) and speculated that 
recombination in the 5ˈUTR and 2A regions may be linked.  In order to investigate 
this potential linkage, we examined phylogenetic trees constructed from the same 
sequence set in both regions (Figure 5.11).  This showed that, contrary to the pattern 
observed in 5ˈUTR region, HRV-Cc sequences did not group together in 2A and 
were interspersed throughout the HRV-C tree (marked in red on Figure 5.11).  In the 
larger dataset, two clades containing 6 and 8 HRV-C types respectively were notably 
contiguous between the 5ˈUTR and 2A regions (marked with dotted lines and grey 
arrows in Figure 5.11).  However, inspection of phylogenetic trees constructed from 
the VP1 region of HRV-C revealed that these groupings were additionally 
maintained in the coding region.  In addition, one further bootstrap supported clade 
in 2A contained both HRV-Ca and HRV-Cc sequences and was present in the VP1 
region.  Indeed, when HRV-C sequences are considered alone, no phylogeny 
violations were recorded between VP1 and the putative recombinant 2A region (data 
not shown).  This suggests that the recombination events observed in the 5ˈUTR and 
2A regions are not, in fact, linked.     
As there were no non-recombinant HRV-C 2A sequences, it was not possible to 
determine putative recombination breakpoints via GroupScan.  However, inspection 
of the amino acid alignment of HRV-A, -B and –C sequences in this region revealed 
an area of obvious similarity corresponding closely with the region identified by 
divergence scanning (Figure 5.12).  Annotation of the sequence alignment with 
known features of the 2A protein revealed the putative breakpoint to fall almost 
exactly at the boundary of the C-terminal domain (Petersen et al., 1999).   




FIGURE 5.11:  Neighbour joining phylogenetic trees showing the 5ˈUTR and recombinant 2A 
regions of HRV-C sequences.  Numbering is as shown and sequences are numbered by EF582385.  
Sequences which are non-recombinant in the 5ˈUTR region (HRV-Cc) are labelled in red type.  
Bootstrap supported clades containing more than two HRV-C types which are maintained in 5ˈUTR 
and recombinant 2A region are marked with white arrows and dotted lines.  Bootstrap supported 
clades containing more than two HRV-C types which are also present in the VP1 region are marked 
with blue arrows and blue boxes.  Branches are scaled by genetic distance.     




FIGURE 5.12:  Sequence alignment of the 2A region of selected HRV-A, -B and –C sequences.  
HRV-A (n=9) and HRV-B (n=8) sequences were selected on the basis of highest observed genetic 
divergence among prototype strains.  HRV-C (n=10) strains include all of the originally published full 
genomes.  Secondary structure elements are superimposed and annotated (Petersen et al., 1999).  
Inferred positions of recombination are shown by dotted lines (positions 3268 – 3525).  Sequences are 
numbered by HRV-A2 : X02316.  Β-strands and catalytic/zinc binding residues are as previously 
proposed (Petersen et al., 1999). 
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The putative recombinant region contained all of the zinc binding sites known within 
this protein (Petersen et al., 1999).  Additionally, the proposed recombination 
breakpoint at position 3268 corresponded closely with the 3ˈ end of the proposed cis-
acting replication element (cre) for HRV-A, which has been previously mapped to 
between positions 3226 – 3270  (Gerber et al., 2001). 
5.4 Discussion 
5.4.1 Absence of recombination within the coding region of HRV-C 
In the study of the phylogenetic relationships between different coding regions of the 
HRV-C genome, the most striking finding was the lack of evidence for 
recombination within the coding region.  This was manifest as almost complete 
phylogenetic congruence between two capsid regions (VP4/VP2 and VP1) and a 
sequence fragment from the 3ˈ end of the genome (3Dpol) (Figure 5.1).  This was in 
stark contrast to the frequent recombination observed in all three species of the 
closely related human EV (Lukashev, 2005; Oprisan et al., 2002; Simmonds and 
Welch, 2006) and indeed in many other Picornavirus genera (Simmonds, 2006; 
Heath et al., 2006; Agol, 1997; Calvert et al., 2010).  However, recombination has 
not been frequently observed within the coding region of other HRV species (Kistler 
et al., 2007b; Lewis-Rogers et al., 2009; Palmenberg et al., 2009). 
One putative recombination event was noted within the coding region of HRV-C 
isolates.  Sequence GQ223227 (N4) changed tree position between VP1 and 3Dpol, 
while the other member of the same type (Resp_10300) maintained a congruent 
position relative to other sequences (Figure 5.2).  While we cannot definitively 
exclude the possibility that recombination occurred within a natural site located in 
this region and gave rise to a viable HRV-C strain, it seems relatively unlikely that 
this putative recombination event is genuine.  Subsequent analyses on the occurrence 
of recombination in all three species of HRV indicated that the sporadic occurrence 
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of recombination within HRV appeared to predominantly involve full HRV types, 
rather than individual sequences (McIntyre et al., 2013b).  It is possible that this 
apparently chimaeric genome has arisen due to contamination in laboratory analysis 
or sequence assembly.  We would suggest that re-sequencing this isolate may be 
warranted to verify its ancestry.  One subsequent study of recombination in HRV 
species showed a grossly elevated recombination frequency in HRV-C due to the 
inclusion of this aberrant sequence (Linsuwanon et al., 2011).  In light of this, we 
have excluded it from this and further analyses of recombination in HRV-C 
sequences.  With this sequence excluded, we found no other evidence of 
recombination occurring between HRV-C types within the coding region. 
In studies of circulating EV strains,  recombination frequency is correlated with both 
geographical and temporal separation of analysed strains (McWilliam Leitch et al., 
2009a).  In fact, even within these highly recombinant species, analysed sequences of 
both EV-A and EV-B were only observed to be 100% recombinant when 10 years 
had elapsed (Simmonds and Welch, 2006).  The sequences produced in this study 
were all isolated from a single geographical location and covered a 2-3 year time 
period (from 2006 – 2008).  With the inclusion of the ten available published full 
genome sequences, this time period was increased only to eight years.  This raises 
the possibility that the detection of recombination may have been limited by the 
included dataset, especially if recombination occurs comparatively more rarely than 
in EV.  In one study of EV strains isolated from Edinburgh blood donors in 2000-
2001, no recombination among the study strains of EV-A was documented 
(Simmonds and Welch, 2006).  However, when EV-A prototype strains and 
published strains covering a much larger time span were included, a high frequency 
of phylogenetic incongruity and putative recombination was observed.  Further 
studies undertaken within this thesis investigated the occurrence of recombination 
within the coding region of HRV strains of all three species spanning 14 years and 
two geographically separate locations (Chapter 6).       
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5.4.2 Recombination within the 5ˈUTR of HRV-C 
In accordance with previous studies (Huang et al., 2009; Wisdom et al., 2009a), we 
noted considerable phylogenetic incongruity between the 5ˈUTR of HRV-C and the 
rest of the genome downstream (VP4/VP2, VP1 and 3Dpol fragments).  The majority 
of HRV-C sequences grouped within the HRV-A clade in the 5ˈUTR region (Figures 
5.3 and 5.4).  The 5ˈUTR/P1 junction is a known recombination hotspot in other 
members of the genus Enterovirus (Santti et al., 1999).   
All HRV-C sequences included in this study maintained their phylogenetic grouping 
within their assigned type in the 5ˈUTR.  Previously published analyses showed two 
HRV-C types which contained strains with both recombinant (HRV-Ca) and non-
recombinant (HRV-Cc) 5ˈUTR sequences (Wisdom et al., 2009a) (marked as Ca/Cc 
on Table 5.2).  One of these groups contained only sequences isolated from 
Edinburgh; three of which were HRV-Cc (Resp_2514, Resp_3938 and Resp_3102) 
and only one (Resp_3856) was HRV-Ca.  Unfortunately, the aberrant strain 
Resp_3856 was missing and could not be further investigated.  In the second Ca/Cc 
group, all published sequences from a Chinese study were reportedly HRV-Ca 
(Huang et al., 2009) and all those from Edinburgh samples were HRV-Cc.  We did 
not find evidence of any other HRV-C types with both HRV-A and HRV-C like 
5ˈUTR sequences.  However, the previously reported existence of these Ca/Cc 
groups may indicate that contemporary recombination can occur within the 5ˈUTR 
region of HRV-C.            
We observed the majority of recombination breakpoints within the 5ˈUTR to fall into 
two hotspot regions; near position 565 in the PPT and 523 in stem-loop 5 of the 
IRES.  This is a considerably more restricted distribution of breakpoints than was 
previously reported (Huang et al., 2009).  However, we were able to utilise a 
different scanning method (GroupScan) and a much larger dataset.  Similarly to the 
coding region of HRV-C, the existence of a biological compatibility barrier and 
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requirement to preserve essential RNA secondary structure may generally limit the 
generation of viable recombinants in the 5ˈUTR to sequence surrounding these 
hotspot regions.  The 5ˈUTR of HRV contains the highly structured and well 
conserved IRES and 5ˈ cloverleaf, which have essential functions in viral replication 
(Palmenberg et al., 2009, 2010) and are also conserved in EV (Pöyry et al., 1996).  
Recombination breakpoints occurring at the hotspot regions described were found to 
have no influence on predicted RNA secondary structure (McIntyre et al., 2010).  
The observation that recombination is more likely to occur in areas of concentrated 
RNA secondary structure may be potentially supported by our observations (Runckel 
et al., 2013).  However, this assertion remains controversial in EV (Simmonds and 
Welch, 2006) and the location of putative recombination breakpoints in HRV-C may 
be simply secondary to the highly conserved sequence in these regions.  Putative 
recombination events observed in the 5ˈUTR of EV-C109 resulted in preservation of 
both the 5ˈ cloverleaf and IRES (Yozwiak et al., 2010).  The conservation of RNA 
secondary structure within recombinant 5ˈUTR sequences suggests a degree of 
functional constraint on the biological viability of chimaeric genomes within this 
region.    
We also found no evidence of the putative second recombination event that was 
proposed at the 5ˈ end of the 5ˈUTR (Huang et al., 2009), instead noting the swap of 
the entire 5ˈUTR in a modular fashion.  Our methods for detection of the 5ˈ 
breakpoint were potentially limited by the use of a 200 base fragment size in 
GroupScan analysis.  However, the additional inspection of phylogenetic trees 
constructed from both 50 and 100 base regions at the 5ˈ end of the UTR showed no 
evidence for grouping of any HRV-Ca sequence out with the HRV-A clade. 
In EV-A71, recombination in the 5ˈUTR has been linked to epidemic spread.  
Specifically, a single epidemic genotype in the Netherlands has been found to have 
same recombinant 5ˈUTR sequence as an outbreak in Asian-Pacific region caused by 
Analysis of genetic diversity and sites of recombination in HRV-C 
169 
 
a different genotype (van der Sanden et al., 2011).  HRV-A/-C 5ˈUTR recombinants 
are likely to have originally had increased viral fitness, as there are multiple 
VP4/VP2 lineages in the recombinant 5ˈUTR clade which indicates the occurrence of 
multiple recombination events (Figure 5.3).  In addition, there is not a single 
recorded instance of an HRV-A variant possessing a HRV-C like 5ˈUTR sequence.  
However, no difference is observed between HRV-Ca and –Cc strains in terms of 
epidemiology or clinical presentation (Wisdom et al., 2009a).  Schibler and co-
workers found that artificially generated chimaeric genomes with a coding region 
derived from HRV-A16 and 5ˈUTR regions from other Enterovirus species 
(specifically HRV-Ca, HRV-Cc, HRV-B and EV-A) were all able to replicate 
successfully in vitro (Schibler et al., 2012).  However, each recombinant genome was 
consistently out-competed by the wild type HRV-A16 in competition experiments.  
This indicates that, in this case, while the 5ˈUTR and coding regions of these viruses 
are functionally compatible, the wild type maintains a replication advantage.     
5.4.3 Putative recombination events within the 2A coding region of 
HRV-C 
The 2A coding region in HRV/EV encodes a chymotrypsin-like proteinase (2A
pro
), 
of 142 amino acids and the crystal structure has been solved (Petersen et al., 1999).  
2A
pro 
has two primary functions within the HRV life cycle.  Firstly, it is responsible 
for the initial cleavage of the viral genome post-translation.  2A
pro
 cleaves the 
structural and non-structural proteins, separating the two domains at its own amino 
terminus (N-terminus) (Toyoda et al., 1986).  In addition, 2A
pro 
is responsible for the 
cleavage of eukaryotic initiation factor eIF4G which is required for the recruitment 
of capped mRNA to the ribosome and therefore essential for host-cell mRNA 
translation (Glaser et al., 2003; Lloyd et al., 1988).  This disruption of host cell 
metabolism (“host cell shut-off”) allows uninhibited initiation of translation of 
picornavirus mRNA through an internally initiated process (via the IRES).      





is comprised of N-terminal (amino) and C-terminal (carboxyl) 
domains, connected by an approximately 12 amino acid interdomain loop (annotated 
onto sequence data in Figure 5.12) (Petersen et al., 1999).  Unexpectedly, we 
observed a possible second site of HRV inter-species recombination manifest as a 
260 base fragment of high sequence similarity between HRV-A and HRV-C.  A 
similar observation was previously made in analysis of sequence GQ223227 (N4), 
which appeared to be more closely related to HRV-A sequences in the 3ˈ end of 2A 
(Huang et al., 2009).  Analysis of our expanded dataset (containing 96 HRV-C 2A 
sequences) revealed that the putative recombinant region corresponded precisely to 
the boundaries of the C-terminal domain.  Phylogenetic trees constructed of the 
putative recombinant region (nucleotide positions 3268 – 3525) showed all known 
HRV-C sequences grouping within the HRV-A clade.  The C-terminal domain of the 
2A
pro 
is highly conserved, not only among HRV, but among all picornaviruses 
(Petersen et al., 1999).  The observation of a putative recombination breakpoint in 
this region raises the possibility of a degree of modularity between the two domains.  
The N-terminal region is much more variable between HRV-A and HRV-C and the 
two species show segregation on phylogenetic trees, as is observed in other coding 
regions (Figure 5.10).  Interestingly, a previous study observed this same modularity 
between the two domains when comparing proteinase sequences of HRV and 
Streptomyces griseus proteinase B (SGPB) by structure based alignment. Although 
the N-terminus was variable and significantly truncated in HRV, the C-terminal 
domain of both distantly related proteins was topologically identical (Petersen et al., 
1999).  This suggests a strong evolutionary constraint related to the structure of this 
type of proteinase, which may account for the observed sequence similarity among 
closely related species.    
Inspection of the amino acid alignment for the 2A region of HRV-A, -B and –C 
highlighted an area of obvious similarity corresponding closely to the C-terminal 
domain of the 2A protein (Figure 5.12).  HRV-B sequences remained divergent from 
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both HRV-A and HRV-C throughout the 2A region, consistent with their separate 
phylogenetic grouping (Figure 5.10).  Analysis of pairwise nucleotide p-distances 
within the 2A coding region showed that there was considerably less genetic 
diversity observed within the putative recombinant region.  This was true of intra-
species distances for HRV-A and HRV-C, as well as inter-species distances between 
HRV-A and HRV-C.  This observation was even more marked when pairwise amino 
acid p-distances were considered (Figure 5.13).  In fact, the observed amino acid p-
distance between HRV-A and HRV-C sequences in the non-recombinant region is 
more than twice that observed in the putative recombinant region.     
 
FIGURE 5.13:  Pairwise nucleotide and amino acid p-distances for the 2A coding region of HRV-
A, HRV-C and HRV-A/-C.  The 2A region has been divided into the non-recombinant (3127-3266) 
and putative recombinant (3267-3525) regions.  Pairwise nucleotide p-distance is shown in A and 
pairwise amino acid p-distance is shown in B.   
The C-terminal domain of 2A
pro
 is structurally composed of 6 β-sheets which co-
ordinate the binding of a zinc ion adjacent to the catalytic site of the protease.  The 
zinc ion is extremely tightly bound within the protein, requiring denaturation of the 
protease in order to chelate it (Sommergruber et al., 1994).  Despite a lack of direct 
involvement in enzyme catalysis, the presence of zinc within the molecule has been 
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found to be essential for function of the enzyme and indeed for viral replication 
(Glaser et al., 2003), secondary to a role in maintaining structural integrity (Voss et 
al., 1995).  All four of the known zinc binding sites are located within the putative 
recombinant region of 2A
pro 
and consist of three cysteine (Cys) residues and one 
histidine (marked on Figure 5.12).  The zinc binding sites are conserved in a broad 
range picornaviruses (Petersen et al., 1999) and in all sequenced HRV strains, with 
only one exception (GQ223228).  This single sequence contains an Arginine (Arg) 
residue at position 3456, in place of Cys, corresponding to a single nucleotide 
mutation within the coding sequence.  Given the differing physicochemical 
properties of these two amino acids, it seems unlikely that this substitution would 
allow efficient zinc binding.  Additional strains of HRV-C8 that were sequenced in 
this region displayed a perfectly conserved Cys residue at the position in question. 
This single base change observed in only one published strain may be due to 
ambiguities often observed with certain sequencing techniques, where 
misincorporation of a nucleotide can lead to infrequent random base mutations.   
Recombination is detected by the observation of the loss of genetic diversity and 
incongruence of phylogenetic relationships within a putative recombinant region.  
We did observe a higher than expected degree of sequence conservation within the 
C-terminal domain of HRV-A and HRV-C sequences.  Our original analysis of 
putative recombination within this region suggests that HRV-C sequences were 
scattered throughout the HRV-A clade and that the conservation of certain 
monophyletic groups of sequences may indicate linkage between the recombination 
observed in the 5ˈUTR and 2A regions (McIntyre et al., 2010).  However, the 
inclusion of almost 10 times the number of sequences included in the original 
analysis revealed that all HRV-C sequences grouped together within the HRV-A 
clade and that bootstrap supported clades maintained between the 5ˈUTR and 2A 
regions were also maintained throughout the coding region.  Additionally, we 
observed largely congruent phylogenetic relationships between sequences in the VP1 
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and 2A coding regions.  This suggests that a strong purifying selection influence in 
this region, rather than inter-species recombination, may be driving the pattern of 
genetic diversity observed. In order to maintain phylogenetic grouping within the 
coding region, a recombination event in this region would have presumably been 
required to have taken place prior to the diversification of HRV-C into genetically 
distinct types.  The markedly reduced amino acid divergence, as compared with 
nucleotide divergence in the C-terminal domain of this protein is consistent with a 
high number of synonymous mutations, again suggesting a region under the 
influence of strong negative selection.     
Consistent with the proposed functional and structural modularity between these two 
domains is the fact that the 5ˈ end of the putative recombinant region corresponds 
almost exactly to the 3ˈ end of the HRV-A cis-acting replication element (cre) 
(Gerber et al., 2001).  A breakpoint in this region would not disrupt the secondary 
structure or function of the cre, which is essential for RNA replication.  Additionally, 
the fact that there is no structural homology between the proposed HRV-A cre and 
the corresponding sequence fragment in HRV-C is consistent with the current 
understanding that the HRV-C cre is located within the VP2 region (Cordey et al., 
2008).   
 In conclusion, recombination within the coding region appears to be extremely rare 
within HRV-C.  This observation is limited by the fact that our analysis of HRV-C 
sequences was restricted to strains that were mostly isolated from a small 
geographical region and over a restricted time period.  Subsequent analysis focussed 
on the occurrence of recombination within all species of HRV over a significantly 
extended time period and isolated from several distinct geographical regions.  The 
occurrence of recombination within the 5ˈUTR of HRV-C sequences has been 
previously documented (Huang et al., 2009; Wisdom et al., 2009b; Palmenberg et al., 
2009).  However, to our knowledge, this was the first study to attempt to accurately 
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pinpoint recombination breakpoints.  The grouping of recombinant HRV-Ca 
sequences with HRV-A at the extreme 5ˈ end of the 5ˈUTR suggests a modular 
exchange of almost the entire 5ˈUTR region.  Sequence analysis of full HRV-C 
genomes revealed a highly conserved sequence fragment corresponding to the C-
terminal domain of the 2A proteinase.  However, we did not find evidence for a 





Recombination in the evolution of HRV genomes 
6.1 Introduction 
The occurrence of recombination within the coding region of all three species of 
HRV is generally considered to be both rare and sporadic, notwithstanding 
significant disagreement about its actual frequency within the currently published 
literature.  For example, a study of 45 HRV-A and HRV-B serotypes found some 
evidence of phylogenetic incongruity within the coding region of the genome, but 
could not confirm any putative recombination events by RDP analysis (Lewis-
Rogers et al., 2009).  In contrast, a study of 35 full genomes of HRV-A/-B found that 
the full genome phylogeny was identical to that constructed from various 
subgenomic regions and the sequence identity throughout the genome was largely 
consistent (Kistler et al., 2007b).  However, several small scattered putative 
recombination events were identified by RDP analysis.  Phylogenetic incongruity 
was detected between VP4/VP2 and 3Dpol sequences of HRV-A/-B (Savolainen et 
al., 2004).  However, due to the poor bootstrap support for inter-type relationships in 
the VP4/VP2 region, none of these potential incongruities could be further analysed.  
Sporadic putative recombination events have also been identified within the coding 
region of HRV genomes (Tapparel et al., 2009b).  Finally, a large study which 
included at least one sequenced isolate of all 100 known HRV-A/-B serotypes found 
that the full genome phylogeny recovered did show a number of inconsistencies with 
subgenomic regions (Palmenberg et al., 2009) and ultimately suggested that several 
contemporary HRV types had arisen due to recombination.  The limitation in 
previous studies may be related to the sample size or time span of data used for the 
analysis.  None of the studies mentioned included both a representative set of full 
genome sequences and several sequenced examples from most HRV types. 
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Our analysis (presented in Chapter 5) of a set of contemporary HRV-C sequences 
was limited by the absence of sequences collected prior to 2001, giving only a 7 year 
time span for analysis.  Analysis of several extensively recombinant EV-B types (E9, 
E11 and E30) indicated that even these required sequence analysis spanning several 
years for recombination to become widely evident (McWilliam Leitch et al., 2009a, 
2010).  In particular, E11 showed a half-life for individual recombinant forms of 
nearly 10 years.  An analysis of HRV-C sequences over an extended time period had 
never been conducted and in addition, HRV-A/-B have not been extensively 
analysed using a large dataset of both contemporary and prototype sequences.  
Therefore, an extended HRV dataset was constructed in order to more definitively 
measure recombination frequencies occurring during the diversification and 
contemporary evolution of HRV types.   The analysis presented within this chapter 
focussed on examination of the occurrence of recombination within all published full 
genome sequences of all three species of HRV and additionally compared sequenced 
isolates spanning 14 years.  This study was the first to comprehensively characterise 
all detectable recombination events in HRV and was published in 2013 (McIntyre et 
al., 2013b) .     
6.2 Materials and Methods 
6.2.1 Sample selection 
28 HRV positive respiratory samples isolated from 1995 – 1997 in Finland were 
provided by Carita Savolainen-Kopra (National Institute for Health and Welfare 
(THL), Mannerheimintie 166, Finland).  The VP4/VP2 sequences for these isolates 
had been previously published and were within the series of accession numbers 
EU590043 – EU590113 (Savolainen-Kopra et al., 2009a) and AY015114 – 
AY015174 (Savolainen et al., 2002).  By analysis of pairwise nucleotide p-distances 
and phylogenetic clustering, these isolates were divided into 22 HRV types (10 
HRV-A, 6 –B and 6 –C).   
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41 HRV positive respiratory samples isolated in Edinburgh of these same 22 HRV 
types were identified and selected.  In addition, a further 23 HRV-C sequences 
relating to 11 previously provisionally assigned HRV-C types were identified during 
the course of this work and were also included in the recombination analysis.   
6.2.2 Amplification of three coding regions of HRV 
The VP4/VP2 and VP1 regions of HRV-A, -B and –C were amplified as previously 
described (Chapter 2).  A fragment of 3Dpol stretching from positions 6414 – 6896 
in HRV-A (numbered by FJ445111- HRV-A1), 6475 – 6960 in HRV-B (numbered 
by X01087 : HRV-B14) and 6361 – 6835 in HRV-C (numbered by EF582385 : 
HRV-C4) was amplified as described in Chapter 2 using primers listed (Appendix 
1)
18
.  The region described above corresponded to that amplified in HRV-C in 
previous work (McIntyre et al., 2010).  Where necessary, for samples which proved 
challenging to amplify, a SuperScript III (Invitrogen, UK) protocol was used as 
previously described.   
Two HRV-B isolates could only be amplified by using a multiplexed mixture of 
primers for all three HRV species.  Subsequent inclusion of inner primers for all 
species in the sequencing reaction gave a clear, readable sequence.  Neither of these 
two HRV-B sequences were found to be recombinant in the 3Dpol region. 
All sequences included in this study have been submitted to Genbank and assigned 
accession numbers in the series KC342054 – KC342173.       
6.2.3 Construction of datasets for recombination analysis 
Two separate datasets were constructed for analysis of recombination within HRV 
genomes.  The first consisted of all VP4/VP2, VP1 and 3Dpol sequences generated 
in this study (McIntyre et al., 2013b), in our previous work on recombination within 
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 Within this chapter, all analysis of the 3Dpol region was undertaken using the fragment between the 
co-ordinates described above.   
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HRV-C (McIntyre et al., 2010) and extracted from all HRV polyprotein sequences 
and population sets available on Genbank (downloaded on 6/6/12).  In order to meet 
the criteria for inclusion in the study, sequences were required to be more than 90% 
complete across the VP4/VP2 region previously described (615 – 1004 numbered by 
EF582385), the full VP1 region and the 3Dpol fragment described above.  In 
addition, all sequences which had been annotated as non-functional or contained stop 
codons were excluded.  This resulted in inclusion of 136 HRV-A, 53 HRV-B and 
121 HRV-C sequences, in which the three regions were concatenated to form a 
single long sequence suitable for recombination analysis.  The second dataset 
constructed included all available HRV polyprotein sequences that were more than 
90% complete across the P1, P2 and P3 regions (numbered by Genbank annotation 
for FJ445111 : HRV-A1, X01087 : HRV-B14 and EF582385 : HRV-C4).   
6.2.4 Likelihood mapping analysis 
Many inferred phylogenetic clades observed in preliminary studies suffered from 
poor bootstrap support and this was especially marked when considering deep 
phylogenetic relationships within the VP4/VP2 and 3Dpol regions.  In order to assess 
whether conclusions based on inspection of bootstrap supported phylogenetic clades 
were valid, it was necessary to confirm the presence of adequate phylogenetic signal 
and that a tree-like topology could adequately describe the phylogenetic relationships 
within the dataset.   
Likelihood mapping analysis was undertaken using TREE-PUZZLE v5.2 (Schmidt et 
al., 2002), using 10000 random quartets, uniform rates and a specified HKY 
substitution model.  All other parameters were estimated from the data by maximum 
likelihood during execution of the program.  Fragment datasets were analysed for 
each studied region and each species separately.  The analysis was also carried out in 
duplicate to ensure convergence of results.   
Recombination in the evolution of HRV genomes 
179 
 
6.2.5 Analysis of mean substitution rates 
A total of 18 HRV-A and 23 HRV-C sequences from 6 distinct HRV types were 
selected for analysis of mean substitution rates.  These included sequences 
representing HRV-A9, -A28, -A78, -C9, -C12 and –C18.  These were selected on the 
basis of a lack of observed inter- and intra-type recombination between VP1 and 
3Dpol.  Datasets were constructed of each individual type group and subjected to 
analysis with SBP (Kosakovsky Pond et al., 2006a), GARD (Kosakovsky Pond et al., 
2006b) and RDP (Martin et al., 2010) prior to inclusion. 
Analysis of mean substitution rates was carried out in BEAST (Drummond and 
Rambaut, 2007).  All analyses were carried out using the SRD06 model of nucleotide 
substitution, as recommended for protein coding sequences (Shapiro et al., 2006).  A 
relaxed uncorrelated lognormal molecular clock and a constant population size were 
utilised and all other priors were optimized during execution of the program.  The 
MCMC chain was run for 20 million states and the output was recorded every 1000 
states.  Trees were directly compared to those produced by bootstrap re-sampled 
MCL neighbour joining methods to ensure consistency of the phylogenetic 
relationships inferred. 
6.2.6     Recombination analysis 
In addition to phylogenetic analysis carried out by visual inspection of bootstrap 
supported clade members, branch length and overall tree topology, several 
computational methods were employed to both screen entire datasets for evidence of 
recombination and also to further characterise any putative recombination events. 
Datasets containing both full HRV species and single HRV types were subjected 
individually to analysis with GARD (Kosakovsky Pond et al., 2006b), SBP 
(Kosakovsky Pond et al., 2006a) and the RDP v4.0 software package (Martin et al., 
2010).  For any putative recombination event highlighted on large-scale screening or 
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inspection of phylogenetic trees, additional confirmatory analysis was undertaken 
with RDP v4.0 programs.  In each instance, a putative recombinant sequence or 
group of sequences were screened along with the nearest neighbours in each region.  
As a control measure, several groups of sequences which were observed to have no 
evidence of phylogenetic incongruence on inspection of bootstrap supported 
phylogenetic trees were analysed by RDP, GARD and SBP.  All analyses confirmed 
no evidence of recombination within these datasets.   
Further characterisation of putative recombination events was undertaken using the 
GroupScan program within the SSE v1.0 software package (Simmonds, 2012) and 
supplemented by construction and inspection of bootstrapped phylogenetic trees of 
the regions flanking every putative recombinant region.  Unlike the other 
computational methods employed, GroupScan specifically scores the extent of 
phylogenetic clustering of a query sequence with specified control groups and 
therefore takes changes in bootstrap supported phylogenetic tree topology into 
account.  This is especially useful in cases where parental sequences are not present 
in the dataset and phylogenetic inference is more likely to determine an accurate 
grouping than sequence distance alone.  Additionally, the usage of full clades as 
control groups prevents the unnecessary aggregation of valuable sequence data that 
occurs when creating a consensus sequence.  As GroupScan outputs a series of 
grouping score values calculated over a specified sliding window and plotted as a 
linear graph, the putative recombination breakpoint can be easily calculated by the 
intersection of the lines.  In these studies, concatenated sequence fragments from 
VP4/VP2, VP1 and 3Dpol were scanned with a fragment size of 300 bases and an 
increment of 30.  In each case, the query sequence was the potential recombinant and 
it was scanned against the full nearest neighbour group in both VP1 and 3Dpol.  
Each analysis was additionally repeated with a fragment size of 600 bases and a 
window of 30 to ensure consistency.  This analysis gave highly similar results.           




6.3.1 Phylogenetic analysis within HRV type groups 
Sequenced HRV isolates were combined with sequences obtained from Genbank to 
give a total of 164 HRV-A, 70 –B and 145 –C sequences that were more than 90% 
complete across the VP4/VP2, VP1 and 3Dpol regions described.  In addition, a 
second dataset was assembled containing all published HRV polyprotein sequences 
that were more than 90% complete across the P1, P2 and P3 regions (201 HRV-A, 71 
–B and 59 –C).   
Inspection and comparison of phylogenetic trees constructed for the VP4/VP2 and 
VP1 regions revealed the majority of HRV sequences grouping in both regions into 
bootstrap supported phylogenetic clusters, analogous to type groups
19
.  The putative 
type groupings defined by VP1 clustering and pairwise nucleotide p-distance 
analysis were largely maintained in both the VP4/VP2 and full P1 regions.       
Bootstrap support observed for clusters of HRV types within all three species was 
generally poor within the short and well conserved VP4/VP2 region (Figure 6.1).  
Only two HRV types showed evidence for any phylogenetic incongruity.  HRV-A31 
and HRV-A47 have previously been described as distinct HRV-A types, due to their 
genetic distance and phylogenetic relationship in VP1 (Chapter 4).  However, on 
inspection of VP4/VP2 trees, contemporary sequences group separately and are not 
easily assigned to either type.  This anomaly has been previously described as a pair 
of HRV types which are less divergent in VP4/VP2 than would be expected.  
Likewise, HRV-A29 and HRV-A44 are equally related to one contemporary 
sequence JN815252 in the VP4/VP2 region.  This serotype pair was previously 
highlighted as potentially able to be combined.   
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 Although we have proposed that certain HRV type groups undergo revisions to their classical 
definitions (for example, HRV-A29 and HRV-A44), all analysis presented within this chapter follows 
the conventional labelling of HRV types.   
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FIGURE 6.1:  Neighbour joining phylogenetic trees showing the VP4/VP2 and VP1 region of 
HRV-A, -B and –C.  Analysis included full VP1 region as previously described and VP4/VP2 region 
between 615 – 1004(numbered by EF582385).  Branches are scaled by genetic distance.     
No evidence of recombination was evident within the capsid region on inspection of 
phylogenetic trees
20
 (Figure 6.1).  In addition, analysis with RDP, GARD and SBP 
failed to highlight any significant instances of putative recombination.   
6.3.2 Likelihood mapping analysis 
Likelihood mapping analysis revealed strong support for a tree-like pattern of 
evolution in all three gene regions of all three species (Figure 6.2).  In TREE-
PUZZLE v5.2 output, the proportion of analysed quartets with a reliably resolved 
tree-like phylogeny is mapped into the three vertices of the triangle, while the 
proportion of quartets which produce a star-like phylogeny or phylogenetic noise are 
mapped in the centre.  For each species and each analysed gene, the proportion of 
unresolved quartets did not exceed 1%.  In contrast, general support for a resolved 
bifurcating phylogenetic tree consistently exceeded 90%.  It can therefore be inferred 
that conclusions based on analysis of bootstrap supported phylogenetic trees are 
likely to be valid.         
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 The sequence JX291115 which was reported as a potential recombinant between VP4/VP2 and VP1 
in the analysis of HRV-C taxonomy was not included in this analysis as the sequence was published 
after the datasets for recombination analysis were assembled.   




FIGURE 6.2:  Likelihood mapping analysis of the VP4/VP2, VP1 and 3Dpol regions of HRV-A, -B 
and –C.  Proportion of quartets in the vertices represent those with fully resolved bifurcating 
phylogeny, whereas the proportion in the centre represent those with star-like or network-like 
evolution.   
6.3.3 Analysis of mean substitution rates 
Mean substitution rates were calculated for the VP1 and 3Dpol regions of three 
HRV-A and HRV-C types.  Phylogenetic trees analysed for each type showed no 
bootstrap supported change in topology within each type or species.  In addition, 
datasets including sequences from either a single type or a single HRV species 
showed no evidence of recombination when analysed with RDP, GARD and SBP.  
The total number of HRV-A and HRV-C sequences analysed was 18 and 23 
respectively and the datasets spanned 40 years (HRV-A) and 14 years (HRV-C).  
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Insufficient sequences of individual HRV-B types were available for inclusion in the 
analysis. 
Calculated mean substitution rates and 95% highest posterior density (HPD) intervals 




substitutions per site per year.  The rates observed 
were largely similar between both regions and both HRV species analysed (Figure 
6.3).  Although both the VP1 and 3Dpol regions of HRV-C showed a 2 to 3-fold 
elevation in substitution rates (6.9138 x 10
-3 
and 9.8491 x 10
-3 
respectively) when 
compared to those estimates obtained for HRV-A strains (3.9954 x 10
-3 
and 3.4586 x 
10
-3
), the 95% HPD intervals (which are analogous to confidence intervals) were 
clearly overlapping between both species. 
 
FIGURE 6.3: Mean substitution rates and 95% highest posterior density intervals for two coding 
regions of HRV-A and HRV-C. 
 
Phylogenetic trees produced by Bayesian methods were identical in branching order 
and type membership to the bootstrap resampled MCL neighbour joining trees 
utilised in subsequent analysis (data not shown).   Both independent executions of 
the BEAST program gave highly similar results.  In addition, analyses run with 
Recombination in the evolution of HRV genomes 
186 
 
sequence data excluded or dates of isolation scrambled showed no overlap with the 
genuine estimates obtained.    
6.3.4 Comparisons of pairwise nucleotide p-distances 
The concurrence of similar mean substitution rates between the VP1 and 3Dpol 
regions of HRV-A and –C should create a linear relationship between sequence 
divergences between these two regions.  This was indeed observed in both intra- and 
inter-type distance ranges for HRV-B and HRV-C (Figure 6.4).  Within distributions 
for both HRV-B and HRV-C, there were very few, if any outlying data points 
representing potentially recombinant sequences and the line of best fit displayed a 
gradient of close to 1 (0.9042 and 0.9418 respectively).  This correlation provides 
evidence for maintained equal substitution rates and a general lack of recombination 
throughout the period of diversification into these distinct types.    
In contrast to the congruent relationship observed in HRV-B and –C sequences, 
HRV-A sequences were almost uniformly less divergent than expected in the 3Dpol 
region when compared to VP1 divergence.  A line of best fit for the entire HRV-A 
dataset gave a gradient of 0.8714.  In addition, a large number of outlying data points 
were observed which may be indicative of individual recombinant sequences during 








FIGURE 6.4: Comparison of pairwise nucleotide p-distances between the VP1 and 3Dpol regions 
of HRV-A, -B and –C.  In each distribution, the line of best fit is indicated by the red dotted line.  
Line is shown for putative recombinant and non-recombinant HRV-A sequences separately.  The 
graph depicting HRV-A comparisons shows putative recombination events involving full HRV-A type 
groups in red and those involving single sequences in yellow.  For HRV-B sequences, all putative 
recombination events are shown in red.  The previously described, likely erroneous recombinant 
HRV-C sequence GQ223227, has been excluded from the analysis.     
Analysis of individual HRV-A pairwise p-distances that were discordant between 
genome regions allowed the identification of potential recombinant sequences.  In 
combination with inspection of bootstrap supported phylogenetic trees, pairwise p-
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distances of HRV-A sequences could be readily divided into three distinct sets.  The 
majority of sequences were non-recombinant and showed no evidence of bootstrap 
supported changes in tree topology (shown in blue on Figure 6.4).  Non-recombinant 
sequences had a line of best fit gradient of 0.9011 similar to that of species B and C.  
The remaining putative recombinant HRV-A sequences could be categorised into 
two distinct distributions; one arising from large groups containing several types 
(shown in red on Figure 6.4) and one containing instances of sporadic phylogenetic 
incongruity involving single sequences alone (shown in yellow on Figure 6.4).  This 
analysis highlighted the possibility of significant recombination acting in both the 
recent diversification of HRV-A (sporadic recombinants) and more ancient events 
that occurred before the diversification of HRV-A into types. 
6.3.5 Analysis of recombination within the coding region of HRV-A 
With the exception of HRV-A12 and HRV-A78, all HRV-A sequences grouped into 
four bootstrap supported clades (numbered on Figure 6.5), which branched basally 
on both VP1 and 3Dpol trees.  These basal clades were maintained in the VP1, 
3Dpol, P1, P2 and P3 regions.  Due to poor bootstrap support for relationships 
between distantly related HRV types, the basal clades were not maintained in 
VP4/VP2.  However, no bootstrap supported incongruity was observed.  The clades 
were additionally observed to be present, bootstrap supported and monophyletic in 
every other individual gene region of HRV-A (data not shown), with the exception of 
the short and well-conserved VP4 and 3B regions.  Interestingly, although multiple 
instances of bootstrap supported recombination events were recorded within clades 1, 
2 and 3, there were no instances of recombination within the coding region occurring 
between these clades.  In addition, no changes in tree topology were observed with 
clade 4 due to the inclusion of only 3 HRV-A types within it.     
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FIGURE 6.5:  Neighbour joining phylogenetic trees showing the VP1 and partial 3Dpol regions of 
all available HRV-A strains.  Where HRV-A types are maintained between both regions, these have 
been collapsed for ease of reference.  Contiguous basal clades 1 to 4 are marked by coloured boxes.  
Clades 2, 3 and 4 are marked by purple, green and black boxes respectively, while Clade 1 is divided 
into sub-clusters which group together in 3Dpol.  Within Clade 1, the orange arrows indicate the 
formation of one 3Dpol clade from three VP1 clades.  Putative recombinant HRV-A types which 
undergo a bootstrap supported change in nearest neighbour between VP1 and 3Dpol are marked with 
a red line.  Any changes in tree topology which are bootstrap supported only on P1, P2 and P3 trees 
are indicated with a yellow line. Branches are scaled by genetic distance.     
The majority of observed putative recombination events within HRV-A involved full 
groups of sequences, analogous to one HRV type undergoing a change in tree 
position between VP1 and 3Dpol.  Within clades 2 and 3, four HRV-A types 
underwent a change in bootstrap supported nearest neighbour between VP1 and 
3Dpol and an additional HRV-A type showed evidence of a putative recombination 
event that was evident on comparison of P1, P2 and P3 trees.   
Clade 1 formed several distinct sub-clusters of HRV-A types and displayed a clear 
breakdown in the phylogenetic relationships between these types between VP1 and 
3Dpol.  One monophyletic, bootstrap supported clade in 3Dpol (marked in orange on 
Figure 6.5) was formed from members of three, distinct and distantly related VP1 
clades.  Relationships between types were largely incongruent within the newly 
formed 3Dpol clade and the comparisons of pairwise p-distances between sequences 
within this clade corresponded to the large cluster of putative recombinant sequences 
between 0.25 and 0.32 VP1 p-distances (coloured red in Figure 6.5).  However, there 
was uniformly observed poor bootstrap support for nearest neighbour relationships 
between some HRV-A types.  These poorly supported relationships were largely 
mirrored on P3 trees.  Remarkably, the majority of observed phylogenetic 
incongruity within all HRV-A sequences corresponded to full HRV-A types and 
more contemporary relationships between strains of the same HRV-A type are 
perfectly congruent.  This may suggest the occurrence of widespread recombination 
during the period of the diversification of HRV-A into the presently observed types.  
The number of bootstrap supported nodes that each putative recombinant group 
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violated in the transition between VP1 and 3Dpol tree position ranged from two to 
eight (summarised in Table 6.1).     
TABLE 6.1:  Phylogenetic incongruities observed between VP1 and 3Dpol in HRV-A sequences 
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(5416 – 5435) 
 
A46 DQ473506 A80 A53 4 3280 
A53 DQ473507 
JN798587 
A28 A46 4 3213 






































A77 A24 6 5652 




A20 A28 4 3998  









A76 A56 7 5130  











(3343 – 3377) 




 This relates to the number of bootstrap supported nodes a group of sequences violates to form the 
new grouping. 
b 
 Where more than one type is listed as a single nearest neighbour, this represents the most closely 
related phylogenetic clade which is bootstrap supported.  For example, in cases where the putative 
recombinant type is an outgroup to a clade or its relationship with the most closely related sequences 
is not supported, all bootstrap supported types were considered as nearest neighbour.   
c 
Sequences indicated in bold italics are those which consist only of non-consecutive sequence 
fragments and are therefore not represented on P1, P2 and P3 trees.  These were excluded from 
breakpoint analysis.   
d 
Sequences indicated in bold font are those which are members of a type which is a putative 
recombinant but are not themselves present on VP1 and 3Dpol trees due to sequence gaps.  These are 
however represented on P1, P2 and P3 trees.    
e 
 Due to a lack of bootstrap support for nearest neighbour grouping in 3Dpol for A18, nodes changes 
are taken from grouping with A34 to A85 (nearest bootstrap supported neighbour in the P3 region). 
f  
JN815252 is part of a group of previously described contemporary sequences which cannot be 
definitively assigned to either the HRV-A29 or HRV-A44 classical groupings.  It is therefore listed as 
a single sequence.    
g  
Node changes for HRV-A38 between VP1 and 3Dpol are taken from grouping with HRV-A60 to 
HRV-A18. 
h 
 Node changes for HRV-A60 between VP1 and 3Dpol are taken from grouping with HRV-A38 to 
HRV-A77.   
 
 
Several HRV-A types showed a pattern of divergence whereby contemporary strains 
grouped separately from older prototype strains in the 3Dpol region.  This represents 
tentative evidence of recombination within the time-frame of this analysis.  As 
previously reported (Tapparel et al., 2009b), contemporary HRV-A76 strains 
collected between 1999 – 2010 group separately from the HRV-A76 prototype strain 
and form a close association with the HRV-A56 group.  HRV-A56 maintains a 
congruent phylogenetic position between VP1 and 3Dpol and so this suggests that 
HRV-A76 have potentially recombined with HRV-A56 between 1999 and 2010 
(Figure 6.6 A1).  The intra-type p-distance range of contemporary HRV-A76 strains 
compared with prototype strains is 0.084 to 0.093 in VP1 and 0.209 to 0.229 in 
3Dpol.  Unfortunately, an insufficient number of contemporary HRV-A76 strains 
were available to perform Bayesian analysis to determine the date of most recent 
common ancestor of this group. 
HRV-A68 and HRV-A33 also displayed a similar pattern of divergence, whereby the 
older prototype strains grouped preferentially with HRV-A28 and HRV-A76 type 
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strains respectively in 3Dpol (Figure 6.6 A2 and A3).  However, both of these events 
relate to putative recombination between types which are closely related and so their 
significance is uncertain.  All of the above listed phylogenetic incongruities were 
confirmed as putative recombination events by analysis with SBP, GARD and RDP 
(data not shown). 
 
FIGURE 6.6:  Neighbour joining phylogenetic trees showing distinct patterns of recombination 
observed in HRV-A sequences.  The branch to tree root has been collapsed for ease of reference and 
the outgroup used for analysis is given below.  A:  Phylogenetic trees showing examples of 
incongruent topology between VP1 and 3Dpol for (1):  HRV-A56 and HRV-A76 (outgroup: HRV-A7), 
(2): HRV-A20, HRV-A28 and HRV-A68 (outgroup: HRV-A95) and (3):  HRV-A33 and HRV-A76 
(outgroup: HRV-A88).  B:  Phylogenetic tree showing branch length discrepancies between VP1 and 
3Dpol within HRV-A80 (outgroup: HRV-A46).  Branches are scaled by genetic distance.   
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HRV-A80 sequences showed a substantial difference in intra-type branch lengths 
between the two regions.  However, there was no accompanying change in tree 
topology (Figure 6.6 B).  The HRV-A80 prototype strain (FJ445156) displayed a 
pairwise nucleotide p-distance from contemporary HRV-A80 strains of 0.078 in VP1 
and 0.207 in 3Dpol.  This discrepancy was confirmed with RDP analysis (data not 
shown).        
6.3.6 Recombination between the P1, P2 and P3 regions of HRV-A 
Sequence groupings observed in phylogenetic trees constructed for the whole P1, P2 
and P3 coding regions were largely consistent with those observed in VP1 and 
3Dpol.  As expected, P1 was analogous to the VP1 tree and P2/P3 were similar to 
3Dpol.  The putative recombinant sequences groups observed in the 3Dpol tree were 
also evident upon inspection of P2 and P3 trees.  However, seven further HRV-A 
types displayed evidence of bootstrap supported phylogenetic incongruity which was 
not bootstrap supported in 3Dpol (Figure 6.7).  Of these seven further HRV-A types 
which were observed to undergo bootstrap supported changes in tree position, four 
showed evidence of incongruity between P1 and P2 and three between P2 and P3 
(marked in yellow in Figure 6.7).  All but one involved full HRV-A types (listed in 
Table 6.2).   
The HRV-A40 type group includes three recently described polyprotein sequences.  
These three sequences were not included in the VP1 and 3Dpol analysis due to the 
presence of gaps which resulted in sequence completeness below the threshold of 
90%.  However, on analysis of the whole P3 region, the three contemporary HRV-
A40 strains (JX074051, JQ245067 and JN798579) formed a bootstrap supported 
clade separate to the HRV-A40 prototype strain (marked in yellow in Figure 6.7).  
The prototype strain maintained its grouping with HRV-A85 (marked with black line 
in Figure 6.7).           




FIGURE 6.7:  Neighbour joining phylogenetic trees showing the P1, P2 and P3 regions of HRV-A 
sequences.  P1, P2 and P3 regions are numbered by FJ445111 : HRV-A1.  Seven HRV-A types which 
change bootstrap supported tree position between these regions and do not have a corresponding 
bootstrap supported phylogenetic incongruity on VP1 and 3Dpol trees are marked with yellow lines.  
The non-recombinant HRV-A40 prototype strain is marked with a black line.  Those 3 HRV-A types 
which change bootstrap supported tree position both between P1/P2 and P2/P3 are marked with 
purple lines.  Putative recombinant sequences which underwent one bootstrap supported change in 
tree topology between VP1 and 3Dpol are not shown.  Branches are scaled by genetic distance.      
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TABLE 6.2: Phylogenetic incongruities observed between the P1, P2 and P3 regions in HRV-A 
sequences which lack bootstrap support in the VP1 or 3Dpol regions 
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3 0 3204  
(3199 – 3209) 














5 0 3292 
 
a  
Sequences indicated in bold italics are those which consist only of non-consecutive sequence 
fragments and are therefore not represented on P1, P2 and P3 trees. 
b  
Sequences indicated in bold are those which are not present on VP1 and 3Dpol trees due to sequence 
gaps.   
c 
 As the new tree position of the contemporary HRV-A40 sequences is as an outgroup to a clade 
which contains the original HRV-A40 prototype sequence and has poor bootstrap support for deep 
phylogenetic relationships, it was not possible to determine an accurate breakpoint for these 
sequences.  However, by phylogenetic anlaysis, it can be assumed that this breakpoint lies between the 
P2 and P3 regions.   
d 
A76c represents contemporary HRV-A76 sequences (EU840726, JN815238, JX074055 and 
JX074049).   
e
 Node changes for A63 between P2 and P3 are taken from A59 to A10 and A56.   
 
In addition, three HRV-A types were observed to undergo two separate changes in 
bootstrap supported nearest neighbour, with a change occurring between P1 and P2 
and again between P2 and P3 (listed in Table 6.3).  The closely related sequence pair 
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HRV-A38/A60 underwent all changes together, suggesting that these events may 
have occurred before their diversification into phylogenetically distinct types.  The 
breakpoint analysis was achieved by considering both HRV types as a single query 
sequence group.  All recombination events described were confirmed by analysis 
with RDP, SBP and GARD software programs (data not shown). 
TABLE 6.3:  HRV-A types which displayed evidence of phylogenetic incongruity between both the 
P1/P2 and P2/P3 regions 























A85 9 5 3397 


















































(3218 – 3296) 
a  
The calculated mean breakpoint given corresponds to that one which was not observed on VP1 and 
3Dpol trees and not described in Table 6.1.   
b  
Node changes for HRV-A38/A60 between P1 and P2 are taken from HRV-A60/A38 to HRV-A19 
c  
Node changes for HRV-A38/A60 between P2 and P3 are taken from HRV-A60/A38 to HRV-A40 
 
Comparisons of pairwise nucleotide p-distances between the P1/P2 and P2/P3 
regions of HRV-A mirrored the patterns observed upon inspection of phylogenetic 
Recombination in the evolution of HRV genomes 
200 
 
trees.  In particular, the majority of the recombination events involving full HRV-A 
type groups were detected upon comparison of P1/P2 (coloured red in Figure 6.8), 
including the large scale re-organisation of inter-type relationships seen within Clade 
1 (Figure 6.5).  A line of best fit imposed on the P1/P2 distribution showed a gradient 
of 0.7341 for putative recombinant comparisons and 0.9799 for non-recombinant, 
similar to the pattern observed for the analysis conducted between VP1 and 3Dpol 
sequences.  In contrast, the comparison of P2/P3 revealed relatively fewer, sporadic 
recombination events.  These included instances where contemporary sequences of a 
particular type group separately to the type strain and are more distantly related than 
would be expected.  For example, the relationship between contemporary HRV-A76 
strains and the HRV-A56 type group and the putative recombination event observed 
within HRV-A80.  A line of best fit for the P2/P3 distribution showed a gradient of 
1.2082 for putative recombinant comparisons and 0.9813 for non-recombinant.  
 
FIGURE 6.8:  Comparison of pairwise nucleotide p-distances between the P1/P2 and P2/P3 
regions of HRV-A.  In each distribution, the line of best fit is indicated by the red dotted line and 
given for putative recombinant and non-recombinant sequences.  P-distance comparisons between 
putative recombinant sequences are shown in red.   
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Within both analyses, the presence of two distinct distributions was apparent; both 
occurring at pairwise distances of over 0.25 in the P2 region.  Detailed inspection of 
pairwise nucleotide p-distances indicated that these all represented p-distance 
comparisons between the observed clades 1 to 4 (Figure 6.5).  Meanwhile, all p-
distance comparisons below this threshold were between members of the same basal 
clades.  The clear division of the two distributions further strengthens the assertion 
that relationships between the deep clades have not been subject to recombination 
within the recent history of diversification of the viruses.    
6.3.7 Analysis of recombination within the coding region of HRV-B and 
HRV-C sequences 
In contrast to the widespread phylogenetic incongruity observed within HRV-A 
sequences, HRV-B and HRV-C showed very limited evidence for recombination 
within the coding region.  Phylogenetic relationships between the two regions within 
both HRV species were largely congruent (Figure 6.9).  Both HRV-B and –C showed 
evidence for grouping into contiguous basal phylogenetic clades which were 
maintained in both regions.  Due to poor basal bootstrap support, one HRV-C and 
seven HRV-B types were excluded from membership of any deep clade.  Similar to 
the clustering observed in HRV-A sequences, there was only extremely limited 
evidence for recombination between the deep clades.  The only exception was the 
potentially erroneous HRV-C sequence GQ223227, which changes deep clade 
membership between VP1 and 3Dpol.     
In accordance with the observed conformity of HRV-B VP1 and 3Dpol pairwise 
nucleotide p-distances (Figure 6.4), the majority of HRV-B sequences displayed 
congruent phylogenetic relationships and maintenance of phylogenetic clustering 
within their types as defined by VP1 (Figure 6.9 A).  In fact, only one bootstrap 
supported change in topology was observed between these two regions of HRV-B 
sequences. 





FIGURE 6.9:  Neighbour joining phylogenetic trees of HRV-B (A) and HRV-C (B) VP1 and partial 
3Dpol sequences.  HRV types have been collapsed for ease of reference.  Putative recombinant 
sequences and types are marked with black lines.  Contiguous clades are marked with black boxes.  
HRV types have retained their classical definition where we have proposed changes to these.  
Branches are scaled by genetic distance.     
HQ123444 is a recently published full genome sequence (Linsuwanon et al., 2011) 
and is currently the only representative of the HRV-B100 type.  This sequence 
changed position to cluster extremely closely with HRV-B35 sequences in the 3Dpol 
region.  Analysis of pairwise nucleotide p-distances revealed that this sequence had a 
minimum inter-type p-distance of 0.19 from HRV-B35 in VP1.  However, on 
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inspection of HRV full genomes, this sequence is identical to HRV-B35 from 
position 6353, within the 3Dpol region.  This observed phylogenetic incongruity was 
confirmed by analysis with RDP, GARD and SBP.       
 
FIGURE 6.10:  Neighbour joining phylogenetic trees showing the P1, P2 and P3 regions of HRV-B 
sequences.  P1, P2 and P3 regions are numbered by X01087: HRV-B14.  One putative recombinant 
HRV-B type (HRV-B70) is indicated by yellow line.  For ease of reference, branch to tree root has 
been collapsed.  Branches are scaled by genetic distance.      
On inspection of phylogenetic trees constructed for the full P1, P2 and P3 regions of 
HRV-B full genome sequences, an incongruity in branching order within HRV-B70 
was noted (shown with yellow line on Figure 6.10).  Contemporary sequences which 
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belong to the HRV-B70 type by VP1/P1 grouping group separately from the HRV-
B70 prototype strain in both P2 and P3.  The prototype strain maintains its original 
tree position, closely related to HRV-B17.  This putative recombination event was 
also evident on inspection of the 3Dpol trees, but only had adequate bootstrap 
support for the recombinant grouping when P2 and P3 trees were considered.  The 
majority of HRV-B sequences were additionally observed to group within the three 
basal clades previously observed in the VP1 and 3Dpol regions (marked with black 
boxes on Figure 6.9). 
 Within HRV-C sequences, there was only one observed bootstrap supported change 
in tree position of a single sequence between VP1 and 3Dpol.  This involved the 
previously reported potentially artefactually recombinant sequence GQ223227.  
Although this change in position was additionally observed within the P2 and P3 
regions, there were no other bootstrap supported topology changes within HRV-C 
(data not shown).  Any inconsistency in branching order showed bootstrap support 
below the threshold of 70% and could not be confirmed by analysis with RDP, 
GARD or SBP.  There was also no recorded bootstrap supported change in basal 
clade membership between the P1, P2 and P3 regions. 
6.3.8 Determining putative recombination breakpoints 
In order to estimate recombination breakpoints for putative recombinant HRV 
sequences, all available full genomes from each noted recombinant type underwent 
GroupScan analysis and were compared directly to their nearest neighbours in the 
P1, P2 and P3 regions.  Breakpoints were localised to the area where the grouping 
score with one control group fell and another increased.  Breakpoint estimates were 
pinpointed by calculating the intersection of the two lines.  Two representative 
examples of GroupScan output are given, with putative recombinant breakpoints 
highlighted (Figure 6.11 A).   
 




FIGURE 6.11 A:  GroupScan of two representative recombinant HRV-A types.  Proposed 
recombination breakpoint are indicated by the dotted line.  B:  Calculated coding region 
recombination breakpoints for all HRV-A recombinant types, mapped onto a diagram of the HRV-
A full genome.  Full genome numbering is taken from FJ445111 – HRV-A1.  Several sequences from 
large recombinant 3Dpol clade have been excluded, as complexity of nearest neighbour relationships 
precluded accurate estimation of recombination breakpoints.   
 
HRV-A18 has a breakpoint near the P1/P2 boundary which falls near position 3397 
(marked by dotted line on Figure 6.11 A).  Although an area of uncertain 
phylogenetic grouping can be observed immediately 5ˈ and 3ˈ to the calculated 
breakpoint, the only genuine point of intersection is at 3397.  HRV-A63 shows a 
putative recombination breakpoint within the P3 region, with the intersection 
calculated at position 5124.  The genome fragment between position 2000 and 2500 
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notably shows a similarly elevated grouping score with HRV-A59.  However, this 
association only borders on significance and did not correspond to any bootstrap 
supported change in tree topology.  It was therefore discounted.   
Breakpoints were successfully determined for the majority of putative recombinant 
HRV-A sequences and types.  However, within the large recombinant 3Dpol clade 
observed (Figure 6.5), several HRV-A types had very complex or closely related 
nearest neighbour relationships in both regions, which precluded the estimation of 
breakpoints.  In addition, no breakpoint could be determined for the putative 
recombination event involving contemporary HRV-A80 or HRV-B70 sequences, as 
no minor recombination parent group existed within the dataset.      
The majority of putative breakpoints occurred near the P1/P2 boundary, specifically 
within the 2A coding region (Figure 6.11 B).  A second putative hotspot region was 
observed around the P2/P3 boundary.  Most breakpoints within this region occurred 
within the 3A coding region or at the 3A/3B junction.   
6.3.9 Recombination within the 5ˈUTR of HRV-A and HRV-B 
Further to the detailed analysis of inter-species recombination within the 5ˈUTR 
region of HRV-A and HRV-C (presented in Chapter 5), intra-species recombination 
within the 5ˈUTR region of HRV-A and HRV-B was analysed.  All sequences that 
were more than 90% complete across the 5ˈUTR fragment numbered 167 – 626 
(numbered by FJ445111) were included in the analysis (167 HRV-A and 38 HRV-B) 
21
.  The occurrence of recombination within the 5ˈUTR was assessed by visual 
inspection of phylogenetic trees for HRV-A (Figure 6.12 A) and HRV-B (Figure 
6.12 B) separately.  An additional analysis including all three species demonstrated 
distinct clustering of HRV-B sequences, distant to HRV-A and HRV-C within the 
5ˈUTR region, indicating no inter-species recombination involving HRV-B. 
                                                     
21
 A fragment significantly smaller than the full 5ˈUTR region was used for analysis, as this allowed 
inclusion of a much larger number of sequences.   




FIGURE 6.12:  Neighbour joining phylogenetic trees constructed for the 5ˈUTR and VP4 regions 
of HRV-A and HRV-B sequences.  Putative recombinant sequences and types are marked by a red 
box on the 5ˈUTR tree and their corresponding position on the VP4/VP2 tree is highlighted by a red 
line.  Branches are scaled by genetic distance.   
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Within HRV-A, 17 putative recombinant sequences from nine HRV types were 
subject to bootstrap supported changes in nearest neighbour between the two regions 
(marked with black boxes on Figure 6.12).  Two sequences (JQ837724 : HRV-A1 
and JN621245 : HRV-A67) formed bootstrap supported groupings in the 5ˈUTR 
distant from other members of the same type.  This may indicate the occurrence of 
recombination events within contemporary sequences.   
In contrast, HRV-B 5ˈUTR sequences were considerably less numerous and only 
three putative recombinant types were noted (marked with black boxes on Figure 
6.12).  Of these, two consisted of a single sequence which was the sole representative 
of the type in question.   
6.4 Discussion 
The results of the analysis presented within this chapter reaffirms the assertion that 
recombination is a rare and sporadic occurrence in the contemporary evolution of 
HRV genomes.  This suggests that contemporary HRV types may exist as generally 
segregating groups with little potential for recombination between them and that the 
mainstay of generation of contemporary HRV diversity is genetic drift.  In contrast, a 
large number of recombination events were noted to have potentially occurred earlier 
during the period of diversification of HRV-A sequences into currently recognised 
types.   
6.4.1 Estimation of mean substitution rates and analysis of pairwise 
nucleotide p-distances 
This study represents the first comparison of mean substitution rates between distant 
genome regions of HRV-A and HRV-C.  Mean substitution rates calculated for 
HRV-A and HRV-C correlated with published estimates for other single stranded 
RNA viruses (Jenkins et al., 2002; Duffy et al., 2008; Hicks and Duffy, 2011).  
However, most previously published studies of substitution rates with picornaviruses 
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focus on the capsid coding region, particularly VP1 (Calvert et al., 2010; Hicks and 
Duffy, 2011).  One previously published estimate of the mean substitution rate 
within VP4/VP2 sequences of HRV-C, 6.6 x 10
-4 
substitutions/site/year, was 
considerably lower than our estimates for other regions of HRV-C (Briese et al., 
2008).  This possibly relates to the much more restricted sampling time of 32 months 
used in this study or to the fact that VP4/VP2 is generally a well conserved coding 
region with significantly less observed genetic diversity than the VP1 or 3Dpol 
regions.   
In a published comparison of mean substitution rates within the Picornavirus family, 
members of the genus Enterovirus (excluded HRV species) were found to have a 
significantly higher mean substitution rate than other genera (including Apthovirus, 
Teschovirus, Hepatovirus and Cardiovirus) (Hicks and Duffy, 2011).  In fact, 
substitution rates estimated for both the VP1 and 3Dpol regions of EV were around 
one order of magnitude faster than those obtained for other members of the 
Picornavirus family.  Our estimates for HRV-A and HRV-C showed overlapping 
95% HPD intervals with both EV and non-EV examples.   
Studies of the evolution of recombinant forms of EV have included estimates of 
substitution rates within the 3Dpol region which  are of the same order of magnitude 
as our estimates for HRV-A and –C (Hicks and Duffy, 2011; McWilliam Leitch et 
al., 2009a, 2012, 2010).  In addition, when recombinant forms of EV71, E9, E11 and 
E30 are considered separately, the same general congruency of rates between the 
VP1 and 3Dpol region is observed (McWilliam Leitch et al., 2009a, 2010, 2012).       
Observed similarity in mean rates of nucleotide substitution between two distant 
genome regions should result in a linear relationship between sequence divergence in 
these two regions (revealing a distribution with a gradient of 1 and a y-intercept of 
0).  In the resulting distribution, any discontinuities or outlying p-distance 
comparisons may relate to potential recombination events (coloured red and yellow 
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in Figure 6.4).  Indeed, this relationship has been documented in EV71 isolates 
(McWilliam Leitch et al., 2012), where outlying data points corresponded to putative 
recombinant sequence groups.  Within our analysis, the observed discrepancies in 
sequence divergence between VP1 and 3Dpol of HRV-A were typically the result of 
comparisons between variants that displayed bootstrap supported changes in 
phylogenetic clustering between the two regions.  The formation of clusters of 
outlying data points supports the observed phylogenetic incongruity involving full 
HRV-A types and in particular, a large cluster of putative recombinant sequences 
between 0.25 and 0.34 pairwise nucleotide p-distance in VP1 (coloured red in Figure 
6.4) corresponds to the widespread reorganisation of inter-type relationships 
observed within Clade 1 of HRV-A.  Several instances of sporadic inter-type 
recombination observed within HRV-A are manifest as scattered discrepant 
comparisons (coloured yellow in Figure 6.4).  In contrast, comparisons of sequence 
divergence in the VP1 and 3Dpol regions of HRV-B and HRV-C showed relatively 
few outlying data points, consistent with the observed congruence of phylogenetic 
relationships and generalised lack of recombination detected within these two 
species.   
6.4.2 Analysis of recombination within the coding region of HRV-A, 
HRV-B and HRV-C 
Despite the generally held view that HRV are not usually subject to recombination, a 
small number of recombination events have been hypothesized to have contributed to 
the formation of some recognised HRV-A and HRV-B types (Palmenberg et al., 
2009).  In addition, it has been speculated that the entire HRV-B species was formed 
by recombination between HEV and HRV-A (Tapparel et al., 2009b).  
The absence of recombination documented between the two subgenomic regions at 
the 5ˈ and 3ˈ extremes of the capsid coding region (VP4/VP2 and VP1) affirms the 
suitability of either of these regions for the purposes of taxonomic classification and 
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epidemiological identification of circulating HRV types (see Chapter 4).  Despite 
poor bootstrap support for basally branching phylogenetic relationships in both 
VP4/VP2 and 3Dpol, likelihood mapping analysis revealed a strong support for the 
representation of HRV sequences as a bifurcating phylogenetic tree in all regions 
studied (Figure 6.2).  This led us to believe that conclusions drawn regarding 
potential recombination events using phylogenetic incongruity as the cornerstone of 
the analysis were valid.  Nonetheless, supplemental examination of all putative 
recombinant sequences was undertaken with the panel of computational analyses 
described previously.   
In common with previous analyses of recombination with HRV full genome 
sequences (Palmenberg et al., 2009) and phylogenetic incongruity between the 
VP4/VP2 and 3Dpol regions of HRV sequences (Savolainen et al., 2004), we found 
the highest proportion of recombinant sequences within HRV-A.  HRV-B and HRV-
C sequences showed only very limited evidence for recombination within the coding 
region.  In contrast, Linsuwanon and co-workers found that recombination frequency 
within HRV full genomes was actually highest within the 3Dpol region of HRV-C 
(Linsuwanon et al., 2011).  However, the relevance of this finding is questionable, as 
the study in question considered only 9 HRV-C full genome sequences, including the 
previously reported potentially artificially mosaic sequence GQ223227.  The low 
sample size combined with the single aberrant sequence is likely to have given an 
erroneously high estimate of recombination frequency.  Our similar analysis included 
59 HRV-C full genome sequences and additionally excluded GQ223227, which 
should give a more robust estimate of recombination frequency in this species.   
HRV-A sequences reliably cluster into four bootstrap supported basal clades, which 
were consistently observed in the regions analysed in this study (VP4/VP2, VP1 and 
3Dpol).  Recombination appears to have occurred relatively frequently within clades 
1-3 (Figure 6.5), especially during the period of diversification of HRV-A into 
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currently recognised type groups.  However, there was no evidence of recombination 
occurring between the basal clades in any coding region indicating that these clades 
are now potentially on distinct and diverging evolutionary paths.  This concept of 
separate divergent evolution is supported by the inspection of comparisons of 
sequence divergence in the P1, P2 and P3 regions, whereby inter-clade comparisons 
form a discrete cluster with no overlap with intra-clade comparisons.  One group of 
three HRV-A types (HRV-A8, -A45 and –A95) has been previously noted to be 
phylogenetically distinct (Palmenberg et al., 2009; Savolainen et al., 2004) and 
additionally possess certain RNA elements which are atypical of other HRV-A 
strains (Palmenberg et al., 2009).  These three types have been tentatively proposed 
as a new species; HRV-D although they do not meet the ICTV guidelines for 
definition as a distinct species in terms of sequence divergence.   
The most comprehensive study of recombination within all prototype full genomes of 
HRV previously published detected a total of 23 recombinant genomes, resulting 
from 12 distinct recombination events (Palmenberg et al., 2009).  Notably, most 
HRV types within this analysis were represented by a single isolate.  Our analysis 
uncovered putative recombination events analogous to most of the previously 
described events within the coding region.  However, as we elected to define nearest 
neighbour relationships by inspection of bootstrap supported phylogenetic trees, our 
estimates of major and minor recombination parents occasionally differed from those 
reported.  The detailed deep phylogeny of nearest neighbour relationships is not 
always well-resolved, particularly in the non-structural protein coding regions studies 
(P2, P3 and 3Dpol).  The use of GroupScan as the mainstay of breakpoint 
determination allowed us to consider full clades as single nearest neighbour groups 
and additionally calculate breakpoints in sequences with no closely related parental 
sequences within the dataset.  In addition to the extensive recombination involving 
full HRV-A types that was documented, we also recorded several instances of 
putative recombination among contemporary HRV-A sequences.  This included 
Recombination in the evolution of HRV genomes 
213 
 
confirmation of the previously reported finding that contemporary HRV-A76 
sequences have undergone a recombination event with HRV-A56 (Tapparel et al., 
2009b).  The original study reported a single recombinant sequence which displayed 
this branching pattern.  However, we have noted that in fact, all contemporary HRV-
A76 isolates currently known group together and therefore, that the recombinant 
group of HRV-A76 is the present dominant lineage.  A similar pattern was also 
observed in several other HRV types, indicating that while contemporary 
recombination occurring with the 50 year time span of this dataset is not frequent, it 
can occur.      
In contrast, only the previously reported putative recombinant HQ123444 
(Linsuwanon et al., 2011) was noted in analysis of HRV-B sequences.  Due to 
differing analysis methods used, the previous study did not detect the 100% identity 
of this sequence with prototype HRV-B35 strains from position 6353 onwards and 
instead noted an association with HRV-B35 throughout the length of the genome.  
As there are no contemporary HRV-B35 sequences available and HQ123444 is the 
only currently known example of HRV-B100, it is not possible to speculate on the 
validity of this observation.  It is notable, however, that the breakpoint noted here is 
near the same region as the previously described putative sequencing error observed 
for GQ223227 (HRV-C8) (McIntyre et al., 2010).  It is possible that this putative 
recombinant sequence may represent a sequencing or assembly error.   
In common with earlier work on recombination within the coding region of HRV-C, 
only one recombinant sequence was observed within this species.  However, 
although the renewed analysis included HRV-C strains spanning a 14 year time 
period, it is regrettably still limited in its scope by the lack of older strains.  Notably, 
all instances of recombination involving only contemporary sequences of HRV-A 
and HRV-B documented involved a sequenced example from the collection of 
prototype strains lodged at the ATCC that were originally collected over 40 years 
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ago.  It is not beyond the realm of possibility that HRV-C strains undergo 
recombination among contemporary sequences at similar frequencies to HRV-A, but 
the time span of the current data set renders detection impossible.   
6.4.3 Putative recombination breakpoints within the coding region 
Recombination breakpoints were determined for all putative recombinant HRV-A 
sequences with adequately supported nearest neighbour groups (Table 6.1).  For 
putative recombination events involving very closely related HRV types (for 
instance, HRV-B17 and –B70), recombination breakpoints could not be accurately 
determined.   
Similarly to documented observations within EV (Lindberg et al., 2003; Lukashev et 
al., 2005) and human parechovirus (Benschop et al., 2010b), the majority of 
recombination breakpoints occur near the P1/P2 junction, at the boundary of 
structural and non-structural protein coding regions.  High within-species divergence 
in observed within the P1 region of HRV sequences, which suggests that there may 
be a biological compatibility barrier which decreases the reproductive fitness of 
progeny which are recombinant within the capsid region.  Therefore, although inter-
typic recombination events likely occur in a random fashion throughout the full 
length of the genome in the course of a natural co-infection, recombination within 
the capsid region may not be represented in routine clinical sampling which only 
detects the predominant variant.     
6.4.4 Recombination within the 5ˈUTR of HRV-A and HRV-B 
Despite the lack of recombination observed within the coding region of HRV 
sequences, there were several documented instances of phylogenetic incongruity 
within the 5ˈUTR region of HRV-A and HRV-B.  Although inter-species 
recombination has been documented among EV isolates (Santti et al., 1999), the only 
instances observed within HRV sequences involved the previously documented 
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relationship between HRV-A and HRV-C (McIntyre et al., 2010; Huang et al., 2009; 
Wisdom et al., 2009a).  Analysis restricted to HRV-A and HRV-B alone showed 
total segregation of the two species in the 5ˈUTR, as in all other gene regions.     
In HRV-A, basal clades 1 to 4 were not maintained in the 5ˈUTR region.  We noted 
considerably more putative recombination events within the 5ˈUTR of HRV-A than 
previous studies (Palmenberg et al., 2009) and these included two instances of 
contemporary recombination involving single sequences grouping separately from 
other sequences of the same type.  The discrepancy in these analyses is potentially 
explained by the differing alignment methods employed and by the use of 
phylogenetic incongruence as the mainstay of our recombination analysis.  In fact, 
several putative recombinant sequences that were previously noted by Palmenberg 
and co-workers displayed inadequate bootstrap support on phylogenetic trees to be 
considered as recombinant by our methods (Figure 6.12).  This lack of support for 
previously reported recombinant sequences was especially evident upon analysis of 
HRV-B.  However, the 5ˈUTR region of HRV-B has not been extensively sequenced 
to date and currently a mere nine HRV-B types are represented by more than one 
sequence.  Future studies may benefit from a focus on obtaining sequence data in 
order to perform a more comprehensive analysis of this region.     
6.4.5 Conclusion 
This study demonstrates that, despite a close phylogenetic relationship with EV, 
recombination within the history of diversification of all three species of HRV was 
substantially less frequent than that observed within EV species.  Following upon 
previous reports which have provided some glimpses of the occurrence of 
recombination in HRV-A (Palmenberg et al., 2009; Tapparel et al., 2009b; 
Savolainen et al., 2004), our study represents a comprehensive analysis of 
recombination in all published HRV full genome sequences to date, an additional 
analysis of HRV sequence fragments obtained from isolates spanning a 14 year time 
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period and, to our knowledge, the first attempt to catalogue all currently detectable 







7.1 A broad view of the global importance of HRV 
Acute respiratory infections are one of the leading causes of paediatric mortality 
worldwide (Bryce et al., 2005).  Severe acute respiratory diseases account for around 
20% of deaths in children under 5 (in the 42 countries where 90% of global child 
deaths take place) (Black et al., 2003; Bryce et al., 2005).  This figure rises to 29% 
when pneumonia and sepsis in neonates is additionally considered (Bryce et al., 
2005).  Although more widely feared serious respiratory infections (including 
influenza, tuberculosis and Streptococcus Pneumoniae) are responsible for by far the 
largest proportion of these illnesses and deaths, the role of HRV as a potential cause 
of lower respiratory tract disease, severe bronchiolitis and life-threatening 
exacerbations of chronic lung disease is now clear (Papadopoulos, 2002; Renwick et 
al., 2007; Broberg et al., 2011; Mallia et al., 2011; Bizzintino et al., 2011; McManus 
et al., 2008).   
The predominance of the life-threatening infections mentioned above and 
opportunistic infections secondary to human immunodeficiency virus (HIV) 
infection in the developing world has generally prevented most investigations of 
seemingly trivial pathogens, such as HRV and as such, there is only very little data 
available on the regional circulation and clinical impact of HRV (Smuts et al., 2011; 
Chidlow et al., 2012).  However, chronic diseases such as chronic obstructive 
pulmonary disease (COPD) and asthma, traditionally the scourges of affluent western 
societies, are now known to be making significant headway into these regions (Chan-
Yeung et al., 2004).  In addition, understanding the circulation, epidemiology and 
evolution of HRV can theoretically inform the development of targeted therapeutic 




inappropriate prescription of antibiotics for viral respiratory tract illness.  The 
common cold is one of the most common reasons for inappropriate antibiotic 
prescription (Nyquist et al., 1998) and with the threat of widespread antibiotic 
resistant pathogens looming, the urgency of dealing with this situation on a global 
scale has become clear.   The realisation of the potential importance of these 
pathogens has meant that the scope of research interest in HRV has been increasing 
steadily over the last 20 years and over 200 research papers were indexed on 
PubMed in 2012 (www.ncbi.nlm.nih.gov/pubmed).   
7.2 Novel findings in the clinical epidemiology of HRV 
One of the main reasons for this substantial upswing in HRV research globally has 
been the realisation that these viruses are potentially responsible for more severe 
clinical illnesses than was previously thought.  Most of the published analyses of the 
impact of HRV in severe illness have focussed on both severe respiratory tract 
infections (Broberg et al., 2011; Renwick et al., 2007; Fuji et al., 2011; Hicks et al., 
2006) and occasional reports of systemic disease in young children (Tapparel et al., 
2009c; Broberg et al., 2011).  The results of epidemiological studies undertaken 
during the course of this PhD (Chapter 3) suggested a surprising link between HRV 
isolation from stool and gastrointestinal infections and also a potential role for HRV 
in aseptic meningitis (Harvala et al., 2012b).  Since the publication of our findings, 
two other studies have also been published that report detection of HRV RNA in 
stool samples (Lau et al., 2012; Honkanen et al., 2013).    
The closely related human EV are routinely isolated from both human stool samples 
obtained in cases of clinical illness and in environmental surveillance of sewage 
(Benschop et al., 2010a).  In fact, screening sewage samples is one of the mainstays 
of the surveillance aspect of the poliovirus eradication campaign.  However, HRV 




acidic environment of the gastrointestinal tract.  Exposure to acidic vapour was 
reported to cause conformational changes in the capsid structure of HRV-B14 and 
these changes may prevent uncoating of the RNA genome (Giranda et al., 1992).  
Although the acid sensitivity of several HRV strains has been demonstrated 
experimentally, the generally held wisdom that HRV are almost universally acid 
labile has been called into question several times.  Several acid stable mutants of 
HRV were reported over 20 years ago (Skern et al., 1991) and viable HRV have been 
isolated from sewage samples by cell culture based screening techniques (Blomqvist 
et al., 2009).  The fact that the study that found HRV in sewage recorded only 24 
strains over an 8 year period is likely to be secondary to the usage of cell culture 
based methods that are specific for the isolation of human EV.  More recent studies, 
including ours, undertaken using molecular methods and specifically screening 
patients with gastrointestinal symptoms have found rates of HRV detection in stool 
ranging from 8-10% (Honkanen et al., 2013; Harvala et al., 2012b; Lau et al., 2012).  
Not only were the HRV detected in sewage able to propagate in vitro, but actually 
one clinical HRV isolate from a stool sample was subsequently grown in RD cells 
(Honkanen et al., 2013; Blomqvist et al., 2009).  This indicates the surprising 
presence of viable and infectious HRV in both sewage and stool samples.   
Interestingly, no study has found evidence for a distinct genetic subgroup of HRV 
being more commonly isolated from the gastrointestinal tract.  Instead, in accordance 
with our findings, studies have generally reported a high level of similarity with 
respiratory strains.  These findings indicate that not only are HRV potentially able to 
withstand more acidic environments than was previously thought, but the boundary 
between the clinical manifestations of HRV and EV infections may be more blurry 
than it is traditionally considered.  In addition to the potential link between HRV and 
gastrointestinal infections, certain human EV strains, such as EV-D68 and EV-C109 
are also associated with URTI.   (Oberste et al., 2004b; Yozwiak et al., 2010) Future 




of acid exposed HRV isolated from both the gut and respiratory tract.  The use of a 
control group of known acid-stable EV would allow direct comparison between the 
two groups of viruses.            
The distribution of ages of patients with HRV detected in their stool samples 
included mainly young children and the elderly.  Both of the other published studies 
screened samples from children alone (Honkanen et al., 2013; Lau et al., 2012) and 
so there is a striking lack of data regarding possible HRV detection in the stool of 
adult patients.  There was also no detailed information available as to the underlying 
medical history of patients with HRV detected in their stool samples and therefore 
pre-existing gastrointestinal pathology and drug history was unknown.  In future, 
prospective studies conducted should probably seek to include this information, 
especially where concerning the presence of gastro-oesophageal reflux disease 
(GORD) and subsequent usage of over-the-counter remedies for this condition.  
Commonly prescribed treatments for gastro-oesophageal reflux are generally aimed 
at reducing gastric acidity.  Drugs such as Omeprazole (proton pump inhibitors; 
PPIs) are extremely commonly prescribed both as direct treatment for GORD and as 
a supplementary gastro-protective agent in cases of therapy with certain painkillers 
within the class of non-steroidal anti-inflammatory drugs (NSAIDs), very commonly 
used for the treatment of arthritis.  PPIs are also, rather controversially, used 
occasionally to treat GORD in infants and young children.  Speculatively, there may 
be potential for a link between the usage of these medications, subsequent alteration 
of the pH of gastric contents and infection with HRV.  The collection of detailed 
medical and prescription histories in a prospective study would allow examination of 
these factors.     
A second surprising finding was the amplification of HRV RNA from the CSF of a 
systemically unwell infant.  HRV has not, to our knowledge, been documented as a 




circumstances, HRV is able to traverse the blood brain barrier and therefore 
potentially cause an infection of the CNS.  The fact that this appears to have been a 
comparatively rare occurrence, as compared to CNS infection with the highly 
genetically and structurally similar human EV may in theory be partially explained 
by the apparently limited tendency of HRV to cause a systemic viraemia.  This is 
thought to be a vital step in the spread of EV infections to the CNS, except in the 
case of PV, which are hypothesized to be additionally able to directly invade 
peripheral nerves (Pallansch and Roos, 2007).  In two studies of HRV viraemia, only 
11-12% of symptomatic HRV infections were linked with HRV detection in blood 
samples and this detection frequency was reduced to zero when those without 
respiratory symptoms were considered (Xatzipsalti et al., 2005; Fuji et al., 2011).  
However, studies on the rates of HRV viraemia in patients with symptomatic 
gastrointestinal infections and HRV detected in stool have not, to our knowledge, 
been undertaken.  Studies such as this would provide further clues as to why, when 
HRV appears to be able to both replicate in the gastrointestinal tract and cross the 
blood brain barrier, it does not cause a similar proportion of aseptic meningitis as 
human EV.               
7.3 Classification of HRV into genotypically defined types 
A core component of the work presented within this thesis has been the development 
of a system of defining and classifying HRV on the basis of readily available 
sequence data.  The determination of associations of specific HRV types with certain 
clinical illnesses, if they exist, is an issue of great importance; especially with the 
hypothesis that certain HRV strains may be more likely to both be implicated in the 
development and cause severe exacerbations of asthma (Palmenberg et al., 2010).   





The system of classification for all three species of HRV that we have proposed is 
similar in nature to that currently in use for the definition of new EV types (Oberste 
et al., 1999a, 1999b).  The realisation that the majority of HRV-C sequences are 
recombinant in the 5ˈUTR region (Huang et al., 2009; Wisdom et al., 2009a; 
McIntyre et al., 2010) should preclude the use of this region for this purpose as the 
majority of HRV-C strains will be misidentified.  The use of capsid regions only for 
the purposes of HRV typing should not cause underestimation of the importance of 
non-structural protein coding regions for investigation of viral phenotypes.  For 
example, one study of EV-A71 pathogenesis in mice found specific mutations in the 
3Dpol region of strains with reduced virulence (Chang et al., 2010).   The extensive 
recombination observed within EV species means that typing EV by VP1 alone is 
tantamount to knowing that around one third of the genome is closely related to a 
known prototype strain.  If virulence and tropism influencing residues are situated 
outside the capsid, then a more comprehensive approach to EV typing could be 
warranted.  Whole genome sequencing has been suggested as the most appropriate 
method for HRV typing (Palmenberg et al., 2009).  However, as recombination 
within the coding region appears to occur only very infrequently within the 
contemporary evolution of HRV, this approach may not be necessary.     
We also noted that the three species of HRV appear to harbour considerable 
antigenic diversity both within and between species.  Over 140 HRV types over three 
species are recognised compared to 130 types (in nine species) for EV and 11 (in 
four species) for Apthovirus (Table 1.1).  This discrepancy may be due to the 
ubiquitous nature and constant circulation of HRV, meaning that many more types 
are detected and catalogued in a single study than other picornavirus groups.    The 
action of diversifying selection pressure on residues within the capsid coding region 
that specifically coincide with neutralizing antigenic sites has previously been 
described (Kistler et al., 2007b) and one could speculate that such pressure could 




a large number of the HRV types that have been newly discovered in recent years 
have shown evidence of circulation long before their initial discovery (Briese et al., 
2008).  These cannot be properly called emerging viruses but rather new discoveries 
made possible by the increasing scope of molecular detection methods.  In addition, 
evidence of the contemporary diversification of HRV into genotypically distinct 
types was only rarely evident within our dataset, although several divergent strains of 
a few types (including HRV-A29) were documented (Chapter 4).  These may 
represent the gradual creation of antigenically distinct types.  Further studies 
focussing on exploring serological cross-reactivity between members of 
genotypically defined types in all three species would be beneficial to gaining a 
deeper understanding of these relationships.   
7.4 Recombination in the evolution of HRV 
The process of recombination can generate strains with differing virulence patterns 
and can cause reversion in the attenuated PV vaccine (Macadam et al., 1989; van der 
Sanden et al., 2011; Burns et al., 2013).  The circulation of recombinant strains has 
been frequently reported in many other picornaviruses, including human EV 
(Oprisan et al., 2002; Simmonds and Welch, 2006; Bouslama et al., 2007; 
McWilliam Leitch et al., 2010; Santti et al., 1999; McWilliam Leitch et al., 2012; 
Oberste et al., 2004d, 2004a; Lindberg et al., 2003; Andersson et al., 2002), 
Apthovirus (Heath et al., 2006; Simmonds, 2006), Cardiovirus (Drexler et al., 2010; 
Blinkova et al., 2009) and Parechovirus (Benschop et al., 2008; Calvert et al., 2010).  
In fact, the occurrence of phylogenetic incongruence between the structural and non-
structural genome regions of many picornaviruses has led to a theory of separate and 
modular evolution of these two genome regions (Lukashev et al., 2005; Santti et al., 
1999).  In contrast, the studies contained within this thesis (Chapters 5 and 6) have 
generally supported a low level of detectable recombination within the coding region 




evidence within HRV for the widespread recombination between contemporary 
strains observed in EV.  Recombinant strains of EV-B have been documented to 
circulate in outbreaks, where one recombinant form (a combination of a particular 
capsid and non-structural region) rises to dominate circulation for a few years and 
then disappears entirely (McWilliam Leitch et al., 2010, 2009a).  In contrast, the 
infecting HRV population appears to consist of a great number of types which 
circulate almost continuously.  These types appear to be somewhat stable and show 
congruent within-type phylogeny between their structural and non-structural genome 
regions.  As EV and HRV in particular exhibit a highly similar genome structure and 
a degree of sequence homology, the mechanism by which recombination is restricted 
in HRV remains puzzling.         
Although the occurrence of recombination during genome replication is essentially a 
random process and probably occurs rather frequently, recombinant genomes must 
necessarily compete with parental strains in order to come to form a detectable 
fraction of the population.  The fact that recombinant HRV genomes are so rarely 
observed within contemporary datasets suggests that recombinant genomes may be 
generally less fit than parental strains.  The fitness of the generated virus depends not 
just on the functioning of individual encoded proteins but on the interactions between 
different parts of the genome.  For instance, the interaction between the 3CD protein 
and the 5ˈUTR is an essential component of negative strand synthesis and therefore 
RNA replication (Rohll et al., 1994; Andino et al., 1990) .  These interactions have 
likely been somewhat optimised over time by co-evolution of different genome 
segments and therefore, even biologically viable recombinants are likely to exhibit 
decreased fitness when compared with parental strains.  A similar point has been 
demonstrated by in vitro studies of recombination in the 5ˈUTR region of HRV.  
Artificial chimaeras were created between the coding genome of HRV-A16 and the 
5ˈUTR region of various different members of the Enterovirus genus (comprising of 




that each chimaera was viable and could replicate efficiently in cell culture but in 
competition experiments was consistently less fit than the wild type virus (Schibler et 
al., 2012).  This suggests that while certain parts of the genome may be functionally 
interchangeable, the restricting factor in the detection of recombinant genomes may 
be a decline in viral fitness.  Indeed, this functional compatibility within the 5ˈUTR 
region can extend to highly divergent viruses.  A study which replaced the IRES of a 
PV1 virus with that of EMCV found that this still resulted in the creation of a viable 
chimaera (Alexander et al., 1994).  This finding is even more remarkable when 
considered in light of the fact that this indicates a degree of functional compatibility 
between a Type I and Type II IRES, which have little or no homology in either 
sequence or structure.  Notably there is also evidence for the exchange of IRES 
elements between diverse picornavirus genera.  For example, as previously discussed 
the Type IV (pestivirus related) IRES has been found in both Sapelovirus and 
Avihepatovirus.  The extremely rare isolation of recombinants from such divergent 
viruses in nature may be secondary to decreased evolutionary fitness or to their 
limited opportunity to co-infect the same host cell.   
Although the well-conserved 5ˈUTR region appears to be somewhat interchangeable 
between diverse viruses, the possibility of a biological compatibility barrier between 
the more divergent structural and non-structural regions of divergent viruses has been 
previously discussed (Kistler et al., 2007b; Simmonds and Welch, 2006; Lukashev et 
al., 2005).   The theory states that viruses that bypass a particular divergence 
threshold in the non-structural region may lack the ability to form viable 
recombinants, as vital interactions between different encoded proteins may be 
severely disturbed.  HRV are generally highly genetically diverse within and 
between species in both structural and non-structural genome regions (Kistler et al., 
2007b) and we have demonstrated a generally higher within-species divergence for 
HRV-C than other HRV (Chapter 5).  This co-incides with the almost completely 




recombinant EV-B shows considerably decreased divergence in the non-structural 
protein region (Lindberg et al., 2003).  This may allow different genome segments to 
have a higher degree of functional compatibility and therefore permit successful 
competition of recombinant genomes with parental strains.  It has been suggested 
that G+C content may play a role in the frequency of generation of recombinant 
genomes; whereby high G+C content increases recombination frequency by 1.3 
times and the existence of GC tracts increase it even further  (Runckel et al., 2013).  
This study used a deep sequencing technique to obtain sequences from all PV 
genomes generated during the replication cycle and so recovered sequences were not 
restricted by the viability or fitness of the variant.  If this observation can be assumed 
to be generally applicable to HRV as well as PV, it may suggest that the frequency of 
generation of recombinants in HRV during replication is less than in EV secondary 
to a generally lower G+C content.  This would also suggest that recombination 
occurs slightly more frequently in the more G+C rich HRV-C genomes than other 
species of HRV.  However, the lack of observation of such recombinants suggests 
that certain restrictions on biological viability and evolutionary fitness render these 
recombinants less able to compete with wild type viruses.   
The emergence of epidemic strains secondary to recombination of the 5ˈUTR region 
in EV has been documented (van der Sanden et al., 2011).  In addition, strains of EV-
A71 with altered virulence secondary to mutations in the 3Dpol region have been 
noted (Chang et al., 2010).  EV-B circulates in a cyclical fashion, whereby 
recombinant strains predominate for a certain period of time and then are 
periodically replaced.  This constant shuffling of distinct genome modules in EV 
may potentially contribute to the epidemic circulation of certain strains.  Studies of 
HRV epidemiology, such as those outlined in Chapter 3, generally note a lack of 
predominance of a certain HRV species or strain circulating in a particular time 




non-structural genome regions in HRV may be a partial explanation for the patterns 
of circulation observed in these viruses.     
7.5 Conclusion 
In summary, the work undertaken throughout the course of this PhD has focussed on 
the epidemiology, classification and evolution of HRV.  In addition to the discovery 
of a novel potential association between HRV infection and both gastrointestinal and 
CNS disease (Chapter 3), we have developed proposals for the classification of HRV 
into genotypically defined types and applied these guidelines to the classification of 
all available HRV sequence data into over 140 types (Chapter 4).  The classification 
of all HRV sequences in this manner allowed investigation of the occurrence of 
recombination in the history of diversification of all three species of HRV (Chapter 5 
and 6).  We found only limited evidence of recombination occurring within the 
contemporary diversification of HRV types, as evidenced by the congruent 
phylogenetic groupings of sequences.  However, we did find evidence for 
phylogenetic incongruity affecting entire HRV-A types, suggesting that these viruses 
may have been subject to extensive recombination during the period of their 
diversification into distinct HRV types.   
One potential long-term application of research into the genetic diversity of HRV 
and evolutionary processes shaping this diversity is the potential identification of 
genome regions which may serve as therapeutic targets for the development of both 
antiviral drugs and vaccines.  The considerable genetic diversity of HRV renders the 
formulation of a common vaccine for even a single HRV species extremely 
challenging.  However, the taxonomic identification and classification of infecting 
strains may allow future determination of potential associations with certain strains 
and severe diseases.  Studies of evolution and recombination in HRV may reveal 




that antibodies to the well-conserved VP4 region may exhibit cross-serotypic 
neutralisation properties (Katpally et al., 2009) coupled with our observations that 
the VP4 region of HRV is both well conserved and largely non-recombinant 
throughout all three species may have implications for the development of such 
targeted therapies.  In addition, the finding that the 2A protein is very well conserved 
within HRV-A and HRV-C may highlight this region as a particularly attractive 
therapeutic target.  With global collaboration and studies concentrated on aspects of 
epidemiology and evolution of HRV strains, it may actually be possible in the future 
to make an impact on the considerable clinical and economic burden of these 
extremely common pathogens.  

































































HRV OAS 1104 C4:EF582385 ACATRTTYTSNCCAAANAYDCCCAT 
Primers for the amplification of the 5ˈUTR of HRV-C 
UTR 1 HRV-A OS/IS 1 C4:EF582385 
       TTMAAACAGCSGBNNGGTTGYACCCA 
 
UTR 1 HRV-C OS/IS 1 C4:EF582385 TTMAAACTGRRWBYRGGTTGYTCCCA 
UTR 1 
HRV-
A/C OAS 375 C4:EF582385 
       GCAGGSMRCCACGCRGGCT 
 
UTR 1 HRV-A OAS 375 C4:EF582385 
       GCAGGCAGCCACGCAGGCT 
 
UTR 1 HRV-C OAS 375 C4:EF582385 GCAGGGCACCACGCGGGCT 
UTR 1 HRV-A IAS 355 C4:EF582385 GAHCACTGTYRCCAGTGGGG 
UTR 1 HRV-C IAS 354 C4:EF582385 GACACCGTCGCCGGTGGGG 
UTR 2 
HRV-
A/C S 164 C4:EF582385 HCAAGYACTTCTGTYWCCCCSG 
UTR 2 
HRV-
A/C OAS 560 C4:EF582385 




A/C IAS 550 C4:EF582385 ACACCCAAAGTAGTYGGTYCCR 
UTR 3 
HRV-
A/C A 445 C4:EF582385 CCGGCCCCTGAATGYGGCTAA 



















A/C OAS 1066 C4:EF582385 TCWGGHARYTTCCAMCACCANCC 
UTR 3 
HRV-
A/C IAS 868 C4:EF582385 
       ATAGTRATTTGYTTDAGCCTATCDGAV A 
 
Primers for the amplification of the VP1 region of HRV-A, -B and –C 
A VP1 HRV-A OS 1943 A1:D00239 MGHTTYAGYTTYATGTTYTGTGG 
A VP1 HRV-A OAS 3485 A1:D00239 CCACARTCWCCWGGYTCACADGG 
A VP1 HRV-A IS 2418 A1:D00239 TRGAYGCWGCWGARACWGG 
A VP1 HRV-A IAS 3290 A1:D00239 GTRTTTGTKCGGTADATGAYTARRTC 




A28 IAS 2702 A1:D00239 ACTTGCAACTGACACCACTAT 
B VP1 HRV-B OS/IS 2250 B14:X01087 TAGTGCRTGTCCAGATTTYA 
B VP1 HRV-B OAS 3455A B14:X01087 TAACTACCACCTTCAATCCA 
B VP1 HRV-B OAS 3455B B14:X01087 TAGTTTCCTCCTTCAATCCA 
B VP1 HRV-B IAS 3256 B14:X01087 ARRTGRTCYTCHTGYGTCAT 
C VP1 
PCR 1 
HRV-C OS 1986 C4:EF582385 ATRGCMTACACMCCHCCWGG 
C VP1 
PCR 1 
HRV-C OAS 3449 C4:EF582385 YTTVCCWCCACARTCHCCWGG 
C VP1 
PCR 1 
HRV-C IS 2256 C4:EF582385 ATGHTRCGWGAYACWCCHATGAT 
C VP1 
PCR 1 
HRV-C IASa 2852 C4:EF582385 ATCATAHCCATCATARAAVATGTARTA 
C VP1 
PCR 1 




HRV-C IS 2745 C4:EF582385 GCYTCHAACCCHAGTGTNTTYT 
C VP1 
PCR 1 




HRV-C OAS 3882        C4:EF582385 ARBCCHYKDGCDGCRTTRCA 
Pr   Primers for the amplification of the 2A region of HRV-C 
C2A HRV-C OS 2832         C4:EF582385       GCHTAYTAYATKTTYTATGATG 
C2A HRV-C OAS 3882        C4:EF582385       ARBCCHYKDGCDGCRTTRCA 
C2A 
PCR1 
HRV-C IS 2898        C4:EF582385 AATGAYAYGGGWWSASMYTRTG 
C2A 
PCR 1 
HRV-C IAS  3429        C4:EF582385       YTTVCCWCCRCARTCHCCHGG 
C2A 
PCR 2 
HRV-C IS  3126        C4:EF582385       GGNCCHAGTGAYMWVTWTG 
Pri  Primers for the amplification of the 3Dpol region of HRV-A, -B and –C 
A 




AS 7130 A1:D00239 ARAAYTTBTCRTACCAYTCRTG 


















3Dpol HRV-A IS 6464 A1:D00239 TTYGAYTAYWCBAAYTATGAYGG 
A 
3Dpol HRV-A OS 6323 A1:D00239 TVAATGAYTCWGTNAAYATGAG 
B 
3Dpol HRV-B OAS 7030 B14:X01087 CCWGARTGCCAGGCYADCATRCA 
B 
3Dpol HRV-B IS 6475 B14:X01087 TTYGAYTAYWCHAAYTWYGATGC 
B 
3Dpol HRV-B IAS 6974A B14:X01087 TCVTRDATDTCHHGCATYGGCAT 
B 
3Dpol HRV-B IAS 6974B B14:X01087 TCVTRDATDTCYTGCATYGGCAT 
C 
3Dpol HRV-C OS 6300 C4:EF582385 TGTGATCCWGAYRTYTTYTGGTCAC 
C 
3Dpol HRV-C OAS 6901 C4:EF582385 ACRTGRTCTTSWGTRTTCTTTGG 
C 
3Dpol HRV-C IS 6360A C4:EF582385 TTTGAYTAYACMAAYTATGATGG 
C 
3Dpol HRV-C IS 6360B C4:EF582385 TTTGAYTAYACMAAYTATGATGGNAG 
C 
3Dpol HRV-C IAS 6877 C4:EF582385 TCYYTDGTCCATCTRATTGAYTCA 
 
a 
Orientation of primer sequences.  OS : outer sense.  OAS : outer antisense.  IS : inner sense.  IAS :  
inner antisense 
b 
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Human rhinoviruses (HRVs) are a highly prevalent and diverse group of respiratory viruses. Although
HRV-A and HRV-B are traditionally detected by virus isolation, a series of unculturable HRV variants have
recently been described and assigned as a new species (HRV-C) within the picornavirus Enterovirus genus. To
investigate their genetic diversity and occurrence of recombination, we have performed comprehensive phylo-
genetic analysis of sequences from the 5 untranslated region (5 UTR), VP4/VP2, VP1, and 3Dpol regions
amplified from 89 HRV-C-positive respiratory samples and available published sequences. Branching orders
of VP4/VP2, VP1, and 3Dpol trees were identical, consistent with the absence of intraspecies recombination in
the coding regions. However, numerous tree topology changes were apparent in the 5 UTR, where >60% of
analyzed HRV-C variants showed recombination with species A sequences. Two recombination hot spots in
stem-loop 5 and the polypyrimidine tract in the 5 UTR were mapped using the program GroupingScan.
Available HRV-C sequences showed evidence for additional interspecies recombination with HRV-A in the 2A
gene, with breakpoints mapping precisely to the boundaries of the C-terminal domain of the encoded protein-
ase. Pairwise distances between HRV-C variants in VP1 and VP4/VP2 regions fell into two separate distribu-
tions, resembling inter- and intraserotype distances of species A and B. These observations suggest that,
without serological cross-neutralization data, HRV-C genetic groups may be equivalently classified into types
using divergence thresholds derived from distance distributions. The extensive sequence data from multiple
genome regions of HRV-C and analyses of recombination in the current study will assist future formulation of
consensus criteria for HRV-C type assignment and identification.
A series of studies published in 2006 to 2007 described a
novel group of human rhinoviruses (HRVs), referred to as A2
or group C (HRV-C), genetically distinct from existing rhino-
viruses (3, 21, 23, 25, 27, 33, 42). These and subsequent inves-
tigations have shown the proposed new species HRV-C to be
remarkably prevalent, widely distributed geographically, and
frequently associated with severe respiratory disease, both fol-
lowing primary infections, particularly in young children (24,
25, 29, 32, 59), and as an exacerbating factor in asthma and
other chronic obstructive airway diseases (20, 25, 29, 36). On
the other hand, HRV-C has also been abundant in specimens
collected from both children and adults with milder cases of
respiratory disease (47, 48).
The HRV-C species is a member of the Enterovirus genus
within the family Picornaviridae (53) and shares many features
of its genome organization and structure with other picorna-
viruses and, more specifically, with other members of the En-
terovirus genus. This includes an approximately 7,100-base ge-
nome containing a single reading frame; this encodes four
capsid proteins and a series of functionally conserved nonstruc-
tural proteins involved in virus replication. HRV-C, in com-
mon with other members of the Enterovirus genus, possesses a
type I internal ribosomal entry site (IRES) that enables initi-
ation of translation from an internal methionine codon several
hundreds of bases from the 5 end of the genome.
Although no more closely related to each other than they are
to other Enterovirus species phylogenetically, the three species
of human rhinoviruses (A, B, and C) share a number of bio-
logical and genetic attributes. Most prominent is their trans-
mission route and primary tropism for the respiratory tract,
associated with the known acid lability of species A and B that
is traditionally believed to prevent their colonization of the
gastrointestinal tract. The HRV genome possesses a lower
GC content than genomes of other enteroviruses, and it is
often speculated that this represents an adaptation for repli-
cation at the lower temperatures found in upper airways.
HRV-C differs from other species, however, in other aspects,
including the siting of the cis-replicating element in VP2 (11)
instead of in 2A (species A) (13) or VP1 (species B) (34).
Species C has so far proven refractory to all attempts at in vitro
culture, despite the use of a wide variety of cell lines and
primary cell cultures (25, 33). This restriction has hindered
investigations of its replication, receptor use, and antigenic
diversity.
Like most picornavirus groups, human rhinoviruses show
substantial genetic heterogeneity that underlies the existence
of a large number of antigenically distinct variants. In the case
of species A and B, a total of 74 and 25 different serotypes,
respectively, have been defined using cross-neutralization as-
says in cell culture (14, 18, 19). Available nucleotide sequences
from the capsid region of HRV-C reveal similar or even
greater diversity than is found between species A and B sero-
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types, but its lack of culturability currently precludes an equiv-
alent classification of HRV-C into serotypes.
Although coding regions of HRV-C are genetically distinct
from those of species A and B rhinoviruses and other entero-
viruses, both the initial detection and subsequent genetic anal-
yses of HRV-C have been complicated by the similarity of most
(60%) sequences of the 5 untranslated region (UTR) to
those of species A (49), with the remainder being phylogeneti-
cally distinct. It has been proposed that one or more interspe-
cies recombination events between species C and species A
rhinoviruses have occurred to generate these chimeric se-
quences (15, 17, 49, 59). Despite these differences in genetic
composition, no differences in clinical presentations or epide-
miology have been detected between HRV-C variants with
species A-like and species C-like 5 UTR (HRV-Ca and HRV-
Cc, respectively) sequences (17, 59).
In the current study we have generated comparative se-
quence data from several genome regions (5 UTR, VP4/VP2,
VP1, and 3Dpol) from a large number of HRV-C-positive
clinical specimens. Combined with published sequence infor-
mation from these regions, we have investigated the occur-
rence, frequency, and location of recombination events within
this rhinovirus species. The information gained on comparative
phylogenies and sequence divergence in different regions pro-
vides data that will assist in the eventual classification of the
current plethora of HRV-C sequences into a number of ge-
netically determined types.
MATERIALS AND METHODS
Genetic characterization of HRV-C variants. A total of 89 HRV-C-positive
samples from the Edinburgh Specialist Virology Centre (SVC) respiratory sam-
ple archive (60) were selected for genetic characterization; these represent a
subset of the 144 samples previously characterized in the VP4/partial VP2 region
(59). RNA was extracted from clinical samples as previously described (60).
Sequences were amplified from four different genomic regions using the methods
described below.
(i) VP4/VP2. The VP4 and 5 end of VP2 were amplified using nested primers
(see Table S1 posted at http://www.virus-evolution.org/Downloads/JVI00962
-10/) as previously described (59).
(ii) VP1. Nested reverse transcription-PCRs (RT-PCRs) were performed as
previously described (35) but using primers shown in Table S1 (posted at the
URL mentioned above). A total of 72 from the 89 samples amplifiable in other
genome regions were successfully amplified in two VP1 regions. The two se-
quence fragments overlapped by 105 bases, allowing a composite 777-base se-
quence to be generated for phylogenetic analysis.
(iii) 3Dpol and 5 UTR. RNA extracted from respiratory samples was reverse
transcribed into cDNA using the Promega reverse transcription system (Pro-
mega, United Kingdom) as per the manufacturer’s instructions except that 5 l
of extracted RNA template was used. Amplification of the 3Dpol region and the
5 UTR region from cDNA used nested primers (see Table S1 posted at the
URL mentioned above) and previously described PCR conditions (59) but with
an annealing temperature of 48°C in the second round. Samples negative on
initial amplification were amplified using the nested PCR strategy described for
VP1 above. A 3Dpol amplicon of 470 nucleotides in length was produced. For
the 5 UTR, two sequence fragments with a 61-base overlap allowed a 680-base
composite 5 UTR sequence overlapping the VP4/VP2 amplicon to be gener-
ated. A subset of HRV-C variants (n  12) was further amplified using hemin-
ested, combined species A and C primers (5 UTR set 1 in Table S1, posted at
http://www.virus-evolution.org/Downloads/JVI00962-10/) to generate an ampli-
con from nucleotide position 1 to 355 (27 to 335, excluding primer sequences).
All amplicons were sequenced using a BigDye Terminator kit (Applied Bio-
systems, Warrington, United Kingdom). Prior to sequencing reactions, all sam-
ples underwent a PCR product cleanup procedure using EXOSAP-IT (GE
Healthcare, United Kingdom).
Sequence analysis. All available VP4/VP2 region sequences were downloaded
from GenBank on 26 April 2010. Sequences that were 90% complete across
the region from position 615 to 1043 were discarded (sequence positions are
numbered throughout the manuscript using the sequence 024 [accession number
EF582385]; the current GenBank entry for the QPM prototype sequence
[EF186077] is incomplete at the 5 end). These comprised 538 sequences along
with a further 16 previously unpublished sequences from the SVC archive. The
sequence data set was supplemented with the 10 complete genome sequences of
HRV-C currently available on public databases as well as all available complete
genome sequences of species A (n  82) and B (n  25) of defined serotypes.
Phylogenetic trees were constructed using the MEGA package, version 4.0
(54), by the neighbor-joining method (44) from 100 bootstrap resampled se-
quence alignments of maximum composite likelihood distances (MCL) (55) with
pairwise deletion for missing data. Distributions of pairwise sequence distances
for identification of type thresholds were calculated using the program Sequence-
Dist in the Simmonics package.
Recombination breakpoints in HRV-Ca 5 UTR sequences were determined
using the program GroupingScan (51), using complete genome sequences of
species A (n  82), B (n  25), and nonrecombinant species C (Cc) sequences
(n  29) as control groups. Trees were constructed using a fragment size of 200
with incremental steps of 10 bases, a bootstrap value of 70% to define phyloge-
netically supported groups, and 10 sequence relabelings (default) to calculate
control values. A second analysis of sequences extending to the extreme 5 end
of the genome was performed to investigate further recombination events
around the replication structures (eight HRV-Cc control sequences). Recombi-
nation breakpoints were interpolated as the nucleotide positions where the
grouping values switched from the A group to the C group.
5 UTR RNA structure prediction. Structure prediction for HRV-C was based
on the established model for HRV-A (6) and previous comparative analyses of
HRV-A and -B sequences (43, 56). Mfold analysis of a selection of HRV-Ca and
HRV-Cc sequences produced minimum-energy secondary structures for HRV-C
variants that closely matched the HRV-A2 structure (data not shown).
Nucleotide sequence accession numbers. All newly generated sequences were
submitted to GenBank and were assigned accession numbers HM236897 to
HM236968 (VP1), HM352737 to HM352752 (VP4), HM485468 to HM485556
(3Dpol), and HM581802 to HM581888 (5 UTR).
RESULTS
Phylogenies of HRV-C 5 UTR, VP4/VP2, VP1, and 3Dpol
regions. To investigate sequence relationships of HRV-C in
different regions of the genome, 89 study samples were se-
quenced in the 5 UTR (nucleotide position 185 to 614; n 
87), VP4 and partial VP2 (615 to 1043), whole VP1 (2348 to
3125; n  72), and partial 3Dpol regions (6384 to 6854) and
aligned with the 10 available complete genome sequences of
HRV-C (Fig. 1). On phylogenetic analysis, sequences in each
region fell into a number of clearly defined, bootstrap-sup-
ported phylogenetic groups, with the majority containing sev-
eral variants and others represented by single sequences. The
small subset of variants for which we were unable to obtain
VP1 sequences were scattered throughout the 5 UTR, VP4/
VP2, and 3Dpol trees. They therefore did not constitute an
identifiable genetic subset of sequences whose omission would
have biased the analysis of VP1 sequence diversity.
The phylogenies of the three coding regions (VP4/VP2,
VP1, and 3Dpol) were remarkably congruent, with identical
grouping patterns for all but one of the sequences analyzed.
Using a bootstrap value of 70% or greater to define clades,
there was only one phylogeny violation between trees con-
structed from coding region sequences (Fig. 1B, C, and D).
This involved the previously characterized complete genome
sequence, N4 (GQ223227) (Fig. 1, shaded box), which changed
tree position between VP1 and 3Dpol regions. Our sample
collection contained a single variant (Resp_10300/08) that
grouped with N4 in the 5 UTR, VP4/VP2, and VP1 regions. In
contrast to N4, its 3Dpol sequence maintained a similar phy-
logenetic position relative to other sequences, as was observed
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in the 5 UTR, VP4/VP2, and VP1 regions (Fig. 1). In inves-
tigating this anomaly, we found on closer inspection of the N4
sequence in the 3Dpol region that its 5 end (position 6384 to
6645) was similar to that of Resp_10300/08 (pairwise distance,
0.08), while its 3 end (position 6646 to 6854) was nearly iden-
tical to another sequence, N10 (GQ223228), originating from
the same laboratory (sequence divergence, 0.01, compared to
0.35 divergence from Resp_10300/08). The chimeric nature of
this sequence is evident from the change in tree position of 5-
and 3-end fragments of the 3Dpol region (see Fig. S1 and
FIG. 1. Phylogenetic analysis of study sequences and corresponding regions from complete genome sequences in the 5 UTR (position 185 to
614, numbered according to the reference sequence EF582385) (A), VP4/VP2 (616 to 1043) (B), VP1 (2348 to 3125) (C), and 3Dpol (6384 to 6854)
(D). Trees were constructed by neighbor joining of pairwise maximum composite likelihood distance implemented in the program MEGA (54);
branches showing at least 70% bootstrap support are indicated. Complete genome sequences were labeled using filled symbols. The putative
recombinant sequence N4 (GQ223227) and the other group 7 sequence Resp_10300/08 are indicated by shaded boxes.
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supplementary data posted at http://www.virus-evolution.org
/Downloads/JVI00962-10/); N4 grouped with Resp_10300/08
at the 5 half of the fragment (comparable to other genome
regions) (Fig. 1B and C) but clustered very closely with N10
(GQ223228) at the 3 end. Possible underlying explanations for
the anomalous phylogeny of the N4 sequence in the 3Dpol
region are discussed below.
In contrast to the identity of coding region phylogenies, a
minimum of 12 phylogeny violations were observed in the
species C sequence data set on comparison of phylogenetic
trees from the 5 UTR and VP4/VP2. Members of the previ-
ously described HRV-Cc 5 UTR group, distinct from the
species A-like 5 UTR sequences of the majority of HRV-C
sequences (labeled in Fig. 1), were drawn from several coding
region lineages. These observations are consistent with the
occurrence of multiple recombination events between the 5
UTR and the rest of the genome.
Pairwise distance distributions. Distributions of pairwise
distances between HRV-C sequences in VP4/VP2 and VP1
regions were computed to investigate whether they contained
clear sequence divergence thresholds that might be used to
define intertype and intratype divergence values (Fig. 2B).
These distributions were compared with those of species A in
the same genome regions (Fig. 2A). They were also similar to
those of species B, but in the latter case there were insufficient
numbers of classified sequences in either genome region for a
conclusive analysis.
The set of HRV-C VP4/VP2 and VP1 pairwise distance
values (Fig. 2B) contained a first distribution (maximum values
of 6.9% and 8%, respectively) that corresponded to pairwise
distances between variants within the same phylogenetic clades
(Fig. 1B and C). These were comparable to the majority of
(intraserotype) distances between the small number of avail-
able HRV-A sequences of the same serotype (Fig. 2A). A
second, nonoverlapping distribution, with minimum values of
10.9% in VP4 and 14.7% in VP1, corresponded to the set of
pairwise distances between HRV-C clades. There was a com-
parable division of pairwise distances between VP4/VP2 and
VP1 sequences of species A (Fig. 2A) and species B (data not
shown) into two largely separate distributions. The previously
proposed VP1 divergence thresholds of 12% and 13% for
serotype assignment (22) correspond closely to the low point in
the distribution of HRV-A and HRV-B VP1 pairwise dis-
tances. With the currently available sequence data, a threshold
around this divergence value in VP1 and 10% in VP4/VP2
would appear appropriate for HRV-C. Observations of the
separate distributions of pairwise distances in VP1 and phylo-
genetic evidence for marked phylogenetic clustering of
HRV-C in all three coding regions analyzed support the idea
that HRV-C variants might be usefully classified into a number
of (genetically determined) groups that correspond to sero-
types of other rhinoviruses. Such assignments might be made
even though we lack serological evidence for antigenic distinc-
tiveness of HRV-C variants.
As a preparatory step toward a future genotypic classifica-
tion of HRV-C, we have tabulated all available HRV-C vari-
ants into groups containing members that show 0.13 se-
quence divergence from each other in VP1 or, if not available,
0.10 in VP4/VP2 (Table 1). Table 1 has been split into two
sections, one for which complete genome sequences are avail-
able (genetic groups numbered 1 to 11) and a second contain-
ing genetic groups for which VP4/VP2 sequences are available,
with or without VP1, 3Dpol, and 5 UTR sequences. Combin-
ing the assignments, if sequences grouped in this way are con-
sidered the equivalent of (sero)types in other rhinoviruses,
then the current data set of sequences can be grouped into a
total of 60 genetically determined types.
Sequence divergence of HRV-C in different genome regions.
Using the genetic groups in the previous section, we compared
the degree of sequence divergence in the analyzed genome
regions with divergence in regions of different serotypes of
HRV-A and HRV-B species (Fig. 3). Both at the nucleotide
and amino acid level, VP1 was the most variable region be-
tween types and serotypes, followed by 3Dpol and VP4/VP2.
However, HRV-C genetic groups were consistently more di-
verse than serotypes of other rhinovirus species, showing, for
example, 35% (nucleotide) and 33% (amino acid) divergence
compared to 25% and 21 to 26% in HRV-A and -B serotypes.
Even more marked differences in 3Dpol and VP4/VP2 regions
were observed, with amino acid divergence between species C
groups almost twice that of species A and B.
Mapping positions of recombination between the 5 UTR
and VP4/VP2. Combining sequences from overlapping 5 UTR
and VP4/VP2 amplicons provided a continuous sequence from
position 185 to 1043 that enabled the recombination break-
point(s) to be determined in each of the Ca recombinant vari-
ants identified to date. The combined set of 10 available com-
plete genomes, 87 samples from the current study, and 34 5
FIG. 2. Distribution of pairwise p distances between HRV-A
sequences (A) and available sequences of study samples and complete
genome sequences of HRV-C (B) in the VP4 and VP1 regions. The
shaded area represents the zone between inter- and intraserotype
divergence values in species A.
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TABLE 1. Division of HRV-C into genetic groups based on divergence in VP1 or VP4/VP2






1 EF077279 NAT001 Ca 10/20/06 21
2 EF077280 NAT045 Ca 10/20/06 21
3 EF186077 QPM Ca 12/14/06 33
4 EF582385 024 Ca 4/27/07 25
5 EF582386 025 Ca 4/27/07 25
6 EF582387 026 Ca 4/27/07 25
7 DQ875932 NY-074 Ca 7/14/08 23
8 GQ223227 N4 Ca 5/29/09 17
9 GQ223228 N10 Cc 5/29/09 17
10 GQ323774 QCE Ca 6/29/09 2
11 FJ392317f CL170085 Ca 10/17/08 58
Groups containing partial
genomes
12 EF077264 NAT083 Ca 10/20/06 21
13 EU081795 tu403 Ca 8/03/07 42
14 EU081796 06-445 Cc 8/03/07 42
15 EU081800 06-20 Ca 8/03/07 42
16 EU081808 g2-4 Ca 8/03/07 42
17 EU081809 06-582 Ca 8/03/07 42
18 EU590074 PNC41788 Ca 3/25/08 48
19 EU697850 7316563 Cc 5/05/08 7
20 EU697851 DK-1 Cc 5/05/08 7
21 EU752377 RV471 Ca 5/26/08 36
22 EU752381 RV541 Ca 5/26/08 36
23 EU752424 RV64 Ca 5/26/08 36
24 EU752426 RV408 Ca 5/26/08 36
25 EU752427 RV1123 Ca 5/26/08 36
26 EU752441 RV177 Ca/Ccg 5/26/08 36
27 GQ223122 N22 Ca/Cc 1/09/09 17
28 GQ223134 N46 Ca 1/09/09 17
29 FJ615699 201882 Cc 1/09/09 37
30 GQ476669 Resp_3898 Ca 8/13/09 60
31 GU294380 Resp_3776 Ca 12/04/09 59
32 GU294466 Resp_5613 Ca 12/04/09 59
33 GU294480 Resp_6157 Cc 12/04/09 59
34 EF077256 NAT069 Cc 10/20/06 21
35 EF077260 NAT069 Cc 10/20/06 21
36 EU081790 06-739 Cc 8/03/07 42
37 EU081791 tu304 Ca 8/03/07 42
38 EU081799 g2-11 8/03/07 42
39 EU081802 g2-25 Ca 8/03/07 42
40 EU081803 g2-23 8/03/07 42
41 EU081805 g2-28 Ca 8/03/07 42
42 EU081807 06-230 8/03/07 42
43 EU590054 PNC86718 Cc 3/25/08 48
44 EU590061 PNC40168 3/25/08 48
45 EU590064 PNC40449 3/25/08 48
46 EU697839 IN-36 5/05/08 7
47 EU697852 SA365412 5/05/08 7
48 EU743925 CO-1368 Cc 5/22/08 11a
49 EU752358 RV1250 5/26/08 36
50 EU752398 RV1039 5/26/08 36
51 EU752412 RV546 Cc 5/26/08 36
52 FJ598096 GDFY100 Cc 12/29/08 Unpublished
53 FJ615722 202511 1/09/09 37
54 FJ615737 202092 1/09/09 37
55 FJ615745 202642 1/09/09 37
56 FJ841957 S05986 3/17/09 9
57 FJ869923 KR1868 3/27/09 15
58 FJ869950 KR2315 Cc 3/27/09 15
59 GQ466482 K1091 301104 8/07/09 47
60 GU214340 PV68 Ca 11/18/09 41
a Genetic groups showing 0.10 sequence divergence in VP4/VP2. Groups for which VP4/VP2 sequences are available, with or without VP1, 3DPol, and 5 UTR
sequences, were considered partial.
b Accession number of the first member of the assigned genetic group.
c Identity of the 5 UTR group (Ca or Cc) associated with viruses of this group (59).
d Submission date of the first sequence of the assigned genetic group in GenBank/EMBL/DDBJ.
e Citation for the first submitted member of the genetic group.
f Accession number FJ392317 refers to a previously published VP1 sequence (58). The full genome of this variant has now been completed (C. Tapparel, personal
communication). In order to preserve the numbering of genetic groups, sequences grouping with this complete genome in VP4/VP2 have been assigned as genetic group 11.
g Variants with Ca and Cc 5 UTR sequences are found in these genetic groups (59).
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UTR sequences described by Huang et al. (17) represented 45
of the 60 sequence groups listed in Table 1. Twenty-nine
HRV-C sequence groups had 5 UTR sequences that grouped
within the species A 5 UTR clade (labeled Ca in Fig. 1), two
contained sequences from both the Ca and Cc groups, and the
remainder were phylogenetically distinct, falling in the Cc
clade that contained the N10 complete genome sequence
(GQ223228).
The program Grouping Scan (51) was used to identify re-
combination breakpoints in the Ca 5 UTR sequences. This
program was chosen in preference to bootscanning methods
because it scores the extent of grouping within predefined
control groups rather than simply the bootstrap support for the
grouping of a query sequence with a group consensus se-
quence. As discussed previously (51), the latter method can
lead to false assignment in cases where a query sequence is not
closely affiliated to any of the control groups. Furthermore, by
simply condensing the often large amount of comparative se-
quence data within control groups to a single consensus se-
quence, bootscanning additionally discards informative data on
sequence diversity within groups that are of value in assessing
phylogeny relationships. The available set of HRV-A and
HRV-B complete genome sequences were used as control
groups while the HRV-Cc control group (nonrecombinant Cc
sequences) was assembled from the N10 sequence and Cc
variants identified in the current study (n  29).
Each of the complete genome and study sequences from the
Ca 5 UTR clade was scanned between position 185 and 903
(three representative results depicting different breakpoints
are shown in Fig. 4A). Superimposed is a diagrammatic sum-
mary of the RNA secondary structure elements comprising the
replication structures (stem-loop 1 cloverleaf) and IRES
(stem-loops 2 to 6, the latter containing the AUG start codon
of the HRV-C open reading frame at position 615).
Recombination breakpoints identified in HRV-Ca variants
were invariably positioned similarly among variants in the
same genetic group (Table 2). Two recombination hot spots
were identified, one occurring in the polypyrimidine tract
(PPT) between stem-loops 5 and 6 (position 561 to 576; mean,
565) and a second around the terminal loop of stem-loop 5
(position 508 to 544; mean, 523), while two HRV-C genetic
groups showed a more 5 site (position 479 to 489; mean, 481).
FIG. 4. (A) Mapping of recombination breakpoints of three repre-
sentative published or study HRV-Ca sequences using the program
Grouping Scan with HRV-A, -B, and HRV-Cc sequences as control
groups, as indicated on the figure. Above the graphs is a diagrammatic
summary of 5 UTR RNA structure elements (stem-loops 1 to 6 [1] and
the PPT). (B) Variability scan of the 5 UTR, showing mean pairwise
interserotype/genetic group distances of HRV-A, -B, and -Cc sequences
averaged over a 30-base window and, separately, the interspecies diver-
gence between HRV-A and HRV-Cc (A-Cc). The position of 5 UTR
structures and range of identified recombination breakpoints (Table 2)
are indicated. (C) Extension of Grouping Scan analysis to the 5 end of
the HRV genome using the subset of control sequences complete from
position 27 onwards and an HRV-Ca query sequence.
FIG. 3. Mean pairwise (uncorrected) p distances of nucleotide
(A) and amino acid (B) sequences in the VP4/VP2, VP1, and 3Dpol
regions between serotypes of HRV-A and HRV-B and between iden-
tified genetic groups of HRV-C (values shown above each bar).
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Sequences of the stem-loop stem regions either side of the
recombination hot spot centering on position 523 were highly
conserved (Fig. 4B). The HRV-Ca recombinants with a 5 stem
sequence derived from species A and a 3 sequence from
species C showed predicted pairings similar to those of
HRV-A and nonrecombinant HRV-Cc sequences (data not
shown) and would therefore accommodate a recombination
event without destabilizing stem-loop 5.
Finally, the occurrence of further recombination events at
the extreme 5 end of the 5 UTR was investigated using a
subset of 11 HRV-Ca sequences with sequences complete from
position 27. All query sequences grouped within the HRV-A
clade, with association values substantially above the 0.5 out-
group position score (an example is shown in Fig. 4C). Al-
though the resolution of this method is limited by the 200-base
fragment size used for analysis, visual inspection of trees con-
structed from shorter sequence fragments (50 and 100 bases)
at the extreme 5 end of the genome provides no evidence for
a change in the phylogenetic position of any Ca variants to a
position outside the HRV-A clade (data not shown).
Interspecies recombination in the 2A region. To investigate
whether other genome regions of HRV-C showed evidence for
interspecies recombination, we performed a scan of sequence
divergence between complete genome sequences and those of
species A and B rhinoviruses (Fig. 5). Between-species diver-
gence was substantially greater than the mean pairwise dis-
tance within species C sequences except for an approximately
260-base region in 2A. This region (position 3268 to 3525)
showed a markedly different phylogeny from flanking regions
of the same length (Fig. 6). More specifically, species C se-
quences grouped within the HRV-A clade in a manner similar
to that observed in the 5 UTR. As found in the latter region,
single HRV-C sequences or groups of HRV-C sequences be-
came scattered among the HRV-A sequences, implying the
occurrence of separate recombination events. Remarkably, the
bootstrap-supported grouping of five HRV-C sequences (ac-
cession numbers EF077279, DQ875932, EF582387, EF186077,
and GQ323774) in 2A was similarly monophyletic in the 5
UTR (Fig. 1A). The main difference from the 5 UTR phylog-
eny was the position of N10 (GQ223228). This formed part of
the Cc 5 UTR clade (Fig. 1A) but contained a 2A sequence
embedded within the HRV-A clade (Fig. 6). A change in the
phylogenetic position of N4 (GQ223227) was additionally ap-
parent in trees from the two regions.
FIG. 4—Continued.
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DISCUSSION
Recombination in HRV-C. This study has investigated the
occurrence and sites of recombination within the genomes of
the recently described species C human rhinoviruses. The most
striking finding was the almost identical phylogenetic trees of
the three coding regions analyzed, including gene regions at
the extreme 5 and 3 ends of the open reading frame (VP4/
VP2 and 3Dpol). The absence of recombination implied by
these observations is consistent with previous comparisons of
VP4/VP2 and 3Dpol region phylogenies of HRV species A and
B (46), where only minimal changes in branching order were
observed among the full set of 101 classified serotypes. These
findings together with the data obtained here for species C
contrast dramatically with the rampant and ongoing recombi-
nation process between structural and nonstructural gene re-
gions in other species within the Enterovirus genus, particularly
in species A, B, and C human enteroviruses (10, 28, 30, 38, 52).
Recombination is also extensively documented in aphthovi-
ruses (16, 50), cardioviruses (5, 12), and parechoviruses (4, 8).
For these, the concept of separate, modular evolution of struc-
tural and nonstructural regions of picornavirus genomes has
been developed (28, 31, 50).
Potentially underlying this difference in recombination fre-
quency in rhinoviruses is their different pattern of sequence
divergence in structural and nonstructural regions from most
other picornaviruses. Species C variants along with HRV-A
and HRV-B show substantial sequence divergence throughout
the coding region. For example, mean intergenetic group pair-
wise distances in the 3Dpol region of HRV-C (33% nucleotide;
29% amino acid) were similar to the divergence of VP1 (35%
and 33%, respectively). This contrasts markedly with human
enteroviruses and several other picornavirus groups where
nonstructural gene regions are much less divergent between
serotypes (10% at the amino acid level). As previously pro-
posed (50), this restricted variability increases the likelihood of
recombinants with breakpoints in the nonstructural regions
being viable biologically. In contrast, the highly divergent se-
quences in equivalent regions of HRV may be functionally
incompatible with each other and effectively isolate each rhi-
novirus serotype into a separate evolutionary path.
One HRV-C sequence showed different phylogenetic rela-
tionships in different regions of the coding region (N4;
GQ223227). Although we cannot exclude the possibility of a
natural recombination site within the 3D region as an expla-
nation for the hybrid nature of its 3Dpol sequence (see Fig. S1
and the supplementary data posted at http://www.virus
-evolution.org/Downloads/JVI00962-10/), its close resem-
blance of the 3 end to the N10 sequence originating from the
same laboratory suggests the possibility of laboratory contam-
ination during assembly of the complete genome sequence.
Another group 7 variant (Resp_10300/08) showed consistent
phylogenetic relationships to other sequences in all three cod-
ing regions analyzed, including 3Dpol (Fig. 1B, C, and D). It
would be of value if the laboratory from which the N4 se-
quence originated (17) were able to perform additional ampli-
fication and sequencing to rule out contamination/assembly
errors and correct the GenBank entry if necessary.
Evidence for a different, likely more evolutionarily ancient,
pattern of recombination in HRV-A has been previously ob-
tained, manifested by differences in sequence relatedness be-
tween sequences in different genome regions (39, 57). For
example, HRV-53 was substantially more similar to HRV-46 in
the nonstructural region than anticipated by their sequence
relationship in the capsid-encoding region; conversely HRV-78
and HRV-12 were more divergent. In these and other specific
examples, changes in the phylogeny relationship usually oc-
curred at the P1/P2 boundary, implying a limited degree of
compatibility between structural and nonstructural gene mod-
ules derived from different serotypes. As described above, this
pattern of recombination is quite distinct from the multiple
recombination sites within nonstructural gene regions of en-
teroviruses and other picornaviruses. No evidence for its oc-
currence was documented among the data set of HRV-C se-
quences assembled in the current study, where both small-scale
(genetic group) and larger sequence groupings were preserved
across the genome. Potentially, the much greater amino acid
sequence divergence between HRV-C sequence groups (Fig.
3) increases the likelihood of biological incompatibility and
restricts further the occurrence of recombination.
Despite the limited evidence for recombination in the cod-
ing regions of rhinoviruses, this study confirmed its frequent
occurrence between VP4 (and the rest of the genome down-
stream) and the 5 UTR (17, 49). The generation of a large
number of 5 UTR Ca and Cc sequences permitted a detailed
investigation of the positions where recombination occurred.
The distribution of recombination hot spots centered around
position 565 (in the PPT), 523 (within stem-loop 5 of the








1 5 520 (519–523)
2 1 564
3 2 526 (526–527)
4 1 561
5 3 563 (563–564)
6 10 524 (524–526)
7 2 574 (574)
8 4 565 (561–570)
10 1 525
11 2 554 (552–557)
12 4 508 (508)
13 1 523
15 3 483 (479–489)
16 3 520 (518–526)
17 1 567
18 8 528 (518–544)
21 6 572 (570–575)
22 2 576 (576)
23 3 562 (552–570)
24 1 560
25 1 558
27 3 535 (522–559)
28 2 543 (536–550)
30 1 561
31 1 528
32 9 524 (523–527)
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IRES), and two groups showing evidence of a breakpoint
around position 481. This is a much more restricted distribu-
tion than previously described in an analysis using a smaller
data set and a different scanning method (17). Nor could we
confirm the second recombination event at the extreme 5 end
of the genome where Ca variants remained grouped with
HRV-A sequences.
As suggested from the analysis of recombination in the cod-
ing regions, the occurrence and positions of recombination
events in the 5 UTR may be governed by biological compat-
ibility restrictions. For example, the conservation of sequences
within stem-loop 5 and potentially independent modular func-
tions of stem-loops 5 and 6 may favor the creation of viable
recombinants. Similarly, the high degree of sequence conser-
vation of the 5 end of the genome between rhinovirus species
may facilitate the interaction between the species C replication
complex and the HRV-A-derived cloverleaf replication struc-
ture (stem-loop 1) (56). In the future, in vitro insertion of the
HRV-C-derived IRES and adjacent coding sequences into spe-
cies A replicons or infectious clones will be of value in func-
tionally mapping these compatibility restrictions.
A new and unexpected finding in the current study was the
second site of HRV-A/HRV-C interspecies recombination in
the 2A region (Fig. 6 and 7). Although a previous bootscanning
analysis showed the N4 sequence to group with the HRV-A
consensus sequence in this region (17), this observation was
misinterpreted. As demonstrated by phylogenetic analysis of
this and flanking regions, all HRV-C variants genetically char-
acterized in this region to date show evidence for recombina-
tion (Fig. 6) in a pattern remarkably similar to that observed in
the 5 UTR (with the noted exceptions of N10 and N4). The
2A protein of rhinoviruses and enteroviruses is a chymotryp-
sin-like proteinase of 142 amino acids. The region between
positions 3268 to 3525 (residues 47 to 133) identified as re-
combinant corresponds precisely to the boundaries of the pre-
viously C-terminal structural domain of 2A, being comprised
FIG. 5. Divergence scan, showing mean nucleotide and amino acid sequence divergence between complete genome sequences of HRV-C with
those of HRV-A and -B and within-species diversity of HRV-C. The scan used fragment lengths of 300 nucleotides, incrementing by 30 bases across
the HRV coding sequence. The genome diagram below the graph shows positions of different HRV-C genes, using annotation supplied with the
sequence EF582385.
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FIG. 6. Comparison of the phylogeny of HRV-A, -B, and -C sequences in the putative recombinant region between position 3268 and 3525 with
those of 5 and 3 flanking regions (positions 3009 to 3267 and 3526 to 3784). See the legend of Fig. 1 for tree construction method, labels, and
symbols. For clarity, the accession numbers of species A and B variants have been prefixed by the species letter and serotype designation (e.g., A8
FJ445113 and B14 NC001490).
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FIG. 7. Annotation of the secondary structure elements in the 2A gene of HRV-2 (40) superimposed on an alignment of the most genetically
divergent HRV-A (n  9) and HRV-B (n  8) sequences and all available HRV-C 2A sequences and the inferred positions of the recombination
breakpoints (dotted lines; nucleotide position 3268 to 3525). 	-Strands and catalytic and zinc binding residues are as previously proposed (40). The
positions of the N-terminal and C-terminal structural domains are indicated in shaded boxes. Numbering of amino acid residues follows that of
the HRV-2 sequence X02316. For clarity, the accession numbers of species A and B variants have been prefixed by the species letter and serotype
designation (as described in the legend of Fig. 6).
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of six 	-sheets that coordinate a zinc ion adjacent to the cat-
alytic site of the protease (Fig. 7) (40). Our observations of
recombination in the HRV-C 2A gene suggest at least some
degree of modularity of its two structural domains. Investiga-
tion of the enzymatic properties of the HRV-C chimeric pro-
tein and the influence of the more variable N terminus of 2A
encoded by HRV-C sequences on its function and specificity
may provide insights into potential biological differences be-
tween HRV species. Finally, the proposed recombination junc-
tion at position 3268 coincides almost exactly with the 3 end of
the species A CRE (cis-acting RNA element) region (mapped
to position 3226 to 3270 [13]). The absence of a homologous
structure in the N terminal domain of species C variants is
consistent with current predictions for its localization in VP2
(11).
The evolutionary events underlying the inferred 5 UTR and
2A recombination events remain unclear. The existence of
multiple recombination breakpoints in the 5 UTR and the
scattering of HRV-Ca genetic groups in the VP4/VP2 tree (17,
59) imply that recombination in the 5 UTR has occurred
several times independently. Similarly, the existence of multi-
ple groupings of HRV-C sequences in the 2A clade of HRV-A
suggests that more than one recombination event of that spe-
cific fragment occurred. What is remarkable is the evidence
that recombination in these two regions is at least partly linked,
with the same grouping of five of the HRV-C variants observed
in both genomic regions. We are currently sequencing the 89
study samples in the 2A region to obtain additional informa-
tion on the occurrence and linkage of recombination at these
two sites in order to obtain a better understanding of the
process and constraints under which these interspecies recom-
bination events occur.
Genetic diversity of HRV-C. HRV-C variants showed sub-
stantially greater diversity than HRV-A or HRV-B serotypes
(Fig. 3) but showed similar clustering of genetic groups into a
number of well-defined (bootstrap-supported) clades (Fig. 1C)
to other rhinovirus species. There were additionally two well-
separated distributions of pairwise distances in VP4/VP2 and
VP1 regions (Fig. 2B), suggesting that genetically defined types
of HRV-C might be readily defined and demarcated for clas-
sification purposes. This genetic approach may be necessitated
by the absence of HRV-C isolates with which to investigate
serological interrelationships, as has been performed previ-
ously for HRV-A and -B species.
For other HRV species, there exists a small number of pairs
of variants with genetic distances at an intermediate position in
the distributions (the gray zone marked in Fig. 2 for HRV-A).
For both HRV-A and -B, while there is a good correlation
between VP1 sequence divergence and serological relation-
ships (22, 26, 45), the latter are of limited value in defining a
precise nucleotide sequence divergence threshold to separate
inter- from intraserotype divergence values (22, 26). These
discrepancies likely reflect the somewhat variable relationship
between sequence divergence, epitope exposure, and antige-
nicity and the possibility that much of the sequence divergence
between serotypes is immunologically driven.
For species C, however, the current data set of VP1 (and
VP4/VP2) sequences shows a marked absence of variants
showing intermediate distances in this sequence divergence
range, and all can be defensibly assigned into different genetic
groups using the 0.13 and 0.10 upper divergence thresholds for
the VP1 and VP4/VP2 regions and into the same group if
below. Also potentially facilitating a possible future genetically
based classification of HRV-C is the lack of observed recom-
bination between the VP4/VP2 and VP1 regions (Fig. 1B and
C). This suggests that, once classified, HRV-C types may be
readily identified using either VP4/VP2 sequences or those
from VP1. This would be particularly helpful, given the pre-
ponderance of VP4/VP2 sequence data and the ease of ampli-
fication of this region for typing purposes. Remarkably, within
5 years of discovery of HRV-C, currently available sequences
would correspond to a total of 60 types if classified in this way
(Table 1).
Future classification proposals and the development of ro-
bust, well-defined type assignment criteria for HRV-C require
discussion and consensus from an expert group, likely affiliated
to the Picornavirus Study Group of the International Commit-
tee for the Taxonomy of Viruses. The data generated in the
current study will be of value in future formulation of diver-
gence thresholds in different genome regions for type assign-
ment if this is to be adopted for classification purposes, and a
consensus paper with formal proposals for type assignment
based on the genetic groups defined in Table 1 has now been
published (52a). Information on recombination frequency will
similarly assist the interpretation of sequence data from other
genomic regions and substantiate the proposed classification of
Ca and Cc 5 UTR variants (17) that we have extended in the
current study. Other issues specific to HRV-C and which re-
quire consideration in formulating classification proposals in-
clude the lack of virus isolates or type strains equivalent to
those of other rhinoviruses that currently precludes their se-
rological and genetic/biological characterization.
ACKNOWLEDGMENTS
We are grateful to Elly Gaunt, Heli Harvala, Kate Templeton, Peter
McCullough, Julie White, Mary Notman, Eleanor Leslie, and Carol
Thomson for providing samples, data, and other virus testing results
from the respiratory sample archive. We thank David J. Evans for
valuable discussion of the manuscript.
Chloe McIntyre’s Ph.D. studentship was funded by the Medical
Research Council.
REFERENCES
1. Anderson, E. C., S. L. Hunt, and R. J. Jackson. 2007. Internal initiation of
translation from the human rhinovirus-2 internal ribosome entry site re-
quires the binding of Unr to two distinct sites on the 5 untranslated region.
J. Gen. Virol. 88:3043–3052.
2. Arden, K. E., C. E. Faux, N. T. O’Neill, P. McErlean, A. Nitsche, S. B.
Lambert, M. D. Nissen, T. P. Sloots, and I. M. Mackay. 2010. Molecular
characterization and distinguishing features of a novel human rhinovirus
(HRV) C, HRVC-QCE, detected in children with fever, cough and wheeze
during 2003. J. Clin. Virol. 47:219–223.
3. Arden, K. E., P. McErlean, M. D. Nissen, T. P. Sloots, and I. M. Mackay.
2006. Frequent detection of human rhinoviruses, paramyxoviruses, corona-
viruses, and bocavirus during acute respiratory tract infections. J. Med. Virol.
78:1232–1240.
4. Benschop, K. S., C. H. Williams, K. C. Wolthers, G. Stanway, and P. Sim-
monds. 2008. Widespread recombination within human parechoviruses:
analysis of temporal dynamics and constraints. J. Gen. Virol. 89:1030–1035.
5. Blinkova, O., A. Kapoor, J. Victoria, M. Jones, N. Wolfe, A. Naeem, S.
Shaukat, S. Sharif, M. M. Alam, M. Angez, S. Zaidi, and E. L. Delwart. 2009.
Cardioviruses are genetically diverse and cause common enteric infections in
South Asian children. J. Virol. 83:4631–4641.
6. Borman, A., and R. J. Jackson. 1992. Initiation of translation of human
rhinovirus RNA: mapping the internal ribosome entry site. Virology 188:
685–696.
7. Briese, T., N. Renwick, M. Venter, R. G. Jarman, D. Ghosh, S. Kondgen,
10308 MCINTYRE ET AL. J. VIROL.
S. K. Shrestha, A. M. Hoegh, I. Casas, E. V. Adjogoua, C. Akoua-Koffi, K. S.
Myint, D. T. Williams, G. Chidlow, B. R. van den, C. Calvo, O. Koch, G.
Palacios, V. Kapoor, J. Villari, S. R. Dominguez, K. V. Holmes, G. Harnett,
D. Smith, J. S. Mackenzie, H. Ellerbrok, B. Schweiger, K. Schonning, M. S.
Chadha, F. H. Leendertz, A. C. Mishra, R. V. Gibbons, E. C. Holmes, and
W. I. Lipkin. 2008. Global distribution of novel rhinovirus genotype. Emerg.
Infect. Dis. 14:944–947.
8. Calvert, J., T. Chieochansin, K. Benschop, E. C. McWilliam-Leitch, J. F.
Drexler, K. Grywna, H. da Costa Ribeiro, C. Drosten, H. Harvala, Y. Poo-
vorawan, K. Wolthers, and P. Simmonds. 2010. The recombination dynamics
of human parechoviruses; investigation of type-specific differences in fre-
quency and epidemiological correlates. J. Gen. Virol. 91:1229–1238.
9. Calvo, C., M. Luz Garcia, F. Pozo, N. Reyes, P. Perez-Brena, and I. Casas.
2009. Role of rhinovirus C in apparently life-threatening events in infants,
Spain. Emerg. Infect. Dis. 15:1506–1508.
10. Chevaliez, S., A. Szendroi, V. Caro, J. Balanant, S. Guillot, G. Berencsi, and
F. Delpeyroux. 2004. Molecular comparison of echovirus 11 strains circulat-
ing in Europe during an epidemic of multisystem hemorrhagic disease of
infants indicates that evolution generally occurs by recombination. Virology
325:56–70.
11. Cordey, S., D. Gerlach, T. Junier, E. M. Zdobnov, L. Kaiser, and C. Tap-
parel. 2008. The cis-acting replication elements define human enterovirus
and rhinovirus species. RNA 14:1568–1578.
11a.Dominguez, S. R., T. Briese, G. Palacious, J. Hui, J. Villari, V. Kapoor, R.
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Abstract Human rhinoviruses (HRV) are highly pre-
valent human respiratory pathogens that belong to the
genus Enterovirus. Although recombination within the
coding region is frequent in other picornavirus groups,
most evidence of recombination in HRV has been restric-
ted to the 5’ untranslated region. We analysed the occur-
rence of recombination within published complete genome
sequences of members of all three HRV species and
additionally compared sequences from HRV strains span-
ning 14 years. HRV-B and HRV-C showed very little
evidence of recombination within the coding region. In
contrast, HRV-A sequences appeared to have undergone a
large number of recombination events, typically involving
whole type groups. This suggests that HRV-A may have
been subject to extensive recombination during the period
of diversification into types. This study demonstrates the
rare and sporadic nature of contemporary recombination of
HRV strains and contrasts with evidence of extensive
recombination within HRV-A and between members of
different species during earlier stages in its evolutionary
diversification.
Introduction
Human rhinoviruses (HRVs) are a highly prevalent and
genetically diverse group of human pathogens that cause a
wide range of disease. Although they have been tradi-
tionally linked to mild, self-limiting upper respiratory tract
infections, there is now evidence for a role of HRV in
lower respiratory tract infection [13, 24, 31], exacerbations
of chronic lung disease [20, 43, 70], severe systemic
infections [66, 69] and gastrointestinal disease [14].
HRVs are single-stranded, positive-sense RNA viruses
that belong to the genus Enterovirus, family Picornaviri-
dae. HRVs are classified into three species on the basis of
phylogenetic relationships and sequence divergence:
Human rhinovirus A, Human rhinovirus B, and Human
rhinovirus C [25, 49, 56]. While species A and B viruses
can be readily isolated and cultured in vitro (and were
among the earliest identified human picornaviruses), the
equally prevalent HRV-C was only discovered very
recently following the introduction of PCR-based diag-
nostic and surveillance screening methods [1, 21, 26, 28,
53]. For reasons that are currently poorly understood,
HRV-C replicates poorly, if at all, in conventional cell
culture, although recently, a variant of HRV-C was suc-
cessfully cultured in sinus mucosal organ culture [4].
Serotypes of HRV-A and HRV-B were originally
defined by serological cross-neutralisation assays [12, 19]
and further characterised by receptor specificity and anti-
viral sensitivity profile. More recently, HRV-A and HRV-B
have been genetically divided into two groups into which
the 74 and 25 HRV types previously defined by serological
methods have been assigned [56]. More recent analyses of
phylogenetic relationships and genetic divergence among
HRV strains has led to the reclassification of EV-68 as
HRV-A87 [3] and of HRV-A21 and the Hanks strain as the
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same genotype [27]. Three new HRV-A types have also
been defined on the basis of sequence divergence in the VP1
region: HRV-A101–HRV-A103 (52, www.picornaviridae.
com). For the more recently described species C rhinovi-
ruses, difficulties associated with in vitro culture have
precluded the development of serology-based virus typing,
and variants are currently divided into 51 genotypically
defined types. Classification into types is based on the
current system used for enteroviruses [46], in this case
based on an assignment threshold of 13 % nucleotide
divergence in the VP1 region [59].
The epidemiological profile of HRVs and occurrence of
infection with different types varies substantially every
epidemic season [57], with high frequencies of asymp-
tomatic infections [50] and no identified link between any
strain, type or species of HRV with particular disease
presentations. Despite an apparent difference in tissue
tropism, the HRVs share many genetic similarities with
other members of the genus Enterovirus. For instance, they
have a single-stranded, positive-sense RNA genome of
around 7100 bases with a 5’ untranslated region (5’UTR)
of around 600–650 bases. The coding region contains a
single open reading frame and is cleaved post-translation-
ally into four structural (VP1–VP4) and seven non-struc-
tural (2A–3D) proteins. The 5’UTR contains a type I
internal ribosomal entry site (IRES) and a conserved 5’
cloverleaf structure [48, 49].
EV serotypes, in particular EV-B, have been docu-
mented to undergo frequent recombination [30, 34, 40, 44,
61], and it has been proposed that structural and non-
structural genome regions evolve independently [33, 45,
55]. EVs can thus be classified into a series of distinct
recombinant forms (RFs), each possessing a phylogeneti-
cally distinct grouping in 3Dpol and other non-structural
genes. These RFs have been shown to arise at intervals,
dominate circulation for a few years and then disappear
entirely [39, 41]. Recombination breakpoints in EV gen-
erally localise to two hotspot regions: between the 5’UTR
and P1 and between P1 and P2 [61].
In contrast, recombination is generally thought to be rare
and sporadic within the coding region of HRV [22, 29, 65],
and a contemporary set of HRV-C sequences were found to
cluster completely congruently in three coding genome
regions [38]. To date, there is limited evidence of inter-
species recombination within the coding region of HRV. It
is well established, however, that HRV-A and HRV-C have
undergone recombination within the 5’UTR, whereby over
half of all HRV-C types group within the HRV-A clade
[17, 68]. In addition, recent reports have highlighted the
possibility that several contemporary HRV-A strains have
been formed by recombination [49].
Until recently, data from the non-structural region of the
HRV genome had only limited availability, as most HRV
types had only one full genome sequence available. In
addition, sequence data for HRV-C strains spanned a very
limited time period due to their relatively recent discovery
and the tendency of studies to focus on capsid-based typ-
ing. In the course of this analysis, we obtained sequences
from isolates of all three HRV species spanning 14 years in
order to determine whether recombination had shaped the
contemporary diversity of these types. In addition, we also
performed a comprehensive analysis of recombination
between the VP1 and 3Dpol regions of all available HRV
full genomes. This study represents an attempt to com-
prehensively characterise all detectable recombination
events in the history of diversification of HRV.
Materials and methods
Sample selection
HRV-positive isolates were selected from distinct geo-
graphical locations (UK and Finland) over a period span-
ning 14 years. These included 28 HRV-positive clinical
respiratory specimens from Finland collected between
1995 and 1997. VP4/VP2 sequences for these isolates were
previously published with accession numbers in the series
EU590043–EU590113 and AY015114–AY015174. Using
previously defined pairwise nucleotide p-distance thresh-
olds in the VP4/VP2 region [59, 67], these 28 samples were
identified as belonging to 22 HRV types (10 HRV-A, 6
HRV-B and 6 HRV-C).
In addition, a total of 552 respiratory samples from
patients previously referred to the Specialist Virology
Centre at the Royal Infirmary of Edinburgh were screened
by our previously described nested PCR method, specific
for the 5’UTR region of HRV/HEV [67]. Positive samples
(n=136) were amplified and sequenced in the VP4/VP2
region as described previously [67]. Samples that were of
the same 22 types described above (n= 41) were identified
and selected for further analysis. A further 23 HRV-C-
positive samples were also identified, which represented 11
of the previously 28 provisionally assigned HRV-C types
[59]. In total, 92 HRV isolates were analysed during the
course of this work.
Amplification of the VP4/VP2, VP1 and 3Dpol regions
of HRV-A, -B and –C
RNA was extracted from clinical samples using a QIAGEN
Virus Spin Kit (QIAGEN, UK), according to manufac-
turer’s instructions. Reverse transcription reactions were
carried out using random hexamers and a Promega Access
Reverse Transcription Kit with modifications as described
previously [15]. Amplification of the VP1 and 3Dpol























































































































































































































































































































































Recombination in the evolution of human rhinovirus genomes
123
regions was carried out using the primers listed (Supple-
mentary Table 1; Supplementary Data) and under the
conditions described below.
HRV-A VP1
The full HRV-A VP1 region was assembled by amplifi-
cation and sequencing of two overlapping sequence frag-
ments. The same first-round product was utilised for
second-round reactions for both VP1 fragments. For frag-
ment 2, VP1 amplification was carried out as described
previously [67]. For those samples that proved problematic
to amplify, a combined reverse transcription and first-round
PCR utilising the SuperScript III system (Invitrogen, UK)
was carried out as described previously [42]. For fragment
1, the second round was a hemi-nested PCR reaction with
primers 1943s and 2504as and previously described tem-
perature cycling conditions. For HRV-A28-positive speci-
mens, amplification of fragment 1 was not possible with
standard primers, and a specific inner antisense primer was
designed.
HRV-B VP1
Amplification of HRV-B VP1 was carried out using hemi-
nested primers. PCR conditions were as for HRV-A, except
for the use of an annealing temperature of 48 C in the
second round. For any samples that could not be amplified
by this method, the SuperScript III system was used.
HRV-C VP1
SuperScript III was used to perform a combined reverse
transcription and first-round PCR reaction directly on
extracted RNA. The second round of the nested PCR
reaction was carried out with an annealing temperature of
45 C and in a 50-ll reaction volume. PCR products were
loaded into wells on a 2 % agarose gel and separated at 150
V for 45 minutes. DNA bands of around 1000 bases were
excised manually under UV transillumination and purified
from the agarose gel using an Illustra GFX PCR DNA and
Gel Band Purification Kit (GE Healthcare, UK) according
to the manufacturer’s instructions.
HRV-A, -B and –C 3Dpol
Amplification of the partial 3Dpol region was carried out
under previously described conditions [38] but using an
annealing temperature of 45 C in the second round. The
amplified segment covered positions 6414–6896 in HRV-A
(numbered according to FJ445111–HRV-A1), 6475-6960
in HRV-B (numbered according to X01087–HRV-B14)
and 6361-6835 in HRV-C (numbered according to
EF582385–HRV-C4).
All amplicons were sequenced using a BigDye Termi-
nator Kit (Applied Biosystems, Warrington, UK).
Sequences generated in this study have been submitted to
GenBank and assigned accession numbers in the series
KC342054–KC342173.
Sequence alignment and pairwise nucleotide p-distance
calculations
All available HRV full genomes were downloaded from
GenBank on 6/6/12. As a number of currently published
HRV polyprotein sequences contain large gaps within the
coding region, only those that were more than 90 %
complete in the VP4/VP2, VP1 and partial 3Dpol regions
were included. The regions analysed were 616–1002 for
VP4/VP2, 2305–3126 for VP1 and 6361–6835 for partial
3Dpol (with all numbering according to reference strain
HRV-C4, strain 024 (EF582385)). These comprised 136
HRV-A, 53 HRV-B and 121 HRV-C sequences, which
were then compiled into separate datasets for each species,
together with sequences generated in the current study: 28
HRV-A, 17 HRV-B and 24 HRV-C. A second dataset
containing all available full genomes that were more than
90 % complete in the P1, P2 and P3 coding regions was
constructed. Sequence alignments were performed in SSE
v1.0 [58], using a combination of CLUSTAL/MUSCLE
algorithms implemented in the program and manual
inspection of nucleotide and amino acid alignments.
Pairwise nucleotide p-distances for individual regions
were calculated using the program SequenceDist, within
the SSE v1.0 package. For HRV-C, pairwise nucleotide
p-distances in the VP1 region were used to confirm the
minimum genetic divergence of the new HRV-C types
[59].
Analysis of mean substitution rates
Sequences representing six HRV-A and HRV-C types were
selected for analysis of mean substitution rates in the VP1
and partial 3Dpol regions. For VP1 datasets, every avail-
able GenBank entry that was [90 % complete across the
region and had a date of isolation specified was included.
3Dpol datasets contained only sequences generated in this
Fig. 1 Neighbour-joining phylogenetic trees showing the VP1 and
partial 3Dpol regions of HRV-A strains. Where possible, HRV-A type
groups have been collapsed for ease of reference. Contiguous clades
are marked by coloured boxes. Clades 2, 3 and 4 are marked by
purple, green and black boxes respectively, while clade 1 is divided
into sub-clusters, which group together in 3Dpol. HRV-A types that
undergo a bootstrap-supported change in nearest neighbour between
VP1 and 3Dpol are marked with a red line. Changes in tree topology
that are bootstrap supported on P1, P2 and P3 trees only are marked
with a yellow line. Orange arrows indicate the formation of one 3Dpol
clade from three VP1 clades
b
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study and published full genomes. HRV-A and HRV-C
datasets were screened with GARD, SBP and RDP for
evidence for intra- and inter-type recombination prior to
substitution rate analysis.
Analysis of mean substitution rates was carried out in
the Bayesian Evolutionary Analysis of Sampling Trees
program (BEAST) [8]. Each analysis used the SRD06
model of nucleotide substitution, as recommended for
protein coding data [8]. The analysis was carried out using
a relaxed uncorrelated lognormal molecular clock and
specified a constant population size, with auto-optimization
of all other priors during execution of the program. Each
MCMC chain was run for 20 million states, and the output
was recorded every 1000 states. All datasets were analysed
in duplicate to ensure convergence of results. In order to
confirm that all observed results were a consequence of
input sequence data, each dataset was subjected to an
‘‘empty’’ execution of BEAST with sequence data exclu-
ded. Additionally, all datasets were analysed with the dates


















































































































































































































































































































































Fig. 2 A: Neighbour-joining phylogenetic trees of HRV-B VP1 and
partial 3Dpol sequences. Putative recombinant sequences and type
groups are marked with black lines. HRV-B type groups are collapsed
where possible for ease of reference. Contiguous clades are marked
with black boxes. B: Neighbour-joining phylogenetic trees of HRV-C
VP1 and partial 3Dpol sequences. HRV-C type groups have been
collapsed where possible for ease of reference. Contiguous clades are
marked with black boxes
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Output was analysed in the TRACER program, within
the BEAST package. Phylogenetic trees generated by
Bayesian methods were annotated in TreeAnnotator v1.6
and visualised in FigTree. These were then directly com-
pared to trees produced by bootstrap re-sampled maximum
composite likelihood neighbour-joining trees to ensure
consistency of phylogenetic relationships inferred using the
two methods.
Phylogenetic analysis
Phylogenetic trees were constructed using the MEGA 5.0
software package [63] by the neighbour-joining method
[54] from 100 bootstrap-resampled sequence alignments
using the maximum composite likelihood (MCL) [11]
distances with pairwise deletion for missing data. Phylo-
genetic trees were examined for changes in branch length
and tree topology between non-consecutive genome frag-
ments (VP4/VP2, VP1 and 3Dpol) and between coding
regions of HRV full genomes (P1, P2 and P3).
Recombination analysis
RDP v4.0 [36] analysis was undertaken to further investigate
observed phylogenetic incongruities. Putative recombinant
sequences were analysed with their observed nearest
neighbours in each region. Each sequence set was examined
using a combination of algorithms, including RDP [37],
GeneConv [47], MaxChi [62], Chimaera [51], SiScan [10]
and Bootscan [35]. A potential recombination event was
accepted for further analysis if it was detected by more than
two of the above algorithms, with a p-value of less than 0.05.
All datasets were further analysed using the GARD and
SBP [23] programs available on the HyPhy datamonkey
webserver (www.datamonkey.org). Prior to analysis of
each dataset, the model selection tool included was
employed, and the appropriate model of nucleotide sub-
stitution was used for further analysis.
In addition, as a control measure, several groups of
sequences that were observed to display congruent phylo-
genetic relationships between VP1 and 3Dpol were
analysed by these methods. All analyses of putative non-
recombinant sequence groups confirmed that there was no
evidence of recombination.
The combination of different recombination detection
algorithms detailed above were used as a screening tool
in order to effectively screen each alignment for evi-
dence of recombination. If evidence of recombination
was detected by these methods, the recorded event was
further analysed by phylogenetic analysis of putative
recombinant regions and further characterised by analysis
with the GroupScan program within the SSE v1.0 soft-
ware package.
Determining putative recombination breakpoints
In order to verify putative recombination events and
determine recombination breakpoints where possible, sets
















JF781500 HRV-B35 0.1982 - HRV-B101
JF781501 HRV-B35 0.1901 - HRV-B101
JX074052 HRV-B35 0.1915 - HRV-B101
JX074053 HRV-B35 0.2267 - HRV-B102
JF416311a HRV-C2 0.2900 HRV-Cpat1 HRV-C36
JF416321 HRV-C26 0.2719 HRV-Cpat2 HRV-C37
JF416322 HRV-C5 0.2147 HRV-Cpat4 HRV-C38
JF416306 HRV-C32 0.1472 HRV-Cpat5 HRV-C39
JF416312 HRV-C2 0.1755 HRV-Cpat6 HRV-C40
JF416323 HRV-C30 0.1904 HRV-Cpat7 HRV-C41
JF416320 HRV-C12 0.2506 HRV-Cpat8 HRV-C42
JF416307 HRV-C22 0.2460 HRV-Cpat9 HRV-C43
JF416310 HRV-C12 0.2077 HRV-Cpat11 HRV-C44
JF416308 HRV-C29 0.2540 HRV-Cpat12 HRV-C45
JF416318 HRV-C26 0.2836 HRV-Cpat25 HRV-C46
a For ease of reference, where more than one example of a previously provisionally assigned HRV-C type was sequenced in this study, only the
earliest isolated strain is shown
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of sequences underwent GroupScan analysis in the
SSEv1.0 software package. GroupScan scores the extent of
phylogenetic grouping of a query sequence with predefined
sequence groups and can pinpoint potential breakpoints if
sequences that are closely related to both parental groups
are included. The GroupScan method relies on detection of
bootstrap-supported changes in tree topology along an
alignment and was used for the determination of recom-
bination breakpoints. For each analysis, the three
sequenced regions of each isolate were concatenated into a
single sequence, and a fragment size of 300 bases with an
increment of 30 bases was used. Additionally, each anal-
ysis was repeated with a fragment size of 600 bases and an
increment of 30 to ensure consistency of results. In each
instance, the query sequence was the potential recombinant
sequence/group and was scanned against the nearest
neighbour/group in both regions. The intersection of the
two lines was calculated to give an estimation of the
recombination breakpoint. Breakpoints were compared and
found to be highly similar in scans carried out with a
300-nucleotide fragment and those done with a
600-nucleotide fragment.
Results
Genotype assignment for HRV-A, HRV-B and HRV-C
sequences
A total of 164 HRV-A, 70 HRV-B and 145 HRV-C vari-
ants that were more than 90 % complete across the
analysed regions were included in the recombination
analysis. A separate recombination analysis was performed
with complete genome sequences (201 HRV-A, 71 HRV-B
and 59 HRV-C).
Examination of phylogenetic trees constructed for the
VP1 region of members of all three HRV species revealed
consistent grouping of individual (sero)types into clades
with uniformly high bootstrap support (Figs. 1, 2). These
type groupings were also apparent in the VP4/VP2 and full
P1 capsid coding region. However, the relationships
between HRV type groups were generally less well
resolved in VP4/VP2 trees as a result of greater sequence
conservation and shorter fragment length (data not shown).
Previously proposed pairwise nucleotide p-distance
divergence thresholds were used to support phylogenetic
genotype groupings and define putative new HRV types
[59, 67] (Table 1).
One newly described HRV-A sequence, JN815252, did
not group with any currently assigned HRV-A type and
shared nearest neighbours, HRV-A29 (FJ445125) and
HRV-A44 (DQ473499), in every region studied. Using the
previously determined pairwise nucleotide p-distance
threshold of 12 % divergence in VP1 for identification of
new HRV-A types [67], JN815252 fell within the intra-
serotype distance range on comparison with both HRV-
A29 and HRV-A44 (0.1051 and 0.1083, respectively).
Divergence between HRV-A29 and HRV-A44 has previ-
ously been shown to fall within the intra-serotype distance
range [67], and these two serotypes have also been dem-
onstrated to be serologically cross-reactive [7]. These three
sequences were treated as the same serotype for recombi-
nation analysis.
In species B, JF781500, JF781501 and JX074052
formed a bootstrap-supported clade in VP1 with a pairwise
nucleotide p-distance of 0.015 to 0.018 from each other and
of consistently greater than 0.19 from the nearest assigned
HRV-B type (HRV-B35). JX074053 also displayed a
p-distance of 0.2267 from HRV-B35, its nearest relative.
By current criteria [67], these two groups represent new
HRV-B types and have been formally designated HRV-
B101 and HRV-B102 (Table 1) (http://www.picornastudy
group.com/types/enterovirus/hrv-b.htm).
HRV-C VP1 sequence data generated during this study
confirmed type assignment of eleven HRV-C types that had
been provisionally identified as new types based on VP4/
VP2 sequences [59]. These had pairwise distances that fell
above the VP1 divergence threshold (Table 1) and have been
formally designated as HRV-C36 – HRV-C46 (http://www.
picornastudygroup.com/types/enterovirus/hrv-c.htm). The
previously proposed nucleotide divergence threshold of
13 % was readily identifiable in the distribution of pairwise
VP1 p-distances generated from the expanded VP1 dataset
(Fig. S1, Supplementary Data).
Fig. 3 Mean substitution rates and 95 % highest posterior density
intervals for two coding regions of selected HRV-A and HRV-C
sequences
Recombination in the evolution of human rhinovirus genomes
123
Analysis of mean substitution rates in selected HRV-A
and HRV-C types
Three non-recombinant types each of HRV-A (HRV-A9,
-A28 and –A78) and HRV-C (HRV-C9, -C12 and –C18) with
dates of isolation spanning at least 13 years were selected for
analysis of mean substitution rates. The HRV-A dataset
assembled contained sequences spanning 40 years, while
HRV-C sequences spanned 14 years. Phylogenetic trees
analysed for each type included showed no bootstrap-sup-
ported change in topology within each type or species (data
not shown). Insufficient sequences of individual HRV-B
types were available for inclusion of members of this species
in the analysis. Analysis was carried out separately for
HRV-A sequences (n=18) and HRV-C sequences (n=23).
For both analysed regions of HRV-A and HRV-C, mean
substitution rates and 95 % highest posterior density (HPD)
intervals were on the order of 10-3–10-2 substitutions per
site per year. Calculated mean substitution rates were lar-
gely similar between the two coding regions and two HRV
species considered (Fig. 3). Although both regions of
HRV-C showed 2- to 3-fold elevated substitution rates
(6.9138 9 10-3 and 9.8491 9 10-3 for VP1 and 3Dpol,
respectively) when compared to the estimates obtained for
Fig. 4 Comparison of pairwise nucleotide p-distances between VP1
and partial 3Dpol regions of HRV-A, HRV-B and HRV-C. The line of
best fit is indicated by a dotted red line. For HRV-A, the line of best
fit is given separately for putative recombinant and non-recombinant
distributions. A graph depicting HRV-A pairwise comparisons shows
putative recombination events involving full HRV-A type groups
[such as observed extensively within clade 1 (Fig. 4)] in red. Sporadic
recombination events involving single HRV-A sequences are marked
in yellow. For graphs depicting HRV-B and HRV-C, all examples of
putative recombination events are marked in red
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HRV-A strains (3.9954 9 10-3 and 3.4586 9 10-3 for VP1
and 3Dpol, respectively), the 95 % HPD intervals over-
lapped for the two species.
In order to ensure that the specified priors were not
inadvertently influencing the posterior distribution of the
calculated mean substitution rate, the BEAST algorithm
was executed with sequence data excluded for each dataset.
As additional confirmation, dates of isolation for individual
sequences were randomised using the SSE v1.0 software
package, and analysis with BEAST was repeated. Scram-
bled datasets gave extremely low substitution rate esti-
mates well below the lower HPD interval of the test
sequences (data not shown).
Comparison of pairwise nucleotide p-distances in VP1
and 3Dpol
The similarity of mean substitution rates between VP1 and
3Dpol regions in HRV-A and HRV-C is consistent with the
observed linear relationships between the pairwise p-dis-
tances of sequences in these two regions (Fig. 4). This
linear relationship was observed in HRV-B and HRV-C, in
both intra- and inter-(sero) type distance ranges (Fig. 4).
Both distributions contained few if any outlying data
points, and lines of best fit had gradients of approximately
1 (0.9042 and 0.9418, respectively). This correlation pro-
vides evidence for maintained equal substitutions rates in
the two regions throughout the period of diversification
into different types.
In contrast, HRV-A sequences showed lower divergence
in the 3Dpol region compared to VP1 and a gradient of
0.8714 for the line of best fit (Fig. 4). The distribution
additionally contained a large number of outlying data
points, consistent with the occurrence of several recombi-
nation events during HRV-A diversification. HRV-A
pairwise distances could be divided into three distinct
distributions, consisting of non-recombinant types, poten-





HRV-A sequences. The branch
to the tree root has been
collapsed, and the outgroup
used for analysis is given below.
A: Phylogenetic trees showing
examples of incongruent
topology between VP1 and
3Dpol involving [1] HRV-A56
and HRV-A76 (outgroup: A7),
[2] HRV-A28 and HRV-A68
(outgroup: A95) and [3] HRV-




between VP1 and 3Dpol of
HRV-A80 (outgroup: A46)
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groups and sporadic instances of phylogenetic incongruity
involving single HRV-A sequences (marked with blue, red
and yellow, respectively, in Fig. 4; see phylogenetic anal-
ysis below). For the putative non-recombinant types that
grouped consistently in VP1 and 3Dpol regions, a gradient
of approximately 1 (0.9011) was observed. Meanwhile,
consideration of pairwise p-distance comparisons between
potentially recombinant HRV-A sequences alone gave a
calculated gradient of 0.7216.
Analysis of phylogenetic incongruity in HRV-B
and HRV-C sequences
In accordance with the observed conformity of HRV-B VP1
and 3Dpol pairwise distances (Fig. 4), the majority of HRV-B
sequences displayed congruent clustering in phylogenetic trees
and clustered within their genotype group, as defined by VP1
(Fig. 2A). The only bootstrap-supported putative recombinant
sequence observed was HQ123444. This full genome
sequence showed a pairwise p-distance of at least 0.19 from
HRV-B35 strains in VP1. However, on inspection of all pub-
lished HRV full genomes, HQ123444 was identical to HRV-
B35 from position 6353 in the 3Dpol region. This incongruity
was detected using RDP, GARD and SBP.
In addition, a closer phylogenetic grouping of the HRV-
B17 and HRV-B70 type strains, as compared to contem-
porary HRV-B70 sequences, was observed in the 3Dpol
region. Although this change of topology did not have
adequate support in 3Dpol (Fig. 2A), it was supported in
both the P2 and P3 regions (data not shown).
The majority of HRV-C sequences fell within six
bootstrap-supported clades, which were congruent between
all regions analysed (Fig. 2B). With the previously repor-
ted artefactually recombinant sequence GQ223227 exclu-
ded from analysis [17, 38], no evidence of inter-type
recombination was observed in HRV-C. Any observed
inconsistency in branching order or phylogenetic relation-
ships between HRV-C types could not be confirmed by
analysis with RDP, GARD or SBP.
Analysis of phylogenetic incongruity in HRV-A
sequences
In contrast to HRV-B and HRV-C, the comparison of VP1
and partial 3Dpol pairwise nucleotide p-distances in HRV-A
suggested a number of separate recombination events
between VP1 and 3Dpol (Fig. 1) and between the P1, P2 and
P3 regions (Fig. S2; Supplementary data). Putative recom-
bination events identified by phylogenetic analysis were
confirmed by analysis with RDP, GARD and SBP.
Several HRV-A types showed a pattern similar to that of
HRV-B70, with contemporary strains grouping separately
from their respective older type strains in the non-structural
protein coding region. As reported previously [65], HRV-
A76 strains collected between 1999 and 2010 grouped most
closely with HRV-A56 in 3Dpol (Fig. 5 A1). The intra-
type pairwise nucleotide p-distances of HRV-A76 strains
ranged from 0.0839 to 0.0933 in VP1 and from 0.2085 to
0.2292 in 3Dpol. HRV-A68 and HRV-A33 also displayed a
similar pattern, whereby the older strains grouped prefer-
entially with HRV-A28 (Fig. 5 A2) and HRV-A76 (Fig. 5
A3) type strains, respectively, in 3Dpol. The HRV-A40
type group includes three recently described full genome
sequences that were not included in VP1 and 3Dpol anal-
ysis due to gaps present in published sequences, which
resulted in sequence completeness below the threshold of
90 %. However, on analysis of the whole P3 region, the
three contemporary HRV-A40 strains (JX074051,
JQ245067 and JN798579) formed a bootstrap-supported
clade separate from the HRV-A40 type strain, which
maintained its grouping with HRV-A85.
HRV-A80 sequences showed a substantial difference in
branch lengths between two regions, with no accompany-
ing change in tree topology (Fig. 5B). The HRV-A80 type
strain had a pairwise nucleotide p-distance of 0.078 from
contemporary HRV-A80 strains in VP1. However, in
3Dpol, the contemporary HRV-A80 strains were much
more divergent from the type strain, with a p-distance of
0.207. All of the above putative recombination events were
verified by analysis with GARD, SBP and RDP.
With the exception of HRV-A12 and HRV-A78, all
HRV-A sequences grouped into four bootstrap-supported
clades (numbered 1-4 in Fig. 1) branching basally in both
VP1 and 3Dpol trees. Clades 1–4 were maintained in all
regions studied, and although bootstrap-supported changes
in tree topology were relatively common within each of
these clades, there were no instances of recombination
occurring between them.
Bootstrap-supported changes in branching order and tree
topology were observed within clades 1, 2 and 3 (marked
with red lines in Fig. 1). The number of bootstrap-supported
nodes that each putative recombinant sequence violated in
the transition between VP1 and 3Dpol grouping ranged from
two to eight (Table 2). Clade 1 formed several sub-clusters
of HRV-A types, and there was a clear breakdown in phy-
logenetic relationships of HRV-A types between VP1 and
3Dpol. For example, one monophyletic bootstrap-supported
clade in 3Dpol (orange box; Fig. 1) was formed from three
distinct bootstrap-supported VP1 clades. Phylogenetic rela-
tionships between involved HRV-A types within this 3Dpol
clade were largely incongruent when compared with the VP1
tree topology. However, there was poor bootstrap support for
nearest-neighbour relationships between HRV-A types in
this region, regardless of whether 3Dpol or full P3 region
trees were inspected. Notably, the large cluster of putative
recombinant HRV-A pairwise nucleotide p-distance
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Table 2 Phylogenetic incongruities observed between VP1 and 3Dpol in HRV-A sequences
HRV type Accession numbers Nearest neighbour Number of changesa B/p
mean
(range)VP1 3Dpol P1 P2 P3 VP1 ? 3Dpol P1 ? P2 P2 ? P3
A13 FJ445116
FJ445117




A28 A46 A28 A46 A46 4 4 0 3213
(3198–3228)
A46 DQ473506 A80 A53 A80 A53 A53 4 4 0 3280
A68 FJ445150
JN798578b

































































































































A77 A24 A77 A77 A24
A90
6 0 6 5652
(5645–5674)
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comparisons between 0.25 and 0.32 VP1 p-distance (col-
oured red in Fig. 4) corresponded to the formation of this
new 3Dpol clade. Putative recombination events involving
HRV-A types from all three clades were further analysed
(Table 2).
Sequence groupings in phylogenetic trees constructed
for whole P1, P2 and P3 coding regions were largely
consistent with those observed in VP1 and 3Dpol; P1 was
similar to the VP1 tree and P2/P2 was similar to 3Dpol
(Fig. S2; Supplementary Data). Sequence analysis of these
longer regions did, however, identify bootstrap-supported
phylogenetic incongruity of a further six HRV-A types
between regions (yellow lines in Fig. 1; listed in Table S1;
Supplementary Data).
All phylogenetic incongruities listed were additionally
confirmed by RDP, GARD and SBP analysis (data not
shown).
Analysis of putative recombination breakpoints
In order to determine putative breakpoints in HRV-A
sequences showing evidence for recombination between
VP1 and 3Dpol, full genomes from each HRV-A type
underwent GroupScan analysis and were compared directly
to their nearest neighbours in P1, P2 and P3. Two repre-
sentative examples of Grouping Scan output are given,
with putative recombination breakpoints highlighted
(Fig. 6A). HRV-A18 has a breakpoint near the P1/P2
Table 2 continued
HRV type Accession numbers Nearest neighbour Number of changesa B/p
mean









































































8g 3h 10 5117
(5111–5123)
a ‘‘Number of changes’’ refers to the number of bootstrap-supported nodes a group of sequences violates to form a new grouping
b Sequences indicated in bold font are those that are not present on VP1 and 3Dpol trees due to sequence gaps
c Sequences indicated in bold italics are those that consist only of non-consecutive sequence fragments (VP4/VP2, VP1 and 3Dpol) and are therefore not
represented on P1, P2 and P3 trees
d Due to lack of bootstrap support for nearest-neighbour grouping in 3Dpol for A18, node changes are taken from grouping with HRV-A34 to HRV-A85
(nearest bootstrap supported neighbour in P3 region)
e Similarly, node changes for HRV-A38 between VP1 and 3Dpol are taken from grouping with HRV-A60 to HRV-A18
f Node changes for HRV-A38 between P2 and P3 are taken from HRV-A60 to HRV-A40
g Node changes for HRV-A60 between VP1 and 3Dpol are taken from HRV-A38 to HRV-A77
h Node changes for HRV-A60 between P2 and P3 are taken from HRV-A38 to HRV-A40
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boundary, and HRV-A63 has a breakpoint within P3. The
genome fragment between positions 2000 and 2500 in
HRV-A63, which shows a similarly elevated grouping
score with HRV-A59, did not correspond to any bootstrap-
supported change in tree topology in this region (data not
shown).
The majority of breakpoints occur near the P1/P2
boundary, specifically within the 2A coding region
(Fig. 6B). There was also a second putative hotspot region
around the P2/P3 boundary, and most of these occurred
within the 3A coding region or at the 3A/3B junction.
Recombination in the 5’ untranslated region of HRV-A,
-B and –C
All sequences that were more than 90 % complete across
the 5’UTR fragment numbered 167–626 (numbered by
FJ445111) were included in the analysis (167 HRV-A, 38
HRV-B and 59 HRV-C). The occurrence of recombination
in the 5’UTR was assessed by visual inspection of phylo-
genetic trees for HRV-A (Fig. 7A), HRV-B (Fig. 7B) and
HRV-A/HRV-C (Fig. S3: Supplementary Data).
All 5’UTR sequences from HRV-B clustered together
and were distinct from those of HRV-A and HRV-C (data
not shown). In contrast, HRV-A and over two-thirds
(69 %) of HRV-C sequences were interspersed in the
5’UTR, consistent with inter-species recombination, as
proposed previously [17, 38, 68].
Inspection of HRV-A sequences exclusively revealed 17
putative recombinant sequences, from nine HRV-A types
(black boxes; Fig. 7A), demonstrated by bootstrap-sup-
ported changes in the nearest neighbour in phylogenetic
trees. Two putative recombinant sequences (JQ837724 :
HRV-A1 and JN621245 : HRV-A67) represent contempo-
rary isolates, which form a bootstrap-supported grouping
distant from other members of the same type. Within HRV-B
5’UTR sequences (Fig. 7B), only three putative recombinant
types were noted, and two consisted of a single sequence,
which was the sole representative of the type in question.
Discussion
Identification of novel HRV strains
Novel strains of HRV representing new genotypically
assigned types have been described frequently during
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Fig. 6 A: GroupScan of two
representative recombinant
HRV-A types. The proposed
recombination breakpoint is
indicated by a dotted line.
B: Diagram showing calculated
coding region recombination
breakpoints for all HRV-A
recombinant types, mapped onto
a diagram of the full genome of
HRV-A sequences (numbering
taken from FJ445111–HRV-
A1). Those from the large
recombinant 3Dpol clade, which
lacked bootstrap support for
nearest-neighbour groupings in
the analysed regions, are
excluded


































































































































































































































































































































































































































































Fig. 7 A: Neighbour-joining phylogenetic trees constructed using
HRV-A 5’UTR sequences that were [90 % complete from 167-626
(numbered according to FJ445111), compared to the corresponding
VP1 region. Putative recombinant sequences are marked by a black line.
B: Neighbour-joining phylogenetic trees constructed using HRV-B
5’UTR sequences that were[90 % complete from 167-626 (numbered
according to FJ445111), compared to the corresponding VP1 region.
Putative recombinant sequences are marked by a black line
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clinical screening [6, 32, 52, 67]. This suggests that there is
still potential for as yet undiscovered genetic variation
within all three species of HRV. Consistent with these
previous studies, our analysis identified 13 putative new
types of HRV-B and HRV-C. These putative new types
have been submitted for consideration to the Picornavirus
Study Group and have been assigned new type numbers.
Estimation of mean substitution rates and analysis
of pairwise p-distances
This study represents the first comparison of mean substi-
tution rates between distant genome regions of HRV-A and
HRV-C. The estimates of mean substitution rates obtained
in both regions correlate with other published estimates for
single-strand RNA viruses [9, 18]. Most previously docu-
mented substitution rate analysis for picornaviruses has
focused on the capsid coding region, particularly VP1
[5, 16]. In one comparison of several picornaviruses, it was
found that members of the genus Enterovirus (EV) had
significantly higher mean substitution rates than other
members of the family Picornaviridae (including members
of the genera Aphthovirus, Teschovirus, Hepatovirus and
Cardiovirus), with very limited overlap of the 95 % HPD
intervals between the two groups [16]. Our estimates for
both HRV-A and HRV-C showed overlapping 95 % HPD
intervals with EV and non-EV examples cited in this paper.
Two studies of the evolution of serotypes of EV have
included estimates of substitution rates in the 3Dpol region
[16, 41], and these are of the same order of magnitude as
our estimates for HRV-A and HRV-C.
Similar to our observations for HRV-A and HRV-C, a
general congruency of substitution rates between VP1 and
3Dpol has previously been observed in the evolution of
recombinant groups of EV71 [40] and recombinant groups
of three HEV-B serotypes: E9, E11 and E30 [41].
As has previously been observed in analysis of EV71
isolates [40], similar mean rates of nucleotide substitution
between two distant genome regions should lead to a dis-
tribution of pairwise p-distances in these two regions with a
gradient of 1 and a y-intercept of 0. This suggests that any
discontinuities or outlying comparisons in distributions of
pairwise p-distances in these two regions relate to potential
recombination events (coloured red and yellow in Fig. 4).
Outlying data points were typically the result of compari-
son with variants that displayed bootstrap-supported
changes in tree topology in the two regions. The most
striking example of this is a large cluster of recombinant
sequences between 0.23 and 0.34 pairwise nucleotide
p-distance in VP1 for HRV-A (coloured red in Fig. 4),
which correspond to the HRV-A type groups in clade 1
(Fig. 1) that undergo a bootstrap-supported change in tree
topology between VP1 and 3Dpol.
Analysis of recombination in HRV-A, HRV-B
and HRV-C
A small number of recombination events have been
hypothesized to have played a role in the formation of a
number of HRV-A and HRV-B types [49]. More specula-
tively, it has also been suggested that the entire HRV-B
species was formed by recombination of HEV with HRV-A
[64].
In common with one previous analysis [49], we found
HRV-A to have the highest number of recombinant
sequences among circulating strains, with only very
infrequently detected recombination events within the
coding regions of HRV-B and HRV-C.
HRV-A sequences are divided into four bootstrap-sup-
ported clades, which were consistently observed in the
regions analysed in this study (VP4/VP2, VP1 and 3Dpol).
Further analysis indicated that these distinct clades were, in
fact, present in every gene region, except for the relatively
short and highly conserved VP4 and 3B regions. Recom-
bination appears to have occurred relatively frequently
within clades 1-3 (Fig. 1). However, there was no evidence
of recombination occurring between the clades within any
coding region, and therefore, we would suggest that these
HRV-A clades are potentially now diverging on distinct
and evolutionarily separate paths.
Within these four clades, most evidence of recombina-
tion involves full HRV type groups, as opposed to indi-
vidual sequences. This would suggest that these events are
likely to have taken place during the process of diversifi-
cation into genetically distinct types.
One previous study, considering only one example from
most HRV types, detected 23 recombinant genomes
resulting from 12 different recombination events [49]. Our
analysis identified events that are analogous to most of
these. However, as we used bootstrap-supported phyloge-
netic trees to define nearest neighbours in different coding
regions, our estimates of recombination parents occasion-
ally differed (Table 2). As the detailed phylogeny of
nearest-neighbour relationships are not well resolved,
particularly in the non-structural protein-coding regions,
we felt it was useful to consider the nearest bootstrap
supported clade members as representing nearest-neigh-
bour groups. Additionally, in some cases, a recombinant
sequence behaves as an outgroup to a new clade, and
therefore, we have treated the entire new clade as the single
nearest neighbour. This approach was facilitated by the use
of GroupScan to confirm recombinant sequences and to
determine putative recombination breakpoints. In prefer-
ence to bootscanning, this method determines the extent of
grouping of a query sequence within entire pre-defined
groups, rather than losing potentially phylogenetically
informative sequence data by reducing control groups to
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single consensus sequences. This eliminates the issue of
bias of results when a query sequence is genetically
divergent from both control groups [60].
Our results also affirm the previously reported finding
that contemporary HRV-A76 sequences have undergone a
recombination event with HRV-A56 [65]. In addition to the
originally reported single recombinant sequence, we have
noted that all contemporary isolates group together and
therefore that the recombinant group of contemporary
HRV-A76 sequences is likely to be the present dominant
lineage. This pattern was observed in several other HRV
types, indicating that while contemporary recombination
occurring within the time period of our dataset (around 50
years) is not frequent, it can occur.
In contrast to the extensive phylogenetic incongruity
observed in HRV-A, HRV-B and HRV-C show relatively
infrequent or entirely absent recombination within the
coding region. One putative recombinant sequence,
HQ123444, belonging to the HRV-B species has been
reported previously [32]. However, the previous analysis
used different methods for determining recombinant
sequences and did not detect the 100 % identity of this
sequence with HRV-B35 sequences in the 3’ end of 3Dpol,
instead noting an association with HRV-B35 throughout. In
fact, this sequence is identical to published strains from
position 6353 onwards. One might speculate on possible
explanations for this observation, as no contemporary
HRV-B35 full genomes are available for comparison. It is
possible that this putative recombinant may also represent a
sequencing or assembly error.
In accordance with our previous study, there is a striking
lack of recombination within HRV-C coding regions [38].
However, in both cases, HRV-C analysis is limited by the
lack of strains older than 15 years. In HRV-A and HRV-B,
all instances of contemporary sequences grouping sepa-
rately from older strains involve a sequenced example that
was originally collected over 40 years ago. It is therefore
possible that HRV-C sequences undergo recombination at
similar frequencies, but the current available time span of
sequences renders their detection problematic.
Recombination within the 5’UTR of HRVs
Within HRV-A sequences, the 5’UTR was the only region
analysed in which clades 1 to 4 were not maintained. We
noted considerably more recombination events within the
5’UTR of HRV-A than were seen in previous studies [49].
This included two instances of contemporary sequences
grouping distantly from other members of their type group.
The discrepancy in results could be due to different
alignment methods and the fact that we relied upon com-
parisons of robust groupings within phylogenetic trees to
determine recombinant sequences. In addition, several
putative recombinant sequences that were identified pre-
viously displayed inadequate bootstrap support on phylo-
genetic trees (Fig. 7A).
Recombination involving the 5’UTR of HRV-B was
relatively rare, and several previously reported putative
recombinants showed no bootstrap support [49]. However,
the 5’UTR region of HRV-B has not been extensively
sequenced to date, and only nine HRV-B types were rep-
resented by more than one sequence.
Similarly to EV [55], HRV showed evidence of inter-
species recombination within the 5’UTR region. The
majority of analysed HRV-C 5’UTR sequences had a
bootstrap-supported grouping within the HRV-A clade
(Fig. S3: Supplementary Data). HRV-C sequences were not
interspersed evenly throughout the HRV-A clade, but all
fell within three distinct clades. These findings are in
accordance with other reports of inter-species recombina-
tion in this region [17, 38].
Analysis of recombination breakpoints
within the coding region
Recombination breakpoints were determined for all puta-
tive recombinant HRV-A sequences with well-supported
nearest-neighbour groups (Table 2). Similarly to EV [30,
34] and HPeV [2], the majority of breakpoints are near the
P1/P2 junction. Coupled with the observation of high
within-species divergence within the capsid coding region,
this suggests that there may be a biological compatibility
barrier that decreases the reproductive fitness of progeny
that are recombinant within the capsid region. Therefore,
although inter-typic recombination may occur throughout
the full length of the genome in the course of a natural
co-infection, recombination within the capsid region may
not be represented in clinical sampling.
This study demonstrates that, despite a close phyloge-
netic relationship to EV, recombination within all three
species of HRV was substantially less frequent than that
observed within EV species. In addition, there was only
very limited evidence of recombination occurring within
the 40-50 years that the dataset spanned. Following upon
previous reports that have provided some glimpses of the
occurrence of recombination in HRV-A [49, 65], our study
represents a comprehensive analysis of recombination in
all published HRV full genome sequences to date, an
additional analysis of HRV sequence fragments obtained
from isolates spanning a 14-year time period and, to our
knowledge, the first attempt to catalogue all currently
detectable recombination events and potential breakpoints
within HRV-A.
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Human rhinoviruses (HRVs) are common respiratory pathogens associated with mild upper
respiratory tract infections, but also increasingly recognized in the aetiology of severe lower
respiratory tract disease. Wider use of molecular diagnostics has led to a recent reappraisal of
HRV genetic diversity, including the discovery of HRV species C (HRV-C), which is refractory to
traditional virus isolation procedures. Although it is heterogeneous genetically, there has to date
been no attempt to classify HRV-C into types analogous to the multiple serotypes identified for
HRV-A and -B and among human enteroviruses. Direct investigation of cross-neutralization
properties of HRV-C is precluded by the lack of methods for in vitro culture, but sequences from
the capsid genes (VP1 and partial VP4/VP2) show evidence for marked phylogenetic clustering,
suggesting the possibility of a genetically based system comparable to that used for the
assignment of new enterovirus types. We propose a threshold of 13 % divergence for VP1
nucleotide sequences for type assignment, a level that classifies the current dataset of 86 HRV-C
VP1 sequences into a total of 33 types. We recognize, however, that most HRV-C sequence data
have been collected in the VP4/VP2 region (currently 701 sequences between positions 615 and
1043). We propose a subsidiary classification of variants showing .10 % divergence in VP4/
VP2, but lacking VP1 sequences, to 28 provisionally assigned types (subject to confirmation once
VP1 sequences are determined). These proposals will assist in future epidemiological and clinical
studies of HRV-C conducted by different groups worldwide, and provide the foundation for future
exploration of type-associated differences in clinical presentations and biological properties.
Introduction
Human rhinoviruses (HRVs) are highly prevalent respi-
ratory pathogens, most commonly associated with mild
upper respiratory tract disease and exacerbations of pre-
existing respiratory disease such as asthma. They are also
increasingly recognized as underlying more severe disease
manifestations, such as bronchiolitis in young children and
in the immunosuppressed. The increasing use of molecular
methods for respiratory virus screening has contributed to
this reappraisal of rhinoviruses, as has the recent discovery
of an entirely novel rhinovirus group, refractory to
previously used virus isolation methods but now known
to be highly prevalent and widely circulating worldwide
(Arden et al., 2006; Kaiser et al., 2006; Lamson et al., 2006;
Kistler et al., 2007; Lau et al., 2007; Lee et al., 2007;
McErlean et al., 2007; Renwick et al., 2007; Olenec et al.,
2010).
These newly characterized rhinoviruses have been pro-
posed to belong to a novel species of rhinovirus
(designated species C; HRV-C), recognizing their substan-
tial sequence divergence from other classified species
within the genus Enterovirus of picornaviruses (Carstens,
2010; Knowles, 2010) (Fig. 1a). Clinically and biologically,
they share many attributes with the other designated HRV
species, HRV-A and -B. Most studies of HRV-C disease
associations, typically focused on children from asthmatic
and/or hospital-based populations (Arden & Mackay,
2010), have demonstrated a similarly broad range of
clinical outcomes to those observed in HRV-A and -B
infections and, indeed, with other respiratory viruses. Some
A full list of all HRV-C variants characterized to date, categorized into a
total of 61 confirmed or provisionally assigned types, is available with the
online version of this paper.
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studies show no difference in clinical outcome between
HRV species (Lau et al., 2007; Piotrowska et al., 2009),
whereas others provide evidence for a more frequent role of
HRV-C in lower respiratory tract disease, febrile wheeze in
infants and toddlers, and asthma exacerbations in older
children (Lau et al., 2007; Khetsuriani et al., 2008; Miller
et al., 2009a; Wisdom et al., 2009b). Contrastingly, one study
described a shorter duration of asthma symptoms and less
cough than seen in HRV-A infection (Arden et al., 2010a).
HRV-C shares a number of features of its genomic
organization with other members of the genus Enterovirus
(Fig. 1b). This includes an approximately 7100 base genome
containing a single reading frame, the absence of a leader
protein, a P1 region encoding four capsid proteins, a 2A
gene encoding a cis-acting proteinase, followed by a series of
non-structural proteins collinear with those of other
enteroviruses, including 3D (which encodes the RNA-
dependent RNA polymerase). HRV-C contains a type I
internal ribosomal entry site that is structurally similar to
and has short regions of striking sequence conservation with
those of other enteroviruses. Members of the genus
Enterovirus do, however, differ in other aspects of their
genome organization. Most evident is the variability in the
position of the cis-acting replication element. This is located
at a homologous position within the 2C coding sequence in
all four human enterovirus (HEV) species A–D, but is
variable in position in each rhinovirus species [within 2A in
HRV-A (Gerber et al., 2001), VP1 in HRV-B and proposed
to be located at the 59 end of VP2 in species C (Cordey et al.,
2008)]. In marked contrast to the ease with which HRV-A
and -B can be isolated, HRV-C has, to date based on the
Fig. 1. (a) Sequence relationships between
species currently assigned to the genus
Enterovirus, depicted by phylogenetic analysis
of aligned sequences from the P1 (capsid
protein-encoding) region [positions 616–
3125, numbered according to the reference
sequence (GenBank accession no.
EF582385); species identified by different
symbols and shading]. The tree was con-
structed by neighbour-joining analysis of pair-
wise amino acid p distances, with branches
showing ¢70 % bootstrap support labelled.
The sequence of porcine enterovirus 8 (genus
Sapelovirus) was used as an outgroup. For
presentation purposes, only the 10 most
divergent sequences were included for spe-
cies containing more than 10 sequences
(HEV-A, -B, -C, HRV-A, -B and bovine enter-
oviruses). Bar, amino acid p distance of 0.05. (b)
Diagram of the rhinovirus genome, identifying
the 59- and 39-UTRs and structural (P1) and
non-structural (P2, P3) gene regions, along with
the designations of their encoded proteins. The
genome is drawn to scale, using the complete
genome sequence 024 (GenBank accession
no. EF582385) for numbering.
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published literature, been unculturable in vitro (Lau et al.,
2007; McErlean et al., 2007). Historically, this hindered its
discovery and has additionally precluded investigation of its
antigenic variability, a feature characteristic of other HRVs
and HEVs.
Proposal aims
Genetic characterization of HRV-C amplified from clinical
specimens has provided evidence for extensive heterogeneity
in the VP4/VP2 region, the existence of two phylogenetically
separate groups of sequences in the 59-UTR (one resembling
sequences found in species A rhinoviruses; Han et al., 2009;
Huang et al., 2009; Savolainen-Kopra et al., 2009b; Wisdom
et al., 2009a) and substantial sequence divergence throughout
the genome of the 11 full-length HRV-C sequences obtained
to date (Lamson et al., 2006; Lau et al., 2007; Kistler et al.,
2007; McErlean et al., 2007; Huang et al., 2009; Tapparel et al.,
2009b; Arden et al., 2010b). Although we currently lack the
means to classify HRV-C serologically (as has been achieved
for other rhinovirus and enterovirus species), we recognize
and are responding to the need to develop a classification
system for this species. This will assist in organizing the
rapidly accumulating sequence data currently being generated
from virological and clinical studies, and allow assignment of
uniform type descriptions that will enable comparison of
genetic variants characterized in separate studies over time
and across different geographical regions.
This process is potentially made easier by the evident
similarities in the pattern of sequence divergence of HRV-
C to other rhinoviruses and enteroviruses for which
classification methods have been developed and standar-
dized. For example, the large number of distinct genetic
lineages identifiable by sequence comparisons in the VP4/
VP2 region matches the diversity in this region shown by
different serotypes of species A and B rhinoviruses (Lau
et al., 2009). These differences are mirrored in VP1 (Huang
et al., 2009; Wisdom et al., 2009b; McIntyre et al., 2010)
and other exposed regions of the capsid that underlie the
latter’s putative antigenic diversity. In developing clas-
sification proposals for HRV-C, we have strived to develop
criteria for type assignment that are consistent with the
principles used for other rhinoviruses and enteroviruses,
whilst acknowledging differences in its diversity, genetic
history and biology.
Classification of enteroviruses and rhinoviruses
into serotypes
HRV-A and -B comprise a number of antigenically distinct
viruses designated on the basis of their cross-neutralization
properties in vitro, currently totalling 74 serotypes of HRV-
A and 25 of HRV-B (Kapikian et al., 1967). These totals
incorporate minor adjustments to the original classification
when HRV was subsequently characterized genetically
(Kapikian et al., 1971; Hamparian et al., 1987). As
examples, one of the classical HRV prototypes, HRV-87,
was found to belong to the species HEV-D as a variant of
HEV-68 (Blomqvist et al., 2002). A strain referred to as
Hanks was considered to represent a candidate new type
Fig. 2. Distributions of pairwise nucleotide p (uncorrected)
distances (y-axis) between HRV-A and -B variants around the
previously proposed thresholds (Savolainen et al., 2002) dividing
inter- and intra-serotype distances in VP1 (lower panel) and VP4/
VP2 (upper panel). Pairwise comparisons in the equivalent
distance range for HRV-C are shown for comparison. Unfilled
boxes indicate pairwise distances between HRV variants pre-
viously classified as the same serotype; black-filled boxes, pairwise
comparisons between different serotypes; grey boxes, pairwise
comparisons of variants with unknown serological cross-reactivity
(HRV-C). For clarity, multiple examples of pairwise distances
between the same (sero)type pairs have not been shown.
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but, on sequence analysis, it was found to be genetically
similar to HRV-21 (Ledford et al., 2004; Laine et al., 2005).
In common with HEVs (Oberste et al., 1999), there is a
close correlation between sequence divergence of HRV-A
and -B in the VP1 region (and other structural genes) and
their designated serotypes (Savolainen et al., 2002; Ledford
et al., 2004; Laine et al., 2005). For HEVs, a nucleotide
sequence divergence value of .25 % in VP1 (.15 % amino
acid sequence difference) may be used as an alternative
means to classify more recently discovered types without
recourse to extensive serological characterization (Oberste
et al., 1999). Application of this principle has led to the
assignment of 40 genotypically defined enterovirus ‘types’
in addition to the 64 traditionally classified serotypes.
Thresholds of 12 % similarly differentiate inter- from intra-
serotype divergences in the VP1 gene of species A and B
rhinoviruses, respectively (Savolainen et al., 2002; McIntyre
et al., 2010), providing the means in principle to detect
novel species A types (e.g. Wisdom et al., 2009b) without
assaying for cross-neutralization (Savolainen et al., 2002).
For rhinoviruses it is, however, recognized that some
inconsistencies and overlap of divergence values between
and within serotypes exist (Savolainen et al., 2002). In
species A, pairwise divergence values in VP1 between
serotypes 95 and 8 (1.6 %), serotypes 44 and 29 (7.3 %),
serotypes 62 and 25 (9.4 %) and serotypes 98 and 54
(11.4 %) are interspersed with those observed within
serotypes, as is the pairwise distance between the species
B serotypes 70 and 17 (12.3 %) (Fig. 2, lower panel).
Overlaps in inter- and intra-serotype distances, often
involving the same serotype pairs, are also evident from
an equivalent analysis of pairwise distances of VP4/VP2
sequences (Fig. 2, upper panel). In two cases (95/8, 44/29),
reanalysis demonstrated that these pairs did indeed show
cross-neutralization (Cooney et al., 1982; Ledford et al.,
2004), whereas one of the more divergent pairs, 62/25, did
not (Cooney et al., 1982). There is clearly scope to
reinvestigate cross-reactivity of the other discrepant pairs.
Overall, however, the actual distributions of pairwise
distances between different serotypes of HEVs and
rhinoviruses overlap minimally with intra-serotype nuc-
leotide distances (as exemplified by HEV-B and HRV-A;
Fig. 3a, b). For enteroviruses, the lowest value between
these two distributions closely matches the type-assign-
ment threshold now used for genotypic assignment of new
Fig. 3. Distribution of pairwise nucleotide p
distances between: (a) available complete
(.90 %) VP1 sequences of HEV-B (n5330);
(b) available complete (.90 %) VP1 sequences
of HRV-A (n5279); (c) available VP1 sequences
of HRV-C (n586; .90 % complete between
positions 2304 and 3125); (d) all available VP4/
VP2 sequences of HRV-C (n5702; .90 %
complete between positions 615 and 1043).
Previously designated (HEV) or proposed type
thresholds are indicated by thick lines.
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types. We propose to adopt this method for a genotypic
classification of HRV-C.
Rhinovirus recombination
The process of recombination creates chimaeric virus
genomes in which different genome regions have separate
evolutionary origins; recombinants may change in their
phylogenetic relationships to other sequences between
genome regions. For enteroviruses and rhinoviruses whose
type assignments are dependent on the capsid genes (and
the encoded differences in antigenic properties), regions
that undergo extremely frequent recombination (such as
the 59-UTR, P2 and P3 non-structural gene regions in
HEV) cannot therefore contribute to their (sero)type
classification (Savolainen-Kopra et al., 2009b).
Rhinovirus species A and B show much more consistent
phylogeny relationships across the genome, as exemplified
by the largely concordant phylogenies of the 3Dpol and
VP4/VP2 regions (Savolainen et al., 2004). There are,
however, some inconsistencies evident on analysis of
complete genome sequences of species A and B
(Palmenberg et al., 2009; Tapparel et al., 2009a). For
example, HRV-53 shows greater similarity to HRV-46 in
the non-structural region than anticipated by their
sequence relationship in the capsid-encoding region, whilst
a similar comparison of HRV-78 and HRV-12 showed
non-structural gene sequences to be more divergent. In
these and other instances, most changes in phylogenetic
relationship occurred at the P1/P2 boundary, implying
separate evolutionary origins for the structural and non-
structural gene blocks in some serotypes.
In contrast to species A and B, our recent extensive
comparison of phylogenies of the VP4/VP2, VP1 and
3Dpol regions of species C demonstrated consistent
branching orders and relative branch lengths in all three
coding regions (McIntyre et al., 2010). However, several
phylogeny violations occurred between the 59-UTR and
VP4/VP2 trees, originating from a series of likely interspecies
recombination events with breakpoints towards the 39 end
of the 59-UTR (Han et al., 2009; Huang et al., 2009;
Savolainen-Kopra et al., 2009b; Wisdom et al., 2009a).
Remarkably, most 59-UTR sequences of species C cluster
within the species A 59-UTR clade, with the remainder
being phylogenetically distinct (Han et al., 2009; Huang
et al., 2009; Savolainen-Kopra et al., 2009b; Wisdom et al.,
2009a). Those with species A-like 59-UTR sequences have
been named HRV-Ca, with the remainder assigned as
HRV-Cc (Huang et al., 2009). We have recently found that
the region of 2A encoding the C-terminal domain of the
proteinase also has a recombinant origin, with all available
HRV-C sequences from this region clustering within the
HRV-A clade (McIntyre et al., 2010). The evolutionary
events and the selection pressures underlying these
instances of HRV-A/-C interspecies recombination are
currently unknown.
HRV-C heterogeneity and proposals for type
assignments
Eleven (near-)complete genome sequences, 541 sequences
from the VP4/VP2 region [.90 % complete between
Fig. 4. Phylogenetic analysis of all available sequences of HRV-C in
the VP1 region (.90 % complete between positions 2304 and
3125). The tree was constructed by neighbour-joining analysis of
pairwise maximum composite likelihood distances implemented in
the program MEGA (Tamura et al., 2007); branches showing ¢70 %
bootstrap support are indicated. Complete genome sequences are
labelled $. Bar, maximum composite likelihood distance of 0.05.
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positions 615 and 1043, numbered here and below using
the complete genome HRV-C sequence 024 (GenBank
accession no. EF582385)] from public databases and a
further 160 unpublished sequences contributed by the
authors of the current study, along with 86 complete VP1
(positions 2304–3125) and 89 partial 3Dpol (positions
6384–6854) sequences, collectively attest to the substantial
genetic heterogeneity of HRV-C. The formation of a
number of discrete clades of HRV-C in each genome
region (Savolainen et al., 2002; McIntyre et al., 2010)
(Fig. 4) supports the idea that genetic variants of HRV-C
might be usefully classified into a number of types,
comparable to types/serotypes of other HRV species.
The current lack of data on antigenic properties of HRV-C is
unlikely to be addressed in the near future, due to difficulties
with in vitro culture and the daunting task of creating and
applying the necessary serotyping reagents should a viral
culture system be developed. These factors necessitate a
genotypic classification method. To investigate whether
clear inter- and intra-type thresholds can be defined for
HRV-C, we constructed a frequency histogram of the set of
pairwise distances between all available sequences from the
VP1 region (Fig. 3c) using previously described methods for
constructing sequence alignments and determining
sequence distances (McIntyre et al., 2010). For comparison,
we have additionally analysed an even larger dataset of
available VP4/VP2 sequences (Fig. 3d).
As described previously (McIntyre et al., 2010), the
distribution of HRV-C VP1 sequence distances is indeed
bimodal, with a clearly defined minimum (zero) value
below 14.9 % and above 8 % (Fig. 2), which may be used as
a threshold for putative assignment of HRV-C types. This
corresponds closely to the 12 % threshold that divides
within- and between-serotype distances in species A and B
rhinoviruses (Savolainen et al., 2002; McIntyre et al., 2010).
The distribution of pairwise distances in the VP4/VP2
region resembles that of VP1, with an equivalent minimum
value corresponding to the type threshold of VP1 at 10 %.
However, as a likely result of its shorter length and lesser
degree of sequence diversity than VP1, the type threshold
for VP4/VP2 was less clearly defined (Fig. 2). This pattern
was also found in a similar comparison of VP4/VP2 region
distance distributions in HRV-A and -B (McIntyre et al.,
2010) and in human enteroviruses (Oberste et al., 1999;
Mulders et al., 2000).
Type-assignment proposals
In formulating the following criteria for type assignment,
we are aware of the need for simplicity and transparency in
the assignment process and the use of criteria comparable
to those used for genotypic classification in other
enterovirus species. At the same time, these proposals
should respect and adapt to differences in the pattern of
diversity in species C and the occurrence of recombination.
In addition, we acknowledge that current surveillance and
genetic characterization of HRV-C are incomplete and we
state the need for review of and, if necessary, revision of
type-assignment criteria as further genetic data become
available in the future. Finally, the use of genetic
comparisons in restricted regions of the genome (VP1
and VP4/VP2) should not diminish perceptions of the
importance of other genomic regions in shaping the
phenotype of HRV-C. However, these, together with
putative biological/epidemiological differences to be found
in the future, lie specifically in the realm of research
enquiry and we advise against their use as subsidiary or
alternative classification criteria unless or until there is a
future major reappraisal of our understanding of HRV
diversity and genetics.
(a) A proposed HRV-C type should be phylogeneti-
cally distinct and show .13 % nucleotide
sequence divergence in VP1 from all other





Strain identifier Submission Variants Reference*
VP4/VP2 VP1
HRV-C1 EF077279 NAT001 20 Oct 2006 17 4 Kistler et al. (2007)
HRV-C2 EF077280 NAT045 20 Oct 2006 36 1 Kistler et al. (2007)
HRV-C3 EF186077 QPM 14 Dec 2006 12 2 McErlean et al. (2007)
HRV-C4 EF582385 024 27 Apr 2007 3 1 Lau et al. (2007)
HRV-C5 EF582386 025 27 Apr 2007 22 1 Lau et al. (2007)
HRV-C6 EF582387 026 27 Apr 2007 32 11 Lau et al. (2007)
HRV-C7 DQ875932 NY-074 14 Jul 2008 4 2 Lamson et al. (2006)
HRV-C8 GQ223227 N4 29 May 2009 6 2 Huang et al. (2009)
HRV-C9 GQ223228 N10 29 May 2009 27 5 Huang et al. (2009)
HRV-C10 GQ323774 QCE 29 Jun 2009 7 1 Arden et al. (2010b)
HRV-C11 EU840952 CL-170085 21 May 2010 11 2 Tapparel et al. (2009b)
*Reference for first submitted sequence for each type.
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Table 2. Proposed type assigment of HRV-C variants represented by VP1 (and VP4/VP2) sequences
Type assignment VP4/VP2 region VP1 region References*
GenBank
accession no.
Submission date Variants GenBank
accession no.
Submission date Variants
HRV-C12 EF077264 20 Oct 2006 25 HM236958 14 May 2010 3 Kistler et al. (2007); McIntyre et al. (2010)
HRV-C13 EU081795 3 Aug 2007 6 HM236908 14 May 2010 1 Renwick et al. (2007); McIntyre et al. (2010)
HRV-C14 EU081796 3 Aug 2007 6 HM236911 14 May 2010 1 Renwick et al. (2007); McIntyre et al. (2010)
HRV-C15 EU081800 3 Aug 2007 22 HM236963 14 May 2010 1 Renwick et al. (2007); McIntyre et al. (2010)
HRV-C16 EU081808 3 Aug 2007 31 HM236944 14 May 2010 3 Renwick et al. (2007); McIntyre et al. (2010)
HRV-C17 EU081809 3 Aug 2007 3 HM236936 14 May 2010 1 Renwick et al. (2007); McIntyre et al. (2010)
HRV-C18 EU590074 25 Mar 2008 30 HM236918 14 May 2010 5 Savolainen-Kopra et al. (2009a); McIntyre et al. (2010)
HRV-C19 EU697850 5 May 2008 9 EU840728 20 Jun 2008 3 Briese et al. (2008); Tapparel et al. (2009a)
HRV-C20 EU697851 5 May 2008 14 HM236923 14 May 2010 6 Briese et al. (2008); McIntyre et al. (2010)
HRV-C21 EU752377 26 May 2008 16 HM236903 14 May 2010 2 Miller et al. (2009a); McIntyre et al. (2010)
HRV-C22 EU752381 26 May 2008 10 HM236905 14 May 2010 2 Miller et al. (2009a); McIntyre et al. (2010)
HRV-C23 EU752424 26 May 2008 21 HM236901 14 May 2010 2 Miller et al. (2009a); McIntyre et al. (2010)
HRV-C24 EU752426 26 May 2008 14 HM236939 14 May 2010 1 Miller et al. (2009a); McIntyre et al. (2010)
HRV-C25 EU752427 26 May 2008 15 HM236952 14 May 2010 1 Miller et al. (2009a); McIntyre et al. (2010)
HRV-C26 EU752441 26 May 2008 19 HM236904 14 May 2010 2 Miller et al. (2009a); McIntyre et al. (2010)
HRV-C27 GQ223122 9 Jan 2009 14 HM236906 14 May 2010 4 Huang et al. (2009); McIntyre et al. (2010)
HRV-C28 GQ223134 9 Jan 2009 11 HM236954 14 May 2010 1 Huang et al. (2009); McIntyre et al. (2010)
HRV-C29 FJ615699 9 Jan 2009 4 HM236949 14 May 2010 1 Miller et al. (2009b); McIntyre et al. (2010)
HRV-C30 GQ476669 13 Aug 2009 2 HM236968 14 May 2010 1 Wisdom et al. (2009b); McIntyre et al. (2010)
HRV-C31 GU294380 4 Dec 2009 4 HM236964 14 May 2010 1 Wisdom et al. (2009b); McIntyre et al. (2010)
HRV-C32 GU294466 4 Dec 2009 13 HM236897 14 May 2010 10 Wisdom et al. (2009b); McIntyre et al. (2010)
HRV-C33 GU294480 4 Dec 2009 3 HM236934 14 May 2010 2 Wisdom et al. (2009b); McIntyre et al. (2010)
















previously classified species C types. The VP1
sequence obtained for this sequence comparison
must be .90 % complete between positions 2304
and 3125 for determining valid nucleotide
sequence distances. The proposed threshold
corresponds to approximately 8 % amino acid
sequence divergence in VP1. However, for clarity
and avoidance of conflicting assignments, we do
not propose amino acid distances as an additional
or alternative criterion for type assignments.
(b) A sequence from the VP4/VP2 region (between
positions 615 and 1043) can be used for
identification of HRV-C types among the much
larger dataset of VP4/VP2 sequences that have
been obtained from surveillance studies.
(c) Types should be numbered sequentially from 1
using a ‘C’ prefix to distinguish them from
serotype designations of other HRV species. In
the tables of assignments drawn up, numbering
commences with the 11 (near)-complete genome
sequences HRV-C1 to -C11 (Table 1), based on
submission date to GenBank.
(d) Subsequent assignments have been made (HRV-
C12 onwards) to genetic variants of HRV-C for
which VP1 and VP4/VP2 sequences are available,
again ordered by submission date of the first
sequence in either VP4/VP2 or VP1 (Table 2).
(e) The remaining genetic variants of HRV-C for
which only VP4/VP2 region sequences are
available and which show .10 % divergence from
other species C sequences in this region should be
assigned as provisionally assigned types (desig-
nated ‘pat’), e.g. HRV-C_pat1, HRV-C_pat2 etc.
(Table 3). If and when VP1 sequence data are
determined for at least one member of this
provisionally assigned type, it can be added to
the list of confirmed types and removed from the
provisional list.
(f) A designated Expert Group takes responsibility
for the future coordinated assignment of HRV-C
types, including a reappraisal of the type assign-
ment as more sequence data accumulate. This
might perhaps be nominated by the ICTV
Picornavirus Study Group and include Study
Table 3. Provisional type assignment of HRV-C variants represented by VP4/VP2 sequences only
Provisional type GenBank accession no. Submission date Variants Reference*
HRV-C_pat1 EF077256 20 Oct 2006 21 Kistler et al. (2007)
HRV-C_pat2 EF077260 20 Oct 2006 8 Kistler et al. (2007)
HRV-C_pat3 EU081790 3 Aug 2007 15 Renwick et al. (2007)
HRV-C_pat4 EU081791 3 Aug 2007 13 Renwick et al. (2007)
HRV-C_pat5 EU081799 3 Aug 2007 20 Renwick et al. (2007)
HRV-C_pat6 EU081802 3 Aug 2007 29 Renwick et al. (2007)
HRV-C_pat7 EU081803 3 Aug 2007 7 Renwick et al. (2007)
HRV-C_pat8 EU081805 3 Aug 2007 11 Renwick et al. (2007)
HRV-C_pat9 EU081807 3 Aug 2007 13 Renwick et al. (2007)
HRV-C_pat10 EU590054 25 Mar 2008 14 Savolainen-Kopra et al. (2009a)
HRV-C_pat11 EU590061 25 Mar 2008 5 Savolainen-Kopra et al. (2009a)
HRV-C_pat12 EU590064 25 Mar 2008 5 Savolainen-Kopra et al. (2009a)
HRV-C_pat13 EU697839 5 May 2008 6 Briese et al. (2008)
HRV-C_pat14 EU697852 5 May 2008 1 Briese et al. (2008)
HRV-C_pat15 EU743925 22 May 2008 10 Dominguez et al. (2008)
HRV-C_pat16 EU752358 26 May 2008 2 Miller et al. (2009a)
HRV-C_pat17 EU752398 26 May 2008 6 Miller et al. (2009a)
HRV-C_pat18 EU752412 26 May 2008 21 Miller et al. (2009a)
HRV-C_pat19 FJ598096 29 Dec 2008 5 Currently unpublished
HRV-C_pat20 FJ615722 9 Jan 2009 1 Miller et al. (2009b)
HRV-C_pat21 FJ615737 9 Jan 2009 4 Miller et al. (2009b)
HRV-C_pat22 FJ615745 9 Jan 2009 1 Miller et al. (2009b)
HRV-C_pat23 FJ841957 17 Mar 2009 2 Calvo et al. (2009)
HRV-C_pat24 FJ869923 27 Mar 2009 1 Calvo et al. (2009)
HRV-C_pat25 FJ869950 27 Mar 2009 4 Calvo et al. (2009)
HRV-C_pat26 GQ466482 7 Aug 2009 1 Savolainen-Kopra et al. (2009c)
HRV-C_pat27 GU214340 18 Nov 2009 5 Piralla et al. (2009)
HRV-C_pat28 HM347248 24 May 2010 1 Currently unpublished
*Reference for first submitted sequence for each type.
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Group members with expertise and experience in
new enterovirus type assignments, as well as
‘outside’ scientists active in HRV-C or more
general HRV research.
(g) Alignments of the VP1 and VP4/VP2 regions,
along with information on the regions used for
sequence comparisons, will be made available on
a publicly available database accessible through
the Picornavirus Study Group. These alignments
will be regularly maintained and updated with
new sequence data and type assignments as these
become available.
(h) This Group should cooperate closely with those
developing future type-assignment criteria for
species A and B rhinoviruses to help ensure
consistency in approach.
Applying these criteria to the currently available dataset of
HRV-C sequences creates a total of 33 confirmed types
(Tables 1 and 2) and a further 28 provisionally assigned
types based on VP4/VP2 sequences (Table 3).
Type identification
In drawing up specific classification proposals, we should
emphasize that the process of type assignment is an activity
distinct from type identification or detection. From the data
obtained from genetic characterization of HRV-C in different
genome regions and the lack of recombination observed
(McIntyre et al., 2010), we consider that identification of an
HRV-C genetic variant as belonging to an already classified
type can be achieved by sequence comparisons in VP4/VP2.
Currently, most sequence data obtained for genetic char-
acterization of HRV-C have been obtained in this region,
including all of the confirmed types. These sequence data are
derived from a wide geographical base, combining sequence
data from Europe, USA, Australia, Japan and South-East Asia.
By phylogenetic analysis and examination of pairwise
distances within the now-extensive dataset of VP4/VP2
sequences, the aforementioned threshold permits all HRV-C
variants characterized to date to be categorized into a total of
61 confirmed or provisionally assigned types, the majority of
which now contain multiple examples from geographically
separate locations (Fig. 5; a full list of individual assignments
is available as Supplementary Table S1 in JGV Online). The
decreasing pace of identification of variants worldwide that
can be assigned (even provisionally) as new types suggests a
finite limit to the number that will eventually be classified.
The actual total will, however, only become clear with more
temporally and geographically widespread sampling.
In summary, this proposal draws together existing know-
ledge of the genetic diversity of HRV-C and applies
principles established for type assignment of other entero-
viruses to create a genotypically based classification scheme
for HRV-C types. We hope that these proposals will be of
value in future rhinovirus research, and provide the impetus
to develop related type-assignment criteria for novel HRV-A
and -B genetic variants that have been described.
Fig. 5. Total numbers of each assigned HRV-C type identified by sequence comparisons in the VP4/VP2 region, divided by
geographical region. The total representation of sequences from each geographical range is indicated by the inset pie chart.
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Human rhinoviruses (HRVs) can be divided
into three species; HRV-A to HRV-C. Up to 148
different HRV (sero)types have been identified
to date. Because of sequence similarity
between 50-NCR of HRVs and enteroviruses
(EVs), it is problematic to design EV-specific
RT-PCR assays. The aims of this study were to
assess the rate of false-detection of different
rhinoviruses by EV RT-PCR, and to evaluate
the diagnostic and clinical significance of
such cross-reactivity. In vitro RNA transcripts
of HRV A-C created from cDNA templates
were quantified spectrophotometrically. Six
hundred twenty-one stool samples screened as
part of routine diagnostic for EV, 17 EV-positive
stool samples referred for typing, 288 stool
samples submitted for gastroenteritis investiga-
tions, and 1,500 CSF samples were included in
the study. EV-specific RT-PCR detected RNA
transcripts of HRV-A1b, HRV-B14, and HRV-
Crpat18 but with 10–1,000 reduced sensitivity
compared to EV transcripts. Screening fecal
samples by EV RT-PCR identified 13 positive
samples identified subsequently as rhinovi-
ruses; a further 26 HRV-positive samples were
identified by nested HRV RT-PCR. All individua-
ls were hospitalized and presented mostly
with diarrhea. A total of 26 HRV types were
identified (HRV-A: 46%; HRV-B: 13%; HRV-C:
41%). Results confirm that EV-specific RT-PCR
can detect HRVs, and at a practical level, identi-
fy potential problems of interpretation if fecal
samples are used for surrogate screening in
cases of suspected viral meningitis. High detec-
tion frequencies (10%) and viral loads in
stool samples provide evidence for enteric
replication of HRV, and its association with
enteric disease requires further etiological
studies. J. Med. Virol. 84:536–542, 2012.
 2012 Wiley Periodicals, Inc.




Human rhinoviruses (HRVs) together with entero-
viruses (EVs) belong to the genus Enterovirus within
the family Picornaviridae. HRVs can be divided into
three species; HRV species A (HRV-A) comprises of
74 different serotypes, HRV-B of 25 serotypes and
more recently characterized HRV-C of at least 49 types
[Stanway et al., 2005; McIntyre et al., 2010]. In most
cases, HRV causes mild and self-limiting upper respi-
ratory tract infections or common colds, but HRVs
have also been associated with bronchiolitis, lower
respiratory infection as well as with exacerbation of
asthma and chronic obstructive airway diseases
[reviewed by Mackay, 2008].
HRV infections are most often diagnosed from
respiratory tract sample by reverse transcription
polymerase chain reaction (RT-PCR) targeting the
50-non-coding region (50-NCR) of the viral genome
[Scheltinga et al., 2005; Mackay, 2008]. Although
relatively highly conserved compared to HRV coding
regions, sequence variation in the 50-NCR between
different HRV (sero)types creates difficulties in
designing primer pairs that can satisfactorily detect
all HRV types and species [Faux et al., 2011].
Additionally, sequence similarity in this region
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between HRVs and enteroviruses (EVs) complicates
the development of EV-specific RT-PCR screening
methods that would not also detect some HRVs.
The current study has two aims. Firstly, the
frequency of cross-reactivity and relative sensitivity of
EV RT-PCR for HRV, both as pre-quantified RNA
transcripts and HRV-positive clinical specimens were
investigated. The second aim was to investigate
the frequency of enteric excretion of rhinoviruses
by HRV-specific PCR and virological and clinical char-
acterization of positive subjects.
MATERIALS AND METHODS
In Vitro Transcribed RNA for Species A–C
Rhinoviruses
Genomic cDNA clones of two different HRVs, HRV-
A1b (species A) and HRV-B14 (species B) were kindly
provided by Professor G. Stanway [HRV-A1b; Hughes
et al., 1988 and HRV-B14; Alsaadi et al., 1989]. Full-
length transcripts were generated from these using
the Ambion T7 Transcription Kit (Promega (UK),
Southampton, UK). In vitro transcribed RNA for spe-
cies C rhinoviruses were made from cDNA clones of
the combined 50-NCR/VP4 region of two HRV-C
variants directly amplified from clinical specimens
(types HRV-CrPat19 and HRV-C40). Transcripts were
purified with the RNeasy Kit (Qiagen (UK), Crawley,
West Sussex, UK) and concentrations were deter-
mined by NanoDrop2000 (Thermo Scientific/Fisher,
Horsham, West Sussex, UK). Integrity of RNA tran-
scripts was demonstrated by denaturing agarose gel
electrophoresis (data not shown). Ten-fold dilution
serious of each RNA transcript were made and
stabilized using citrate buffer (pH 6.0, Ambion,
Life Technologies, Glasgow, UK) supplemented with
0.05 mg/ml carrier tRNA and 0.1 U/ml RNAsin
inhibitor.
RT-PCR Assays and Sequencing
HRV and EV detection in a diagnostic laboratory
used one-step RT-PCR assays as modified from pub-
lished protocols [Scheltinga et al., 2005; Dierssen
et al., 2008; Bennett et al., 2011], whereas the
additional retrospective screening was done using the
nested RT-PCR targeting the 50-UTR as prescribed
previously [Wisdom et al., 2009]. EV-positive samples
were primarily typed by VP1 sequencing [Leitch
et al., 2009]; those refractory to EV typing were
amplified and sequenced in the VP4 region for type
identification [Wisdom et al., 2009]. Similarly,
HRV-positives sample were further identified by VP4
sequencing [Wisdom et al., 2009].
Clinical Samples
A total of 621 diagnostic stool samples predominantly
referred from young children (age under 2 years; 63%
of samples) with suspected viral meningitis or pyrexia
of unknown origin during a 14-month period
(March 2010 to April 2011) were investigated in this
study. This study additionally included 17 EV-positive
stool samples referred from Aberdeen for enterovirus
typing and a subset of stool samples (n ¼ 288) submit-
ted mostly for gastroenteritis investigations (mostly
suspected norovirus infection) in May (n ¼ 90),
September (n ¼ 108), and December (n ¼ 90). Finally,
1,500 CSF samples from the Specialist Virology
Center were also included.
All samples tested retrospectively were anonymized
before testing, but epidemiologic and demographic
information was retained while patient confidentiality
was protected (in accordance with a protocol approved
by the Lothian Regional Ethics Committee [Protocol
2002/4/36]).
RESULTS
Detection of HRV Sequences by 50-UTR PCR
The number of mismatches between EV RT-PCR
primers and probes used for diagnostic screening with
representative sequences of all assigned HRV and EV
(sero)types was determined (Table I). This revealed a
substantially greater number of mismatches between
primers and probes with all three HRV species
than with EV. Mismatches were similarly identified
between the probe and primers sequences with the
HRV RNA transcript sequences used in the current
study as assay controls.
The actual degree of assay cross-reactivity was
determined experimentally for HRV sequences by
comparing Ct-values of HRV RNA transcripts derived
from the cDNA clones of HRV-A1b, HRV-B14, HRV-
CrPat19, and HRV-C40 amplified by both methods
(Fig. 1). RNA transcripts were quantified biophysi-
cally before dilution for assay calibration into RNA
copies. The four HRV transcripts showed different
amplification kinetics in the HRV RT-PCR; the end-
point titers for HRV-B14, HRV-C40, and HRV-
CrPat19 transcripts were one, two, and three logs
lower than for HRV-A1b. However, the EV-specific
RT-PCR was also able to detect RNA transcripts of
HRV-A1b, HRV-B14, and HRV-C19 but with substan-
tially less sensitivity; 9,000 copies of HRV-A1b and
HRV-B14, and 90,000 copies of HRV-C19 could be
detected. Interestingly, the detection efficiency of
HRV-A1b and HRV-B14 by EV-specific RT-PCR assay
was comparable to that of HRV-C19 by HRV-specific
RT-PCR.
EV RT-PCR Cross-Reactivity in Clinical Samples
A total of 67 EV RT-PCR reactive samples
identified on diagnostic screening of 621 stool samples
(frequency of 11%) were further characterized in
this study. From those, seven samples untypeable by
the EV-specific VP1 typing assays were subsequently
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identified as HRV-positives by VP4 amplification and
sequencing (10.4%; Table II). VP4 typing similarly
identified 6 HRV-positive samples in a second
group of 17 EV-positive stool samples referred from
Aberdeen (35%; Table II).
To investigate the frequency of HRV excretion in
feces, 288 stool samples were retrospectively screened
for HRV by nested RT-PCR. A total of 26 further
HRV-positive samples were further identified and
typed by VP4 amplification and sequencing (frequency
10%, including three identified by EV RT-PCR,
Table III). Detection frequencies varied from 7.4% in
May and 7.7% in December to 12.2% in September.
One-step real-time RT-PCR would have detected only
11 of these 26 samples (42%; data not shown).
Viral loads of HRV and EV in fecal samples were
comparable (Fig. 2). Mean Ct-values of the HRV-
positive samples in the HRV RT-PCR and of EV-
positive samples in the EV RT-PCR were 28.5
(standard deviation 3.5) and 28.9 (1.9), respectively
(P ¼ 0.77).
No specific type of HRV was associated with detec-
tion in fecal samples. A total of 26 different HRV
types accounted for the 39 identified HRV-positive
samples; 16 samples (41%) were identified as species
A (HRV-A1, A7, A19, A34, A40, A46, A71, A78, A89,
and A103), 5 (13%) as species B (HRV-B6, B52, and
B97), and 18 (46%) as species C (HRV-C5, C6, C12,
C14, C24, C25, C36, C37, C39, C42, C43, and C45).
Positive samples were mostly obtained from young
children under the age of 2 years (26/39) or from the
patients over the age of 65 years (7/39). All of these
individuals were hospitalized, and seven of them
required intensive therapy unit (ITU) admission.
Patients presented with variety of clinical symptoms,
most often with fever, diarrhea, and/or vomiting; 72%
of patients did not have any respiratory symptoms at
admission (28/39). Nine patients were investigated as
part of unconfirmed norovirus outbreak in hospital.
A total of 11 patients (28%) presented with acute
respiratory symptoms, accompanied with loose stool
or diarrhea. Enteric co-pathogens were identified in
TABLE I. Number of Mismatches Between Primer and Probe Sequences of the HRV and EV RT-PCRs With Prototype HRV
and EV 50-UTR Sequences
Mean number of mismatches (range)
Forward1 Forward2 Reverse Probe
(A) Rhinovirus PCR
Rhinovirus species
HRV-A (75 types) 1.3 (0–2) 4.2 (3–5) 1.2 (1–3) 1 (1–2)
HRV-B (28 types) 1.8 (1–4) 2.2 (2–3) 1.6 (1–2) 1 (1–2)
HRV-C (10 types) 1.4 (1–3) 4 (4) 2 (1–3) 1 (1)




HRV-A (75 types) 5.9 (3–7) 3.5 (1–4) 1.7 (0–3)
HRV-B (28 types) 5.5 (3–7) 2.4 (2–3) 1 (1–2)
HRV-C (10 types) 4.4 (3–7) 2.7 (1–4) 0.9 (0–2)
Enterovirus species
EV-A (17 types) 1 (0–2) 0 0 (0–1)
EV-B (58 types) 1 (0–3) 0 (0–1) 0 (0–1)
EV-C (24 types) 2.3 (2–4) 0 (0–1) 0 (0–2)






























Fig. 1. Amplification of RNA transcripts of defined concentrations
by EV RT-PCR and HRV RT-PCR. Ct-values (y-axis) were plotted for
serial 10-fold dilutions of each transcript (x-axis). The PCR assay
used for amplification (EV, HRV) is indicated as a suffix to each
label (e.g., HRV-1B–EV: amplification of the HRV-1B transcript in
the EV RT PCR).
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five patients (adenovirus n ¼ 3, rotavirus n ¼ 1, and
Salmonella gastroenteritidis n ¼ 1).
To investigate whether non-specificity of EV RT-
PCR extended to diagnostic testing of CSF samples,
and indeed whether HRV can cause CNS-associated
infection, 1,500 CSF samples were screened by nested
HRV RT-PCR. From these, HRV RNA was detected
in a total of one individual sample; this sample was
negative by routine EV RT-PCR assay most likely
due to a low viral load. A finding was confirmed after
re-extraction of RNA from original CSF sample.
The sample was obtained from a young girl under the
age of 3 months who presented with suspected sepsis-
like illness, and has also HRV detected in her throat
swab. The virus was identified as HRV-B6 in both CSF
sample and throat swab (stool sample not obtained).
DISCUSSION
This study documents substantial cross-reactivity
between EV and HRV real-time PCR methods for
HRV RNA sequences and identifies a relatively high
TABLE III. Characteristics of Patients Identified as HRV-Positive by Screening Stool Samples by HRV-Specific
RT-PCR Assay
Sample Date Age Location Clinical details Type
10_91 Sep_10 >65 years RIE Diarrheaa HRV-A1
10_92 Sep_10 37–65 years ITU Diarrhea and fevera HRV-A1
10_93 Sep_10 >65 years ITU Diarrhea and fevera HRV-A1
10_94 Sep_10 1–2 years RHSC Diarrhea and fever HRV-A1
10_95 Sep_10 <3 months RHSC Diarrhea and vomiting HRV-A1
10_100 Sep_10 7–12 months RHSC Loose stool and irritable HRV-C24
10_128 Sep_10 <3 months RHSC Bronchiolitis, loose stool HRV-C43
10_129 Sep_10 1–2 years RHSC Fever (post-transplant) HRV-C43b
10_141 Sep_10 3–6 months RHSC Diarrhea HRV-C39c
10_149 Sep_10 2 years RHSC URTI and loose stool HRV-A19b
10_153 Sep_10 >65 years ITU Diarrhea and fevera HRV-C39
10_511 May_10 6–10 years RHSC Diarrhea HRV-C45
10_512 May_10 7–12 months RHSC URTI, diarrhea and vomiting HRV-C12
10_518 May_10 3–5 years RHSC Diarrhea and fever HRV-A34
10_520 May_10 7–12 months ESCITU Diarrhea and seizure HRV-A89
10_521 May_10 <3 months ESCITU Diarrhea, vomiting and fever HRV-C37
10_522 May_10 <3 months RHSC Bronchiolitis and vomiting HRV-C36
10_547 May_10 7–12 months RHSC Diarrhea and vomitinga HRV-C36
10_568 May_10 3–5 years RHSC Diarrhea and vomitinga HRV-A103
10_121 Dec_10 3–6 months ESCITU Bronchiolitis and vomiting HRV-A34
10_123 Dec_10 7–12 months ESCITU Bronchiolitis and vomiting HRV-A89
10_124 Dec_10 7–12 months RHSC Gastroenteritis HRV-C37
10_125 Dec_10 7–12 months RHSC Diarrhea and seizure HRV-C36
10_128 Dec_10 >65 years RIE Diarrhea and vomitinga HRV-B97
10_1213 Dec_10 >65 years RIE Diarrhea and vomitinga HRV-C14
10_1218 Dec_10 >65 years RIE Diarrhea and vomitinga HRV-B52
RIE, Royal Infirmary Edinburgh; RHSC, Royal Hospital for Sick Children; ITU, Intensive Therapy Unit; ESCITU, Edinburgh Sick Children
ITU.
aInvestigated as part of norovirus outbreak.
bTwo co-infections with adenovirus identified.
cOne co-infection with Salmonella enteritidis identified.
TABLE II. HRV-Positive Patients Identified by Real-Time EV RT-PCR
Date Age Clinical details EV PCR HRV PCR Type
Nov_10 7–12 months Bronchiolitis, apnoeic episodes 38.09 32.89 HRV-B52
Nov_10 7–12 months Fever, diarrhea and vomiting 33.89 30.78 HRV-C25
Feb_11 3–5 years LRTI and fever 41.1 ND HRV-C6
May_10 1–2 years URTI, fever and diarrhea 38.48 ND HRV-A40a
July_10 3–6 months Seizure and loose stool 36.31 ND HRV-A46
Sep_10 7–12 months Bronchiolitis and diarrhea 36.46 ND HRV-C12
Sep_10 <3 months Loose stool and poor weight gain 42.55 29.01 HRV-C42
Aug_10 3–6 months Loose stool and fever NA 28.55 HRV-B52
Aug_10 6–12 months Diarrhea NA 26.39 HRV-A78
Aug_10 <3 months Fever and poor feeding NA 29.62 HRV-B6b
Aug_10 >65 years Seizure and loose stool NA 30.39 HRV-A7
Sep_10 10–15 years Fever, diarrhea and vomiting 28.02 23.43 HRV-A71
Nov_10 1–2 years LRTI and fever 33.01 28.75 HRV-C5
NA, data not available; ND, not done, sample finished.
aOne co-infection with adenovirus identified.
bOne co-infection with rotavirus identified.
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frequency of HRV excretion in feces (comparable to
EV detection rates). The similarity in viral loads
between HRV and EV in feces provides evidence for a
much greater propensity of HRV to establish enteric
infections than previously described.
Detection of HRV by EV RT-PCR
Although infrequently described and not formally
quantified [Faux et al., 2011], cross-reactivity of HRV
in EV detection assays may be reasonably anticipated
given the sequence similarity of the region of the 50-
UTR typically targeted by EV screening assays. Both
HRVs and EVs have a type I internal ribosomal entry
site and there are substantial similarities in key func-
tional areas including RNA secondary structures
between all members of the Enterovirus genus that
extend to the targeted region (nucleotides from 412
to 553). Indeed, the greater number of mismatches
between the EV RT-PCR primers and probes with the
HRV-A1b and HRV-B14 than with EV sequences
(max 6, 3, and 1 for sense primer, antisense primer,
and probe) did not preclude their amplification by
HRV RT-PCR, although with a sensitivity approxi-
mately 100-fold lower that for EV sequences.
The detection frequency and potential mis-identifi-
cation of HRV-positive samples as EV positive using
standard EV RT-PCR creates a number of interpreta-
tion difficulties for diagnostic screening of fecal sam-
ples and to a much more limited extent in the current
study of CSF samples. The relatively high viral loads
of HRV in fecal samples potentially creates problems
for laboratories that use this sample type as an addi-
tional or alternative surrogate sample to CSF samples
to guide diagnosis of EV meningitis and encephalitis
as frequently directed by local or national guidelines.
As shown here, approximately 10% of stool samples
referred for virology diagnostic testing are genuine
HRV-positive generally with high viral loads. If even
a small proportion of these cross-reacted in the EV
RT-PCR, as can be predicted from the study findings
where approximately 15% (13/84) of EVs identified by
EV RT-PCR in stool samples were indeed HRVs, then
this could create a number of falsely reported EV
detections in meningitis cases caused by other organ-
isms. In this situation, virus typing as an adjunct to
screening that included methods to detect HRV
variants would identify instances of false-detection of
EVs; our analysis of CSF samples does not suggest
HRV being a frequent cause of central nervous system
associated infections.
Tissue Tropism of HRV
An unanticipated finding from the current study
was the high rate of HRV detection in fecal samples
and the comparability of their viral loads to entero-
viruses that are long known to replicate primarily in
the lower gastrointestinal tract [Sabin and Ward,
1941; Iwasaki et al., 2002]. HRV are labile to the
acidic environment of the stomach that leads to irre-
versible conformational changes in capsid. Experi-
mentally, HRVs differ from enteroviruses in being
inactivated at pH of <5 as well as pH values above 9–
10. For this reason, HRV detection in fecal samples or
sewage has generally been attributed in the past to
swallowed respiratory secretions [Blomqvist et al.,
2009]. In our opinion, this is unlikely for two reasons;
firstly, the acid lability of HRVs that destroys their
infectivity when passing through the stomach would
lead to HRV RNA degradation if the virion capsid was
breached. Secondly, the dilution of HRV secretions
with the much larger volumes of gut contents could
not conceivably create the high viral loads detected in
the current study by HRV PCR. Indeed, the simplest
explanation for the near identity of viral loads of HRV
and EV in fecal samples is that viruses replicate com-
parably in the gastrointestinal tract. However, studies
are required to demonstrate this further. The restric-
tion of HRV-positive samples to children of <2 years
of age and to the elderly may have arisen from
survival of infectious HRV through the less acidic
stomach environment in these groups [Lopez-Alonso
and Ribas, 1991]. Survival of HRV may additionally













Fig. 2. Ct-values of EV-positive samples in the EV RT-PCR (left
graph) and HRV-positive samples by the HRV RT-PCR (right
graph). Mean values and 67 percentile distributions shown as
bars. Ct-values were compared by the non-parametric Kruskall–Wal-
lace test, P-value shown above graph.
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such as MgCl2 that are favorable for the replication of
HRV by stabilizing virions [Blough et al., 1969]. As an
additional possibility, in vitro culture of HRV-B14 in
acidic medium has been shown to select rapidly for a
point mutation in the capsid (VP1) gene that confers
resistance to low pH [Skern et al., 1991]. This may
represent a more general and necessary adaptive
change for successful replication in the GI tract.
Whether each of the wide range of HRV (sero)types
and species detected in fecal samples in the current
study are capable of an equivalent phenotypic change
and identification of the associated genetic changes
are intriguing areas of further research. The other po-
tential requirement for successful gut replication by
rhinoviruses is adaptation to replication at 378C
instead of the 33–348C in the respiratory tract,
traditionally assumed to be the optimum temperature
of HRVs. However, when actually experimentally
investigated [Papadopoulos et al., 1999], a wide range
of reference species A and B serotypes and primary
clinical isolates showed minimal differences in
replication ability at 33 and 378C, and indeed some
isolates actually grew better at the higher incubation
temperature.
The frequent detection and high viral loads of HRV
in fecal samples in the current study is consistent
with the frequent detection of HRV by virus isolation
during environmental screening of human sewage
[Blomqvist et al., 2009]. It was speculated that the
HRV variants derived from respiratory secretions
carried into sewage by discarded used tissues or in
wastewater. Our findings of potential gut replication
of HRV implied by the high viral loads in fecal sam-
ples (Fig. 2) provide a more direct explanation for the
presence of infectious HRV in sewage. The plethora of
different HRV types (n ¼ 26) detected in fecal samples
argues against the existence of specifically entero-
pathic strains of HRV. Furthermore, using PCR-based
screening methods equally sensitive for all three
species, the relative proportions of HRV-A (46%),
HRV-B (13%), and HRV-C (41%) were broadly compa-
rable to previously reported detection frequencies in
respiratory samples [63%, 7%, and 30%, respectively;
Wisdom et al., 2009].
HRV have traditionally been associated with respi-
ratory tract infections. Although HRV are mostly
regarded as harmless cause of common colds, they
have been linked more recently with severe neonatal
infections [van Piggelen et al., 2010; Broberg et al.,
2011] and pericarditis [Tapparel et al., 2009]. In these
case reports HRV was also detected in stool samples,
consistent with the more severe systemic nature of
HRV infections in young children. Although not
formally tested by prospective study and without
control groups, our data support the idea that HRV
may on some occasions be responsible cause of gastro-
enteritis, given the high frequency of diarrhea,
absence of any respiratory symptoms in 70% of
the positive subjects as well as absence of detected
co-pathogens. Indeed, eight of our patients were
investigated as a part of suspected gastroenteritis out-
break in hospital, and HRV (in fecal samples) has
been the only etiological agent identified so far. More
focused screening of fecal samples for HRV in patients
presenting with gastroenteritis, sepsis, and other
systemic diseases, along with parallel estimation of
HRV detection frequency in control groups will be
required to demonstrate these additional potential
disease association of HRV infections. Furthermore,
the possible presence of infectious HRV in fecal
samples potentially creates infection control problems.
Whereas HRV are usually regarded to spread via
direct contact with respiratory droplets, findings
in the current study point towards the very real possi-
bility of fecal–oral transmission of HRV. This would
have a number of implications for the management of
HRV-infected patients in a hospital or institutional
setting.
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